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Australia's Health 1994 is the fourth 
biennial health report of the Australian 
Institute of Health and Welfare. 
It provides current information on almost 
all aspects of health and health services 
in Australia, as well as detailing key 
sources of health information and 
statistics in this country, and directions 
for the future. 
Australia's Health 1994 is an 
important reference text and information 
source for all Australians with an interest 
in health, in addition to medical and 
paramedical personnel and students, 
health workers and those working in or 
studying health administration, policy, 
planning and management. 
Australian Institute of Health and Welfare 
The Institute is an independent statistics and research agency within the Common­
wealth Human Services and Health portfolio. Established as the Australian Institute of 
Health in 1987, its Act was amended in 1992 to expand its role to study welfare-related 
information and statistics. . *! v ^ 
The mission of the Australian Institute of Health and Welfare is to inform community 
discussion and to support public policy-making on health and welfare issues by coordi­
nating, developing, analysing and disseminating national statistics on the health of 
Australians and their health and welfare services, and by undertaking and supporting 
related research and analysis. 
The Institute addresses this mission by pursuing the requirements of its Act to: 
• collect and assist in the production of health- and welfare-related information and 
statistics; • : r " 
• conduct and promote research"into the health of Australians and their health 
services; 
• develop statistical standards relevant to health and to health and welfare services; 
• publish reports on work carried out by or in association with the Institute; 
• undertake studies_intor_the. provision and„effentivpness_of_health services and 
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Dear Minister 
The Institute is pleased to present to you Australia's health 1994, a report covering 
those aspects of Australia's health and health services for which data are 
currently being collected either nationally or in some States and Territories. The 
report is required under the Australian Institute of Health and Welfare Act 1987. 
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Fiona Stanley 
Chair 
16 June 1994 
Australia's health 1994 
Editorial team 
John Donovan (Editor) 
Michael de Looper 
Stephanie Thompson 
Karin Cerasani 
Lena Searle 
Contributors 
Anne Bartlett (Worksafe Australia) 
John Bass 
Stan Bennett 
Kuldeep Bhatia 
David Brennan 
Rob Carter 
Ching Choi 
Joe Christensen (DHSH) 
Lynne Conway 
Michael Cook 
Mark Cooper-Stanbury 
Delma Cowley 
Bernie Crowe 
Wolodja Dankiw 
Michael Davies 
John Donovan 
Edouard d'Espaignet 
Steve Gillett 
John Goss 
Tony Greville 
David Hailey 
John Harding 
James Harrison 
Roy Harvey 
Naarilla Hirsch 
Paul Jelfs 
Paul Lancaster 
Tony Lea 
Ian Lester 
Colin Mathers 
Peter O'Connor 
Mary Patton (ABS) 
Bill Sardana 
Mike Smith (DVA) 
John Spencer 
Chris Stevenson 
Anne-Marie Waters 
Referees 
Bruce Armstrong 
Peter Barnard 
Ching Choi 
Annette Dobson 
Ken Donald 
John Donovan 
Stephen Duckett 
John Elias 
David Filby 
James Harrison 
Greg Herring 
D'Arcy Holman 
John Kaldor 
Gary Kennedy 
Erich Kliewer 
Ian McDonald 
Jack McLean 
Craig Martin 
Heather Mitchell 
John Moss 
Terry Nolan 
Sid Sax 
Chris Selby Smith 
Dick Scotton 
Fiona Stanley 
Peter Vulcan 
Tony Wood 
Production team 
Nigel Harding 
Alannah Smith 
Jan Whelan 
The Institute wishes particularly to thank those people from other bodies who 
have contributed to the production of Australia's health 1994. 
vi 
Objectives of the Australian Institute of Health and Welfare 
Seven specific objectives have been identified as essential elements of the 
Institute's endeavour from 1993-94 to 1995-96. They require the Institute: 
A: To lead the development of national systems of health statistics and welfare 
services statistics, to improve the availability and quality of national data and 
to avoid duplication of effort. 
B: To develop, maintain and promote the use of statistical standards for health 
and welfare services to ensure the comparability of national and State/ 
Territory data (in collaboration with the Australian Bureau of Statistics). 
C: To develop national data collections and national databases to support its 
own reporting, analysis and research, and that of others 
D: To conduct and promote research into the health of Australians, and their 
health and welfare services, and to assess the provision, use, cost and 
effectiveness of health services and technologies. 
E: To make its data and the findings of its analysis and research widely 
available. 
F: To seek to raise the level of understanding of its contribution to health and 
welfare statistics and research, by health and welfare leaders in government 
and the community. 
G: To ensure that its resources are used efficiently and effectively. 
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Preface 
The mission of the Australian Institute of Health and Welfare is to inform 
community discussion and to support public policy-making on health and 
welfare issues by coordinating, developing, analysing and disseminating 
national statistics on the health of Australians and their health and welfare 
services, and by undertaking and supporting related research and analysis. 
The Institute's national statistical collections include the annual Hospital 
Utilisation and Cost Studies combining information about expenditure and use 
of all public hospitals, national data on the incidence of cancer assembled 
collaboratively with the State and Territory Cancer Registries, a not-yet-complete 
National Death Index developed with the support of Registrars of Births, Deaths 
and Marriages in all States and Territories, and national collections on health 
labourforce based on annual surveys carried out in association with professional 
registration boards. Four key factors have made these collections possible: first, 
negotiation with the States and Territories so that National Minimum Data Sets 
are used in data supplied to the Institute; second, the establishment of common 
definitions and standards for the collection of each item of data—in the health 
area this work appears as an increasingly substantial National Health Data 
Dictionary; third, the signing with the relevant Commonwealth and State and 
Territory authorities and the Australian Bureau of Statistics of National Health 
and Welfare Information Agreements which commit the parties to cooperation in 
the collection of national data; and, finally, very strict safeguards on use and 
confidentiality mandated by the Institute's Act, which commit it to rigorous 
protection of the interests of both the providers of data and the data subjects. 
The Institute is now working on a plan for health information in Australia that 
examines existing provisions and future needs, identifies what is most 
important, and thereby sets priorities for the continuation and further 
development of existing collections or the development of new ones. This the 
Institute proposes to do in association with the 1994 National Health 
Information Forum which is introduced in Section 5.8 of this report. 
Through Australia's health 1994, the Institute fulfils again its statutory obligation 
to report biennially on health. As a compendium of current information on 
health and health services in Australia and the key resources and directions in 
health information and statistics, this volume will be important to all those 
involved in health policy, planning and evaluation in this country. In addition, it 
will be an important reference and useful text for courses in public health, health 
management and related fields. 
Bruce Armstrong 
Director 
Australian Institute of Health and Welfare 
1 The health of Australians 
Australia is one of the healthiest countries in the world and the health of Australians 
generally continues to improve. There are, however, some aspects of health and some 
population subgroups in which substantial improvements are necessary. 
Australia's health 1994 describes improvements in health but concentrates on what 
remains to be done. The first two chapters review data on the health of Australians. This 
first chapter examines information on mortality, sickness and disease, disabiUty, 
handicap and risk factors for disease as measures of the health (or lack of it) of the 
nation. It shows substantial differences among subgroups of the Australian population 
characterised by age, sex, socioeconomic status, country of origin and place of 
residence. The analysis also shows that the health of the nation is related to its levels of 
nutrition, education, employment, income and housing, safety in the environment, and 
social and cultural factors. 
1.1 Health and its determinants 
What is health? 
In 1946 the World Health Organization (WHO) defined health as 'a state of complete 
physical, mental and social well-being and not merely the absence of disease or 
infirmity' (WHO 1946). 
This definition has stood the test of time. It has the virtue of placing a strong emphasis 
on health as a positive experience, rather than as the absence of negatives. Another 
strength, to which this discussion will return, is that the inclusion of social well-being 
places health in a broad social context. However, the broad context makes development 
of measures of health difficult. 
In daily use, 'health' can mean the absence of disease, impairment, disability, or 
handicap. These problems can be physical or mental. 'Health' can also refer to vitality. 
These are all essential elements of health but do not capture the breadth of the WHO 
definition. Health can be seen as a major contributor to total well-being (AIHW 1993) 
which itself includes: 
• health; 
• social well-being; 
• economic well-being; 
• environmental well-being; 
• life satisfaction; 
• spiritual or existential well-being; and 
• other characteristics valued by humans. 
To complicate the problems of definition, almost all 'health statistics' (and, indeed, 
statistics in this volume) are of ill-health, not of the lack of it. 
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What determines health? 
The evolution of thinking about what determines health is instructive. Twenty years 
ago, disease was seen as an outcome of the interaction of human biology, lifestyle 
factors and environmental factors, as well as being modified by health care (Lalonde 
1974). An analysis of the factors related to the ten leading causes of death in the United 
States attributed 50% of premature mortality to unhealthy behaviour and lifestyles, 20% 
to human biology, 20% to the physical environment and 10% to inadequate health care 
(Centers for Disease Control 1977). 
Later, despite persisting uncertainties about the actual causative mechanisms (Last 
1987; Marmot & Morris 1984; Syme 1986), the importance of social factors was 
recognised. The elements of the social environment seen as important in health and 
disease include psychological, cultural, educational, and economic factors. They also 
include occupation, marital status, major life events, social networks and social 
support. 
The Ottawa Charter (WHO 1986) reflected these developing views by placing great 
emphasis on the need to develop very broad health promotion strategies to bring about 
changes in the physical, social and economic environment in which people live. It 
recognised that the capacity of individuals to alter their behaviour is greatly influenced 
by social and cultural factors. ~ 
The Ottawa Charter's health promotion strategies included the advocacy of a clear 
political commitment to health (sometimes referred to as healthy public policy); 
creating supportive environments; strengthening community action; developing 
personal skills; re-orienting health services towards the promotion of health; and 
changes in professional education and training. The strategy was reviewed in detail in 
Australia's health 1992. 
The Ottawa Charter provided a broader framework for public policy to influence 
health. It provided for intersectoral and health promotion approaches to improving 
health. An example of their successful application is a study which reduced the 
proportion of low-birthweight babies by providing an -income supplement to single 
social security beneficiaries during pregnancy (Kehrer & Wohn 1979). 
Some insight into the mechanisms by which social factors influence health came from 
the United Kingdom, where the Working Group on Inequalities in Health considered 
explanations for differences in health according to social class as indicated by 
occupation (Townsend & Davidson 1982). It recognised 'the multi-causal" nature of 
health inequalities' and that there was not 'any single and simple explanation of the 
complex data' it had assembled. It added-material and structural factors to the list of 
factors influencing health. These factors 'locate the responsibility for inequalities in 
health in the social structure governing the distribution of resources towards different 
groups of people' (Power, Manor & Fox 1991). 
The UK Group stressed 'the importance of material conditions in life' in its policy 
recommendations, thus recognising the inequity of factors affecting health over which 
individuals and sectors of society have limited, if any, control (Townsend & Davidson 
1982). 
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Recent work in Europe has directed attention to the combined effects of individual and 
social factors in determining patterns of health in populations. For example, Whitehead 
(1990) identified seven main determinants of health differences: 
• natural, biological variation; 
• health-damaging behaviour if freely chosen (such as through participation in 
hazardous sports and pastimes); 
• the transient health advantage of one group over another, when that group is the 
first to adopt a health-promoting behaviour (as long as other groups have the means 
to catch up fairly soon); 
• health-damaging behaviour, where the degree of choice of lifestyles is severely 
limited; 
• exposure to unhealthy, stressful living and working conditions; 
• inadequate access to essential health and other public services; and 
• health-related social mobility. 
A recent model defining the determinants of health is shown in Figure 1.1. 
Social 
environment 
Physical 
environment 
Genetic 
endowment 
Individual response: 
Behaviour 
Biology 
Health 
and 
function 
Disease Health 
care 
V 
Well-being 
V 
Prosperity 
Source: Evans & Stoddart 1990 
Figure 1.1: Health, zuell-being and prosperity 
This model acknowledges that health and economic well-being are related and that 
health care services compete with social goods and private disposable income for a 
share of national wealth. It also recognises that health care both contributes to the 
productivity of the population and reduces productive capacity by drawing capital and 
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highly skilled people into the sector. Economic prosperity generally contributes to the 
well-being of the population, and this, of itself, reduces illness. 
Money spent on health reduces the amount available to be spent on other activities 
which increase total well-being; where resources are limited, improvements to health 
may have a cost in other aspects of total well-being. Many of the factors that contribute 
to other aspects of well-being are also important determinants of health. 
Implications 
A consequence of health being influenced by factors beyond the control of the health 
sector is that many other areas of government can influence health. A UK review 
(Jacobson, Smith & Whitehead 1991) stated, 'The actions that will have an impact are (as 
the World Health Organization never ceases to remind us) multi-sectoral. The NHS on 
its own can do relatively little to improve the health of the nation above the current high 
levels. Housing, employment, education, transport, tax policy, all have their parts to 
play in improving the "bottom line" for the people of this country—which is not simply 
a matter of more wealth, but also involves raising the quality of life in Britain, 
particularly for our poorest citizens.' 
Australian health authorities are now pointing to the effects on health of social, 
economic and physical factors in the environment, with the aim of creating a supportive 
and nurturing environment capable of sustaining healthy living. In recognition of the 
fact that people are not entirely free to choose particular lifestyles but must adapt their 
behaviour to their life situations, attention is also being directed to changing the 
adverse influences on health that are beyond the control of the individual. 
It would be premature to claim that other areas of government in Australia have 
accepted this view wholeheartedly. They do accept that health should be a 
consideration in all areas of public policy, but that is all. 
1.2 Measures of ill-health 
1.2.1 Mortality 
There are many ways of measuring health or ill-health. Mortality is one of the best 
known measures, and certainly the most widely available. The availability is important, 
because in studies of health statistics the question is almost always one of comparison— 
is the mortality in one place better or worse than in another?, is the mortality in one 
population subgroup better or worse than in another?—and rarely of the absolute 
value. Records of deaths have been kept for centuries in some places; national statistics 
of cause of death have been available for Australia since soon after federation. 
Mortality in migrants is discussed in Section 1.3.2, page 25, and mortality in Aboriginal 
and Torres Strait Islander peoples in Section 1.3.3, page 26. 
Death rates 
When national statistics first became available in 1907, there were 12 deaths per 1,000 
population per year. By the middle of the century, the crude death rate had fallen to 10 
per 1,000, and in 1992 it was 7.1 per 1,000 population per year. The lowest crude death 
rate recorded was 6.9 deaths per 1,000 population in 1991. 
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Box 1.1: Comparing death rates 
Statistics relating to deaths are sometimes presented as crude death rates, that is, the 
number of deaths in a year divided by the number in the corresponding population. For 
example, the crude death rate in Australia in 1992 was 7.1 per 1,000 population. 
Since the risk of dying varies greatly with age and sex, even small differences in the age and 
sex structure of populations, especially at older ages, may affect comparison of crude death 
rates. One way around this difficulty is to compare age-specific death rates, mortality at 
particular ages for each sex, but this may mean that a separate comparison has to be made 
for each of many age and sex groups. 
Age-standardised death rates are summary measures which allow comparison of 
populations with different age distributions; either different populations at the same time or 
the same population at different times. They are usually presented separately for males and 
females. 
For comparisons of Australian death rates over time, rates have been standardised to the 
Australian population at 30 June 1988 (ABS 1989). The WHO European standard 
population (WHO 1992) has been used for computing age-standardised rates for 
international comparisons. These standard popidations were also used in Australia's health 
1992, so that most rates in this publication may be directly compared with those in its 
predecessor. 
In 1921, the male and female age-standardised death rates were, respectively, 16.9 and 
13.6 deaths per 1,000 population. By 1992, they had declined to 8.6 and 5.2 per 1,000 
population respectively. 
Major causes of death 
Trends in major causes of death since 1921 are shown in Figure 1.2. In 1921, infectious 
and parasitic diseases were the second major cause of death and, with an 
age-standardised death rate of 1.8 deaths per 1,000 population, accounted for about 
12% of all deaths. By the 1950s, the death rate from these causes had declined to less 
than 0.4 per 1,000 population, accounting for about 3% of all deaths. In the last 40 years 
there has been a further decline in the death rate to 0.05 deaths per 1,000 population. 
The shift away from infectious diseases was accompanied by an increase in both the 
age-standardised death rates and the proportion of deaths attributed to diseases of the 
circulatory system and to cancers. In 1921, most deaths in Australia were caused by 
diseases of the circulatory system. With an age-standardised death rate of 3.5 per 1,000 
population, these diseases then accounted for about 22% of all deaths in Australia. At 
the same time, cancers accounted for 10% of deaths. By 1965, these causes together 
accounted for nearly 75% of deaths. 
Around 1965, the general consensus was that prospects for lower mortality as a result of 
advances in prevention or treatment were limited, so that further declines in mortality 
would be minimal. This expectation, which persisted into the 1970s, arose mainly from 
the constancy of mortality rates, especially among males, from the 1940s through to the 
1960s. 
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D e a t h s p e r 100,000 p o p u l a t i o n 
1920 
2,000, 
M a l e s 
1930 1940 1950 1960 1970 1980 1990 
1920 
Females 
1930 1940 1950 1960 
Y e a r 
1970 1980 1990 
| Neoplasms Circulatory Infectious and parasitic 
] Injury and poisoning Respiratory | All other causes 
Source: d'Espaignet et al. 1991, AIHW unpublished data 
Figure 1.2: Major causes of death, age-standardised rates by sex, 1921 to 1992 
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2,000. 
To a large extent this has held true for deaths from cancers, with small increases in the 
age-standardised death rates for males and females from 2.0 and 1.3 per 1,000 males 
and females in 1965, to 2.3 and 1.4 respectively in 1992. Despite this relatively small 
absolute increase in cancer death rates, because of the decrease in total mortality, the 
proportion of total standardised mortality attributed to cancers increased from 15% in 
1965 to 27% in 1992. 
For diseases of the circulatory system, the expectation was not borne out. Following a 
steady increase in mortality from cardiovascular diseases from the early 1900s, a phase 
of decline started in the late 1960s and has continued to the present. In 1968, the 
age-standardised cardiovascular disease death rates per 1,000 population were at their 
highest, at 8.1 deaths per 1,000 for males and 5.3 deaths for females. In 1992, the 
age-standardised death rates, at 3.6 per 1,000 for males and 2.4 for females, were less 
than half of those of 1968. 
There have been considerable year-to-year variations in deaths from respiratory 
disease. The general trend was for rapid decreases in both sexes until the early 1950s. 
Male mortality then increased until about 1970, since when it has fallen back to below 
the level of the early 1950s. Female mortality from respiratory disease has decreased 
slowly over the entire period since the early 1950s. 
The fall in rates of death from cardiovascular and respiratory diseases since the late 
1960s has had a major impact on Australia's total mortality profile. Although most of 
the reduction in mortality in the early part of the century was among younger people, 
the reduction in the last 25 years has been mostly among the elderly. 
That is not to say that there have not been any recent reductions in death rates at 
younger ages. Mortality from injury and poisoning has decreased substantially in 
recent years, lower mortality from road traffic injury (Section 2.6, page 100) having 
more than offset some increases in suicide rates in younger men (Section 2.7, page 107). 
Mortality by State 
In recent years, there have been substantial differences in death rates between the 
Australian States and Territories. Table S16, page 246, shows that the Australian Capital 
Territory has the lowest age-standardised mortality for both males and females and the 
Northern Territory the highest. 
The much higher death rates for the Northern Territory than for the States and the 
Australian Capital Territory mainly reflect the much higher mortality of Aboriginal 
people, who make up 31% of the population in the Northern Territory. Reasons for 
death rates for Tasmania, which has the next highest rates, exceeding those in the 
Australian Capital Territory by 25% (males) and 26% (females), and other variations in 
death rates among States and Territories, have not been studied in detail. 
Life expectancy 
Life expectancy is the average number of years of life remaining to a person. It is 
usually calculated using age-specific death rates for a particular period. 
An Australian boy born in 1992 can expect to live 74.5 years and a girl can expect to live 
80.4 years. In 1920-22, life expectancy at birth was 59.2 years for boys and 63.3 years for 
girls. 
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The reductions in the death rates at the older ages, especially from diseases of the 
circulatory system, have led to significant improvements in life expectancy of adults. 
Between 1920-22 and 1960-62, the life expectancy of men aged 65 years increased from 
12.0 to 12.5 years. This gain of 0.5 years over a 40 year period may be compared with a 
gain of 2.9 years over the 31-year period from 1960-62 to 1992 when life expectancy for 
men at age 65 reached 15.4 years. 
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F i g u r e 1.3: Life expectancy at birth by sex, selected countries, 1990 
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For women, life expectancy at age 65 improved by 2.1 years between 1920-22 (when it 
was 13.6 years) and 1960-62 (15.7 years). This compares with an increase in life 
expectancy of 3.5 years in the period from 1960-62 to 1992, when life expectancy for 
women at age 65 reached 19.2 years (Table Sll , page 242). 
Figure 1.3 compares expectation of life in Australia in 1990 with that in a number of 
other countries. Japan has the highest life expectancy at birth for both sexes. Australia 
occupies an intermediate position among OECD countries. The lower expectation of life 
in Eastern European countries has attracted much attention in recent years. 
Box 1.2: More detailed analyses of mortality in Australia 
More detailed analyses of mortality in Australia are presented in specialised series produced 
by the Institute. These include: 
Mortality Series: 
• Trends in Australian mortality, 1921-1988 
• Trends in Australian mortality—diseases ofthe circulatory system, 1950-1992 
Mortality Surveillance Series: 
• Mortality surveillance, Australia, 1979-1990 
Cancer Series: 
• Cancer in Australia, 1983-1985 
• Cancer in Australia, 1986-1988 
1.2.2 Admission to hospital 
In descending order of seriousness for the individual, the next indicator of health is 
admission to hospital. 
Statistics relating to admission to hospital are discussed in Section 4.3, page 160. In this 
chapter, which describes the generally improving health of Australians, it is relevant to 
note that from 1982-83 until 1988-89 hospital admission rates fluctuated around 215 per 
1,000 population per year; since then they have increased substantially, to 240 per 1,000 
population in 1991-92 (Table 4.11). 
The health of Australians has been improving throughout this period. The relation 
between health and use of hospitals has not been studied in detail, but the increasing 
rate of admissions has certainly been influenced by the increasing rate of same-day 
admissions. This in turn has reflected technological developments (see Section 4.7, 
page 180), the introduction of which has made some admissions worthwhile when 
formerly that would not have been the case. The extent to which same-day admission 
rates for minor surgery and admission rates for longer stays reflect increasing 
community expectations also has not been studied. 
1.2.3 Seeing a doctor 
The use of medical services is discussed in detail in Section 4.5, page 172. 
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Medicare statistics show that in 1992-93 Australians on average consulted a general 
practitioner 5.3 times and a specialist 0.9 times. The frequency of visiting doctors has 
risen slowly since 1984-85, when there were, on average, 4.1 general practitioner and 
0.7 specialist consultations. Again it is not known how these increases relate to 
improvements in health and to increasing community expectations. 
Use of medical services varies with sex and age (Figure 4.4, page 175). It is high in 
infancy and early childhood, decreasing to a minimum at 10 to 14 years. From then the 
number of services for men increases slowly with age. Women have much greater use of 
medical services during the childbearing years, but even after age 45 they continue to 
use more services than men do. 
1.2.4 Disability and handicap 
Impairment, disability, and handicap are consequences of disease. There were ABS 
surveys of disability in Australia in 1981,1988 and 1993, using definitions related to the 
conceptual framework embodied in the World Health Organization's International 
Classification of Impairments, Disabilities, and Handicaps (ICIDH) (WHO 1980). 
The conceptual framework used in the surveys was that disease or disorder or loss may 
lead to impairment, which in turn may lead to disability, and this in turn may lead to 
handicap. 
An example of disease, disorder or loss is loss of a leg, whether congenital, accidental or 
as a result of disease. This can lead to impairment, defined as loss or abnormality of 
psychological, physiological or anatomical structure or function. In turn, this can cause 
disability, defined as disturbance to customarily expected activity, behaviour or 
performance, either directly or as a response by the individual to the impairment. 
Handicap is social disadvantage resulting from disability or impairment. The presence 
or absence of handicap and its severity are consequences of the interaction between the 
underlying impairment (i.e. medical condition), individual behaviour and attitudes, 
and the resources and social opportunities and restrictions affecting the individual. 
Disability and handicap in migrants are discussed in Section 1.3.2 and disability and 
handicap in Aboriginal and Torres Strait Islander peoples in Section 1.3.3 (page 26). 
Disability 
The 1993 ABS Survey of Disability, Ageing and Carers estimated that 18% of Australians 
(3.2 million people) were disabled in some way (see Box 1.3 for ABS definition of 
disability). The proportions of people reporting one or more disabilities rose with age 
(Figure 1.4, page 12). One or more disabilities were reported by 67% of people aged 75 
years or more, compared with 7.0% at 0 to 14 years and 8.7% at 15 to 34 years. 
The proportions reporting one or more disabilities were higher for males than for 
females except at ages 15 to 34 years (Figure 1.4). A higher proportion of males than 
females reported physical disabilities as the primary disabling condition at all ages 
(Table 1.1, page 14). On the other hand, a higher proportion of women than men 
reported primary disabling mental disorders at all ages from 15 onwards. 
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Box 1.3: ABS surveys of d i sab i l i ty 
The 1981 and 1988 ABS surveys on disability defined a person with a disability as Imving 
one or more ofthe following conditions which liad lasted or were likely to last for six months 
or more: 
• loss of sight (even when wearing glasses or contact lenses) 
• loss of hearing 
• speech difficulties in native language 
• blackouts, fits or loss of consciousness 
• slowness at learning or understanding 
• incomplete use of arms or fingers 
• incomplete use of feet or legs 
• long-term treatment for nerves or an emotional condition 
• restriction in physical activities or in doing physical work 
• disfigurement or deformity 
• need for help or supervision because of a mental disability 
• long-term treatment or medication (although still restricted in some way by the 
condition being treated (ABS 1990)). 
These conditions include impairments, disabilities, and a handicap, as defined in the WHO 
International Classification of Impairments, Disabilities, and Handicaps framework, and 
even some health conditions, and should perhaps be viewed as defining a wider population 
likely to contain people with a disability. 
In the 1993 ABS Survey of Disability, Ageing and Carers, the list of screening questions for 
disability zvas expanded to include: 
• difficulty gripping and holding small objects 
• long-term effects of head injury, stroke, or any other brain damage 
• any other long-term condition resulting in a restriction. 
The ABS surveys defined a handicapped person as 'a disabled person aged 5 years or over 
who was further identified as being limited to some degree in his/her ability to perform task* 
in relation to one or more of the following five areas: self-care, mobility, verbal 
communication, schooling, and/or employment'. Seivrity of handicap for people aged 5 
years or over zvas assessed, for self-care, mobility, and verbal communication, as follows: 
severe handicap: personal help or supervision are required or the person is unable to 
perform one or more of the tasks; in the 1993 survey this category was further divided into 
severe and profound handicap. In this section, the term 'severe handicap' refers to severe 
and profound handicap combined. 
moderate handicap: no personal help or supervision are required; but the person has 
difficulty in performing one or more of the tasks. 
mild handicap: no personal help or supervision are required and no difficulty is 
experienced in performing the tasks, but the person uses an aid, or has difficulty walking 
200 metres or up and down stairs. 
All disabled children under the age of 5 years were regarded as being handicapped; the 
severity of their handicap was not assessed. 
Note that these definitions of disability and handicap do not necessarily match those used in 
various government assistance programs. Australia's welfare 1993 discusses criteria used 
in various welfare programs in more detail. 
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Figure 1.4: Prevalence of disability by age and sex, 1993 
The most frequently reported primary disabling conditions (see Figure 1.5) were those 
of the musculoskeletal system and connective tissue, with 4.9% of Australians (863,300 
people) being disabled by these conditions. The next most frequently reported primary 
disabling conditions were hearing loss (2.6% or 450,000 people) and mental disorders 
(2.0% or 353,500 people). Higher proportions of females than males reported 
musculoskeletal conditions, largely reflecting the preponderance of females among 
older people, whereas higher proportions of males than females reported hearing loss 
and circulatory-related disability (Table 1.1). In young adults, the leading causes of 
disabilities were mental disorders, then respiratory diseases, whereas in children, 
respiratory diseases were the leading cause (ABS 1993). The breakdown of primary 
disabling conditions by age and sex is shown in Table 1.1. 
The 18% of Australians who were disabled in some way in the 1993 ABS survey 
included 14.2% of Australians (2.5 million people) classified as handicapped, of whom 
721,000 (4.1% of the population) were classified as severely handicapped. Of people 
aged 75 years or more, 61% (496,600 people) reported that they were handicapped, 
compared with 5.8% of those aged 15 to 34 years. 
The age-specific pattern and sex differentials for handicap are similar to those for 
disability, with more males than females reporting handicap at most ages below 75. 
However, when severity of handicap is taken into account, a different pattern emerges 
(Figure 1.6, page 15). For all age groups from 15 onwards, more females than males 
were classified as severely handicapped. This is the level at which assistance is needed 
for activities of daily living such as self-care, mobility and communication. 
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Figure 1.5: Primary disabling conditions, 1993 
The most frequent handicap was in mobility, reported by 10.4% of Australians (1.8 
million people) and by 68% of those with a handicap (ABS 1993). The next most 
frequently reported handicaps were in employment (reported by 8.5% of Australians 
and by 60% of those with a handicap), self-care (5.7% and 37%) and communication 
(2.9% and 19%). Note that people may be handicapped in more than one way, and are 
thus counted in several of these categories. 
Of those who were severely handicapped, 78% were handicapped in self-care, 93% in 
mobility and 31% in communication. The prevalence of severe handicap rises steeply 
with age, from 2.5% in children aged 5 to 14 years to 22% and 33% in males and females 
aged 75 years or more respectively. 
Changes in prevalence of disability and handicap from 1981 to 1993 
Prevalences of disability and handicap reported in ABS publications from the 1993 
survey are not directly comparable with those from the earlier surveys because of 
changes to definitions (see Box 1.3). For the analysis that follows, estimates have been 
derived from the 1993 survey data, using definitions common to the 1981 and 1988 
surveys. 
The age-standardised prevalence of disability increased substantially between 1981 and 
1988, from 14.9% to 16.8% for males, and from 1,2.8 to 14.4% for females (Figure 1.7, 
page 15). The increase in the reported prevalence of handicap was much greater, from 
9.4% to 13.7% for males and from 8.7% to 12.2% for females. In contrast, the prevalence 
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of severe handicap did not increase for men between 1981 and 1988, and increased by 
only a small amount for women. 
Table 1.1: Primary disabling conditions, age-specific proportions (%) by sex, 1993 
Age group (years) 
75 and All 
Primary disabling condition 0-14 15-29 30-44 45-59 60-74 over ages ( a ) 
Males 
Mental disorders 
Mental psychoses 
-
0.3 0.4 0.4 0.5 2.8 0.4 
Other mental disorders 2.2 1.4 1.1 1.6 1.2 1.1 1.5 
All mental disorders 2.2 1.6 1.4 2.0 1.7 4.0 1.8 
Physical conditions 
Disorders of eye and adnexa 0.2 0.5 0.6 0.8 1.5 3.2 0.7 
Disorders of ear and mastoid 
process 0.8 1.5 3.4 5.9 10.3 13.9 3.2 
Nervous system diseases 0.5 0.7 1.2 1.4 1.8 3.3 1.0 
Circulatory diseases 0.1 0.1 1.0 5.6 8.3 10.7 1.7 
Respiratory diseases 2.0 0.9 1.0 2.5 4.9 4.5 1.7 
Arthritis 
-
0.4 2.0 5.9 8.3 13.7 2.2 
Other musculoskeletal disorders 0.2 1.1 3.4 5.3 4.7 2.7 2.2 
Head injury / stroke / other brain 
damage 0.1 0.3 0.2 1.1 0.9 1.0 0.4 
All other conditions 2.2 1.7 3.4 7.3 10.0 12.0 3.6 
All physical conditions 6.1 7.1 16.2 35.7 50.7 65.0 16.6 
All conditions 8.3 8.7 17.7 37.7 52.4 68.9 18.4 
Females 
Mental disorders 
Mental psychoses 
-
0.2 0.4 0.4 0.6 3.9 0.5 
Other mental disorders 1.0 1.5 2.2 2.4 2.1 2.0 1.7 
All mental disorders 1.0 1.7 2.6 2.7 2.6 6.0 2.2 
Physical conditions 
Disorders of eye and adnexa 0.2 0.1 0.4 0.8 2.3 5.6 0.7 
Disorders of ear and mastoid 
process 0.8 1.1 1.9 2.3 5.2 5.9 1.9 
Nervous system diseases 0.5 0.7 1.0 1.4 1.6 3.5 1.0 
Circulatory diseases 
-
0.4 0.5 2.9 4.9 10.2 1.4 
Respiratory diseases 1.7 1.3 1.2 2.2 2.8 2.4 1.6 
Arthritis 
-
0.6 2.4 7.4 15.5 16.7 3.5 
Other musculoskeletal disorders 0.3 0.9 3.0 4.0 3.5 3.8 1.9 
Head injury / stroke / other brain 
damage 0.1 0.2 0.2 0.3 1.0 1.0 0.3 
All other conditions 1.1 1.7 2.7 5.4 6.4 10.3 3.0 
All physical conditions 4.6 7.0 13.2 26.6 43.1 59.4 15.4 
All conditions 5.6 8.7 15.8 29.3 45.7 65.3 17.6 
(a) Crude rate. 
Source: ABS 1993 
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Figure 1.6: Prevalence of handicap by age, sex and severity, 1993 
1981 1988 
Year 
1993 
Note: Age standardised to total Australian population, 1988. Note that 1993 prevalence rates are 
derived on the basis of the 1988 form of the disability screening question. 
Source: AIHW, from unpublished data supplied by ABS 
Figure 1.7: Trends in age-standardised prevalence of disability, handicap and severe 
handicap, by sex, 1981 to 1993 
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For both sexes, the age-standardised prevalence of disability increased slightly between 
1988 and 1993 (Figure 1.7). In contrast, the age-standardised prevalence of handicap 
declined slightly, from 13.7% to 13.3% for males and from 12.2% to 11.7% for females. 
The prevalence of severe handicap also declined slightly, to become very close to its 
levels in 1981 (Figure 1.7). For both sexes, the prevalence of severe handicap increased 
between 1988 and 1993 for people aged less than 40 years, but decreased slightly for 
people of 40 years and over. 
Although the prevalence of disability has increased slightly and that of handicap 
decreased slightly between 1988 and 1993, prevalences for 1993 remain close to those 
for 1988, and are substantially higher than those found in 1981. 
Possible factors involved in the substantial increase in reported disability and handicap 
prevalence levels during the 1980s have been discussed in detail by Mathers (1991). 
Self-assessment of limitations or need for assistance in relation to specified activities 
may have changed in line with changing community perceptions of disability and 
handicap during the 1980s. Changing attitudes may have resulted in people being more 
aware of disabling conditions, or more willing to report such conditions, and may also 
have affected how people interpreted 'need' and 'difficulty', concepts used to 
determine presence and severity of handicap. Another factor may have been changes in 
the availability of aids for disabled people, as use of an aid is a determinant of mild 
handicap. Government programs for provision of aids expanded during the 1980s 
(AIHW 1992) and may have contributed to the increase in self-reported prevalence of 
handicap. 
Severity of handicap was assessed on the basis of limitations in self-care, mobility and 
communications. A handicapped person could report limitations in more than one of 
these areas. 
The prevalence of limitations in these three areas increased substantially between 1988 
and 1993 for severely handicapped people (Table 1.2). At the same time the prevalence 
of severe handicap decreased slightly (Figure 1.7). Severely handicapped people 
reported limitations in more areas in 1993 than in 1988; there was a particularly large 
increase (93%) in the proportion of people reporting limitations in communication. 
There was also a substantial increase in limitations of communication reported by 
moderately handicapped people. Mildly handicapped people reported fewer 
limitations in self-care and communication, but there was little change in their reported 
limitations in mobility. 
Are Australians becoming more disabled and handicapped? 
Olshansky et al. (1991) have argued that there is 'trade-off between lower mortality and 
morbidity from fatal diseases, for a small increase in life expectancy and an 
accompanying increase in the duration of time for the expression of non-fatal diseases 
of ageing'. Thus 'reductions in the risk of death from fatal diseases could shift the 
distribution of disability away from fatal diseases to non fatal diseases of ageing'. 
Gruenberg (1977) and Kramer (1980) expressed concern that improvements in medical 
care may have increased the survival of chronically ill and disabled people thus 
resulting in higher prevalence of disability; by staying alive longer, such people may 
have more years for their illness to advance in severity and more time to develop other 
chronic illness. 
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Table 1.2: Area of handicap by severity, handicapped persons aged five years or more, 1981,1988 
and 1993 
S e v e r i t y o f h a n d i c a p 
Y e a r / A r e a o f h a n d i c a p S e v e r e M o d e r a t e M i l d T o t a l 
P r e v a l e n c e ( p e r c e n t ) 
1981 
Self-care 1.91 1.51 0.18 3.60 
Mobility 2.98 1.33 1.79 6.10 
Communication 0.51 0.20 1.02 1.72 
1968 
Self-care 2.63 2.86 0.52 6.01 
Mobility 3.66 2.96 4.20 10.81 
Communication 0.72 0.27 1.78 2.77 
1 9 9 3 < a > 
Self-care 3.43 1.94 0.34 5.71 
Mobility 4.09 2.05 4.28 10.41 
Communication 1.39 0.39 1.12 2.89 
P e r c e n t i n c r e a s e 
1981-1988 
Sell-care 37.5 90.1 183.3 66.9 
Mobility 22.9 122.8 133.9 77.3 
Communication 42.5 40.3 74.0 60.9 
1988-1993 
Selt-care 30.4 -32.1 -34.6 -5.0 
Mobility 11.7 -30.7 1.8 -3.7 
Communication 92.6 43.1 -37.3 4.3 
(a) The 1993 handicap rates are derived on the basis of the 1988 form of the disability screening question. 
Source: ABS 1982,1988 and unpublished data 
International evidence suggests that increases in disability prevalence began in 
different countries at various times in the late 1960s and 1970s. This was also the time 
when mortality rates at older ages began to decline significantly, and when secondary 
prevention (that is, the early detection of disease and subsequent intervention to slow 
its progress) was emphasised for many major fatal and non-fatal diseases. In addition, 
greater awareness of chronic conditions due to improved diagnostic techniques, more 
frequent contacts with the health care system and, perhaps, better communication by 
doctors to patients have probably led to increased reporting of chronic disease 
conditions in surveys (Colvez & Blanche! 1981) and to behaviour modification. For 
example, over the last two decades there has been substantially increased screening for 
and treatment of-high blood pressure which may have led to more people knowing of 
their disease and restricting their activity, without any change in the underlying 
incidence or prevalence of high blood pressure. 
Data from the Australian disability surveys suggest there has been little change in 
age-specific prevalences of disability and handicap x>ver the last five years, although the 
numbers of disabled and handicapped people are increasing as the population ages. 
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Many researchers, have noted that there are major differences between the causes of 
disability and of mortality' (Crirnmins 1990). The control of risk factors associated with 
the major chronic diseases which are today mostly fatal diseases may have a larger 
effect on mortality rather than on disability (Manton 1987). A further question is 
whether lifestyle improvements would also reduce incidence of ageing-related 
debilitating diseases (osteoporosis, osteoarthritis, sensory impairments, etc.). If these 
reductions were not to happen, the prevalence of disabilities is likely to increase even 
further. It is striking that there is no strategy aimed at avoiding debilitating diseases 
such as arthritis. This is in stark contrast with the strategy for cardiovascular diseases 
(Adams 1987). These are emerging challenges for Australian and other societies in 
which life expectancies are now very high and in which the population is ageing. 
1.2.5 Cost of illness 
Disease costing, or cost of illness (COI) analysis, is used to estimate the cost impact of 
disease on the community. By measuring the impact of disease in economic terms, it 
presents yet another picture of the way in which diseases affect the community. The 
main uses of cost of illness data are in providing an economic justification for disease 
control action and an input into evaluating the cost-effectiveness of interventions for 
the purpose of priority setting. 
The Australian Institute of Health and Welfare started its COI analysis in 1992, as part 
of a broader approach to evaluation, the Disease Costs and Impact Study (DCIS) (Carter 
1992). 
As the basis for determining priorities for health interventions, particularly preventive 
interventions, the approach used in DCIS requires information on the public health 
significance of health problems, or burden of suffering. It also requires information on 
the theoretical benefit (efficacy) and the practical benefit (effectiveness) of programs 
addressing these problems. Lastly, it requires information on the relative 
cost-effectiveness (efficiency) of individual measures aimed at achieving the benefit. 
Illness has both direct and indirect costs. Direct costs are the money spent on 
diagnosing, treating and caring for the sick and the money spent on prevention. They 
are the costs of forgone alternatives: if there were no illness, money could be put to 
other uses. Indirect costs are the value of the output lost because people become too ill 
to work or die prematurely. 
The DCIS aims to provide soundly based estimates for the direct costs of a range of 
diseases. It has developed formulae to apportion known aggregate expenditures in the 
various health sectors (hospitals, nursing homes, medical services, pharmaceuticals and 
allied .health professionals) among diseases. For hospitals and nursing homes, this is 
based on diagnoses given in the hospital morbidity data collections. For medical 
services, pharmaceuticals and allied professionals' services, it is based on the National 
Survey of Morbidity and Treatment in General Practice. 
Although it is possible to measure the economic burden caused by illness and 
premature death, disease costing is not yet able to provide a comprehensive assessment 
of the impact of disease on the total welfare of society. This would require a dollar 
measure for the impact of anxiety, pain and suffering, for which satisfactory measures 
have yet to be developed. 
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Box 1.4: Methods and limitations of cost of i l lness (COI) studies) 
The methods and applications of COI studies are the subject of spirited debate among health 
economists. There are dangers in using them to set priorities and choose courses of action. 
COI studies may be seen by policy makers as a pragmatic alternative to cost-effectiveness or 
cost-utility analysis. Such studies should not be used to justify further expenditure simply 
because money is currently devoted to treatment of a disease; decisions on the allocation of 
health resources should depend on the costs and benefits of management options 
(Drummond 1992). Allocation on the basis of cost alone is unlikely to lead to resources 
being used most efficiently. 
Estimating indirect cost of illness is particularly difficult and contentious (Collins & 
Lapsley 1991). There are two principal methods. The first, used in most studies, is called the 
human capital or output accounting approach. An employed person is seen as producing 
output over the years that is valued at that person's earnings. The main criticisms of this 
method are that it excludes intangibles, counts only earnings, and undervalues some 
groups relative toothers where earnings do not accurately reflect a person's value or ability 
to produce. Thus men are more highly valued than women, and middle-aged people more 
highly valued than the young or the old. 
The second approach, the willingness-to-pay method, values human life according to the 
amount people are willing to spend to obtain reductions in the probability of death. It could 
be helpful in indicating how individuals value health and life, in deriving social preferences 
regarding public policy, and in assessing the burden of pain and suffering. All these have an 
intangible quality that is less amenable to evaluation in terms of the monetary value of 
resources used or forgone (Rice et al. 1990). One objection to this method is that the values 
of individual lives depend on income, with the rich able to pay more titan the poor. Also, it is 
exceedingly difficult for people to place a value on small reductions in the probability of 
death; lifetime earnings as estimated by the human capital method may at least be a lower 
bound to a person's willingness to pay for a decreased risk of death. 
The strengths and weaknesses of these methods are discussed fully by Hodgson & Meiners 
(1982) and by Hodgson (1983). 
The human capital and willingness-to-pay methods are not simply alternatives. They 
measure different concepts and can each provide insights into particular circumstances. The 
human capital approach has conceptual limitations, but lias the advantage of being able to 
make use of reliable statistics. 
Cost-of-illness studies usually address a different research question from micro-economic 
evaluations, and the inclusion of indirect costs is more widely accepted in the disease 
costing context. Most micro-economic evaluations in the health area, for example, prefer not 
to cost the value of life, but rather to put direct costs over 'life years gained' or 'quality 
adjusted life years gained' as the decision index. 
Standards for cost-of-illness studies have been set by a USA Task Force on Disease Costing, 
to make studies in different centres more comparable and to permit evaluation of cost 
estimates presented in publications (Hodgson & Meiners 1982). 
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T a b l e 1.3: Cost of diseases ofthe circulatory system, by sector of expenditure, 1989-90 ($'000) 
Ischaemic Cerebro­ Other All 
Sector of Hypertensive heart vascular circulatory circulatory 
expenditure disease disease disease diseases diseases 
Public hospitals 15,824 298,553 131,229 331,744 777,350 
Private hospitals 4,620 35,092 23,620 84,667 147,999 
All hospitals 20,444 333,645 154,849 416,411 925,349 
Nursing homes 13,636 35,358 307,606 163,239 519,839 
Medical 152,786 43,137 11,816 107,178 314,917 
Pharmaceutical 247,162 62,760 8,305 94,288 412,515 
Allied professionals 31,569 7,084 4,485 27,411 70,549 
Total direct costs 465,598 481,985 487,060 808,526 2,243,169 
Sick leave ( a ) 74,727 67,432 27,475 108,093 277,727 
Foregone earnings^' 13,116 540,372 122,891 188,302 864,681 
Total indirect costs 87,843 607,804 150,366 296,395 1,142,408 
Total costs 553,441 1,089,788 637,426 1,104,922 3,385,577 
(a) Includes sick leave associated with a hospital and/or medical attendance. 
(b) Net present value using 5% discount rate for earnings foregone during working age 15 to 64, including 
age-specific workforce participation and sex-specific average weekly earnings. 
Source: AIHW unpublished data 
Table 1.3 gives cost of illness estimates from the DCIS for diseases of the circulatory 
system in Australia, 1989-90. The identified cost of these diseases exceeds $3,300 
million per year: $2,200 million is direct cost and $1,100 million is indirect cost. 
Ischaemic heart disease is the major contributor to both, especially to indirect cost. 
Uses of cost of illness studies 
Godfrey, Hardman & Maynard (1989) have noted: 'Ideally, as part of the exercise of 
ranking health priorities, it would also be useful to compile information on morbidity, 
costs and other indicators of the burden of illness. As well as providing information that 
would be needed to build improved indicators, the robustness of ranking priorities by 
life years lost could be tested.' 
COI studies can be useful for identifying and analysing how resources are currently 
allocated among different types of costs, among different types of services and among 
different diseases. On their own, however, they cannot show whether the resource 
allocation is efficient. This can be done only by using evaluation techniques that 
combine both costs and outcomes (such as the DCIS or micro-economic evaluations). 
Although estimating indirect cost is contentious (see Box 1.4), COI studies can be useful 
to researchers and health planners by providing data on the cost side of the 
cost-effectiveness equation for a later economic evaluation (Davey & Leeder 1993). This 
is why the DCIS undertakes COI studies. COI calculations can also provide the base 
against which new interventions can be assessed (Drummond 1992). Planners can 
compare the relative burden of different diseases in considering priorities for 
prevention. DCIS provides a method for ranking large numbers of projects. 
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COI estimates can be used to model the 'do nothing' or current case option, and to 
investigate the impact of different treatment practices. The latter follows naturally from 
separately identifying the components of costs (such as hospital, medical, 
pharmaceutical, nursing home and allied health costs). Comparisons of results of COI 
studies undertaken in different locations may also assist such analysis (Drummond 
1992). 
COI studies can also be useful to health planners who wish to know the relationship 
between the incidence or prevalence of disease and the consequent use of health 
services. Planners may wish to identify what potential changes in use might be 
achieved by prevention or to estimate possible cost savings. 
Such estimates need to be carefully interpreted. They are usually only indicative. They 
are not estimates of immediately realisable savings, but rather 'opportunity cost' 
estimates measuring resources devoted to the treatment of preventable disease that 
could be available for treatment of non-preventable diseases. Conversion of 
'opportunity cost savings' into financial savings involves a number of other practical 
and theoretical considerations. 
COI data can also be useful for researchers and planners who wish to know where in 
the health system expenditures are incurred, such as by type of illness, and by age and 
sex. Use of such information to help analyse equity and ethical issues would require a 
wide knowledge of the health care financing system so that any recommendations 
could be placed in context. 
1.3 Health and ill-health of special populations 
1.3.1 Mothers and infants 
Live births and birth rates 
There were 264,151 live births registered in Australia in 1992, 2.7% more than the 
257,247 live births in 1991, and 4.4% fewer than the peak annual registration of 276,362 
live births in Australia in 1971. After declining to 223,129 in 1979, annual numbers 
gradually increased to 1990, fell slightly in 1991, then rose again in 1992. 
The crude birth rate relates the number of live births in any one year to the total 
population size. This rate has declined from 21.7 per 1,000 people in 1971, to 14.9 per 
1,000 in 1991, and 15.1 per 1,000 in 1992. 
Age-specific birth rates express the number of women in selected five-year age groups 
giving birth in a year as a proportion of the number of women of the same age group in 
the population. Recent trends in these rates have differed with age. For teenagers of 15 
to 19 years, the birth rate has increased slightly from its historical low of 20.3 live births 
per 1,000 women in 1988, to 22.1 per 1,000 in 1991, and 21.9 per 1,000 in 1992. On the 
other hand, the birth rates for women in their twenties have continued to decline to 
reach their lowest levels ever in 1991 (75.0 per 1,000 for women aged 20 to 24 years, and 
132.0 per 1,000 for women aged 25 to 29 years), rising slightly in 1992 (74.9 per 1,000 for 
women aged 20 to 24 years, and 132.6 per 1,000 for women aged 25 to 29 years). 
Age-specific birth rates for older women have generally increased in recent years, 
reflecting the trend for some women to defer child-bearing until their thirties, or even 
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later. Women aged 30 to 34 years had their lowest rates in the mid-1970s, those aged 35 
to 39 in the late-1970s, and those aged 40 to 44 in the mid-1980s (Table S2). 
Multiple births 
Twin confinements have increased since the mid-1970s, and reached their highest rate 
ever in Australia in 1991 when there were 3,266 twin confinements among 253,861 total 
confinements, a rate of 12.9 per 1,000 confinements (Figure 1.8). In 1992 there were 3,323 
twin confinements among 260,669 confinements, a rate of 12.7 per 1,000 confinements. 
Because multiple births increase with advancing maternal age up to the late thirties, 
rates of multiple births will be influenced by changes in maternal age distribution. 
Another important factor contributing to the higher rates of multiple births in the last 
decade has been the increasing use of assisted conception (in-vitro fertilisation and 
related techniques) to treat infertile couples. 
In 1991, assisted conception accounted for 9% of twin confinements in Australia and 
about 40% of triplets. An unknown proportion of other multiple births occurs after 
fertility drugs are used independently of assisted conception. Among the 8,239 
pregnancies resulting in births since assisted conception began in Australia in 1979, 
twins occurred in 19.4%, triplets in 3.3%, and other multiple births in 0.3%. These 
multiple births usually follow transfer of more than one embryo into the uterus, or 
more than one egg into the fallopian tube, in the course of the various treatment 
procedures. In the past few years, the policy of reducing the number of embryos or eggs 
transferred during assisted conception has been partly effective in reducing the 
incidence of multiple births (Figures 1.9 and 1.10) (National Perinatal Statistics Unit and 
the Fertility Society of Australia 1993). 
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Figure 1.8: Twin confinements, Australia, 1971 to 1992 
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Figure 1.9: Twin pregnancies of at least tiventy zveeks gestation after assisted conception, 
Australia and N c i v Zealand, 1979-83 to 1991 
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Figure 1.10: Triplet pregnancies of at least twenty zveeks gestation after assisted 
conception, Australia and Nezv Zealand, 1979-83 to 1991 
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Termination of pregnancy 
National information on fertility patterns is lacking because only South Australia and 
the Northern Territory collect population-based data on induced abortions. In South 
Australia in 1989, there were 4,342 abortions and 19,610 live births; thus 18% of the 
pregnancies resulted in abortions (Chan & Taylor 1991). Almost 50% of teenage 
pregnancies were terminated. 
Perinatal mortality 
The perinatal mortality rate has declined markedly in the last two decades, to 9.4 
perinatal deaths per 1,000 total births in 1992, the lowest rate ever achieved (Figure 1.11, 
page 24). Foetal deaths (5.6 per 1,000 total births) accounted for 59.5%, and neonatal 
deaths (3.8 per 1,000 live births) accounted for 40.5% of perinatal deaths. The perinatal 
death rate for males (10.1 per 1,000 total births) is consistently higher than for females 
(8.8 per 1,000 total births). 
Maternal mortality 
For many years the National Health and Medical Research Council (NHMRC) has 
published triennial reports on maternal mortality. The latest report covering the 
triennium 1988-90 records, for the first time since the series started, an increase in 
maternal mortality, from 11.8 deaths per 100,000 live births and stillbirths in 1985-87 to 
12.7 in 1988-90. There was also an increase, from 4.4 to 4.9 deaths per 100,000, in the 
direct maternal mortality rate, that is, in deaths resulting from obstetric complications 
(NHMRC 1993). 
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Figure 1.11: Fetal, neonatal and perinatal death rates, 1973 to 1992 
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Maternal mortality in Aboriginals and Torres Strait Islanders is discussed in 
Section 1.3.3 (page 26). 
1.3.2 Migrants 
The 1986 Census showed that 21% of Australians were born outside Australia and that 
11% were born in countries where English was not the main language. 
Until recently, much of what has been known on the health of migrants in Australia has 
been based on mortality data or on small surveys conducted to elicit information on 
specific ethnic groups (Reid and Trompf 1990). Although these surveys have provided 
information on the health of these groups, there has been no global picture of migrant 
health. In 1991-92, in response to the need for fuller understanding of migrant health, 
the Institute undertook a review of the health of people born outside Australia relative 
to that of Australian-born people (Donovan et al. 1992). 
In conducting the review, the Institute attempted to provide as broad a picture of 
migrant health as possible. Where these existed, national mortality and morbidity data 
collections and surveys were used as sources of information on the health status of 
migrants. 
The review found that migrants generally enjoyed better health, in terms of mortality 
and morbidity, than people born in Australia. 
Mortality 
At 15 to 74 years, most migrant groups had lower, and in many groups significantly 
lower, total mortality than the Australian population as a whole. For both sexes, 
mortality of people born in Australia was 3% higher than the mortality in the Australian 
population as a whole. 
A trend analysis for three periods—1980-82, 1984-86 and 1987-89—confirmed the 
continuing relatively low mortality of several of the major migrant groups, particularly 
Greeks, Italians, Central and South Americans, Vietnamese and Yugoslavs. Age-specific 
death rates for each ethnic group generally decreased between 1980-82 and 1987-89. 
Hospitalisation 
Because of a lack of national data, 1986 New South Wales data on hospitalisation were 
used to provide a partial picture of morbidity patterns among the different ethnic 
groups. 
After adjusting for the effect of age, it was found that people born outside Australia 
were less likely to be hospitalised than those bom in Australia. This finding is in 
keeping with the finding of relatively low mortality in migrants. There is no evidence 
that it includes a component representing differential access to hospital care. 
The analysis in men produced some novel findings. Men born in Egypt, Asia (other 
than Kampuchea, Laos, and Vietnam), and the Middle East had the highest level of 
hospitalisation for ischaemic heart disease. Those bom in Canada and the United States 
experienced the highest levels for cerebrovascular disease, at the same time having 
among the lowest levels of hospitalisation for all other diseases of the circulatory 
system. 
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Women born in the Middle East experienced the highest level of hospitalisations for all 
causes, but this finding was heavily influenced by pregnancy and birth-related 
admissions, When these conditions were excluded, women from the Middle East 
ranked considerably lower, and women born in Australia had the highest admission 
rates. 
Again there were some new findings. For example, women born in the Middle East 
experienced the highest level of hospitalisation for ischaemic heart disease, and women 
born in Asia experienced the lowest rates of hospitalisation for almost all causes. As 
was found for men, women born in Canada and the United States had the highest level 
of hospitalisation for cerebrovascular disease, at the same time showing the lowest level 
for ischaemic heart disease. 
Disability and handicap 
In the 1988 ABS Survey of Disabled and Aged Persons, a person was classified as 
disabled if he or she suffered from one of a group of impairments lasting six months or 
more, and as handicapped if limited in ability to perform certain everyday tasks. 
Further detail is given in Box 1.3 on page 11. 
In this survey, Australian-born people had the highest prevalences of disability and 
handicap. Among migrants, those born in Europe had the highest prevalences and 
those born in Asia and the Middle East the lowest (d'Espaignet & van Ommeren 1992). 
Migrants from Italy and Greece had particularly high prevalences of self-reported 
severe handicap (see Table 1.4). 
Risk factors in migrants 
Bennett (1993) analysed data from the 1980, 1983 and 1989 Risk Factor Prevalence 
Surveys to compare the levels of biomedical and behavioural risk factors for 
cardiovascular disease of migrant and Australian-born participants. Differences were 
reported between migrant groups and Australian-born, particularly for systolic blood 
pressure, body mass index and behavioural risk factors. After adjusting for age and 
study design factors, migrants generally had lower mean systolic blood pressure and 
higher body mass index than their Australian-born counterparts. Male migrants were 
generally more likely to smoke than Australian-born males, and both men and women 
born overseas were more likely to be physically inactive. 
The risk factor profiles of migrants were an insufficient explanation of their lower 
cardiovascular mortality. Systolic blood pressure was found to be the best single 
explanatory factor for variation in cardiovascular mortality among men, and smoking 
prevalence was the best among women. There were no clear differentials in blood 
lipids, and the evidence suggests that blood lipids have made little contribution to the 
lower cardiovascular mortality among Australia's migrants. 
Nutritional risk factors in migrants are discussed in Section 1.4.1. 
1.3.3 Aboriginal and Torres Strait Islander people 
Over the past two decades, there has been a significant improvement in many aspects of 
the health of Aboriginal and Torres Strait Islander people, for brevity referred to as 
Aboriginals. Higher life expectancy, reduced infant mortality and a lower burden of 
infectious and parasitic diseases are all evidence of improvement. However, as reflected 
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in rates of hospitalisation, maternal mortality and disability, and in continuing high 
mortality in adults, the burden of disease in Aboriginals continues to be higher than in 
non-Aboriginal Australians. This burden is likely to continue until effects on Aboriginal 
health of socioeconomic factors such as unemployment and poor housing can be 
eliminated. 
Table 1.4: Age-adjusted disabled, handicapped and severely handicapped ratios, by country/ 
region of birth and sex, persons aged 15 to 74 
S e v e r e l y 
S e x / R e g i o n o f b i r t h D i s a b l e d H a n d i c a p p e d h a n d i c a p p e d 
Total Australian population 100 100 100 
M e n 
Australia 105 104 100 
Asia and Middle East 61 64 63 
Europe 
Greece 122 136 214 
UK and Ireland 94 92 79 
Italy 97 94 164 
Yugoslavia 95 113 131 
Other Europe 94 81 94 
Other countries 74 72 69 
W o m e n 
Australia 102 100 97 
Asia and Middle East 56 64 87 
Europe 
Greece 134 149 187 
UK and Ireland 105 104 87 
Italy 97 106 170 
Yugoslavia 91 96 112 
Other Europe 105 108 102 
Other countries 95 91 118 
Source: Modified from Donovan et al. (eds) 1992 
Some of the data in this section relate to parts only of the Aboriginal population, where 
data for the entire Aboriginal population are not available. In these instances it is not 
possible to calculate data for the non-Aboriginal population by subtraction from the 
corresponding data for the total Australian population. The comparisons presented are 
thus of the Aboriginal population and of the total Australian population. 
Mortality 
Age-specific death rates 
Death rates of Aboriginals greatly exceed the corresponding total Australian rates at all 
ages (Table 1.5). The ratio of age-standardised mortality rates is 2.8 for males and 3.3 for 
females (Figure 1.12, page 29). 
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Table 1.5: Age-specific death rates and rate ratio by sex, Aboriginal and total Australian 
populations, 1990-92 (per 1,000 population) 
M a l e s F e m a l e s 
A g e g r o u p 
( y e a r s ) A b o r i g i n a l s ^ 1 
T o t a l 
A u s t r a l i a 
R a t e 
r a t i o A b o r i g i n a l s ' 3 ' 
T o t a l 
A u s t r a l i a 
R a t e 
r a t i o 
0 26.B 8.5 3.2 24.9 6.6 3.8 
1-4 1.6 0.4 4.0 1.3 0.3 4.3 
5-14 0.5 0.2 2.5 0.5 0.1 5.0 
15-24 4.0 1.1 3,6 1.6 0.4 4.0 
25-34 6.7 1.3 5.2 3.7 0.5 7.4 
35-44 11.2 1.8 6.2 5.8 0.9 6.4 
45-54 22.3 4.0 5.6 14.8 2.4 6.2 
55-64 36.0 12.3 2.9 35.3 6.5 5.4 
65-74 61.9 31.5 2.0 64.0 17.1 3.7 
75 and over 138.4 95.3 1.5 103.6 71.9 1.4 
(a) Rates for the Aboriginal population are based on data from Western Australia, South Australia and 
Northern Territory. 
Sources: AIHW unpublished data; ABS 1992 
The pattern of age- and sex-specific mortality in Aboriginals differs from the pattern in 
the population as a whole. The ratio of Aboriginal to total population rates is highest for 
females aged 25 to 34 years. At 55 to 74 years, the mortality for Aboriginal females is 
close to that for Aboriginal males whereas in the total population at these ages, female 
mortality is close to half the male mortality. 
Significant regional variation in Aboriginal mortality also exists. Age-standardised 
mortality for female Aboriginals in the Northern Territory is higher than in Western 
Australia and South Australia. Aboriginal males from the Northern Territory also have 
the highest mortality. 
Expectation of life 
Improvements in Aboriginal life expectancy over the past two decades have been 
achieved mainly through reduction in infant mortality. However, the expectation of life 
at birth, a useful indicator of mortality, remains much lower for Aboriginals than for the 
total Australian population. In 1990-92, the average life expectancy of a newborn 
Aboriginal boy was, depending on where he lived, up to 18.2 years shorter than his 
non-Aboriginal counterpart; the gap was up to "19.8 years for ah Aboriginal girl 
(Figure 1.13, page 30). The proportion of newborn boys who could expect to live to age 
65 was 45% for Aboriginals but 81% for non-Aboriginals. A larger proportion (54%) of 
Aboriginal girls could expect to live to 65, compared with 89% of non-Aboriginal girls. 
Higher mortality at all ages implies lower life expectancy in adult life too. Expectation 
of life at adult ages is also much lower in Aboriginals than in non-Aboriginals. 
Perinatal mortality 
The other useful indicator of Aboriginal foetal and infant survival, the perinatal 
mortality, has also decreased over the last two decades, although it, too, varies greatly 
with location (Table 1.6, page 30). 
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estimated using age-specific death rates for the total Australian population during the corresponding 
period (1990 to 1992). 
Source: AIHW unpublished data 
Figure 1.12: Ratio of Aboriginal age-standardised mortality to total Australian 
population, selected States, 1990 to 1992 
Infant mortality 
Aboriginal infant mortality has declined greatly since 1973 (Table 1.7, page 31). 
Improvements in this indicator can be attributed partly to the provision of better health 
care. However, Aboriginal infant mortality rates remain unacceptably high and, 
depending on location, can be more than three times the rate for all Australians. 
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F i g u r e 1.13: Expectation of life at birth, Aboriginals in WA, SA and NT, and total 
Australian population, by sex, 1990 to 1992 
T a b l e 1.6: Perinatal mortality rates per 1,000 total births, Aboriginal and total Australian 
populations, 1973 to 1991 
Aboriginals 
Period Qld<a> WA SA NT Total Australia 
1973 to 1975 62.6 
- -
53.1 22.3 
1976 to 1978 50.8 
- -
60.7 18.2 
1979 to 1981 26.8 29.9 
-
49.0 14.5 
1982 to 1984 29.8 25.6 
-
39.3 12.8 
1985 to 1987 28.3 19.8 39.8 43.6 11.7 
1988 to 1990 26.9 17.6 38.8 44.4 10.8 
1991 na 15.6 34.3 32.1 9.6 
(a) The figures relate to Aboriginals living in the Queensland communities (Hogg & Thomson 1992). 
Sources: Northern Territory Department of Health and Community Services 1992; Gee 1992; 
South Australian Health Commission 1993 
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Table 1.7: Infant mortality rates per 1,000 live births, Aboriginal and total Australian 
populations, 1973 to 1991 
Aboriginals 
Period Qld<a> WA SA NT Total Australia 
1973 to 1975 78.8 
-
- 61.7 15.7 
1976 to 1978 56.1 
-
58.4 12.8 
1979 to 1981 27.4 24 7 - 36.8 10.7 
1982 to 1984 28.6 24.8 
-
32.9 9.7 
1985 to 1987 19.3 21.6 20.9 34.9 9.1 
1988 to 1990 15.6 22.3 23.2 31.2 8.3 
1991 na ( b )19.2 24.9 26.9 7.1 
(a) The figures relate to Aboriginals living in the Queensland communities (Hogg & Thomson 1992). 
(b) Estimate provided by the Department of Health, Western Australia. 
Sources: Northern Territory Department of Health and Community Services 1992; Gee 1992; 
South Australian Health Commission 1993 
Maternal deaths 
The number of maternal deaths in Australia has decreased by almost two thirds since 
1970-72 (Table 1.8). However, no concomitant reduction in the number of Aboriginal 
maternal deaths has been noted. Aboriginals are 1.6% of women aged 15 to 44 years, 
and the birth rate in Aboriginal women is 46% higher than in non-Aboriginal women. 
Nonetheless, 11 of the 37 direct maternal deaths (those resulting from obstetric 
complications) in 1988-90 and 5 of 12 maternal deaths where an avoidable factor was 
judged to have been present were of mothers known to be Aboriginal. 
Table 1.8: Maternal deaths by triennium, Aboriginals and non-Aboriginals, 1970 to 1990 
Aboriginals Non-Aboriginals 
Triennium Direct deaths Total deaths Direct deaths Total deaths 
1970 to 1972 13 18 137 226 
1973 to 1975 5 6 55 131 
1976 to 1978 5 9 47 97 
1979 to 1981 6 15 48 83 
1982 to 1984 5 8 37 86 
1985 to 1987 4 13 28 75 
1988 to 1990 11 14 26 82 
Source: NHMRC 1993 
Causes of death 
The causes of Aboriginal mortality have not changed greatly over the past five years. 
Diseases of the circulatory system, particularly ischaemic heart disease and 
cerebrovascular disease, and injury and poisoning continue to account for most deaths 
(Figure 1.14). 
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Australia and the Northern Territory. 
Source: AIHW unpublished data 
Figure 1.14: Aboriginal and total Australian death rates, by cause and sex, 1990 to 1992 
400 
In Aboriginal males, the death rate from diseases of the respiratory system was 7.3 
times that of all Australian males; among Aboriginal females it was 7.9 times that of all 
Australian females. Respiratory infections due to overcrowding, and high rates of 
smoking, have contributed to these deaths. 
The other major contributor to excess mortality among Aboriginals was diabetes, which 
accounts for almost all the differences between Aboriginal and total Australian 
mortality from endocrine and nutritional diseases, as shown in Figure 1.14. 
Infectious and parasitic diseases also cause disproportionate mortality among 
Aboriginals. Aboriginal mortality from these preventable causes was 12.2 times (males) 
and 13.4 times (females) that in Australia as a whole in 1990-92. Genitourinary 
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disorders constituted another group of diseases'causing relatively high mortality 
among the Aboriginals. 
Morbidity 
Although a number of States and Territories have the capacity to identify Aboriginals in 
their statistical collections, provision for identification does not necessarily guarantee 
its reliable use (see Section 5.4, page 216). Availability of morbidity data for Aboriginals 
is also limited. 
In this analysis, hospital separation data from New South Wales and South Australia 
have been pooled to yield a profile of Aboriginal morbidity (Table 1.9). There are 
substantial differences in the levels of morbidity between the two States, but in both 
States the standardised hospital admission rates for Aboriginals are much higher than 
those for the non-Aboriginal population. 
Table 1.9: Age-specific hospital admission rates by sex, Aboriginals and non-Aboriginals,* 
1991-92 (per 1,000 persons) 
M a l e s F e m a l e s 
A g e g r o u p 
( y e a r s ) A b o r i g i n a l s 
N o n -
A b o r i g i n a l s R a t e r a t i o A b o r i g i n a l s 
N o n -
A b o r i g i n a l s R a t e r a t i o 
0-4 514 353 1.5 413 245 
.1-7 
"5-14 99 102 1.0 93 78 1.2 
15-24 . 165 118 1.4 362 223 1.6 
25-34 290 133 2.2 388 346 1.1 
35-44 370 153 2.4 365 238 1.5 
45-54 470 223 2.1 408 259 1.6 
5 5 - 6 4 645 352 1.8 674 315 2.1 
65-74 714 532 1.3 895 423 - 2.1 
75 and over 1,139 741 1.5 861 600 1.4 
Al l a g e s 3 7 1 2 1 8 (°11.7 4 2 8 2 7 2 ,«*1.6 
(a) Rates tor both Aboriginal and non-Aboriginal populations represent combined data (or NSW and SA. 
(b) Age-standardised rate ratios. 
Source: AIHW unpublished data 
Hospital admission rates 
For Aboriginal males, the standardised hospital admission rate of 371 per 1,000 
population was 71% higher than for non-Aboriginal males. The admission rate for 
Aboriginal females, which includes admissions for childbirth, was 354 per 1,000, 57% 
higher than for non-Aboriginal females. 
The hospitalisation rates for Aboriginals were higher in all age groups than for 
non-Aboriginals. The relative rates were particularly high among males aged 25 to 54; 
Aboriginal women were relatively higher users of hospital services in later years.. 
Disability 
Disability leads to a significant loss of healthy life. In 1988, 16% of the Australian 
population, a large proportion of whom were also handicapped, were disabled 
(see Box 1.3, page 11, for definitions). Both sexes shared the burden of disability, 
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although the proportion of severely handicapped females significantly exceeded that of 
males (ABS 1990). 
The ABS sampling for the 1988 Survey of Disability and Handicap did not enable it to 
provide separate data on disability among Aboriginals. However, a survey in an 
Aboriginal community in the Taree area in New South Wales, conducted under the 
auspices of the Institute and using the survey methods and definitions recommended 
by the ABS, has quantified the extent of disability and handicap in one group of 
Aboriginals. One in four people reported a disabling condition (Table 1.10), the most 
common of which involved loss of sight or hearing. Other leading reported causes of 
disability included diseases of the musculoskeletal system and connective tissues. Most 
frequent specific disabilities were asthma (5.0%), slow learning and specific delays in 
development (4.1%), and heart disease (4.0%). Slow learning and specific delays in 
development often caused educational handicap (Thomson & Snow 1993). 
Although these results from a local survey may not be representative, in comparison to 
the total Australian population, the Aboriginals were 70% more likely, after adjusting 
for differences in the age distributions, to be handicapped (Table 1.10). The relative 
importance of the areas of handicap was also different, although a mobility handicap 
was the most frequently reported handicap in both populations. More Aboriginals 
reported handicap in the areas of employment and education than did people in the 
total AustraUan population. 
Chronic otitis media (middle ear infection) and the associated hearing loss affect a 
significant proportion of Aboriginal adults and children. Otitis media develops during 
infancy and contributes heavily to ear perforations and effusions (Boswell et al. 1993). 
As much as 41% of the children in one remote Aboriginal community have been shown 
to suffer from the disease (Menzies School of Health Research 1993). The hearing loss 
has a strong impact on Aboriginal schoolchildren's classroom attendance, behaviour 
and learning. These in turn contribute to a variety of social and health problems. 
T a b l e 3 . 1 0 : Disability and handicap, Aboriginals ofthe Taree area of New South Wales 
N u m b e r d i s a b l e d ( p e r 1 , 0 0 0 p e r s o n s ) A g e - a d j u s t e d r a t e r a t i o w i t h 
9 5 % c o n f i d e n c e i n t e r v a l A b o r i g i n a l s T o t a l A u s t r a l i a 
C o n d i t i o n M a l e s F e m a l e s M a l e s F e m a l e s M a l e s F e m a l e s 
D i s a b l e d 
H a n d i c a p p e d 
S e v e r e l y h a n d i c a p p e d 
249 251 
139 148 
49 53 
160 152 
130 130 
32 49 
2.5 (2.1-3.0) 2.9 (2.4-3.5) 
1.7 (1.4-2.1) 1.8 (1.5-2.3) 
2.4(1.5-3.6) 2.3(1.5-3.4) 
Sources: Thomson & Snow 1993; ABS 1990 
Risk factors in Aboriginals 
It is difficult to estimate accurately the prevalence of risk factors in Aboriginals, who are 
usually under-represented in large population studies such as the Risk Factor 
Prevalence Study (RFPS). However, several recent studies have examined risk factors in 
Aboriginals living in regions of Western Australia and New South Wales. 
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Smith et al. (1992a) studied the prevalence of hypertension and its relationship to 
coronary heart disease among Kimberley Aboriginals and found the prevalence of 
hypertension to be substantially higher than in non-Aboriginal Australians (Table 1.11). 
Table 1.11: Age-specific prevalence of hypertension in male and female Aboriginals 1988-89, and 
expected prevalence from 1983 RFPS (per 1,000 population) 
M a l e s F e m a l e s 
H y p e r t e n s i o n / A g e 
g r o u p ( y e a r s ) 
S a m p l e 
s i z e A b o r i g i n a l s 
1 9 8 3 
R F P S 
S a m p l e 
s i z e A b o r i g i n a l s 
1 9 B 3 
R F P S 
S y s t o l i c ( > 1 6 0 m m H g ) 
15-24 43 20 na 39 
-
na 
25-34 45 90 10 44 
-
* 
35-44 40 75 36 31 65 19 
45-54 30 130 109 36 250 80 
55-64 38 
, T 3 4 0 
239 42 525 
•
 1 8 2
_ 
65 arid over 40 "375 na 30 365 na, 
D i a s t o l i c ( £ 9 5 m m H g ) 
15-24 43 45 na 39 
-
na. 
25-34 45 200 43 44 
- J ° 
35-44 40 200 92 31 195 4 4 
45-54 30 235 158 36 220 93 
55-64 38 340 193 42 380 "* 117 
65 and over 40 275 na 30 200 na 
Source: Derived from Smith et al. 1992a 
Both alcohol consumption and overweight were associated with hypertension among 
Kimberley Aboriginals, and there was a relationship between high blood pressure and 
high plasma cholesterol level (Smith et al. 1992b). 
Another survey of 516 Aboriginal men and women in the Kimberley region found that 
although non-drinkers were more common among Aboriginal men and women in the 
Kimberley region than in the general Australian community the proportion who drank 
at harmful levels was much higher among Kimberley Aboriginals. Of the men, 76% 
were found to be drinkers, and 46% of the women (Hunter, Hall & Spargo 1992). The 
proportion consuming harmful quantities of alcohol (see Box 1.12, page 64) was 66% for 
men and 38% for women (Table 1.12). 
Four of twenty-one New South Wales projects that measured cardiovascular disease 
risk factors included data from Aboriginal populations. A summary of these (Boyle & 
Dobson 1992) reported that the Wilcannia Aboriginal population had a high proportion 
of male and female smokers, of women with high blood cholesterol (> 6.5 mmol/L), of 
men and women with high diastolic blood pressure (> 90 mmHg), and of women who 
were overweight or obese compared with non-Aboriginal groups. Mean body mass 
index (see Box 1.10, page 60) was high for both the Wilcannia Aboriginal population 
and for the North Coast Aboriginal and Islander population compared with other 
groups, and the prevalence of diabetes among the Bourke and the Enngonia Aboriginal 
populations was also very high compared with other groups. 
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Table 1.12: Population estimates ofthe prevalence of drinking patterns among Aborigines in the 
Kimberley^ (percent) 
Drinking pattern Males Females Persons 
Abstainers 8 (4-11) 37 (31^13) 22 (18-26) 
Ex-drinkers 16(12-21) 17 (13-22) 17(14-20) 
Drinkers 76 (71-82) 46 (40-52) 61 (57-65) 
Episodic drinkers 26 (21-31) 20 (15-25) 23 (20-27) 
Intermittent drinkers 29 (24-35) 16(12-21) 23 (20-26) 
Constant drinkers 21 (16-26) 9 (6-13) 15(12-18) 
Drinkers at harmful levels'^ 66 (60-72) 38 (32-44) 52 (48-56) 
(a) 95% confidence intervals shown in parentheses. 
(b) Persons drinking more than the NHMRC harmful level. 
Source: Hunter, Hall & Spargo 1992 
1.3.4 Residents of rural Australia 
About 36% of Australians live outside capital cities, half in major regional centres and 
the remainder in rural and remote areas. Non-city dwellers experience wide variation 
in health and in their access to and use of health services. Although there is little 
apparent difference in health and service use between residents of major regional 
centres and of capital cities, this is in marked contrast with that of many rural 
Aboriginal communities whose poorer health (see Section 1.3.3) is compounded by lack 
of access to services. 
Until recently there have been relatively few studies of rural health and the knowledge 
is still incomplete. This is partly because there have not been standard definitions of 
what constitute 'rural', 'remote', and 'non-metropolitan' areas. There is considerable 
demographic, socioeconomic and geographic heterogeneity in non-metropolitan 
Australia, and the choice of definition has a significant bearing on the pattern of health 
status that emerges. 
The geographical information collected in the 1989-90 National Health Survey allows 
only broad differentiation of capital city residents from other residents. For this reason, 
the analyses below, for ages 25 to 64, compare metropolitan and non-metropolitan 
residents only. Such comparisons of very broadly defined areas mask important 
regional differences, and differences between urban, rural and remote dwellers. They 
provide only a very general picture of average differences between metropolitan and 
non-metropolitan Australians. It is not intended to imply that this one measure of 
metropolitan/non-metropolitan health differential adequately reflects differentials for 
all rural areas. 
Among Australian men and women aged 25 to 64 years, non-metropolitan residents 
experience higher mortality than metropolitan residents: 15% higher for men and 9% 
higher for women during 1985-87 (Table 1.13, page 39). The differentials for avoidable 
deaths (see Box 1.5) are even larger (47% for men and 30% for women). 
Non-metropolitan residents have higher death rates for all major causes of death except 
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cancers and mental disorders. Some of the strongest differentials for selected causes of 
death are: 
• pneumonia/influenza—56% higher for men and 94% higher for women 
• traffic accidents—59% higher for men and 52% higher for women 
• diabetes—46% higher for women (but not higher for men) 
• cerebrovascular disease—24% higher for men and 27% higher for women 
• ischaemic heart disease—11% higher for men and 17% higher for women. 
In contrast, non-metropolitan women have lower death rates from breast cancer and 
suicide. 
No clear pattern in reported morbidity is evident. Analyses of the first Australian 
Health Survey 1978-79 show that rural residents reported more recent and chronic 
illness and higher rates of smoking and drinking (Humphreys 1990), whereas the 
second survey in 1983 found fewer reported illnesses in rural residents (Clarke 1990). 
The 1988 ABS Survey of Disabled and Aged Persons found that men living in 
non-metropolitan areas experienced higher levels of handicap, disability and reduced 
activity, unlike women, for whom there were only very minor geographical differences 
(Table 1.13). These men were also more likely to report fair to poor health in the 1989-90 
National Health Survey. 
Box 1.5: Avoidable deaths 
Avoidable deaths are deaths from conditions which should be wholly or substantially 
manageable with adequate medical care, at least in people under 65 years of age. A US 
working group (Rutstein et al. 1976, 1980) developed a list of diseases for which there is 
evidence that medical treatment can prevent death after the disease has been contracted. 
This approach has been widely used to develop indicators of health service outcomes to 
assess the adequacy and effectiveness of health care delivery (Holland 1988, Desmeules & 
Semencizv 1991). For ages 25 to 64, avoidable deaths are defined as deaths due to the 
following causes: 
• tuberculosis 
• cervical cancer 
• Hodgkin's disease 
• deficiency anaemias 
• rheumatic heart disease 
• hypertensive heart disease 
• acute respiratory disease 
• pneumonia, bronchitis and influenza 
• appendicitis 
• hernia 
• cholecystitis. 
Potential years of life lost arc years of life not lived between age at death and age 65, where 
the person dies an avoidable death. Avoidable death rates and potential years of life lost are 
age-adjusted using the 30 June 1988 Australian population as the reference population. 
37 
Box 1.6: National Health Survey definitions 
Fair/poor health: An answer of 'Fair' or 'Poor' when asked for self-assessed health status 
on a scale of Excellent, Good, Fair, Poor. 
Unhappiness: An answer of 'Unhappy' or 'Very unhappy' when respondents asked how 
they felt generally on a scale of Very happy, Happy, Unhappy, Very unhappy. 
Overweight and obesity: A body mass index of greater than 25.0 kg/m2 (see Box 1.10, 
page 60). 
Inactivity: Undertaking no physical exercise for recreation, sport or health/fitness reasons. 
Calculated using data from the National Health Survey on the amount of time spent in the 
last two weeks in walking, moderate exercise and vigorous exercise for recreation, sport or 
fitness reasons. 
Smoking: Current smokers. 
Alcohol risk: Medium or high relative health risk due to alcohol consumption (see Box 
1.12, page 64). 
Hospital episodes: Number of inpatient episodes during last twelve months where both 
admission and discharge took place within the twelve-month period. 
Doctor visits: Number of doctor consultations per annum (including telephone calls and 
proxy visits). Doctor consultations during hospital inpatient episodes or visits to hospital 
outpatient/casualty clinics not included. 'Doctor' includes general practitioners and 
specialists. Estimated by multiplying by 26 the average number of doctor visits in the two 
weeks prior to interview. 
Dental visits: Number of dental consultations per annum. Dental consultations include 
consultations with all dental professionals (e.g. dentists, orthodontists, dental nurses and 
dental technicians) about teeth, dentures or gums. Estimated by multiplying by 26 the 
average number of dental consultations in the two weeks prior to interview. 
Other health professional visits: Number of consultations per annum with the 
following health professionals: chemist (for advice), optician/optometrist, physiotherapist, 
psychologist, social worker/welfare officer, chiropodist/podiatrist, nurse (school, baby 
health, other excluding dental nurse), dietitian, chiropractor, osteopath, naturopath, 
herbalist, acupuncturist. Includes only consultations at which some discussion and/or 
treatment of a health-related or medical condition took place or was arranged. Estimated by 
multiplying by 26 the average number of consultations with the health professionals listed 
above in the two weeks prior to interview. 
Mammography screening rate: Percentage of women aged 40 to 64 years who have had a 
mammogram in the last three years. 
Pap smear screening rate: Percentage of women aged 25 to 64 years who have had a Pap 
smear test in the last three years. 
Rubella immunisation rate: Percentage of women aged 25 to 44 years who have been 
immunised against rubella. 
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Table 1.13: Health indicators, age-standardised rates™ and rate ratios by region and sex, age 25 
to 64 years, late 1980s 
Men Women 
Metro Non-metro Rate Metro Non-metro Rate 
Health indicator ASR ASR ratio ASR ASR ratio 
Health status indicators 
Mortality 424.18 488.48 1.15 »" 226.39 247.30 1.09 *** 
Avoidable deaths 7.88 11.55 1.47 *** 10.01 12.96 1.30 •** 
Potential years of life lost 51.06 62.23 1.22 »** 27.12 30.96 1.14 
Fair / poor health 17.06 18.59 1.09 18.40 17.83 0.97 
Severe handicap 2.45 3.05 1.25 * 3.33 3.05 0.92 
Handicap 12.33 14.98 1.21 11.75 11.41 0.97 
Disability 15.14 18.45 1.22 **• 13.80 13.38 0.97 
Chronic illness 1.13 1.12 0.99 1.31 1.21 0.92 *** 
Unhappiness 5.02 3.60 0.72 *** 5.24 2.31 0.44 *** 
Risk factors 
Overweight and obesity 48.14 49.55 1.03 31.95 34.38 1.08 * 
Inactivity 35.69 40.85 1.14 *** 36.03 35.63 0.99 
Smoking 33.49 34.27 1.02 24.71 27.30 1.10 ** 
Alcohol risk 14.24 18.20 1.28 *** 8.01 6.84 0.85 * 
Height 1.76 1.77 1.00 1.62 1.63 1.00 
(a) Age-standardised to 1988 Australian population. 
* p < 0.05 
** p < 0 . 0 1 
* " p < 0.001 
Source: Mathers 1994 
The only chronic illnesses reported more frequently by non-metropolitan residents 
were: 
• arthritis—19% more often for men 
• deafness—29% more often for men. 
Non-metropolitan residents reported the following illnesses less often: 
• hay fever—28% less often for men 
• migraine—19% less often for women 
• headache—14% less often for men and 11% for women 
• nerves, tension or emotional problems—28% less often for men and 23% less often 
for women 
• insomnia—30°/) less often for men 
• high cholesterol—31% less often for men and 27% less often for women (these 
differences may in part reflect differential access to diagnostic services). 
Both men and women living in non-metropolitan areas were less likely to report that 
they are unhappy (28% less for men and 56% less for women). 
In non-metropolitan areas men tended to be more inactive (14°/) higher) and 
intermediate to high risk drinkers (see Box 1.11) (28% higher), whereas women were 
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less likely to be medium to high risk drinkers (15% lower), but more likely to be 
overweight and obese (see Box 1.10) (8% higher) and smokers (10% higher). 
Nutrition in rural residents is discussed in Section 1.4.1. 
A focus of attention over recent years has been on the unequal distribution of health 
services between urban and rural areas, in particular the recruitment and retention of 
doctors in small country towns (National Rural Health Conference Organising 
Committee 1991). The differences in health service use shown in Table 1.14 are 
consistent with more detailed analyses of health service provision by Mathers & 
Harvey (1988), and Reid & Solomon (1992). 
T a b l e 1 .14: Health service use, age-standardised rates™ and rate ratios by region and sex, age 25 
to 64 years, late 1980s 
Men Women 
Metro Non-metro Rate Metro Non-metro Rate 
Health service ASR ASR ratio ASR ASR ratio 
Hospital episodes 0.13 0.16 1.25 0.22 0.27 1.21 
Doctor visits 5.45 4.80 0.88 8.72 6.74 0.77 *** 
Dental visits 1.59 1.15 0.72 *** 2.07 1.56 0.75 *** 
Other health professional 
visits 3.76 3.23 0.86 4.97 4.39 0.88 
Mammography screening 
rate (40+ years) na na 23.60 20.79 0.88 * 
Pap smear screening rate na na 73.64 78.52 1.07 ** 
Rubella immunisation rate 
(25-44 years) na na 73.09 74.90 1.02 
(a) Age-standardised to 1988 Australian population. 
* p < 0.05 
" p < 0 . 0 1 
*** p < 0.001 
Source: Mathers 1994 
Residents of non-metropolitan areas reported over 20% more hospital admissions and 
more outpatient visits but fewer doctor and dentist visits than their metropolitan 
counterparts (Table 1.14). Britt et al. (1993) compared country and metropolitan general 
practice. They found that country practitioners were more than twice as likely to admit 
their patients to hospital than metropolitan practitioners, as measured by admissions 
per 100 encounters, suggesting that this reflects greater involvement of country general 
practitioners with the hospital care of their patients. Although the mammography 
screening rate was lower for non-metropolitan women, their Pap smear screening rate 
was 7% higher, but lower in small country towns. 
In recent years there has been increasing recognition that rural Australians suffer poorer 
health than city dwellers and, additionally, have significant problems of access to health 
services (Reid & Solomon 1992, Davenport, Mant & Flishie 1989, Humphreys & Rolley 
1993). This recognition has resulted in some important national initiatives including the 
1991 Toowoomba National Rural Health Conference, which produced a national rural 
health strategy; the National Health Strategy Report, Improving Australia's rural health 
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and aged care services; and the funding by the Australian Health Ministers' Advisory 
Council of a National Rural Health Unit. The Rural Incentives Program and the 
establishment of Divisions of General Practice are major Commonwealth budget 
initiatives designed to influence the recruitment, retention and training of rural doctors. 
At the State level, the recently established Rural Training Units are working towards the 
same end. The Commonwealth Government's North Australia Social Justice Strategy 
and the Rural Health Support Education and Training Programs have also been set up 
to address the problems relating to getting services to rural areas and the considerable 
inequity that characterises rural and remote areas. The activities of the recently 
established National Rural Health Unit are likely to enhance this momentum and 
should help to provide a better picture of the health status and service needs of rural 
and remote communities. 
1.3.5 Employed people 
As part of its responsibility for national monitoring of work-related injuries and 
diseases, the National Occupational Health and Safety Commission (Worksafe 
Australia) has developed a National Data Set for compensation-based statistics (NDS). 
The NDS, originally agreed to in 1987, recommends a standard set of data items, 
concepts, and definitions (see Box 1.7) for inclusion in workers' compensation 
collections. Its main purpose is to enable the production of national and nationally 
comparable workers' compensation data. 
The NDS is being implemented progressively across Australia. By early 1994, only 
seven jurisdictions (New South Wales, Western Australia, South Australia, Tasmania, 
the Northern Territory, and Comcare and Australia Post) had supplied data in the NDS 
format to Worksafe Australia. 
Box 1.7: Definitions of selected terms used in the National Data Set 
for compensation-based statistics 
Industry: the predominant industry at the location at which the occupational injury 
occurred, classified in accordance with the Australian standard industrial classification, 
1983 edition, ABS Catalogue No. 1201.0. 
Occupation ofthe injured worker: classified in accordance with the Australian standard 
classification of occupations, 1986 edition, ABS Catalogue No. 1222.0. 
Duration of absence: classified for absences of five working days or more and shown in 
complete working weeks. Thus an absence of twelve working days is shozvn as of two 
working weeks. 
Data from the Australian Bureau of Statistics (ABS) Labour force survey, Catalogue No. 
6203.0, and Survey of employee earnings and hours, Catalogue No. 6306.0, were used 
in calculation of incidence rates. 
Estimates of the cost of workers' compensation claims were derived from the ABS 
Australian national accounts (unpublished). 
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The data are derived from workers' compensation claims received by workers' 
compensation agencies from insurance companies, self-insurers, and some government 
departments. The claims were for workers' compensation relating to a fatality, a 
permanent disability, or a temporary disability resulting in an absence from work of 
one week (five working days) or more. 
Workers' compensation data 
In the seven jurisdictions for which data were available, a total of 193 occupational 
fatalities were reported to workers' compensation authorities for 1991-92; 180 (93%) 
deaths were of males and 13 (7%) of females. The fatality rate for these jurisdictions was 
50 per 1,000,000 wage and salary earners. The industry and occupation distributions of 
the deaths are shown in Figures 1.15 and 1.16. 
New workers' compensation cases reported for 1991-92 for the seven jurisdictions 
totalled 90,571, 76.3% being for males and 23.7% for females. Figure 1.17 (page 44) 
shows the incidence of new workers' compensation cases by sex in industry divisions. 
The predominance of males in workers' compensation cases in some industries reflects 
the different occupation distributions of men and women in these industries. 
Transport and storage 
Manufacturing 
Agriculture, forestry 
fishing and hunting 
Wholesale and retail trade 
Construction 
Mining 
Finance, property and 
business services 
Public administration 
and defence 
Electricity, gas and water 
Recreation, personal 
and other services 
Community services 
Not stated / other 
T I | I I 
10 
Per cent of total 
15 20 
Note: Excludes Vic, Qld, ACT and Telecom. Total fatalities = 193. 
Source: Worksafe Australia 
Figure 1.15: Reported occupational fatalities by industry, 1991-92 
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Occupation data were available for 83,114 new workers' compensation cases, 77.5% 
male and 22.5% female. Figure 1.18 (page 45) shows the incidence of new workers' 
compensation cases reported for major occupation groups. 
0 5 10 15 20 25 30 
Per cent of total 
Note: Excludes Vic, Qld, ACT, Comcare, Telecom and Australia Post. Total fatalities = 184. 
Source: Worksafe Australia 
Figure 1.16: Reported occupational fatalities by occupation, 1991-92 
For the total of 90,571 new workers' compensation cases, working time lost totalled 
624,368 weeks, with an average time lost of 7.7 weeks per occurrence. For men, the 
average time lost was 7.2 weeks, and for women it was 9.2 weeks. 
The highest number of cases (31.8% of all cases) lost one complete working week. This 
proportion decreased rapidly for longer absences. Two complete working weeks were 
lost in 13.9% of cases, and 8.0% of cases lost three complete working weeks. Absences of 
four complete working weeks or longer made up the remainder. 
Costs of w o r k e r s ' c o m p e n s a t i o n 
The estimated direct cost of workers' compensation claims for all of Australia was 
$4,830 million for 1992-93. This represented 1.2% of non-farm gross domestic product, 
and 2.4% of non-farm wages, salaries and supplements in 1992-93. Figure 1.19 (page 45) 
shows constant price estimates of the cost of workers' compensation claims for the 
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period from 1977-78 to 1992-93, as derived from the Australian Bureau of Statistics 
Australian National Accounts. It shows the cost of claims increasing until 1986-87, but 
not changing greatly since 1987-88. 
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Construction 
Transport and storage 
Manufacturing 
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Community services 
Recreation, personal 
and other services 
Wholesale and retail trade 
Finance, property and 
business services 
Communication 
Men 
Women 
70 80 
Per 1,000 wage and salary earners 
Note: Excludes Vic, Qld, ACT and Telecom. 
Source: Worksafe Australia 
Figure 1.17: Incidence of new workers' compensation cases, by industry, 1991-92 
As well as direct costs, workers' compensation has significant indirect economic and 
social costs. In Australia, a conservative ratio of 1:1 for indirect costs to direct costs has 
been used in recent years to calculate the total costs of occupational injury and disease 
to the community. The ratio of indirect costs to direct costs within a number of 
industries in industrialised countries has been of the order of 1:1 to 1:7, but the ratio 
may be higher or lower and may vary over time. Using the 1:1 ratio, the total cost to the 
Australian community of occupational injuries and diseases is estimated at $9,700 
million for 1992-93. 
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F i g u r e 1.18: Incidence of new workers' compensation cases, by occupation , 1991-92 
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F i g u r e 1.19: Total workers' compensation claims (constant prices 1992-93 dollars), 
1977-78 to 1992-93 
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1.4 Factors which influence health 
1.4.1 Nutritional status 
Relationship between nutrition and health 
Nutrition is an important contributor to health, and the evidence linking diet with the 
chronic, preventable, non-communicable diseases is sufficiently strong for public health 
initiatives to include improved nutrition as a major component. These diseases and 
their risk factors arise from overconsumption. Although there are less than optimum 
intakes of some nutrients in some groups, undernutrition is uncommon in Australia. 
A national policy on food and nutrition, with the equitable improvement of nutritional 
status for Australians as its goal, came into existence in September 1992 
(Commonwealth Department of Health, Housing and Community Services 1992). 
The Institute has recently published Australia's food & nutrition (Lester 1994). This report 
gives more detail and fuller references to sources than are presented here. 
Food consumption 
Table 1.15 (page 48) shows changes in the composition of the available food supply 
between 1985-86 and 1990-91. The most notable changes were increases in seafood and 
non-alcoholic beverage consumption, and decreases in egg and alcoholic beverage 
consumption. 
Box 1 .8: Dietary guidel ines for Australians 
Dietary guidelines are the basis for public health nutrition action. First announced in 1981, 
they were revised in 1992 in recognition of the different requirements of some groups. Tire 
revised guidelines (NHMRC 1992a) are: 
1. Enjoy a wide variety of nutritious foods. 
2. Eat plenty of breads and cereals (preferably wholegrain), vegetables (including legumes) 
and fruits. 
3. Eat a diet low in fat and, in particular, low in saturated fat. 
4. Maintain a healthy body weight by balancing physical activity and food intake. 
5. If you drink alcohol, limit your intake. 
6. Eat only a moderate amount of sugars and foods containing added sugars. 
7. Choose low salt foods and use salt sparingly. 
8. Encourage and support breastfeeding. 
Guidelines on specific nutrients 
1. Eat foods containing calcium. This is particularly important for girls and women. 
2. Eat foods containing iron. This applies particularly to girls, women, vegetarians and 
athletes. 
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Preliminary data for 1991-92 show a record low 217g per person per day meat 
consumption, with an 8.6% decrease in beef and veal consumption between 1990-91 
( l l l g per person per day) and 1991-92 (102g); there were also decreases in consumption 
of sheep meat and offal, and a continuation of the long-term upward trend in pig meat 
and poultry consumption. 
Changes in the food supply can affect habits and food intakes. Important food supply 
changes over the last few years have been the introduction of fat-modified milks and 
other dairy products, and changes in the way in which meat products are marketed 
have also occurred. 
Over the last decade the variety of liquid milk products has expanded to include a 
range of fat contents from skim milk (0.1% fat) to whole milk (4.8%), a range of 
flavoured products, and products with increased calcium content. Recently, 
lactose-modified milks, and a modified milk in which milk fat is replaced by canola oil 
have also entered the market. The most important changes in the meat supply have 
been the increased availability of lean beef and the introduction of 'trim lamb'. 
Consistent with known physical and physiological differences between the sexes, all 
dietary survey data since 1983 demonstrate higher mean total consumption in men than 
in women. However, this does not hold for all foods and food groups; for instance, 
women consume more fruit and non-alcoholic beverages (Commonwealth Department 
of Health 1986; CSIRO unpublished data). Men consume much greater quantities of 
alcoholic beverages. 
Box 1.9: Defini t ions of some te rms re la t ing to nu t r i t i on 
Micro-nutrients: chemical elements and organic molecules that cannot be sunthesised 
through human metabolism but which are essential for metabolic function. For example, 
zinc is a co-factor for many enzymes and is involved in most metabolic processes; iodine is 
required for thyroid hormones; folic acid is essential for nucleic acid synthesis, and hence 
cell growth. 
Macro-nutrients: generally defined as those food components that supply energy, that is, 
carbohydrates, protein, fat, ethanol and some organic acids. Usually, however, dietary fibre 
(some forms of which do provide energy), water and cholesterol are included in this 
category. 
Recommended Dietary Intakes (RDIs): 'levels of intakes of essential nutrients 
considered...to be adequate to meet the known nutritional requirements of practically all 
healthy persons' (NHMRC 1991). Except for the RDIs for energy, RDIs are not applicable 
to individuals. They are a group or population measure, and may also be used to estimate 
the adequacy of the food supply. 
Nutrient density: the ratio of the nutrient content or intake to the estimated energy 
content or intake. It is usually expressed as amount of nutrient per 1000 k]. 
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T a b l e 1 .15: Apparent per capita consumption of selected foodstuffs, 1985-86 to 1990-91 
(g per day, except where stated) 
1985-86 1986-87 1987-88 1988-89 1989-90 1990-91 
Grain products 232 232 242 241 246 253 
Vegetables^ 373 381 412 416 443 428 
Fruit & fruit products ( a ) 293 292 289 311 308 302 
Meat & meat products' 6' 233 224 229 228 233 231 
Poultry 63.0 64.4 67.7 67.7 67.4 69.6 
Seafood 20.5 20.8 21.6 23.8 24.1 26.0 
Eggs & egg products (number 
per year) 140 138 135 128 125 126 
Nuts 14.8 15.6 14.8 15.6 16.7 15.9 
Dairy products' 0' 62.5 64.7 65.5 64.9 64.7 63.6 
Market milk (fluid whole) 
(ml_ per day) 281 282 278 276 276 277 
Oils & fa ts ( d ) 57.3 56.4 55.9 55.3 54.2 54.2 
Sugars ( e ) 137 134 130 132 133 129 
Beverages (mL per day) 
Aerated and carbonated 
waters 218 222 240 256 262 265 
Alcoholic 376 362 360 362 356 346 
(a) Fresh equivalent weight. 
(b) Carcass equivalent weight. Cured carcass weight of bacon and ham is not included in the above total, 
and added 19.5 g per capita in 1990-91 . 
(c) Converted to milk solids, fat and non-fat. Includes market milk. 
(d) Fat content. Includes an estimate for vegetable oils and other fats. 
(e) Includes sugars content of syrups and glucose. 
Source: ABS Cat. No. 4306.0 
The 1989 CSIRO Survey of the Elderly found that 92% of men and 96% of women aged 
55 years and over had tried to change their diets: most respondents felt that they had 
increased their fibre intake and reduced total amount of food, and fat, sugar, and salt 
intakes in the previous few years. 
Data from the Longitudinal Study of Adolescents for 1992 show that 22% of 
16-year-olds, 23% of 17-18-year-olds and 27% of 19-22-year-olds said that they were 'on 
a d ie t ; this included slimming diets, eating less fat, or more fruit and vegetables, or less 
'junk food', or less chocolate or, simply, less food. 
Food prepared outside the home has become an important contributor to total 
consumption. In a 1991-92 survey of consumers aged 18 years and over, 60% of male 
and 57% of female respondents had consumed 'fast foods' at least once in the previous 
four weeks, and 16% and 15% respectively had ordered home-delivered pizza 
(Table 1.16). The purchase of fast foods decreases with age (Table 1.16). 
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Table 1.16: Fast-food buyers during previous four weeks, by age and sex, April 1991 to March 
1992 (per cent) 
Sex / Age group 
Purchasing in 
last four weeks 
Home 
pizza delivery 
Sex 
Men 
Women 
Age group 
18-24 
25-44 
45-64 
65 and over 
60 
57 
84 
70 
43 
20 
16 
15 
28 
21 
8 
2 
Source: Morgan 1992. Adapted by permission. 
Revised National Health Goals and Targets were released in 1992 (see Section 1.5). 
Some of the targets related to food supply. There is little information as yet about 
progress towards them; the only monitoring tool that has provided trend data thus far 
is the Apparent Consumption of Foodstuffs and Nutrients series (ABS Cat. No. 4306.0). 
Also, some targets have not been well chosen. The target to 'increase the amount of low 
and reduced alcohol beer from 14.5% of all beers to 20% in 10 years' was chosen on 
nutritional grounds alone; because of other public health action relating to alcohol 
abuse, it has been exceeded after three years (see Figure 1.20). 
Per cent of total beer 
25 
1989 1990 1991 1992 1993 1994 1995 1996 1997 i~998 
Year ending 30 June 
Sources: ABS Cat. No. 4306.0; Nutbeam et al. 1993 
Figure 1.20: Trends in reduced-alcohol beer as a proportion of total beer supply 
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Breastfeeding 
The 1989-90 ABS National Health Survey (unpublished) and a small survey conducted 
by the Brotherhood of St Laurence in 1992 (Gilley 1993) found self-reported percentages 
of 77% and 78% breastfeeding at discharge from hospital. In 1983 the rate was 85% 
(Palmer 1985). The earlier trend to increasing breastfeeding at 3 and 6 months, as shown 
in Figure 1.21, has also ceased. In 1991-92, 53% of Victorian mothers were fully 
breastfeeding at 3 months and 39% at 6 months (Nursing Mothers Association of 
Australia 1993). 
Per cent 
6 0 . 
10-
At 3 months 
At 6 months 
1975 
T 1 1 1 1 1 1 
1980 1985 
Year 
T 1 r 
1990 
Source: Nursing Mothers Association of Australia unpublished data 
Figure 1.21: Mothers fully breastfeeding at 3 and 6 months, Victoria, 1975 to 1992 
The National Health Survey asked mothers aged 18 to 50 years with a child aged 5 
vears or less at the time of interview whether thev had breastfed (or were breastfeeding) 
and duration of breastfeeding. The survey showed that mothers aged 25 to 34 years had 
the highest proportion reporting breastfeeding (80%) followed by mothers aged 18 to 24 
years (77%) and 35 to 44 years (71%). Women aged 45 to 50 years indicated that they 
were more likely to have bottle-fed babies. Of mothers who breastfed, most were likely 
to have breastfed between 6 and 12 months (37%). Only 7% of breastfeeding mothers 
did so for longer than 18 months. The Brotherhood of St Laurence survey also found 
that mothers on low incomes were less likely to breastfeed, and that between 4 and 7 
months, the rate of breastfeeding fell to 58%. 
The National Health Survey indicated that younger mothers were likely to have 
breastfed for shorter periods than older mothers; 48% of mothers aged 18 to 24 years 
breastfed for less than 3 months, 32% for more than 6 months, and 10% for more than 12 
months. In comparison, 74% of mothers aged 35 to 44 years and 63% of mothers aged 25 
50 
to 34 years breastfed for more than 6 months; and 40% of mothers aged 35 to 44 years 
breastfed for more than 12 months. 
Nutrient intakes 
To tell whether nutrient intakes are adequate we must compare them with nutrient 
requirements. These, however, vary widely from one individual to another, even when 
age, sex, activity level, height and weight are taken into account, so that direct 
measurement of biochemical and clinical indicators is the only way to assess an 
individual's status. At the population level, however, Recommended Dietary Intakes 
(RDIs) may be used as indicators of groups within the population whose intakes of 
nutrients are relatively low, and whose nutritional status thus requires closer 
examination. RDIs are set at a level where they are almost certainly higher than 
physiological requirements—they are based on an estimate of requirement plus a safety 
margin, so where groups do have intakes below RDIs, these intakes are not necessarily 
inadequate. A level below 0.7 RDI is often used as an indicator that further examination 
is needed; this approximates the 'safety margin' for most nutrients, and therefore 
indicates a level of intake which may not be adequate for individuals with higher than 
average requirements. 
Nutrient intakes of adults 
Mean total fat intakes were 35% of energy (14% from saturated fatty acids) in the 1988 
national survey, and 32% (13%) in the 1989 survey of the elderly (Table 1.17). 
Table 1.17: Macronutrient intake and contribution to energy intake, selected surveys, 1980s 
I n t a k e (g/day) C o n t r i b u t i o n t o e n e r g y ( p e r c e n t ) 
S u r v e y / n u t r i e n t M e n W o m e n M e n W o m e n 
1983 N a t i o n a l D i e t a r y S u r v e y o f A d u l t s ( a g e 2 5 t o 6 4 ) 
Protein 106 74 16.4 17.0 
Fat 110 76 37.0 38.0 
Carbohydrate 274 192 39.8 41.5 
Alcohol 25 9 6.5 3.5 
1988 A u s t r a l i a n H e a l t h a n d N u t r i t i o n S u r v e y ( a g e 18 a n d o v e r ) 
Protein 89 78 15.9 17.0 
Fat 90 75 35.1 36.6 
Carbohydrate 268 222 45.1 45.6 
Alcohol 12 5 3.7 1.8 
1989 C S I R O S u r v e y o f E l d e r l y A u s t r a l i a n s ( a g e 5 5 a n d o v e r ) 
Protein 82 75 15.3 16.2 
Fat 81 68 33.0 32.0 
Carbohydrate 271 246 47.7 50.0 
Alcohol 13 5 4.1 1.8 
Sources: Commonwealth Department of Health 1986; CSIRO Division of Human Nutrition unpublished data 
Unfortunately, the data from thesesurveys are not'directly comparable, because of the 
different data collection methods and age groupings used. 
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The food supply is more than adequate'to meet the RDIs of elements and vitamins, and 
data from dietary surveys confirm that inadequate intakes of micro-nutrients are 
uncommon. There are, however, identifiable subgroups within the population with low 
intakes of some nutrients. Groups with intakes below 0.7 of the RDI are usually 
regarded as meriting closer examination (Table 1.18). 
Table 1.18: Proportion of persons with intakes on survey day below 0.7 RDI and 0.5 RDI, selected 
nutrients, by age and sex, 1988 and 1989 
P e r c e n t w i t h i n t a k e s : 
N u t r i e n t / S e x A g e r a n g e Y e a r < 0.7 R D I < 0.5 R D I 
I r o n 
Women 18-59 1988 15 4 
C a l c i u m 
Men 40 and over 1988 13 5 
54 and over 1989 13 6 
Women 18 and over 1988 13 5 
54 and over 1989 30 12 
Z i n c 
Men 40-59 1988 na 6 
60 and over 1988 na 9 
54 and over 1989 na 4 
Women 40-59 1988 na 6 
60 and over 1988 na 13 
54 and over 1989 na 4 
M a g n e s i u m 
Men' 18 and over 1988 na 9-16 
54 and over 1989 na 9-16 
F o l a t e 
All persons 18 and over 1988 na 5-17 
54 and over 1989 na 5-17 
Source: CSIRO Division of Human Nutrition unpublished data 
In addition to the intakes shown in Table 1.18, the Survey of the-Elderly also suggested 
low intakes of vitamin.B-12 by 3% of women aged 54 years and over (there were no data 
for men) and low intakes of vitamin E in 4% of women and 13% of men aged 54 years 
and over. Of those aged 70 years and Over, 5% of women had low intakes of vitamin 
B-12; 5% of women and 8% of men had low intakes of vitamin E. 
In 1982 the average sodium intake of Australian adults was 130-200 mmol/day with 
certain individuals habitually consuming more than 400 mmol/day (NHMRC 1984). 
Estimated sodium intakes from the 1988 Australian Health and Nutrition Survey and 
the 1989 CSIRO Survey of the Elderly were much lower (see Table 1.19). Potassium 
intakes for the 1988 and 1989 surveys were similarly much less than had been estimated 
in 1982. 
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T a b l e 1 . 1 9 : Sodium and potassium intake, by sex (mmol/day) 
S u r v e y / S e x S o d i u m P o t a s s i u m 
R e c o m m e n d e d d i e t a r y i n t a k e 
All adults 
N H M R C w o r k i n g p a r t y , 1 9 8 2 
All adults 130-200 
40-100 50-140 
n a 
1 9 8 8 A u s t r a l i a n H e a l t h a n d N u t r i t i o n S u r v e y 
Men 
Women 
54 
45 
52 
49 
1 9 8 9 C S I R O S u r v e y o f t h e E l d e r l y 
Men 
Women 
45 
39 
55 
57 
Sources: NHMRC 1984, 1991; CSIRO Division of Human Nutrition unpublished data 
Nutrient intakes of children 
The National Dietary Survey of Schoolchildren (Department of Community Services 
and Health 1989) was carried out in 1985 and dietary surveys of schoolchildren were 
carried out in Western Australia in 1987 and 1988 Qenner & Miller 1991), using a 
comparable data collection method. In 1985 more than 20% of the energy intake of 
children came from soft drinks, confectionery, other foods with a high added sugar 
content (for example biscuits, cakes), takeaways and snack products. Data matched for 
age from the three surveys are given in Table 1.20 (page 54). Energy intakes were similar 
at 11 and 12 years, with girls' intakes 87-90% those of boys, and there was no apparent 
trend over time for macro-nutrients. 
The National Dietary Survey of Schoolchildren aged 10 to 15 years indicated that 
calcium intakes were a concern in that age group, particularly for girls. Over 40% of 
girls (12 to 15 years) and boys (12 and 13 years) had intakes less than 0.7 RDI, with 
one-quarter being less than 0.5 RDI. This merits further investigation. 
Nutritional deficiencies 
Food supply and dietary intake data suggest that nutrient deficiencies should be 
uncommon. The two nutrients of most concern are calcium and iron. At present, dietary 
intake and food supply data are available only for calcium. 
There have been two Australian surveys of iron status. English & Bennett (1990) have 
reported a 9.2% prevalence of iron deficiency in girls aged 15 years. An iron status 
study of 1,704 men and 4,267 women aged 20 to 69 was undertaken in 1989, in 
conjunction with the National Heart Foundation Risk Factor Prevalence Survey. Less 
than 1% of men, but 7.5% of women, were iron deficient, with women of reproductive 
age most likely to be so (Lester 1994). 
Diet-related diseases 
What are the diet-related diseases? 
Diet-related disease in Australia is due more to overconsumption than to deficiency. 
The major causes of death, illness and disability in Australia thought to have an 
overconsumption component in their aetiology are coronary heart disease, stroke, 
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hypertension, atherosclerosis, some forms of cancer (stomach, colon, rectal, breast and 
endometrial), non-insulin-dependent diabetes mellitus (NIDDM), osteoporosis, dental 
caries, gall bladder disease, and non-cancer disorders of the large bowel (diverticular 
disease and constipation). 
T a b l e 1 . 2 0 : Nutrient intake of children, by age and sex, selected surveys, 1980s 
S u r v e y / A g e / I n t a k e ( g / d a y u n l e s s s t a t e d ) C o n t r i b u t i o n t o e n e r g y ( p e r c e n t ) 
N u t r i e n t B o y s G i r l s B o y s G i r l s 
1 9 8 5 N a t i o n a l D i e t a r y S u r v e y o f S c h o o l c h i l d r e n , 1 1 y e a r s 
Energy (MJ) 8.5 7.4 100.0 100.0 
Protein 74 63 15.1 14.5 
Fat 85 72 36.6 35.6 
Total carbohydrates 255 227 48.1 49.5 
Fibre 18 16 
Calcium (mg) 883 724 
Number of respondents 459 460 
1 9 8 7 W e s t e r n A u s t r a l i a n s u r v e y , 1 1 y e a r s 
Energy (MJ) 8.4 7.6 100.0 100.0 
Protein 70 63 
Fat 84 78 36.8 37.8 
Saturated fatty acids 35 35 15.5 16.7 
Total carbohydrates 256 227 48.0 48.8 
Fibre 18 15 
Calcium (mg) 870 770 
Number of respondents 61 57 i 
1 9 8 5 N a t i o n a l D i e t a r y S u r v e y o f S c h o o l c h i l d r e n , 1 2 y e a r s 
Energy (MJ) 8.8 7.7 100.0 100.0 
Protein 75 64 14.6 14.3 
Fat 88 77 36.3 36.6 
Total carbohydrates 268 233 48.9 48.9 
Fibre 19 16 
Calcium (mg) 930 790 
Number of respondents 456 479 
1 9 8 8 W e s t e r n A u s t r a l i a n s u r v e y , 1 2 y e a r s 
Energy (MJ) 8.6 7.5 100.0 100.0 
Protein 71 60 
Fat 84 75 36.1 36.5 
Saturated fatty acids 34 25 14.3 14.4 
Total carbohydrates 264 231 49,6 49.5 
Fibre 19 17 ' 
Calcium (mg) 990 830 
Number of respondents 626 589 
Sources: Department of Community Services and Health 1989; Jenner & Miller 1991 
Alcohol consumption, total energy consumption, total fat consumption, dietary fatty 
acid profiles, and sodium and fibre intake are important factors in health. For example, 
high sodium and alcohol intakes and weight gain (excess energy intake) are associated 
54 
with hypertension; potassium and dietary fibre intakes may be inversely related to 
hypertension, and so also may dietary calcium and magnesium. Obesity—the result of 
chronic energy overnutrition—is a morbid condition in itself, and a risk factor for 
several other conditions. 
The prevalence of diabetes mellitus (including insulin-dependent diabetes mellitus) in 
Australia is estimated at 4%, but 11% in those over 65 years; in the older age group, 
almost all have NIDDM. It was also estimated that of approximately 500,000 
Australians with diabetes, up to half are undiagnosed (Diabetes Australia NSW 
unpublished data). 
The only deficiency conditions of any significance are the nutritional anaemias, 
particularly iron-deficiency anaemia. There is little information on incidence of these. 
The contribution of diet to diet-related disease 
The importance of a disease or group of diseases depends on how importance is viewed 
and measured. Indicators of mortality, morbidity and cost can give different 
impressions of the impact of a disease or disease group. Although only 2% of deaths 
can be related to diet, the proportions of health service expenditure attributed to diet 
include 6% of recurrent hospital expenditure, 5% of medical expenditure, 9% of 
pharmaceutical expenditure, 14% of nursing home expenditure and 24% of expenditure 
on allied health professional services. The last largely comprises expenditure on dental 
services, of which it is estimated that 75% is related to the treatment of dental caries, of 
which 50% is taken to be due to diet. 
The cost to the community of diet-related disease 
The direct cost of health care services—hospital, medical, pharmaceutical, allied 
professional and nursing home—for diet-related disease was estimated to be $1,432 
million in 1989-90. The estimated direct cost of alcohol-related disease was $430 
million. These direct costs total $1,862 million. When $1,418 million indirect costs (i.e. 
the earnings forgone through illness and premature death) of diet- and alcohol-related 
disease are added, the total estimated cost of diet- and alcohol-related disease in 
1989-90 rises to $3,280 million (Table 1.21, page 56). 
Equity and nutrition 
Adequate nutrition depends on a quality food supply being affordable and available, 
and the ability to make discerning choices from the food available depends on the 
individual's food, health and social skills and knowledge. Many associations with poor 
nutrition are thus social or socioeconomic in origin. 
A survey of 874 urban residents found differences in macro- and micro-nutrient 
patterns when examined separately by occupational prestige, education level, income 
and occupational category. High social status was positively associated with nutrient 
densities for iron, zinc, magnesium, potassium and with intake of natural sugars, and 
inversely associated with energy from fat (Smith & Baghurst 1992, 1994). In an earlier 
survey of 291 South Australians aged 18 and over, there was no correlation between 
occupational status (based on head of household status) and measured zinc and 
magnesium levels in blood to determine nutritional status for these nutrients, although 
there were many respondents whose dietary intakes were below the RDIs for these 
nutrients (Baghurst et al. 1991). 
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T a b l e 1 . 2 1 : Impact of diet-related (including alcohol-related) diseases, 1989-90 
N u m b e r C o s t ( $ m ) P e r c e n t o f t o t a l t a ) 
M o r t a l i t y 
Deaths 37,636 30.30 
Potential years of life lost to age 75 95,817 
M o r b i d i t y a n d c o s t o f h e a l t h c a r e 
Hospital admissions 206,287 594 6.05 
Hospital bed-days 1,902,834 
Medical consultations 6,806,599 212 4.35 
Pharmaceutical scripts 15,728,911 221 8.81 
Allied professional care referrals 233,026 517 21.19 
Nursing home admissions^' 3,311 317 13.88 
Total direct costs 1,862 
I n d i r e c t c o s t s 
Forgone earnings due to premature death 1,222 
Absenteeism 196 
Total indirect costs 1,418 
T o t a l c o s t s 3 , 2 8 0 
(a) Per cent of total relevant expenditure 1989-90, except for deaths which is per cent of all deaths in 1989. 
(b) Includes only patients who are transferred from hospitals to nursing homes. 
Sources: Crowley et al. 1992 (updated); AIHW unpublished data 
Occupational prestige and education, but not income, were directly associated with 
nutrient densities for carotene, vitamin C, thiamine, folic acid and—weakly—niacin 
and fibre intake in the larger survey; energy from mono-ufisaturated fatty acids and 
from saturated fatty acids was inversely associated with occupational prestige (strongly 
for mono-unsaturates) and education (weakly). Retinol density and total energy intake 
(weak) were inversely associated with occupational prestige; alcohol intake was 
strongly associated with income and weakly with occupational prestige; starch intake 
was inversely associated with income. There were also significant differences for 
occupation category for several nutrients and for energy, alcohol, and fibre (Smith & 
Baghurst 1992,1994). 
Sole parents and their dependants 
Sole parents are an economically and socially disadvantaged group, and five out of six 
single parents are women. Crotty, Rutishauser & Cahill (1992) studied 29 sole-parent 
families with low incomes in Geelong in 1989-90. They spent about the.same amount 
($28) on cereals, dairy products, fruit and vegetables as the average for all households 
in the 1988-89 Household Expenditure Survey, but this was 48% of their food 
expenditure compared with the 30% average for all households. Less was spent on 
meat and non-alcoholic beverages ($11 against $27, or 18% against 28%). There was a 
'marked difference in expenditure on food in the first and second weeks of a Social 
Security payment fortnight' that was reflected in the energy and nutrient intakes for the 
two weeks only as a lower median vitamin C intake in the second week. 
The. 1985 National Dietary Survey of Schoolchildren found that boys of 10 to 11 years 
from single-parent homes had lower intakes of nutrients than boys from two-parent 
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homes. Of girls from single-parent families, 35-38% (the exact figure depending on age) 
reported iron consumption below 0.7 RDI compared with 26-29% of girls from 
two-parent families (Lester 1994). 
Rural-urban differences 
Rural children in 1985 consumed more vegetables, milk and milk products, and meat 
and meat products than did urban children. Generally, mral-dweiling boys had higher 
nutrient intakes than urban boys, but 25-29% of rural girls reported vitamin A 
consumption below 0.7 RDI compared with 35-38% of urban girls. A difference was 
also found in cereal consumption: urban children at 10 and 15 years ate more bread, 
whereas rural boys but not girls ate more breakfast cereals (see Table 1.22). 
Table 1 .22: Trends in bread and breakfast cereal consumption, by age, sex and area of residence, 
1985 (glday) 
B o y s G i r l s 
U r b a n R u r a l U r b a n R u r a l 
F o o d A g e 1 0 A g e 1 5 A g e 1 0 A g e 1 5 A g e 1 0 A g e 1 5 A g e 10 A g e 1 5 
Bread 82 131 78 115 79 81 64 74 
Breakfast cereal 44 59 58 77 36 34 37 29 
Source: AIHW unpublished data 
The 1985 Victorian Nutrition Survey showed very little difference between adult 
metropolitan and non-metropolitan respondents, but this may be because Victoria is a 
highly urbanised state, with no remote areas. 
Sex 
The 1989-90 National Health Survey found that women were more likely than men to 
have taken a health-related action, to be underweight, and to be taking vitamin and 
mineral supplements; and that more women than men reported changing their diets for 
reasons related to health (ABS unpublished data). Also, 43.3% of women but only 37.9% 
of men reported changing their diets in the preceding two years. The greatest difference 
in dietary habits between women and men is in the consumption of alcoholic 
beverages, with women consuming much less beer than men (Table 1.23, page 58). 
Physiological requirements for several nutrients, notably iron and calcium, are different 
for men and women, and this is reflected in RDIs. The RDI for calcium is higher for 
post-menopausal women, who are at higher risk of osteoporosis. Menstruation greatly 
increases the risk of iron deficiency, and pregnancy increases the requirement for many 
nutrients. For example, pregnant women are at higher risk of anaemias due to folic acid 
deficiency and iron deficiency. 
Ethnicity 
Using language spoken at home as an indicator of non-English-speaking background, 
there were important differences in calcium and iron intakes by ethnic group (Table 
1.24). Vitamin A intakes for girls and zinc intakes for boys were higher where English 
was spoken at home. Meat consumption of girls from non-English-speaking 
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backgrounds was 20% lower at age 15 than at age 10; this was very different from the 
45% higher consumption at age 15 for girls from English-speaking backgrounds 
compared with their counterparts aged 10 years. 
Table 1.23: Alcoholic beverage intake of women as per cent of men's intake, by age, 1988 and 1989 
S u r v e y / 
A g e g r o u p 
Al l 
b e e r s 
S t a n d a r d 
b e e r 
L o w a l c o h o l 
b e e r W i n e 
S h e r r y , p o r t , 
l i q u e u r s S p i r i t s 
1 9 8 8 A u s t r a l i a n H e a l t h a n d N u t r i t i o n S u r v e y 
18 to 39 10 9 14 114 85 75 
40 to 59 17 11 33 106 97 116 
60 and over 8 6 14 55 65 41 
All ages 11 9 20 96 81 78 
1 9 8 9 C S I R O S u r v e y o f t h e E l d e r l y 
54 to 59 10 9 12 91 122 37 
60 to 64 14 10 19 70 81 43 
65 to 69 18 8 33 65 80 42 
70 and over 21 17 36 77 103 88 
All ages 14 11 22 79 96 49 
Source: CSIRO Division of Human Nutrition unpublished data 
A survey of 200 Vietnamese migrant women in Adelaide in 1989 (Table 1.25) found that 
the diets of the sample were lower in fat and fibre but higher in total carbohydrate and 
protein than for all Australian women (Baghurst, Syrette & Tran 1991; CSIRO 
unpublished data). 
Further nutrition monitoring 
AIHW has the responsibility to develop a comprehensive nutrition monitoring and 
surveillance system for Australia, which is one of few developed countries not to have 
such a system in place. The first major monitoring activity scheduled is a national 
dietary survey in 1994-95, in conjunction with the next ABS National Health Survey. 
Table 1.24: Nutrient intake differences between children of English-speaking and non-English-
speaking backgrounds, 1985 
N u t r i e n t / S e x 
. P e r c e n t < 0.7 R D I 
N o n - E n g l i s h E n g l i s h 
I r o n 
Female 27 32-42 
C a l c i u m 
Female 45 56 
Male 33 47 
Source: AIHW unpublished data 
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Table 1.25: Mean daily nutrient intake, Australian and Vietnamese women 
Nutrient 
Australian 
women, 1988 
Vietnamese migrant 
women, Adelaide 1989 
Number of respondents 2,410 200 
Protein (g) 73.6 89.8 
Fat(g) 76 55 
Carbohydrate (g) 192 249 
Dietary fibre (g) 19.3 15.5 
Energy value (kJ) 7,386 7,530 
Calcium (mg) 712 520 
Iron (mg) 11.2 10.2 
Retinol equivalents (\ig) 1,362 179 
Vitamin C (mg) 102 101 
Thiamin (mg) 1.04 1.25 
Riboflavin (mg) 1.76 1.18 
Niacin equivalents (mg) 28.6 17.0 
Zinc (mg) 10.2 10.8 
Sources: Baghurst, Syrette & Tran 1991; CSIRO Division of Human Nutrition unpublished data 
1.4.2 Other major risk factors for disease 
Risk factors are attributes, exposures or other factors that are believed to increase the 
risk of ill-health. Australia's health 1992 listed risk factors associated with major causes of 
morbidity, disability and death. It also provided prevalence estimates for selected risk 
factors using data from the 1989 National Heart Foundation Risk Factor Prevalence 
Survey (RFPS) and the 1989-90 ABS National Health Survey (NHS), which are still the 
most recent sources of national data on risk factors. This section reviews further data 
from these surveys and from other recent Australian studies. It deals with risk factors 
mainly from the perspective of heart disease. 
Cholesterol 
The National Heart Foundation defines a plasma cholesterol level of over 5.5 mmol /L 
as indicating an increased risk of heart disease for adults, and one of over 6.5 mmol /L 
as indicating a high risk of coronary heart disease (CHD). The 1989 RFPS (Risk Factor 
Prevalence Study Management Committee 1990) found that among people aged 20 to 
69 years, 47% of men and 39% of women had plasma cholesterol levels of 5.5 mmol /L 
or more, and 16% of men and 14% of women had levels of 6.5 mmol /L or more. 
The Australian Consensus Panel for the Management of Hyperlipidaemia (raised levels 
of cholesterol and other blood lipids) has stated that there is strong scientific evidence 
linking blood cholesterol level with the development and progression of atherosclerosis 
and subsequent CHD (Consensus Panel 1992). This panel recommended that dietary 
modification, by restricting total and saturated fat intake, should be the first step in 
treatment for people with high blood cholesterol. Together with moderate physical 
exercise, this dietary modification should reduce body fat, particularlv abdominal body 
fat. 
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Blood pressure 
Hypertension (high blood pressure) is an independent risk factor for CHD and stroke 
(MacMahon et al. 1990). The National Heart Foundation's 1989 RFPS defined 
hypertension as systolic blood pressure of 160 mmHg or greater and/or diastolic blood 
pressure of 95 mmHg or greater and /or receiving treatment for blood pressure, and 
estimated that 18% of men and 14% of women are hypertensive. The prevalence of 
hypertension increases steadily with age in both sexes. 
The (New South Wales) Lower Hunter Stroke Study provides evidence of the 
importance of hypertension in stroke in people aged 35 to 69 years (Al-Roomi et al. 
1992). The risk of first stroke for those being treated for high blood pressure was 3.1 
times that for people not being treated for high blood pressure. Further, those being 
treated for high blood pressure were 5.5 times more likely to suffer a haemorrhagic 
stroke and 2.5 times more likely to suffer a non-haemorrhagic stroke than those not 
being treated for high blood pressure. 
Smoking 
It has long been acknowledged that cigarette smoking is a major cause of 
cardiovascular disease (United States Department of Health and Human Services 1983). 
A recent Australian study (Chun, Dobson & Heller 1993) examined the effect of 
smoking on the incidence of CHD in men and women aged 35 to 69 years. It found that 
men who are current smokers had 2.9 times the age-adjusted risk of a first coronary 
event (fatal or non-fatal) in non-smokers. The corresponding risk for female current 
smokers was 3.5 times. 
Box 1.10: Measuring obesity 
Measurements in surveys must be taken according to precise instructions so that they are 
reproducible, and comparable between observers and survey centres. In the 1989 Risk 
Factor Prevalence Study, participants were measured wearing light street clothing, 
including socks or stockings, but without shoes, coats, jumpers, belts or sashes. Measured 
heights were not adjusted, but 1 kg was deducted from measured weight to allow for the 
clothing. 
Body mass index (BMI) is calculated as weight in kilograms divided by the square of height 
in metres: 
• Underweight was used to describe a BMI of less than 20.0. 
• Acceptable weight was used to describe a BMI of 20.0 to 25.0 inclusive. 
• Overweight was used to describe a BMI of over 25.0 up to and including 30.0. 
• Obese was used to describe a BMI of over 30.0. 
Waist-to-hip ratio (WHR) is, as its name suggests, calculated as the ratio of waist and hip 
measurements. Waist circumference was measured at the end of normal expiration around 
the narrowest point between the ribs and the hips when viewed from the front. Hip 
circumference was measured at the point of maximum extension of the buttocks when 
viewed from the side. Both measurements were taken in the horizontal plane, and the skin 
was not compressed. Two measurements were taken of each with a metal tape, recorded to 
the nearest 1 cm, and averaged. 
Pregnant women were excluded from the calculations for both measures. 
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There is also mounting evidence that passive smoking is associated with increased risk 
of heart disease (Steenland 1992). In a study of residents of the lower Hunter region of 
New South Wales aged 35 to 69 years, Dobson et al. (1991) estimated that 13% of 
non-smoking (both never smokers and ex-smokers) healthy men and 19% of 
non-smoking women were exposed to tobacco smoke at home. The prevalence of 
passive smoking at work was similarly estimated to be 44% for non-smoking men and 
37% for non-smoking women. Exposure to passive smoking at home was found to be 
associated with excess risk of heart attack or death for both sexes. 
Excess weight for height 
Overweight and obesity are risk factors for many diseases including CHD (Pi-Sunyer 
1991). It has been suggested that abdominal obesity, as measured by waist-to-hip ratios 
(WHR, see Box 1.10), may be a better indicator of risk of developing CHD than 
whole-body measures such as body mass index (BMI) (Bjorntorp 1992; Karmel et al. 
1991). 
Boyle et al. (1993) analysed data from the 1989 RFPS to provide 'normal' values for 
WHR ratios in Australian men and women. Mean WHR was 0.89 for men and 0.76 for 
women. A WHR of 1.0 for men and 0.9 for women is indicative of excessive abdominal 
obesity (Bray 1987); 5.2% of men and 2.6% of women had a WHR above these levels. 
WHR increased with age in both men and women. For men, most change in WHR 
occurred before age 45 whereas for women the change was greatest after age 50 
(Figure 1.22). 
Mean WHR 
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Source: Adapted from Boyle et al. 1993 
Figure 1.22: Average waist-to-hip ratio by age and sex 
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There were some differences between the patterns of WHR and BMI. For example, 
average WHR was highest for men in Brisbane and Darwin, despite the fact that these 
men had relatively lower BMI. Asian-born women had low BMI but had a relatively 
high average WHR. 
WHR and BMI were examined also in relation to other risk factors. High values of both 
WHR and BMI were found to be associated with lower socioeconomic status and lack of 
exercise. For men, WHR and BMI increased with increasing alcohol consumption, and 
BMI decreased with cigarette smoking. Among women, both WHR and BMI increased 
with smoking and, although mean BMI decreased with alcohol consumption, a 
U-shaped association was observed between WHR and alcohol consumption. 
Alcohol 
Excess alcohol intake is associated with many chronic diseases and conditions such as 
CHD, stroke, hypertension, and certain types of cancer (Kannel 1988; Regan 1990; WHO 
Study Group on Diet 1990). In addition, excess consumption of alcohol can cause 
diseases such as liver cirrhosis, alcohol-related brain damage and alcoholic 
cardiomyopathy (WHO Study Group on Diet 1990). Light to moderate alcohol intake, 
however, has been shown by many epidemiological studies to be protective against 
CHD (Rimm et al. 1991; Marmot & Brunner 1991). 
Cullen, Knuiman & Ward (1993) used data from Busselton, Western Australia, to 
examine mortality in 2,171 subjects aged 40 years and over during a 23-year period. 
Busselton men and women who were moderate drinkers (mean intake of 49.8 g /day for 
men and 35.5 g /day for women) had a lower risk of mortality from all causes than 
non-drinkers (Table 1.26). This was also true for cardiovascular disease mortality and 
for CHD death. Fewer than one quarter of the abstainers in the Busselton study were 
ex-drinkers, suggesting that the proportion of non-drinkers who may have stopped 
drinking for health reasons was small. 
A survey of public perception of the risks and benefits of alcohol consumption, and the 
understanding of recommended safe levels of alcohol consumption, was undertaken in 
1989 (Hall, Flaherty & Homel 1992). In household interviews of 500 adults aged 18 to 65 
years, in metropolitan and rural New South Wales, 46% reported that they had not 
consumed any alcohol in the past week, 48% were 'safe' drinkers', 3.6% were 
'hazardous' drinkers and 2.4% were 'harmful' drinkers as defined by the NHMRC 
guidelines (see Box 1.12, page 64). 
Over 35% of the sample wrongly identified alcohol as the drug responsible for most 
drug-related deaths (Holman et al. (1988) estimated tobacco to be the cause of most 
drug-related deaths). One quarter believed that some health benefits, such as relaxation 
and stress reduction, could be derived from alcohol use. 
'Having a drinking problem' was interpreted by 35% of the sample as drinking to 
excess, and 81% of respondents believed that people who frequently drove a car with a 
blood alcohol limit of over 0.05 had a 'drinking problem'. 
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Table 1.26: Adjusted relative risks for 23-year all-cause mortality (1966 to 1989), Bussleton WA 
cohort study, by baseline alcohol consumption 
Alcohol consumption category 
Number of 
subjects 
Number of 
deaths 
Adjusted 
RR<a> 
95% confidence 
interval 
Men (mean intake g/day) 
Non-drinker (0) 154 96 1.00 
Ex-drinker (0) 79 47 0.98 0.68-1.41 
Mild (8.9) 517 272 0.84 0.66-1.08 
Moderate (49.8) 335 170 0.71 0.54-0.94 
p for trend 0.01 
Women (mean intake g/day) 
Non-drinker (0) 480 226 1.00 
Ex-drinker (0) 26 9 1.28 0.64-2.57 
Mild (4.6) 482 175 0.95 0.77-1.17 
Moderate (35.5) 98 26 0.85 0.55-1.32 
p for trend 0.45 
(a) Relative risk adjusted for age, sex, occupation, smoking, blood pressure, probable or suspected coronary 
heart disease, forced expiratory volume, diabetes, cholesterol, uric acid and treatment for hypertension. 
Source: Cullen, Knuiman & Ward 1993 
Women were more likely than men to overestimate the number of drinks that could be 
consumed with low risk to the health of someone of their own sex. For both men and 
women, the more they drank, the more they estimated themselves to be at low risk, and 
the higher their level of education, the less they estimated themselves to be at low risk. 
Box 1.11: The risk of drinking 
In the 1989 Risk Factor Prevalence Survey, questions were asked about both frequency and 
quantity of alcohol consumption. These were then used to categorise drinking, separately 
for women and for men, on a scale ranging from 'no risk' to 'very high risk'. The categories 
and the associated terminology were: 
Risk category 
Men Women 
Non-drinkers None None 
Average daily intake of less tlian 3 drinks None Low 
Average daily intake of 4 drinks, or 9-12 drinks in any day Low Intermediate 
Average daily intake of 5-8 drinks, or occasional excess Intermediate Nigh 
Average daily intake of 9-12 drinks, or frequent or great 
occasional excessive intake High Very high 
Average daily intake of over 12 drinks Very high Very high 
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Box 1.12: Safe drinking 
In 1992 the NHMRC published revised guidelines for preventing alcohol abuse (National 
Health and Medical Research Council 1992b): 
That the concept of a standard drink, or unit, containing approximately 8-10 g of absolute 
alcohol be adopted for clinical and educational purposes. 
That the following guidelines be promoted as consistent with responsible drinking: 
• that the consumption of alcohol by men should not exceed 4 units or 40 g of absolute 
alcohol per day on a regular basis, or 28 units per week; that 4-6 units per day or 28-42 
units per week be considered as hazardous and that more than 6 units per day or 42 
units per week be regarded as harmful; 
• that the consumption of alcohol by women should not exceed 2 units per day or 14 units 
per week on a regular basis; that 2-4 units per day or 14-28 units per week be 
considered as hazardous, and that more than 4 units per day or 28 units per week be 
considered harmful; 
• that binge drinking is potentially iiazardous; 
• that all people have at least two alcohol-free days each week; 
• that abstinence be promoted as desirable in pregnancy; 
• that people who intend to drive, operate machinery or undertake activities in hazardous 
or potentially hazardous situations shoidd not drink; and 
• that specific information be given to drinkers of practical ways of reducing alcohol 
consumption in social situations. 
Physical activity 
Physical inactivity is a risk factor for the development of coronary artery disease and 
for mortality from it. Exercise may help to control blood lipid abnormalities, diabetes, 
obesity and hypertension, and may be protective against osteoporosis (Fletcher et al. 
1992; WHO Study Group on Diet 1990). The 1989 RFPS found that 27% of men and 
women had not undertaken any exercise during leisure time in the two weeks prior to 
interview (Risk Factor Prevalence Study Management Committee 1990). 
Multiple risk factors 
The 1989 RFPS (Risk Factor Prevalence Study Management Committee 1990) examined 
the three major established risk factors for cardiovascular disease—high blood 
pressure, high blood cholesterol, and cigarette smoking—as multiple risk factors within 
individuals. The definitions used were: 
• high blood pressure: diastolic blood pressure > 95 mmHg 
• high blood cholesterol: plasma cholesterol > 6.5 mmol/L 
• cigarette smoking: smoking one or more manufactured and/or 'hand-rolled' 
cigarettes daily (cigar and /o r pipe smoking is not included). 
The proportion with at least one major risk factor is shown in Figure 1.23. In all, 42% of 
men and 35% of women had at least one of the three major risk factors, with the 
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prevalence of one or more risk factors generally increasing with age; 8% of men and 5% 
of women had two or more of the major risk factors. 
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Source: Risk Factor Prevalence Study Management Committee 1990 
F igure 1.23: Proportion of men and women with at least one major risk factor (high 
blood pressure or high blood cholesterol or cigarette smoking) 
Chun, Dobson & Heller (1993) found that men who smoked and also had a history of 
hypertension were 4.6 times more likely to suffer a coronary event (fatal or non-fatal) 
than non-smokers without a history of hypertension. The equivalent figure for women 
was 7.9 times. 
Setting goals and targets is generally recognised as good management practice. In the 
health area, goals and targets indicate the desired direction and pace of change in 
pursuing improvements in the health of the population. Nutbeam et al. (1993) noted: 
'They are intended to inspire, to motivate, and to encourage cooperation among all 
those individuals and sectors whose actions affect the health of the community. 
National goals and targets support decisions about national health priorities and 
provide a mechanism to monitor and review progress — a means of assessing the 
effectiveness of the combined actions taken to improve the health of all Australians.' 
Stevenson (1993) defined the main components of a set of goals and targets. A goal is a 
broad statement of a desired improvement in the health of the population. An example 
of a goal is: 'To reduce the impact of coronary heart disease on the health of 
Australians.' 
1.5 National health goals and targets 
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An indicator is a specific and measurable way of assessing progress towards the goal. A 
goal may have more than one indicator. For example, indicators which could be used 
with the above goal are mortality rates and morbidity rates from heart disease. 
A target is the value of the indicator which will be regarded as a measure of 
achievement of the goal. For example, Nutbeam et al. (1993) included a 30% reduction 
in mortality from heart disease among men aged 30 to 64, by the year 2000, as a target. 
Development of health goals and targets for Australia 
In 1985, the Commonwealth Government established the Better Health Commission, 
which reported in 1986. Health goals and targets in a number of areas were included in 
its report. Later, the Australian Health Ministers' Advisory Council established the 
Health Targets and Implementation (Health for All) Committee. Its principal task was 
to develop a set of health goals and targets, with the aim of reducing inequalities in 
health. The 1988 report from this Committee contained a set of goals and targets that 
focused on specific population groups, major causes of illness and death, and risk 
factors. It later became apparent that not only had these goals and targets not been 
adopted and used by the mainstream health professions, but that they were also not 
helpful in addressing the underlying causes of ill-health. 
As a result, a new and more comprehensive set of National Health Goals and Targets 
(NHGT) was developed by Nutbeam et al. (1993). Subsequently, an expert group was 
established to develop a strategy for finalising and implementing the NHGT. Its key 
tasks were to select areas of focus for national agreement and action, and to establish 
implementation groups for each area. At the April 1993 Health Summit, the Australian 
Health Ministers agreed to four areas for implementing NHGT: cardiovascular disease, 
cancers, injury and mental health. 
A core function of AIHW is to monitor and report on progress towards the new range of 
national health targets. Without a clear mechanism and systematic approach to 
monitoring and formal reporting, these goals and targets will remain no more than an 
interesting set of proposals. 
The Institute has therefore stressed the need for a uniform and integrated approach to 
further development, and the implementation and monitoring of the NHGT. It has 
reviewed the data and associated monitoring requirements for the goals and targets 
proposed by Nutbeam et al. (1993) and has assisted in the data provision for the expert 
implementation groups for each area of focus, which are due to provide provisional 
reports in March 1994. The groups are responsible for recommending a final set of goals 
and targets and for developing five-year implementation plans. Under the Medicare 
Agreements, this process will be completed by 1 July 1994. 
Issues in goal and target setting 
The development of goals, indicators and targets will vary according to the specific 
subject area and is primarily a matter of judgement by subject matter experts. However, 
the application of good statistical practice to their development will help ensure that the 
goals and targets are attainable, and will enhance their use as health policy tools. 
Stoto (1990), Stevenson (1993) and Mathers, d'Espaignet & Stevenson (1993) have 
examined the issues involved in setting health goals and targets. These are discussed 
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below and illustrated with an example—the development of a target for coronary heart 
disease. 
Criteria for setting national health goals 
Criteria for setting national health goals should include: 
• the public health significance of the goal; 
• the availability of and the will to implement effective and efficient interventions to 
achieve the goal; and 
• the availability of a measurable health indicator relating to the goal. 
The second criterion is sometimes overlooked. Goals should be a statement of an 
objective we are consciously seeking to attain through intervention, whether that be 
health promotion campaigns, prevention programs, or treatment programs. If there is 
no strategy or set of interventions aimed to address a health problem, a goal should not 
be set. Similarly, if there are known effective interventions for a health problem, but the 
will does not exist to implement them or if they are unacceptable to the community, 
there is no point in setting a goal. 
A national goal for coronary heart disease satisfies all three criteria—it is a leading 
cause of death for Australians, there are known risk factors which can be addressed, 
and there are suitable indicators. 
Choosing the indicator 
The primary issues in choosing indicators for health goals are that the indicators need 
to: 
• be valid; 
• be defined in a standard manner; 
• be able to be measured; and 
• have at least quasi-national and comparable data available at suitable intervals for 
monitoring purposes. 
Validity 
An indicator needs to have validity—that is, fidelity in measuring progress towards the 
goal. The indicator must be interpretable and its values must be meaningful in relation 
to the goal. For example, an age-standardised mortality rate for coronary heart disease 
is directly interpretable as measuring changes in mortality rates, excluding the effects of 
changes in the population age structure, and as a meaningful and interpretable 
indicator of progress towards a goal of reducing the impact of coronary heart disease. 
Proxy indicators and process indicators may also be appropriate for some goals, as long 
as they are interpretable and bear a meaningful relationship to the goal. For example, 
using apparent consumption of fat per capita may be an acceptable indicator for 
monitoring a dietary goal. A process indicator may be appropriate where it relates 
directly to a major intervention strategy and where the causal link between the process 
and the outcome (referred to in the goal) is well established. An example is the 
proportion of women who have had a screening mammogram in the last three years, as 
an indicator for a goal to prevent breast cancer. 
Indicators need to be chosen carefully to reflect the nature of the health goals to which 
they refer. Incidence measures are preferable for prevention activities that seek to avoid 
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new occurrences of a health problem or acquisition of a risk behaviour, whereas 
prevalence measures are preferable for goals that seek to reduce the impact of a health 
problem or risk factor. In practice, the choice of indicator is limited by the kinds of data 
that are available and prevalence measures may have to be used as proxies for 
incidence measures. 
Definition of an indicator 
The indicator should be defined in the way most suitable for monitoring progress 
towards the goal. For example, a target for serum cholesterol could be phrased as 'to 
achieve a mean blood cholesterol level among men aged 20 to 69 of 5.5 mmol/L'. 
Definitions are arrived at after consultation with experts in the field and recommended 
for use in all data collections unless there are adequate reasons for not doing so. This is 
to ensure that the same information is collected on an activity or status, irrespective of 
where collection occurs. The National Health Data Dictionary (see Section 5.1, page 203) 
is an appropriate vehicle for disseminating information on recommended indicators. 
This approach provides a useful framework for coordinating statistical definitions in 
population health monitoring work being carried out at Commonwealth and State and 
Territory level. 
As well as definitions relating to classification, such as smoker/non-smoker, there is a 
need to establish standards for the construction of indicators, such as the standard 
population for use in age-standardisation of indicators. Additionally, since some 
indicators will be based on data collected through sample surveys, there may be a need 
to agree on standard instruments, for example preferred questionnaire wording, as well 
as on standard definitions and classifications. 
Measurement of an indicator 
An indicator is useful only if it can be measured. For example, it may not be appropriate 
to establish a national goal for reducing pain in the Australian population (desirable 
though that goal may be) unless there is a validated measurement instrument which 
can be used to construct an indicator of pain at the population level. 
Data availability for monitoring 
In order to measure progress towards national health goals, data for a measurable 
health indicator must be available for a national or quasi-national population over time. 
National data collections such as the AIHW mortality databases should be used where 
relevant. If national data are unavailable, quasi-national data may be used. For 
example, data from two or three States might be aggregated, or the National Heart 
Foundation Risk Factor Surveys of capital city residents could be used. However, the 
coverage of such an indicator must be sufficient to give it credibility as a measure of 
progress towards a national goal. Data from small-scale surveys do not have this 
credibility. 
In addition, data must be available on a comparable basis at repeated time intervals if 
progress towards a goal is to be monitored. For example, there are two main ways of 
measuring obesity (see Box 1.10 on page 60). Some authorities recommend using 
waist-to-hip ratio (WHR). This gives a more direct measure of abdominal fat, which is 
thought to be a more important health risk factor. However, WHR has not been widely 
assessed in populations, so baseline data is less likely to be available than for body mass 
index, which has been widely used for a longer time. Hence, choosing an indicator of 
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obesity requires consideration of the trade-off between using one measure with readily 
available baseline data and another possibly more appropriate measure with less 
readily available baseline data. 
Data from the ABS National Health Survey will be available at five-year intervals, 
probably the maximum time between measurements that is useable for monitoring 
progress towards a goal. Even then, it will be barely possible to measure progress 
towards year 2000 goals using such data, as there will be only two national health 
surveys between now and the year 2000. A substantial change in an indicator between 
1994-95 and 1999-2000 may be encouraging, but it will be difficult to be sure that we 
have made progress until further indicator values confirm that a trend is real. 
Each indicator should be accompanied by documentation of the data sources used in its 
formulation. If no data currently exist, a suitable strategy for obtaining them should be 
identified. Examples of such strategies may be to include questions annually on the 
ABS Population Survey Monitor to supplement the five-yearly data from National 
Health Surveys or to explore further the coordinated use of telephone interviewing by 
State health authorities. 
An indicator for coronary heart disease 
Several indicators are suitable for use with goals for coronary heart disease, but we will 
concentrate on the simplest—mortality from coronary heart disease. This indicator is 
unambiguously defined and, since mortality data in Australia are routinely collected 
and published, it is easily monitored. 
The patterns of the disease are different for men and women, so the indicators should 
be measured separately by sex. As we are most interested in preventing premature 
death, the example will exclude the elderly. The indicator will be the annual 
age-standardised death rate from coronary heart disease for men aged 30 to 64 years, 
with the rates standardised to the 1988 Australian population. 
Specifying target values 
Setting target values is primarily a matter of judgement by subject matter experts, but 
there are some statistical principles and techniques which can help. 
Statistical modelling can help form judgements about the target values and dates. At 
the simplest level, models can estimate an underlying trend and projection for the 
indicator. The implication is that targets should usually be more favourable than the 
figure suggested by the trend analysis. 
For example, trend analyses carried out at the AIHW show that the estimated current 
annual average fall in coronary heart disease mortality among men aged 30 to 64 is 
approximately 5.5%. Thus, on current trends, the target value should require an average 
annual fall in mortality of at least 5.5%. 
Such analyses can assist decision makers in selecting meaningful and attainable targets. 
More complex modelling can examine the relationship between different indicators and 
between indicators for different population subgroups. This can help decision makers 
arrive at a range of coherent and feasible targets. 
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The form of the target 
The final target value can be expressed as either an absolute value or a percentage 
change. Nutbeam et al. (1993) use both formulations. The absolute target value is 
generally preferred because it is unambiguous, easier to monitor and generally has a 
greater impact on policy makers. However, if percentage reductions are used, care must 
be taken in their measurement. The inherent variability in most indicators means that 
simply looking at the difference between a baseline value and a single monitoring value 
may give a misleading idea of the indicator's rate of change. The change in an indicator 
must be measured over several years so that the effect of year-to-year chance variation 
can be removed from the estimate of underlying change. 
Setting a target for coronary heart disease 
The target for mortality from coronary heart disease will be expressed as an 
age-standardised number of deaths per 100,000 population. Nutbeam et al. (1993) have 
two target dates for coronary heart disease—the years 2000 and 2010. We will discuss a 
target for the year 2010. 
Deaths per 100,000 population 
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Figure 1.24: Coronary heart disease, tnales aged 30 to 64 years, actual, fitted and 
projected death rates per 100,000 population, 1979 to 2010 
Figure 1.24 shows the results of a trend analysis for our indicator. The analysis was 
done in three steps. First, the average annual percentage fall in the death rate for 1979 to 
1992 was estimated. Then a fitted trend for 1979 to 1992, based on this average fall, was 
calculated from the model. Finally, a projected trend was calculated for 1993 to 2010 
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using the assumption that the estimated average annual fall in the death rate would 
continue to apply for this period. In addition, the 1992 death rate was tested to see if it 
was statistically significantly different from the fitted line. 
This analysis represents the assumption that the average annual fall in mortality 
achieved over recent years can be maintained into the future. If this is the case, the 
projected age-standardised death rate by the year 2010 for males aged 30 to 64 years is 
36.7 deaths per 100,000 population. The 1992 death rate was not statistically 
significantly different from the fitted line. Hence, there is no reason to believe that the 
average annual fall in mortality cannot be maintained at least for the immediate future. 
The actual value of the target for our indicator is a matter for judgement by experts in 
coronary heart disease. However, in the light of this analysis, an appropriate target 
value should at least be less than 37 deaths per 100,000 population by the year 2010. 
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2 Important causes of ill-health 
in Australia 
2.1 Communicable diseases 
Communicable diseases preventable by immunisation 
Although the impact of diseases preventable by immunisation has been much reduced, 
the diseases have not been conquered. 
Measles is a case in point. Between 1921 and 1925, it was responsible for the deaths of 
508 Australian children up to 14 years, at a mortality rate of 5.7 per 100,000 per year. 
Twenty years later, between 1941 and 1945, it was responsible for the deaths of 307 
children at a rate of 3.5 per 100,000 per year. Twenty years later again, between 1961 
and 1965, by which time antibiotics were readily available, measles killed 90 children at 
a rate of 0.6 per 100,000 per year. Then, between 1981 and 1985, by which time 
immunisation had been available for many years, it killed 18 children at a rate of 0.1 
per 100,000 per year. For this last period it is also possible to identify deaths from 
subacute sclerosing panencephalitis (SSPE), a delayed complication of measles; there 
were 22 additional deaths from this condition. 
Since 1989, deaths from both measles and SSPE have become less frequent—there were 
only four measles and two SSPE deaths in children between 1989 and 1992. There were, 
however, 1,380 cases of measles notified in 1991, the first year the disease was notifiable 
in all States and Territories. 
A high level of immunisation is important if measles is to be controlled. A survey of 
reported measles immunisation was conducted among children enrolling in 
kindergarten classes in the eastern Sydney area in 1989 (Ferson & Christie 1992). 
Information was collected for 2,230 children from an enrolment of 2,738 (81% of total). 
The proportion reported as fully immunised with measles-mumps vaccine was 91%. 
This proportion was significantly lower among public school children than among 
those attending other schools. Among children attending public schools, those from 
English-speaking families were more likely to be reported as immunised than those 
from non-English-speaking families. 
The 1989-90 National Health Survey similarly found that approximately 90% of 
children aged 1 to 6 years were reported as fully immunised against measles. 
However, the reports were not necessarily correct. Causer et al. (1993) have found a 
higher prevalence of measles antibody in children in whom measles immunisation was 
documented than in children in whom immunisation was reported but could not be 
documented (Figure 2.1). Although the numbers in the latter group were small, the 
lower prevalence of antibody does cast doubt on unsupported parental reports of 
immunisation, and provides some justification for regarding these children as 
unimmunised for purposes of exclusion from schools and preschools during 
epidemics. 
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P e r c e n t a n t i b o d y p o s i t i v e 
Measles Mumps Rubella 
| Documented immunisation 
| Reported immunisation 
Source: Causer etal. 1993 
Figure 2.1: Prevalence of immunity to measles, mumps and rubella in a sample of 
preschool children with documented or reported immunisation 
The other infectious diseases of childhood also still cause deaths. Between 1980 and 
1992 there were 14 deaths (all under one year) from pertussis (whooping cough). Lester 
& Nolan (1993) examined statistics of vaccine use, concluding that 89.3% of Victorian 
children received three injections in their primary immunisation (three injections of 
diphtheria-pertussis-tetanus vaccine are recommended). However, 4.6% of infants 
were receiving diphtheria-tetanus vaccine rather than a third dose of 
diphtheria-pertussis-tetanus vaccine, thus being inadequately vaccinated against 
pertussis. 
Also between 1980 and 1992, there were 24 deaths from hepatitis B, 2 from mumps, and 
119 from Haemophilus influenzae B meningitis. There were no deaths from rubella, 
although 620 cases of rubella were notified in 1991. Nor were there any deaths from 
diphtheria; the epidemic of 150 cases in the Northern Territory between 1985 and 1988 
was of skin diphtheria. 
Effective prevention can require more than promoting immunisation in those who will 
benefit by it. There can also be problems arising from immunisation of those who do 
not need it. Macintyre, Carnie & Plant (1993) have reported that 47% of the influenza 
vaccine supply for Victoria in 1992 was administered to people at low risk. This figure 
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is of concern, since vaccine supplies ran short in that year, and some at high risk were 
unable to be immunised. 
Sexually transmitted diseases 
Most information on sexually transmitted diseases, other than on HIV infection and 
AIDS which are considered separately below, comes from statistics of notifiable 
diseases. 
Table S21 on page 235 gives national statistics of all notifiable diseases from 1987 to 
1992. It shows that there were 2,908 notifications of gonococcal infection in 1992. 
Notifications of gonococcal infection decreased until 1990, but have increased by 52% 
since then. This apparent reversal of trend must be interpreted with care, as the 
introduction of laboratory notification in 1991 may have substantially increased the 
proportion of cases reported (Communicable Diseases Network—Australia 1993). 
Most of the notifications of gonococcal infection related to sexually transmitted 
gonorrhoea, but there were 27 infections in infants in 1991, and some non-sexually 
transmitted infections. Sex of the patient was not always reported, but was available 
for 1,750 males and 720 females; this sex ratio may be because gonorrhoea often does 
not cause symptoms in females. The highest notification rates per 100,000 population 
were at 20 to 24 years in both sexes. 
Notifications of syphilis, the next most frequently reported sexually transmitted 
disease, increased by 54% between 1990 and 1992. As with gonorrhoea, this may 
represent more complete notification, as laboratory notification of syphilis was 
introduced following a period of decline in cases notified. However, there was a very 
different sex ratio. In 1991 there were 1,052 infections known to have been in males and 
962 in females. The highest infection rates were at 25 to 29 years in males and 15 to 19 
years in females. 
Chancroid, donovanosis, and lymphogranuloma venereum are not notifiable diseases 
in New South Wales, South Australia or Tasmania, and lymphogranuloma venereum is 
also not notifiable in Western Australia. There were 78 cases of donovanosis notified in 
1992, five of chancroid and three of lymphogranuloma venereum. The last previous 
notifications of lymphogranuloma venereum had been in 1986. 
Notifications of sexually transmitted diseases in each State and Territory in 1991 are 
shown in Table 2.1. Converting these numbers to notification rates per 100,000 
population yields rates ranging from 441 in the Northern Territory to 3 in the 
Australian Capital Territory and in Tasmania. There is similar variation for syphilis, 
from 276 per 100,000 population in the Northern Territory to 2 in Victoria, the 
Australian Capital Territory and Tasmania. The ratio of syphilis infections to 
gonococcal infections does not vary greatly by State, and much of the apparent 
variation in incidence between States appears to reflect variation in the proportions of 
cases that are notified. There is thus great scope for improvement in these important 
statistical collections. 
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T a b l e 2.1: Number of cases of selected notifiable diseases, by State or Territory, 1992 
Disease NSW Vic Qld WA SA Tas ACT NT Aust 
Chancroid nn 1 1 2 nn nn 1 - 5 
Donovanosis nn - 17 24 nn nn - 37 78 
Gonococcal 
infection ( a ) 480 228 620 814 165 9 9 583 2,908 
Lymphogranuloma 
venereum nn 3 
-
nn nn nn 
-
-
3 
Syphilis 891 39 687 316 92 
-
11 659 2,695 
nn Not notifiable 
(a) Vic, Qld, SAand NT include gonococcal neonatal ophthalmia. 
Source: Communicable Diseases Network Australia and New Zealand, National Notifiable Diseases 
Surveillance System, personal communication 
AIDS 
Previous issues of Australia's health have described how the AIDS epidemic is made up 
of sub-epidemics in largely separate population groups, and how, in those infected by 
blood transfusion, the sub-epidemic has already passed its peak. More recent data 
relating to these sub-epidemics are shown in Table S23, page 259. 
It now appears that both the epidemic as a whole and the major sub-epidemic, in 
homosexual and bisexual men, may be at their peak. Figure 2.2 (page 82) shows the 
number of cases of AIDS by year of diagnosis. The number of cases notified in 1991 
exceeds the number of cases notified in 1992, even after adjustment of the latter for late 
notification. The 451 diagnoses of AIDS between January and September 1993 notified 
before 31 December 1993 are 4.4% more than the 432 diagnoses of AIDS between 
January and September 1992 notified before 31 December 1992. 
There were 178 diagnoses of newly acquired HIV infection in 1993 (Table 2.2), and this 
number has increased from 79 in 1991. The number of new infections that remain 
undiagnosed is necessarily unknown, but it is clear that there is no room for 
complacency over newly acquired infections. 
T a b l e 2.2: Newly diagnosed cases of HIV infection, by sex, 1991 to 1993 
Newly acquired ( a ) Other diagnosis Total HIV diagnoses 
Year Male Female Male Female Male Female Total ( b ) 
1991 77 2 1,173 73 1,250 75 1,418 
1992 140 8 957 84 1,097 92 1,206 
1993 171 7 733 69 904 76 996 
(a) Cases of newly acquired HIV infection were identified on the basis of a previous negative test within 12 
months of the diagnosis of infection or the report of an HIV seroconversion illness. 
(b) Total includes 6 people whose sex was reported as transsexual and 120 whose sex was not reported. 
Source: Source: National Centre in HIV Epidemiology and Clinical Research unpublished data 
8 1 
Number of cases 
800 
1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1 9 9 3 ( a ) 
Year 
(a) Projected number of cases if delays in notification were the same as in 1992. 
Source: National Centre in HIV Epidemiology and Clinical Research 
Figure 2.2: AIDS cases by calendar year of diagnosis 
The impact of HIV infections including AIDS is approximately 40 times greater for men 
than for women. The indirect cost impact is even further biased towards men, 
reflecting both disease incidence and forgone earnings factors. The 20-39 years age 
group accounted for the largest share (43%) of direct costs, followed by the 40-49 years 
age group. Shares of indirect and of total costs were similarly distributed by age group. 
The cost of AIDS 
The importance attached to a disease depends on how importance is viewed and 
measured. Mortality, morbidity and cost indicators can give different impressions of 
the burden of suffering a disease imposes on the community. Table 2.3 provides some 
summary indicators of the burden of suffering associated with HIV infection including 
AIDS. 
Only 0.31% of deaths are due to AIDS, and HIV infections including AIDS accounted 
for an only slightly higher proportion (0.47%) of total recurrent hospital expenditure in 
1989-90. Direct costs for personal treatment in hospitals, medical services, 
pharmaceuticals, and community care were estimated at $54.1 million in 1989-90. Non-
personal direct costs for prevention, research, screening, education and administration 
added a further $51.1 million in estimated health care costs. 
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Table 2.3: AIDS I HIV, burden of suffering, 1989-90 
Number Cost ($m) Per cent of total ( a ) 
Mortality 
Deaths ( b ) 390 0.31 
Potential years of life lost to age 75 11,056 
Morbidity and cost of health care 
Hospital admissions 7,765 46.5 0.47 
Hospital bed-days 35,951 
Medical consultations 65,532 1.9 0.04 
Pharmaceutical scripts 48,667 0.7 
Community care 5 0 
Prevention, research, screening, 
education, administration 51.1 
Total direct costs 105.2 
Indirect costs 
Forgone earnings due to premature death 117.2 
Absenteeism 11.5 
(a) Per cent of total relevant expenditure 1989-90, except for deaths which is per cent of all deaths in 1989. 
(b) Cause of death AIDS or toxoplasmosis or Pneumocystis carinii pneumonia. The number of deaths 
primarily due to HIV infection may therefore be underestimated. 
Sources: AIHW unpublished data; Antioch et al. 1992 
2.2 Cancer 
Cancer is a diverse group of diseases characterised by the proliferation and spread of 
abnormal cells. These abnormal cells invade and destroy surrounding tissue and 
spread (metastasise) to distant parts of the body. Cancer can develop from most types 
of cells, and each cancer has its own pattern of local behaviour and metastasis. 
Although some cancers share common risk factors, most cancers have a unique set of 
risk factors which can be responsible for the onset of the cancer. 
Each year, approximately 190,000 new cancer cases are diagnosed in Australia. A large 
proportion of these, 135,000, are non-melanocytic skin cancers which, if treated early, 
are not life-threatening. The other new cancers attack other body systems, and most are 
potentially fatal. Cancer accounts for 27% of male deaths and 24% of female deaths, 
second only to circulatory disease deaths. 
The registration of cancer is mandatory under legislation in each of the States and the 
Northern Territory, where the data are collated by cancer registries. The Australian 
Capital Territory operates under a voluntary reporting system to the New South Wales 
Registry, but is currently reviewing options for legislation. 
Cancer inc idence 
The cancer registries collect clinical and demographic information about people with 
newly diagnosed cancers. This incidence information is collected from hospitals, 
pathologists, radiologists, cancer treatment centres and nursing homes. Further 
demographic information related to deaths from cancer is collected from Registrars of 
Births, Deaths and Marriages. By combining information from these sources, cancer 
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registries are able to estimate State and Territory cancer incidence and mortality. The 
National Cancer Statistics Clearing House at the Australian Institute of Health and 
Welfare, in conjunction with the State and Territory cancer registries, further collates 
the information to produce national estimates of cancer incidence and mortality. These 
national estimates are available for 1982 to 1988 and provide the basis for the analysis 
that follows. 
Excluding non-melanocytic skin cancers (NMSC), there were 30,511 new cancers in 
males and 26,490 new cancers in females in 1988, with age-standardised incidence rates 
of 414.5 per 100,000 males and 297.5 per 100,000 females. In the same year, there were 
16,747 male deaths due to cancer at the age-standardised death rate of 234.7 per 
100,000, and 12,652 female deaths due to cancer at the rate of 137.7 per 100,000. These 
age-standardised rates mean that men have a 39% higher risk of being diagnosed with 
cancer, and a 70% higher risk of dying of cancer than do women. 
The risk of cancer is lowest in late childhood, and in adult life it increases with age. 
Figure 2.3 presents the age-specific incidence rates for all cancers. Males have the 
higher incidence beyond 55 years and females have higher incidence at 25 to 54 years. 
This reflects the fact that female-only cancers (of the cervix, uterus, ovary and breast) 
have an incidence almost three times that of the male-only cancers in this age range. 
The most common cancers in Australia are the NMSC. Details of these cancers are not 
recorded by all cancer registries as most of them are not histologically confirmed, or are 
not reported. These skin cancers, almost all of which are basal cell and squamous cell 
carcinomas, are often self-detected and are usually removed in doctors' surgeries by 
simple excision, curettage, or cryosurgery. Giles, Marks & Foley (1988) estimated, using 
survey methods, that the national age-standardised treatment rate for NMSC was 823 
cases per 100,000 per year. Over the age of 60 years, male NMSC rates were higher than 
female rates. 
The incidence of the other most common cancers is presented in Figure 2.4 (page 86). 
Lung cancer in men and breast cancer in women account respectively for 15.8% and 
24.8% of all cancers, and represent major focuses in public health campaigns. 
Trends in incidence have varied from cancer to cancer. Between 1982 and 1988, the 
incidence among women of cancer of the breast and of melanoma showed significant 
increases, and of lung cancer a somewhat lesser increase. In men, incidence of cancer of 
the lung fell slightly, but cancer of the prostate and melanoma of the skin showed 
significant increases (Figure 2.5, page 87). Other changes were increases in incidence of 
cancer of the oesophagus and of the lip in women, and in non-Hodgkin's lymphoma in 
men; only a small proportion of the last represents non-Hodgkin's lymphoma due to 
HIV infection. 
Mortality from cancer 
In cancer death rates, a most alarming trend is the rapid rise since the 1960s in female 
lung cancer, where the age-standardised death rate rose from 5.7 per 100,000 in 1966 to 
17.5 per 100,000 in 1992 (Figure 2.6, page 88), as a result of the increased cigarette 
consumption by women since the 1940s. There have been declines in lung cancer death 
rates in men (to 58.0 per 100,000 per year in 1992) but they remain three times those of 
women. The proportion of men smoking declined through the 1980s and into the 1990s 
and it is expected that this will reduce men's lung cancer death rates over the next 
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decade. Smoking rates in women have also declined but at a slower rate, which may 
curb the increase in women's lung cancer death rates. 
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Figure 2.3: Maligttant neoplasms (excluding non-melanocytic skin cancer), age-specific 
incidence and death rates by sex, 1988 
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Figure 2.4: Leading cancers (excluding non-melanocytic skin cancer), incidence and 
mortality, by sex, 1988 
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F igure 2.5: Major cancers, age-standardised incidence rates, by sex, 1982 to 1988 
Cancers of the lung, breast, cervix, and testis, and melanoma are currently being made 
a priority in public health campaigns, such as in the national screening programs for 
breast and cervical cancer. Outcome targets for the year 2000, for example to reduce 
8 7 
mortality and morbidity from cervical cancer by 30%, have been set. Related to these 
outcome targets is a series of risk factor targets, for example to reduce ultraviolet 
radiation exposure, which, if achieved, should reduce the impact of these cancers (in 
this case the incidence of melanoma). These and many other cancers represent a large 
cost to the community as well as to the individuals affected, as the management of 
cancer involves extensive treatment. 
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Source: AIHW unpublished data 
F i g u r e 2 .6: Cancer of the lung, age-standardised death rates, by sex, 1960 to 1992 
Survival following cancer 
Five-year relative survival ratios for cancer (these are the ratio of the proportion of 
cancer patients surviving five years and of the proportion of an age and sex matched 
population surviving five years) have generally improved in recent years. The South 
Australian Cancer Registry is at present the only Australian cancer registry to publish 
survival estimates. Its data indicate that the relative survival ratio for all cancers for 
males is 45%, and for females 57%. Of the most common cancers, for males, lung cancer 
has an 11% survival ratio, and for females, breast cancer has a much better outlook, at 
75% relative survival ratio. 
The South Australian Cancer Registry has noted significant improvements in survival 
from some cancers. For example, the five-year survival ratio for cancer of the cervix 
improved by 8% to 73% between cases diagnosed in 1977-82 and cases diagnosed in 
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1983-90; for prostate cancer, the improvement was by 7% to 67%; and for cancer of the 
oesophagus (one of the more lethal cancers), the improvement was by 8% to 15%. 
Improved results of treatment for cancers of the cervix and uterus and for Hodgkin's 
disease have also been observed over the last ten years. 
2.3 Cardiovascular disease 
Mortality 
Cardiovascular disease (CVD), which includes all diseases of the heart and the 
circulatory system, accounted for 54,912 deaths or 44.4% of deaths from all causes 
among Australians in 1992 (ABS 1993). Ischaemic heart disease (more commonly called 
coronary heart disease (CHD)) was the major cardiovascular cause of death, 
accounting for 25.5% of deaths from all causes. Cerebrovascular disease (stroke) 
accounted for 9.7% of all deaths and peripheral vascular disease for 2.7% of all deaths. 
There were 31,482 CHD deaths registered in 1992, representing 57.3% of total CVD 
mortality. The age-specific CHD death rate for males was consistently higher than that 
for females with the largest relative differences occurring for the age groups 25—14 
years and 45-54 years, where the male death rate was just over 4.5 times the female rate 
(Table 2.4). 
Death from stroke represented 21.8% of deaths from CVD in 1992, and 74.0% of all 
deaths from stroke were in people aged 75 years and over. 
Australia has experienced a great decline in mortality from CVD over recent decades. 
The decline in CHD mortality started during the late 1960s and the current annual 
decrease has been estimated at 3.2% in males and 2.1% in females (Bennett et al. 1992). 
Mortality from heart attacks (acute myocardial infarction), the major contributor to 
CHD mortality, is declining at an annual rate of 4.0% in men and 2.7% in women. 
Stroke mortality is currently declining at around 4.5% per year in both sexes. 
Tab le 2.4: Cardiovascular disease mortality, age-specific rates by sex and age group, 1992 (per 
1,000 population) 
Other CVD 
Ischaemic Cerebrovascular (ICD 390-405, 415- All CVD 
Sex / Age group (ICD 410-414) (ICD 430-438) 429, 440-459) (ICD 390-459) 
Men 
25-44 12 3 5 20 
45 -54 93 13 20 126 
55 -64 324 50 78 451 
65 -74 905 205 227 1,336 
75 and over 2,776 1,038 985 4,798 
Women 
25-44 3 3 3 8 
45 -54 20 14 10 44 
55-64 106 37 40 183 
65 -74 401 136 132 668 
75 and over 2,169 1,161 992 4,322 
Source: ABS 1993 
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The declines in mortality rates are reflected in declines in potential years of life lost 
(PYLL). In 1971, heart disease (primarily CHD) among males accounted for 18.9% of 
PYLL between the ages of 0 and 65 compared with 13.9% in 1989 (Jain 1992). For 
females, it contributed 10.9% of PYLL in 1971 and 7.9% in 1989. Cerebrovascular 
disease among females accounted for 6.0% of PYLL in 1971 and 3.0% in 1989. 
d'Espaignet (1994) has noted that, of those who died from CHD in 1971, 43.0% of men 
and 31.0% of women were aged less than 70. By 1991 these proportions had reduced to 
33.6% and 21.6% respectively. These reductions were greater than equivalent figures 
for all causes of mortality. 
Declines in CHD deaths have been attributed mainly to declines in incident cases 
which in turn have resulted from changes in the risk factor status of the population 
(Manson et al. 1992; Beaglehole 1990; Blackburn 1989; Rose 1989; Martin et al. 1989). 
Improved medical care and treatment has also contributed to reduced CHD mortality 
(Beaglehole et al. 1989; Martin et al. 1989). Declines in stroke mortality have also been 
attributed to a combination of primary and secondary prevention (Bonita & Beaglehole 
1993; McGovern et al. 1992; Bonita, Stewart & Beaglehole 1990). 
Table 2.5: Cardiovascular disease mortality, age-standardised rates™ by sex and selected 
countries, latest available year (per 1,000 population) 
Males Females 
Cardio­ Cerebro­ Cardio­ Cerebro­
Country Year vascular Ischaemic vascular vascular Ischaemic vascular 
Australia 1992 227 144 40 141 74 35 
Canada 1990 218 139 33 120 65 26 
Chile 1989 212 85 68 144 49 50 
France 1990 161 57 38 90 23 27 
Germany 1990 307 140 58 186 62 45 
Greece 1990 253 90 75 182 35 74 
Iceland 1991 244 161 47 121 67 32 
Ireland 1990 337 214 53 186 93 46 
Israel 1989 236 128 43 170 73 40 
Italy 1989 230 88 64 143 37 47 
Japan 1991 160 29 60 103 16 42 
Malta 1991 293 163 67 223 105 60 
Netherlands 1990 239 123 44 125 48 35 
New Zealand 1989 292 195 50 165 89 45 
Norway 1990 283 175 54 144 67 43 
Poland 1991 499 142 57 280 44 41 
Singapore 1990 262 147 76 180 84 66 
Spain 1989 206 68 59 141 27 48 
Sweden 1989 267 165 42 142 69 35 
Switzerland 1991 215 99 34 120 38 27 
UK 1991 286 191 55 164 87 48 
USA 1989 266 151 32 158 77 28 
Yugoslavia 1990 375 86 99 274 37 81 
(a) Age-standardised to World Standard Population. 
Source: World Health Organization 1993; AIHW unpublished data 
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Despite the declines in CVD mortality, Australia still compares unfavourably with 
many other countries. Australia's 1992 age-standardised death rates are compared with 
the latest available from selected other countries in Table 2.5. Australian CVD death 
rates are towards the lowest of those shown, but even so are 41% higher (males) and 
57% higher (females) than for France. Australia's relative position is different for the 
two major components of CVD. Australian ischaemic heart disease death rates are 
towards the highest of those shown in Table 2.5, and nearly 5 times greater (males), and 
over 4 times greater (females) than in Japan. Australian stroke death rates are towards 
the lowest of those shown, but those in Canada and the United States were 
approximately 20% lower for both sexes. 
Hospital morbidity data provide a measure of CVD morbidity based on separations 
from hospital. In 1989-90, there were 3,410,200 separations (220 per 1,000 population) 
from acute hospitals (Gillett, Liu & Solon 1993). CVD was the principal diagnosis for 
8% of these separations. CHD was the principal diagnosis for 34.8% of the CVD 
separations followed by diseases of the pulmonary circulatory system (23.2%) and 
stroke (13.3%) (Figure 2.7). 
Another source of morbidity data is provided by the regular series of population health 
surveys conducted by the Australian Bureau of Statistics. From the 1989-90 National 
Health Survey it is estimated that over 2 million people or 13.0% of the population had 
a recent and /or a long-term cardiovascular condition (ABS 1991). Hypertension and 
heart disease were the most commonly reported cardiovascular conditions. 
Morbidity 
ICD 401-405 
Hypertensive disease (3. .3%) 
ICD 390-398, 440-459 
Other diseases of the 
circulatory system (25.4' 
ICD 430-438 
Cerebrovascular 
disease (13.3%) 
ICD 410-414 
Ischaemic heart 
disease (34.8%) 
ICD 415-429 
Diseases of the pulmonary 
circulatory system (23.2%) 
Source: Gillett, Liu & Solon 1993 
Figure 2.7: Distribution of estimated CVD separations from acute hospitals, 1989-90 
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The prevalence of each cardiovascular condition increased rapidly with age (Figure 2.8, 
page 93). Men had a higher prevalence of heart disease than women for most age 
groups. Men 55 years and over had a higher prevalence of cerebrovascular disease than 
women, and women 45 years and over had a higher prevalence of hypertension and ill-
defined heart conditions than men. If all cardiovascular conditions are considered, 
women have a higher prevalence than men in all age groups except 35 to 44 years 
(Table 2.6). 
Table 2.6: Persons with cardiovascular conditions, by age group and sex, 1989-90 ('000 
persons) 
Sex / Type of 
condition 0-24 25-34 35-44 45-54 55-64 65-74 
75 and 
over 
All 
ages 
Males 
Hypertension 6.0 24.7 69.7 118.7 176.8 181.7 70.0 647.6 
Heart disease 8.0 3.4 10.7 24.0 68.6 78.7 46.9 240.4 
Atherosclerosis 
-
0.4 0.9 1.8 7.9 7.1 5.6 23.7 
Cerebrovascular 
d isease^ 0.7 0.3 2.2 2.3 11.7 19.6 12.2 49.0 
Other circulatory 5.3 4.1 7.1 14.3 33.7 40.0 24.2 128.6 
Ill-defined 19.1 4.4 11.5 11.9 17.7 26.9 26.0 117.4 
All cardiovascular ( c ) 38.4 36.2 95.6 153.2 248.7 262.1 136.4 970.6 
Females 
Hypertension 10.8 22.9 60.1 135.8 212.4 265.8 181.9 889.7 
Heart disease 6.5 5.3 7.2 13.9 31.9 72.4 72.7 209.8 
Atherosclerosis 0.1 
- -
2.0 5.0 9.0 6.1 22.1 
Cerebrovascular 
disease ( b ) 1.4 1.8 2.0 3.2 6.0 12.2 15.4 42.1 
Other circulatory 8.5 14.0 12.5 15.3 28.7 39.4 32.8 151.3 
Ill-defined 22.9 21.5 11.2 15.7 20.9 33.3 43.5 169.1 
All cardiovascular ( c > 48.1 61.8 86.8 170.4 259.4 342.6 273.2 1,242.3 
(a) Reported as a recent and/or long-term condition. 
(b) Includes after-effects of stroke. 
(c) Each person may have reported more than one type of condition and therefore components do not add 
to totals. 
Source: AIHW unpublished data, derived from ABS 1989-90 National Health Survey 
Detailed age-standardised analysis of hypertension as a chronic condition has used 
data from the 1989-90 National Health Survey (National Health Strategy 1992b). Low-
income women are 30.7% more likely to report hypertension than high-income 
women. Both men and women with a low level of education are more likely to report 
hypertension (26.6% and 52.0% respectively) than men and women with a high level of 
education. Similarly, men and women who are not in the workforce have a 
significantly higher prevalence of reported hypertension (69.7% and 24.1% 
respectively) than men and women who are employed. Men and women born in the 
United Kingdom and Ireland are 26.2% and 21.7%, respectively, less likely to report 
hypertension than their Australian-born counterparts. 
92 
Box 2.1: Cardiovascular disease as denned in the 1989-90 National 
Health Survey 
Respondents in this survey were regarded as having cardiovascular disease if they reported 
any of the following conditions (ABS 1991): 
• hypertension 
• heart disease (including coronary heart disease, heart attack, coronary thrombosis, 
angina and leaking valve) 
• atherosclerosis 
• cerebrovascular disease 
• other circulatory diseases (including thrombosis) 
• ill-defined heart conditions (such as irregular heartbeat and palpitations). 
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F igure 2.8: Reported recent and/or long-term cardiovascular conditions, proportions 
by age group and sex, 1989-90 
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2.4 Dental disease 
Changes in oral health of Australian children 
There has been a marked reduction in caries experience in Australian children since 
national records in the School Dental Service began in 1977. The dift and dmft (see 
Box 2.2) of children aged 6 years have decreased substantially since then. Figure 2.9 
shows trends in the components of the indexes. 
In 1977, there was a higher level of active decay than of restorations. The prevalence of 
active decay diminished rapidly from 1977 through to the early 1980s, then slowed, but 
because of changes to the collection and assessment methods used in the Survey, it is 
not yet possible to say whether the declines have since resumed. Up to 1987 the 
prevalence of active decay decreased by 40%, and the ratio of decayed to filled teeth 
fell from 2:1 to 1.1:1. This is a substantial improvement, with reductions in both disease 
and unmet need for treatment. 
Box 2 .2: Measurement of oral health in children 
Oral health in children is most commonly assessed by their dental caries (decay) experience. 
For the Child Dental Health Survey data for 1977 to 1988, the index of caries for primary 
teeth consists of the number of decayed teeth (d), the number of teeth indicated for 
extraction due to caries (i), and the number of restored or filled teeth (f). For the more recent 
data, the index of caries consists ofthe number of decayed teeth (d), the number missing due 
to caries (m), and the number of restored or filled teeth (f). Both sets of numbers can be 
summed to produce scores, the 'decayed, indicated for extraction, or filled primary teeth' 
score (dift), and the 'decayed, missing or filled primary teeth' score (dmft). 
The 'decayed, missing or filled permanent teeth' score (DMFT) for permanent teeth is 
similar to the dmft for primary teeth. 
Caries experience in permanent teeth among 12-year-old Australian children as 
measured by DMFT scores (see Box 2.2) has declined by approximately 46% since 1977, 
although in recent years the rate of decline has slowed, because of the limited scope for 
further improvement in those areas where children have very few caries (Figure 2.9). 
There was a rapid decline in the level of decayed teeth during the early 1980s as unmet 
need for treatment was satisfied. Projection of the present downward trend suggests 
that the dental health target for the year 2000, of a mean DMFT of 1.0 for 12-year-old 
children, should be achieved. 
The decline in caries experience in children is partly attributable to increased use of 
preventive practices and treatment strategies within both community dental practice 
and the School Dental Services. It is also due to the increasingly extensive application 
of fluorides in several forms, including water fluoridation, fluoridated toothpastes, 
direct applications to the teeth and dietary supplements (NHMRC 1991). 
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Figure 2.9: Caries experience in 6- and 12-year-old children, 1977 to 1990 
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Changes in oral health of Australian adults 
The loss of all natural teeth, or edentulism, is the end point of dental disease, and in a 
public health sense is a measure of dental mortality. Edentulism, therefore, represents 
the final failure of preventive and restorative care. 
Figure 2.10 gives data of interview-reported edentulism from two surveys conducted 
by the ABS in 1979 and 1989-90, and from a survey conducted by the Dental Statistics 
and Research Unit in 1992-93. It shows that the prevalence of edentulism is generally 
very low in people aged less than 35 years, but rises steeply across age groups. 
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F i g u r e 2 .10: Prevalence of edentulism by age group, 1979, 1989 and 1993 
Prevalence is also decreasing over time. The changes are substantial. For instance, 
67.7% of people aged 65 years and over were edentulous in 1979, but only 44.4% in 
1992-93. In all age groups to 64 years, the prevalence of edentulism more than halved 
over 14 years. The prevalence for 35^44-year-olds decreased from 14.0% to 5.4%, a 
reduction of 62%. The prevalence of 5.4% is better than the Health for All target for the 
year 2000, which was set at 7.0%. 
This trend in the reduction of edentulism should continue into future decades, as 
present younger age groups continue to maintain their natural dentition far more 
successfully than those born in earlier years. 
The trend in edentulism also correlates well with the increasing percentages of adults 
visiting a dentist within the last 12 months. The increasing number with natural teeth 
leads to an increasing number using dental services. This use in turn will increase the 
number retaining their teeth. 
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Figure 2.11 presents DMFT data from various Australian studies. Among young adults 
in the 1987-88 National Oral Health Survey (DHHLGCS 1993), caries experience was 
predominantly manifest as filled teeth. Missing teeth are dominant from 45 years, 
reflecting both the accumulation of disease and past patterns of care. Untreated 
decayed teeth, by contrast, show minimal variation across adult age groups. 
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Sources: AIHW Dental Statistics and Research Unit, DHHLGCS 1993 
Figure 2 .11: Caries experience in Australian adults, by age group, various surveys 
Data for people aged 35 to 44 years are shown on the right-hand side of Figure 2.11 for 
three time periods, 1973, 1987-88, and 1992-93. Comparison of these three periods 
indicates that the overall prevalence of caries may not have changed substantially over 
time. However, there has been a major improvement in oral health, with a reduction in 
the number of teeth lost to caries, and a corresponding increase in the number of filled 
teeth. 
There is also evidence that young adults' needs for treatment are being met. However, 
it is possible that some of the apparent decrease in prevalence of active decay between 
1987-88 and 1992-93 may be due to differences in study methods and differences 
between study locations. 
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2.5 Perinatal health 
Birthweight 
A key indicator of the health of babies born in Australia is the proportion having a 
birthweight of less than 2,500 grams. These low-birthweight infants have a greater risk 
of dying, of requiring a longer period of hospitalisation after birth, and of developing 
significant disabilities or handicaps. In 1991, there were 15,794 infants of low 
birthweight, a rate of 6.2%. Low birthweight is more common in the Northern Territory 
due to the relatively high proportion of Aboriginal births. The birthweight distribution 
is remarkably similar in the other States. 
Type of delivery 
Obstetric intervention may be needed if complications arise during pregnancy or 
labour, although there is debate about the optimal rate of intervention. Caesarean birth 
rates have increased markedly in the last few decades (National Perinatal Statistics 
Unit 1993a). In 1990, the national caesarean birth rate was 17.5%, ranging from 14.7% in 
Tasmania to 21.4% in South Australia (Table 2.7). There was also considerable variation 
in the rates of forceps deliveries and the use of vacuum extraction. 
Table 2.7: Type of delivery, States and Territories, 1990 
Confinements / Type 
of delivery NSW Vic Qld<a) WA SA Tas ACT NT Australia 
(Number) 
Total confinements 86,545 66,000 44,479 25,637 19,687 7,004 4,735 3,349 257,436 
(Per cent) 
Spontaneous vertex 70.2 68.6 67.6 64.0 62.7 70.0 64.3 74.6 68.1 
Forceps 10.3 12.3 9.2 8.6 12.7 12.7 13.6 6.0 10.7 
Vaginal breech 1.3 1.3 1.2 0.8 1.0 1.3 1.2 1.4 1.2 
Caesarean section 16.0 16.7 19.3 18.8 21.4 14.7 18.9 16.6 17.5 
Vacuum extraction 1.7 1.1 2.4 7.8 2.2 0.5 2.0 1.3 2.3 
Other / unknown 0.4 - 0.2 -
-
0.7 
-
0.2 
(a) Provisional data 
Source: AIHW National Perinatal Statistics Unit unpublished data 
Some States were able to provide information on caesarean birth rates according to 
whether the woman was a private or public patient (Table 2.8). The differential was 
greatest in Queensland where the caesarean rate was 55% higher in private than in 
public patients. 
Congenital malformations 
All States and Territories notify the birth of foetuses and infants with major congenital 
malformations to a national monitoring system (National Perinatal Statistics Unit 
1993b). Malformations can be grouped into the main anatomical systems, based on the 
International Classification of Diseases (Table 2.9), or can be tabulated individually 
(Table 2.10). The most frequently notified groups of malformations in 1991 were of the 
musculoskeletal system, malformations of the heart and circulatory system, genital 
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malformations, and chromosomal abnormalities. The specific malformations 
accounting for these high rates were respectively congenital dislocation of the hip, 
ventricular septal defect (hole between chambers of the heart), hypospadias 
(incomplete development of the underside of the penis), and Down's syndrome. 
Another relatively common malformation was cleft lip and palate. 
Table 2.8: Caesarean sections, by health insurance status, selected States and Territories, 1990 
NSW Qld<a> WA Tas ACT 
(Number) 
Caesarean sections 
Private 7,747 4,499 2,491 587 558 
Public 5,622 4,094 2,337 446 316 
Total ( b ) 13,869 8,593 4,828 1,033 874 
All confinements 
Private 41,207 18,357 11,280 3,462 2,848 
Public 41,791 25,960 14,357 3,541 1,835 
Total<b) 86,545 44,479 25,637 7,004 4,735 
(Per cent) 
Caesarean section rate 
Private 18.8 24.5 22.1 17.0 19.6 
Public 13.5 15.8 16.3 12.6 17.2 
Total ( b ) 16.0 19.3 18.8 14.7 18.5 
(a) Provisional data 
(b) Totals include confinements for which patient classification was not stated. 
Source: AIHW National Perinatal Statistics Unit 1993a 
Table 2.9: Major congenital malformations, by anatomical system, Australia, 1991 
ICD-9 code Anatomical system Number Rate per 10,000 births 
7 4 0 , 7 4 1 , 742 Nervous system 404 15.6 
743 Eye 105 4.1 
744 Ear, face and neck 49 1.9 
745 ,746 Heart 807 31.2 
747 Circulatory system 367 14.2 
748 Respiratory system 155 6.0 
749 Cleft palate / lip 367 14.2 
750, 751 Digestive system 330 12.8 
752 Genital organ 764 29.5 
753 Urinary system 472 18.2 
755 Limbs 431 16.7 
754,756 Other musculoskeletal 1,162 44.9 
757 Integument 34 1.3 
758 Chromosomal 586 22.6 
759 Other and unspecified 120 4.6 
740-759 All fetuses and infants 4,587 177.3 
Source: AIHW National Perinatal Statistics Unit 1993b 
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Table 2.10: Selected congenital malformations, Australia, 1991 
ICD-9 code Congenital malformation Number Rate per 10,000 births 
740 Anencephalus 54 2.1 
741 Spina bifida 146 5.6 
742.3 Hydrocephalus 89 3.4 
745.1 Transposition of great vessels 88 3.4 
745.4 Ventricular septal defect 416 16.1 
749 Cleft lip and / or cleft palate 367 14.2 
750.3 Tracheo-oesophageal fistula, 78 3.0 
oesophageal atresia and stenosis 
751.2 Atresia and stenosis of large 87 3 4 
intestine, rectum and anus 
752.6 Hypospadias 593 22.9 
753.0 Renal agenesis and dysgenesis 108 4.2 
754.3 Congenital dislocation of hip 627 24.2 
756.6 Diaphragmatic hernia 98 3.8 
758.0 Down's syndrome 332 12.8 
Source: AIHW National Perinatal Statistics Unit 1993b 
2.6 Transport-related injury 
Deaths due to transport injury are dominated by road injury deaths (Table 2.11). The 
problem of transport-related injury is thus overwhelmingly a problem of road 
transport. The Bureau of Transport and Communications Economics (1992) showed 
that 94% of the total cost of transport crashes in Australia is due to road crashes. The 
direct and indirect costs of road crashes in Australia now amount to more than $6,000 
million annually. In the next decade one in every ten Australian families will be 
directly affected by a road death or serious injury (Federal Office of Road Safety 1992). 
Table 2.11: Transport fatalities, 1992 
Males Females 
Number Per cent Number Per cent 
Rail 43 2.6 18 2.5 
Road 1,492 88.9 680 95.4 
Air 72 4.3 8 1.1 
Water 71 4.2 7 1.0 
Total 1,678 100.0 713 100.0 
Source: ABS unpublished data 
Trends in road deaths since 1968 are presented in Figure 2.12. Deaths have declined 
substantially, especially from 1988 to 1992. Using time series modelling for the period 
1981 to 1991, Pettitt, Haynes & Low Choy (1992) showed that economic activity affects 
crash numbers significantly. They concluded that a substantial proportion of this recent 
decline in fatal crashes was due to the recession. They predicted that a return to the 
economic conditions typical of 1989 would result in a continued downward trend in 
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fatal crashes, although this would be less pronounced than during the recession. In 
fact, preliminary data for 1993 suggested that the number of fatal crashes would be just 
below that in 1992. 
Source: O'Connor 1993 
F i g u r e 2 .12: Motor vehicle traffic accident deaths, age-standardised rates by sex, 
1968 to 1992 
Road crashes in Australia account for more years of life lost during the working age 
span than do all forms of heart disease, and over half the loss through all cancers 
(Ginpil, Schneider & Stone 1992). The significance of road injury as a public health 
problem is represented not only in statistics on lives lost and economic costs, but also 
in widespread effects on the quality of life, which may be dramatically reduced, of the 
survivors and their families (Oxley & Fildes 1993). When it is considered that road 
injury affects a much younger age group than do heart disease and cancer, the social 
impact of road crashes is particularly disturbing. 
Public health campaigns against drink driving and legislation for random breath 
testing (Cameron & Strang 1980) provide a notable example of successful prevention. 
Figure 2.13 (page 102) relates to another successful countermeasure. It demonstrates a 
reduction in head injury among pedal cyclists as helmet-wearing rates increased, and 
particularly following legislation requiring helmet wearing (Finch et al. 1993). 
A major priority of the National Injury Surveillance Unit Road Injury Information 
Program has been to create a National Road Injury Database using hospital data. A 
recent report (O'Connor 1993) from this database presents more comprehensive data 
than has been available before on the incidence and severity of road injuries in 
Australia. The following sections are drawn primarily from that report; the references 
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to hospital admissions for injury are conclusions from statistics of hospital separations, 
as described in Box 4.2 on page 160. 
Per cent head injured 
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Fitted trend 
Projected trend before introduction of mandatory helmet use 
Note: Head injuries among pedal cyclists killed or admitted to hospital. Based on claims to the 
Transport Accident Commission. 
Source: Finch et al. 1993 
Figure 2.13: Pedal cyclist head injuries before and after the introduction of mandatory 
helmet use, Victoria, 1982-83 to 1991-92 
Age 
Hospital admission rates peak at 15 to 19 years, whereas fatalities peak at 20 to 24 
years. Both rates decrease progressively through middle age with a slight increase for 
elderly road users (Table 2.12). 
The ratio of the death rate to the hospital admission rate provides an indication of the 
case fatality. This ratio is highest in the elderly; there are 10 deaths for every 100 
hospital admissions for road injury of persons aged 70 and over. The ratio is lowest at 5 
to 14 years, where there are 2 deaths for every 100 hospital admissions. 
Road user type 
Vehicle occupants constitute 45% of admissions and 65% of fatalities. Pedestrians also 
make up a lesser proportion of admissions than fatalities (12% of admissions and 18% 
of fatalities). Cyclists, who account for 16% of admissions, constitute only 4% of 
fatalities. Motorcyclists constitute 13% of admissions and 12% of fatalities. 
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Table 2.12: Road injury fatality and hospital separation rates, by age group, 1990 
F a t a l i t i e s H o s p i t a l s e p a r a t i o n s 
R a t e p e r % c h a n g e R a t e p e r % c h a n g e 
A g e g r o u p 1 0 0 , 0 0 0 1 9 8 8 t o 1 9 9 0 < a ) 1 0 0 , 0 0 0 1 9 8 8 t o 1 9 9 0 ' a ) 
0-4 4 -17.5 92 -15.4 
5-14 5 -8.6 232 -6.9 
15-19 24 -21.1 518 -14.0 
20-24 28 -24.0 452 -15.0 
25-29 17 -27.4 296 -13.4 
30-39 11 -17.8 196 -7.6 
40-49 9 -10.0 148 -9.3 
50-59 9 -28.6 148 -11.5 
60-69 12 -9.8 137 -14.1 
70 and over 18 -21.0 183 -10.9 
Al l a g e s 1 3 - 1 9 . 8 2 3 2 - 1 1 . 6 
(a) Per cent change in number of cases between 1988 and 1990. 
Source: O'Connor 1993 
Variations in fatalities by age group and road user type are presented in Table 2.13. 
Road users aged 0 to 14 years die primarily as passengers in motor vehicles, as 
pedestrians and as pedal cyclists. Those aged 15 to 24 years die primarily as drivers 
and passengers in motor vehicles and as motor cyclists. Road users aged 70 and over 
are the only adult group to die more frequently as pedestrians than as drivers. 
Table 2.13: Road injury fatalities, by road user type and age group, 1990 
R o a d u s e r t y p e 
A g e g r o u p D r i v e r 
P a s s e n g e r i n 
m o t o r v e h i c l e 
M o t o r 
c y c l e r i d e r 
P e d a l 
c y c l i s t P e d e s t r i a n 
U n k n o w n 
/ O t h e r T o t a l 
0-4 
-
25 
-
2 16 4 47 
5-14 1 44 2 23 56 2 128 
15-19 122 102 55 16 27 10 332 
20-24 154 97 73 6 35 9 374 
25-29 98 42 57 7 34 6 244 
30-39 150 52 44 7 38 5 296 
40-49 117 30 16 6 34 4 207 
50-59 69 33 1 4 28 
-
135 
60-69 67 55 2 4 37 
-
165 
70 and over 75 57 
-
2 91 1 226 
Not known 2 5 1 
-
2 
-
10 
Al l a g e s 855 542 251 7 7 398 4 1 2,164 
Source: O'Connor 1993 
Injury severity 
In 1990 there were 2,318 road injury fatalities, nearly 40,000 hospital admissions and 
nearly 120,000 hospital accident and emergency department attendances (Federal 
103 
Office of Road Safety .1990; O'Connor 1993; KPMG Peat Marwick 1993). For every 
fatality there were 17 hospital admissions and 50 hospital attendances. 
There has been a general reduction in the number of fatalities and severe injuries. The 
20% reduction in fatalities between 1988 and 1990 was accompanied by a 19% 
reduction in admissions in the critical category the most severe injury category for 
admissions. However, over this period there was a lesser reduction, of only 12%, in less 
serious injury (O'Connor 1993). 
Injury severity of people admitted to hospital varies with road user activity. Few 
pedestrians suffer minor injury. Injured motorcycle riders have a higher proportion of 
moderate to serious injuries than other injured road users. Cyclists have a substantially 
higher proportion of moderate injuries compared with other road user types and a 
lower proportion of more severe injuries. 
Body region of injury 
Table 2.14 follows the convention in injury studies that fatalities are attributed to injury 
to the most severely injured body region. There is also a category for multiple injury. 
The table shows head injury, chest injury, and multiple injury, which have rates of 4, 3, 
and 3 per 100,000 of population respectively, as the leading body regions involved in 
death in road crashes. 
Table 2.14: Road injury fatality and hospital separation rates, by body region of most severe 
injury, 1990 
F a t a l i t i e s P r i n c i p a l d i a g n o s i s All d i a g n o s e s 
B o d y r e g i o n 
R a t e p e r 
1 0 0 , 0 0 0 
% c h a n g e 
1 9 8 8 t o 
1 9 9 0 < a ) 
R a t e p e r 
1 0 0 , 0 0 0 
% c h a n g e 
1 9 8 8 t o 
1 9 9 0 < a ) 
R a t e p e r 
1 0 0 , 0 0 0 
% c h a n g e 
1 9 8 8 t o 
1 9 9 0 ( a ) 
External 0.2 (b) 40 -13.6 118 -9.4 
Head 4 +7.4 45 -23.3 58 -27.8 
Face <0.1 b 13 -14.1 28 -14.2 
Chest 3 -10.6 16 -4.2 34 -9.0 
Abdomen 0.4 -52.4 6 -9.5 12 -5.0 
Spine 0.4 -53.1 12 -4.5 19 -12.0 
Upper extremity <0.1 (b) 33 -3.7 58 -7.5 
Lower extremity 0.1 tt>) 47 -6.6 80 -12.1 
Multiple 3 53.5 na na na na 
Unspecified/ 
Other 2 95.2 22 -8.8 31 +37.9 
T o t a l 1 3 - 1 9 . 8 2 3 2 - 1 1 . 6 4 3 8 - 1 0 . 8 
(a) Per cent change in number of cases between 1988 and 1990. 
(b) Percentage base less than 50 cases for 1988. 
Source: O'Connor 1993 
The.injury rate (for principal diagnosis) to the lower extremities is 47 per 100,000 
compared with 45 for the head, 33 for upper extremity, 16 for chest, and 12 for spine. 
Head injuries (as principal diagnosis) declined by 23% between 1988 and 1990, 
compared with a 12% decline for all other body regions (Table 2.14). 
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For pedal cyclists, the greatest reduction in injury rate between 1988 and 1990 occurred 
in injuries to the head, which decreased by 16%, whereas injuries to the face increased 
by 14%. The reduction in head injuries was expected on the basis of research evidence 
(Finch et al. 1993) of increased helmet wearing and the effectiveness of helmets in 
reducing injury to the head. 
More head injuries to pedestrians were in the serious to critical categories than was the 
case with driver head injuries (39% and 22%, respectively). Pedal cyclists were the road 
user group with the lowest proportion (15%) of admissions to hospital for head injuries 
which were in the serious to critical categories. 
Nature of injury 
Intracranial injury (excluding skull fracture) made up 16% of principal diagnoses, with 
a population-based rate of 38 per 100,000. Between 1988 and 1990, intracranial injuries 
for principal diagnoses declined by 25%, representing the greatest decline of any injury 
type. 
Lower limb fractures were also common principal diagnoses, with a rate of 35 per 
100,000. These injuries have not declined substantially over recent years. Fractures of 
the spine, trunk and upper limbs, which also constituted a substantial proportion of 
principal diagnoses, have decreased only slightly. 
Length of stay in hospital 
Vehicle occupants constitute 45% of road injury admissions and contribute 45% of total 
occupied bed-days due to road injury. Only 12% of hospital admissions are pedestrians 
who contribute 19% of total bed-days. Pedestrians have a substantially higher average 
length of stay than any other road user group (Table 2.15). This is partly due to the high 
proportion of elderly people among injured pedestrians. 
T a b l e 2 .15 : Road injury hospital separations, by length of hospital stay and road user type, 1990 
L e n g t h o f s t a y 
M o r e t h a n M e a n T o t a l 
R o a d u s e r t y p e 1 t o 2 d a y s 3 t o 6 d a y s 6 d a y s b e d - d a y s b e d - d a y s 
Driver 4,889 2,358 3,091 7.7 80,054 
Passenger in 
motor vehicle 3,703 1,702 2,193 8.2 61.964 
Motorcycle rider 1,982 1,286 1,867 9.2 47,192 
Pedal cyclist 4,122 1,283 861 3.9 24,710 
Pedestrian 1,742 943 2,070 12.9 61,343 
Unspecified / Other 2,947 1,164 1,424 7.6 42,105 
T o t a l 1 9 , 3 8 6 8 , 7 3 6 11,505 8 .0 3 1 7 , 3 6 9 
Source: O'Connor 1993 
People with lower-limb injuries use 36% of total occupied bed-days for road injury. 
Average length of stay is highest for spinal injury and lower-limb injuries (Table 2.16). 
105 
T a b l e 2 . 1 6 : Road injury hospital separations, by length of hospital stay and body region of 
principal diagnosis, 1990 
L e n g t h o f s t a y 
M o r e t h a n M e a n T o t a l 
B o d y r e g i o n 1 t o 2 d a y s .3 t o 6 d a y s 6 d a y s b e d - d a y s b e d - d a y s 
External i 4,300 1,529 927 3.8 25,525 
Head , 5,014 • 1,118 1,577 7.7 59.150 
Face 1,101 617 418 4.6 9,773 
Chest 823 929 887 7.1 18,760 
Abdomen 275 206 534 10.1 10,240 
Spine 682 471 840 15.0 29,991 
Upper extremity 3,237 1,280 1,053 4.9 27,433 
Lower extremity 1,603 1,889 4,578 14.2 114,843 
Unspecified / Other • 2,341 695 691 5.8 21,655 
T o t a l 19,386 8,736 11,505 8.0 317,369 
Source: O'Connor 1993 
Timing of death in road crashes 
Vehicle occupants make up the majority of cases dying at any time before or after 
provision of treatment or transport. The proportion of road crash victims who die 
instantaneously is 22% for drivers, 11% for pedestrians, 13% for cyclists, 18% for 
motorcycle riders, and 21% for vehicle passengers. Half of the road crash victims who 
die in hospital are vehicle occupants, and more than a quarter are pedestrians. 
Alcohol involvement 
Alcohol is the single most important human factor in road crashes. The relationship 
between the risk of crash involvement and level of alcohol in the blood has been shown 
to be strong. The crash involvement of drivers having a blood alcohol concentration 
(BAC) in the range 0.10^0.149 was 6 times that of drivers having a BAC of less than 0.05 
(McLean; Holubowycz & Sandow 1980). 
Attewell & Dowse (1992) showed that the proportion of road fatalities tested for BAC 
who had a BAC in excess of 0.05 was higher for pedestrians (42%) than for motorcycle 
riders (41%) and car drivers (37%). Recently, problems with data on alcohol 
involvement in road crashes have been detected. They include under-enumeration and 
bias in data both on fatalities and hospital admissions (Trembath & O'Connor 1993). 
For example, in the road crash databases collated by the.Federal Office of Road Safety 
from police and coroners' reports of road crashes, the level of BAC is missing for 25% 
of drivers killed and 40% of drivers admitted to hospital. There is further evidence of a 
higher proportion of high BAC readings not reported to police among vehicle drivers 
attending hospital after crashes; this suggests that estimates based on police data are 
biased towards a lower BAC level. These problems are being identified and addressed 
in a study under the National Injury Surveillance Unit Road Injury Information 
Program. 
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2.7 Suicide and other self-injury 
There are now more deaths in Australia from suicide than from motor vehicle traffic 
crashes. 
In recent years there has been considerable attention given to the increasing suicide 
rates among young males. This is not a new phenomenon; suicide has been an 
increasing problem in young males since the 1950s (Figure 2.14). The change in pre­
existing trend has in fact occurred in older men, where suicide rates have recently 
stabilised after a period of decrease. There were high male suicide rates during the 
depression years around 1930, and low suicide rates during the 1939-45 war 
(Figure 2.14). 
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Source: AIHW National Injury Surveillance Unit unpublished data 
Figure 2.14: Suicide and self-inflicted injury, selected age-specific death rates, by sex, 
1922 to 1992 
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Suicide in women has exhibited very different long-term trends. The highest rates 
occurred in the 1960s, since when rates below age 25 have changed little and rates past 
age 25 have slowly decreased. 
Many people who attempt suicide are admitted to hospital. Figure 2.15 shows hospital 
admission rates of suicide or attempted suicide in New South Wales in 1991-92. Only 
at ages 15 to 24 are female suicide admission rates substantially higher than male. For 
both sexes, the great majority of suicide attempts admitted to hospital involve self-
poisoning. Other methods of suicide tend to lead to rapid death, or to 'near misses' 
with little or no injury. In either case, admission is unlikely. 
Per 100,000 population 
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Source: AIHW National Injury Surveillance Unit unpublished data 
F i g u r e 2 .15: New South Wales hospital admissions due to intentional self-inflicted 
injury, by age-group and sex, 1991-92 
Suicide is not always identified as such. For example, suicide by motor vehicle crash is 
usually very difficult to distinguish from many types of accidental death from motor 
vehicle crash, as is suicide by overdose in a drug abuser. Also, in Australian culture, 
suicide tends to carry a stigma (until recently it was a criminal offence), which may 
lead family or professionals to tend to under-report suicides and attempted suicides. 
The rates shown in this section must therefore be regarded as possibly underestimating 
the problem. 
The use of particular means of suicide varies with sex, age and other factors, and has 
changed over time. For males, firearms account for a large proportion of suicides; the 
proportion has decreased somewhat over the last few years. There was a period to 1940 
when self-poisoning was a more common method of suicide in males than it was for 
108 
the next 20 years; self-poisoning (mostly by pharmaceuticals) became relatively 
frequent again in the 1960s, but has since become less so. This largely reflects 
decreasing prescription of barbiturates and hence decreased availability of these drugs. 
Hanging has become a more frequent method of suicide (Figure 2.16, page 110). 
Suicide is less common in females, and poisoning is the dominant means. The time 
trends for each means are similar to those for males. Note that the vertical scale of 
Figure 2.16 is different for females. 
For both sexes, poisoning by motor vehicle exhaust has become a more common means 
of suicide; drowning, jumping from high places, and cutting and stabbing have 
become less frequently used methods. 
A research paper prepared for the National Health Strategy (National Health Strategy 
1992a) examined suicide rates in subgroups of the population. It found that the suicide 
rate for men aged 25 to 64 changed progressively through five categories of 
socioeconomic disadvantage of area of residence (see Box 2.3, page 111), being lowest 
among men who lived in the least disadvantaged areas and highest among men living 
in the most disadvantaged areas. Women living in the most disadvantaged areas had 
the highest suicide rates, but there was no progressive change in the other four 
categories of socioeconomic disadvantage of area of residence (Table 2.17, page 112). 
Other findings of the National Health Strategy review (see Table 2.17) were that suicide 
rates among unemployed men, including those not in the workforce, were 8% higher 
than in employed men. Suicide rates for men were similar in metropolitan and non-
metropolitan areas, but women in non-metropolitan areas had lower suicide rates than 
women living in metropolitan areas. In both sexes, suicide rates at 25 to 64 years were 
much higher among the never married, and among the divorced and widowed, than 
among those currently married. Men and women born in Asia had lower suicide rates 
than those born in Australia; those born in Europe had similar rates to those born in 
Australia. 
Suicide in Aboriginals received some prominence in relation to the work of the Royal 
Commission into Aboriginal Deaths in Custody. Research papers prepared for the 
Royal Commission found that although Aboriginals died in police custody at a rate 
more than 40 times that of non-Aboriginal people, and in prison at a rate 13 times that 
of non-Aboriginal people, both findings were almost entirely explained by the over-
representation of Aboriginal people in custody (Biles, McDonald & Fleming 1992a, 
1992b). 
A complex web of environmental and behavioural factors needs to be understood if 
public health action against suicide is to be effective. Currently, the question of the 
potential benefit of more stringent firearm controls is being debated. Although 
stringent gun control has plausibility as a possible intervention, available data and 
research cannot provide a clear picture of intended and unintended consequences of 
such a measure. 
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Figure 2.16: Methods of suicide, age-standardised rates by sex, 1922 to 1992 
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Box 2.3: Socioeconomic disadvantage of area 
Aggregate socioeconomic characteristics of the populations of defined geographical areas 
represent the characteristics of the local environment but can also be used as a proxy for 
individual socioeconomic status. The value of such indexes decreases as the size ofthe areas 
increases, as larger areas are more likely to be heterogeneous. 
ABS has constructed a number of socioeconomic indexes designed to categorise areas on the 
basis of information collected in the 1986 Population Census (ABS 1990). The indexes are 
compiled at small geographic levels known as Collection Districts and then aggregated to 
larger geographic areas such as postcodes or Statistical Local Areas (SLAs). A Collection 
District is equivalent to a small group of suburban blocks in urban areas. Most SLAs 
correspond to local government areas. 
The Index of Relative Socio-Economic Disadvantage (IRSD) is constructed by 
summarising information from social and economic variables relating to socioeconomic 
disadvantage, such as low income and high unemployment. An area with a comparatively 
large proportion of disadvantaged households has a low IRSD. 
The IRSD is compiled from the following variables, expressed as ratios or percentages ofthe 
population): 
• family income of less than $12,000 
• households with no motor cars 
• households with one or no bedrooms 
• households renting (non-government) 
• households renting (government authority) 
• households in improvised dwellings 
• no qualifications 
• left school less than 15 years of age 
• never at school 
• employed males classified in Trades 
• employed females classified in Trades 
• employed females classified in Sales/Personal 
• employed people classified as Labourer or related 
• males unemployed 
• females unemployed 
• families consisting of Head and dependents 
• aged 15+ separated or divorced 
• occupied dwellings with 2 or more families 
• Aboriginal or Torres Strait Islanders 
• recent migrant from non-English-speaking country 
• lacking English fluency. 
Mortality data supplied by ABS normally contains the SLA of usual residence of the 
deceased person. Men and women dying aged 25 to 64 years were classified into quintiles of 
socioeconomic disadvantage according to the value of the IRSD for their SLA of usual 
residence. This zvas either missing or could not be mapped to an IRSD value for 3% of male 
and 2% of female deaths. These deaths were excluded from the analysis. 
The quintiles are defined so as to contain equal numbers of people aged 25 to 64 years. The 
first quintile contains people living in the least disadvantaged areas and the fifth quintile 
contains people living in the most disadvantaged areas. 
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T a b l e 2 .17: Suicide, by socioeconomic differential and sex, age 25 to 64 years, 1985-1987 
(rate ratio) 
Differential Males Females 
Socioeconomic advantage 
First quintile 1.00 1.00 
Second quintile 1.25 * 0.94 
Third quintile 1.28 * 1.05 
Fourth quintile 1.43 * 0.96 
Fifth quintile 1.77 * 1.46 * 
Employment status 
Employed 1.00 na 
Unemployed / Not in workforce 1.08 na 
Marital status 
Married / Separated 1.00 1.00 
Never married 2.84 * 2.76 * 
Divorced / Widowed 3.37 * 3.33 * 
Country of birth 
Australia 1.00 1.00 
UK / Ireland 0.99 1.09 
Other Europe 1.05 1.08 
Asia 0.49 * 0.76 
Other 1.13 0.79 
Location 
Metropolitan 1.00 1.00 
Non-metropolitan 1.04 0.74 * 
* p < 0.001 
Source: AIHW unpublished data, derived from ABS 1985-1987 mortality data 
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3 Health service organisation, 
funding and expenditure 
3.1 Structure and administration of health 
services in Australia 
The health care system in Australia is pluralistic, complex and loosely organised. A 
distinguishing feature is the extent to which responsibilities are split between different 
levels of government. The system involves Commonwealth, State and local 
governments, as well as public and private providers, both individuals and 
institutions. Governments increasingly are influencing the structure of health services, 
although most medical and dental care and some other professional services are 
provided by private practitioners. 
Although the relative responsibilities have changed greatly since Federation in 1901, 
State and Territory governments retain the major responsibility for the public provision 
of health services, including public and psychiatric hospital systems, and for public 
health. The health responsibilities of local governments vary from State to State, but are 
mainly in environmental control and in a range of personal preventive and home care 
services. 
A Commonwealth Department of Health was not established until 1921, and for many 
years its main responsibility was quarantine. The Commonwealth Government also 
exercised some responsibility for the health needs of veterans. An amendment of the 
Constitution in 1946 gave the Commonwealth powers to make laws about 
pharmaceutical, sickness and hospital benefits, and medical and dental services. These 
powers, and the provision of specific-purpose grants to States under Section 96 of the 
Constitution, have enabled the Commonwealth to expand its role in the health system. 
Since the 1950s, the Commonwealth Government has introduced major benefit 
schemes covering medical, pharmaceutical, hospital and nursing home services, and 
has established a number of other health programs, many of which have involved 
funding- through specific-purpose grants. Important recent programs in the latter 
category are directed towards health promotion, towards the control of alcohol and 
drug abuse, and against AIDS. 
In recent years, governments have been taking an increasing interest in promoting 
health, and additional resources have been provided for the measurement of health, 
the evaluation of health services, the promotion of well-being and the prevention of 
illness and disability. 
Commonwealth, State and Territory health authorities 
—The-structures of the ..various-Commonwealth,* State_and Territory, health authorities 
have most recently been described in The Australian health care system 1992 (Grant & 
Lapsley 1993):" Comparison of editions~of this annual publication shows that the 
structures have undergone frequent change, involving the reallocation of functions to 
new and different divisions within departments, the transfer of functions to and from 
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other departments, or the amalgamation of entire departments. Peripheral health units 
have had to make rapid adjustments to these changes in central agencies. 
At the Commonwealth level, the most recent change was the expansion of the 
Department of Health, Housing and Community Services following the 1993 election. 
Local government was added to its responsibilities, so that it became the Department 
of Health, Housing, Local Government and Community Services. Late in 1993 its name 
was altered to tlie Department of Human Services and Health (DHSH), and in 1994 
responsibility for housing and for local government passed to a new Department. 
State and Territory health administrations also have been reorganised or renamed 
many times, usually as departments or commissions. Some jurisdictions have 
combined health and community services functions, whereas others have kept them 
separate. The momentum has been towards the creation of central agencies with 
varying degrees of delegation of responsibility to regional or area authorities. The 
principal functions of State and Territory authorities include: 
• hospital services 
• mental health programs 
• dental health services 
• systems of extended care 
• child, adolescent and family health services 
• women's health programs 
• health promotion 
• rehabilitation systems 
• regulation, inspection, licensing and monitoring of premises, institutions and 
personnel. 
The central authorities at State level are concerned mainly with the determination of 
policy, budgeting and financial control, planning, standards of performance and their 
measurement, program and budget reviews, industrial and personnel matters and 
major capital works. 
Other Commonwealth Government agencies 
Most health programs in the public sector are administered by health authorities, but 
other government departments and agencies have important roles. The 
Commonwealth Department of Veterans' Affairs arranges medical care for ex-service 
personnel and other beneficiaries. Statutory bodies within the Human Services and 
Health portfolio include the Australian Institute of Health and Welfare, the Australian 
Hearing Service, and the Commonwealth Rehabilitation Service. 
Between the early 1970s and 1984, specific assistance for Aboriginal health was 
provided by two Commonwealth departments, the Department of Aboriginal Affairs 
and the Department of Health. Between 1984 and 1991, this assistance was provided 
through the Commonwealth Department of Aboriginal Affairs. It is now administered 
by the Aboriginal and Torres Strait Islander Commission. 
Worksafe Australia is responsible for occupational health policy and standards 
development, and State and Territory agencies (in many States and Territories not the 
health authorities) administer occupational health legislation. 
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Environmental health and hygiene 
Health surveyors, usually employed by local governments, undertake surveillance of 
environmental hygiene and sanitation practices to ensure compliance with State and 
Territory public health law. Statutory water supply authorities are responsible for the 
quality of piped water and in some areas for sewage disposal and drainage. Another 
set of authorities is responsible for monitoring and regulating air quality. Central 
agencies have been established in most States to control the disposal of wastes, and 
these agencies administer the disposal sites in metropolitan areas, leaving local 
government to be responsible for the collection and transport of waste material. 
Institutional health services 
Public general hospitals in most States are administered by hospital boards constituted 
as corporate entities. Some are administered by religious or charitable bodies. Where 
area health boards have been established, as in New South Wales, public hospitals are 
managed by executive personnel responsible to the area board. Public hospitals have 
become increasingly dependent on State grants and are required to comply with 
conditions of subsidy. 
Some public psychiatric hospitals are now administered by boards similar to those for 
public general hospitals, but most continue to be run as State institutions. However, 
psychiatric admission and treatment centres have been established in selected public 
hospitals, and residential care for mentally ill patients has been provided in small-scale 
accommodation in the community in recent years. 
In 1991-92,25.7% of acute hospital beds were in private hospitals. These hospitals may 
be run by religious or charitable organisations or by proprietors operating for profit. 
Nursing homes provide accommodation and long-term nursing care for chronically ill, 
disabled or demented patients. The Commonwealth incurs most of the financial 
burden of running nursing homes, providing a daily monetary benefit to help each 
resident meet the cost of care. The resident is not required to contribute more than 
87.5% of the sum of the single-rate pension and rent assistance. 
To ensure that only those who are highly dependent are placed in residential care, aged 
care assessment teams have been established nationally. They recommend a large 
proportion of people for care outside institutions and make appropriate referrals to 
other services. 
Community health services 
In 1985, the Home and Community Care program was established to support services 
for frail aged and younger disabled people who are not in residential care. The aim of 
the program is to enhance opportunities and to avoid inappropriate admission to 
institutions. The program is administered jointly by the Commonwealth and each State 
and Territory, and innovative services have been introduced to meet the needs of 
groups with special requirements. 
Medical care outside hospitals is based on general practitioners, mainly in "private 
practice, who.constitute the.principal gateway to specialised services. In addition. State 
and local government health authorities are active in the fields of health promotion and 
disease prevention. Advisory services are provided at baby health centres, antenatal 
clinics and community health centres. Immunisation clinics are offered. ' 
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Community mental health services and community services for older people expanded 
quite rapidly after the early 1970s and are provided through a variety of government 
and non-government agencies. The services have grown in a relatively uncoordinated 
manner, and interaction with private clinical services has been variable. 
Measures have been taken to ensure that people with disabilities are able to gain access 
to services in all parts of the various systems of health care, and special services and 
facilities have been provided for them by State and Territory governments and non­
government organisations. The Department of Human Services and Health 
administers financial programs that offer rehabilitation, employment and hearing 
services for people with disabilities. Emphasis is given to facilitating access to services 
that enable participation in integrated community activities. 
Information, coordination and research 
Government agencies routinely collect and analyse data produced in the course of 
managing their programs. Selected information of this kind is transmitted to the 
Australian Institute of Health and Welfare, where it is incorporated into national data 
sets and used to prepare reports on the health of Australians and their health services. 
The Australian Bureau of Statistics conducts large-scale population surveys of health 
and health services. 
The Australian Health Ministers' Advisory Council (AHMAC) is a committee of the 
heads of the Commonwealth, State and Territory health authorities and the 
Commonwealth Department of Veterans' Affairs. AHMAC advises the Australian 
Health Ministers' Conference (AHMC) on resource matters and financial issues. 
AHMC also considers recommendations from the National Health and Medical 
Research Council (NHMRC). Specific national bodies have been established to 
coordinate information and advice on major problems such as drug and alcohol abuse, 
and AIDS. 
The NHMRC was established in 1936, but was created as a separate statutory body in 
1993. It is responsible for the coordination of public health policy at the national level. 
Its principal concerns today are with medical research, professional aspects of health 
care, public health, public health research and development, and health ethics. 
In addition to research that is funded through NHMRC, the Department of Human 
Services and Health administers separate extramural research programs primarily to 
provide additional program management information. Some States provide substantial 
infrastructure support for medical research institutes established in association with 
their universities and teaching hospitals, and revenue from special State tobacco taxes 
supports health research as well as health promotion activities. 
Paying for personal health care 
Another Commonwealth statutory authority, the Health Insurance Commission (HIC) 
administers the Medicare program of universal health insurance and the 
Pharmaceutical Benefits Scheme. 
Medicare 
Medicare, a universal system of health insurance, came into operation in 1984. All 
people normally resident in Australia, except foreign diplomats and their dependants, 
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are eligible for Medicare benefits. Short-term visitors, except those from countries with 
which agreements have been made, are not eligible. A schedule of fees has been 
established, and benefits for medical services in the community relate to that schedule. 
The amount of benefit also depends on the fee charged. Doctors are not obliged to 
adhere to the schedule fees, but if they direct bill the HIC for any service, the amount 
payable is the Medicare benefit and the patient is not required to pay any additional 
amount. 
Benefits are also paid for services provided by optometrists and for oral surgery 
performed by dental surgeons. 
For private patients in hospitals, the Medicare benefit is only 75% of the schedule fee, 
but the gap between benefit and schedule fee is insurable. In other circumstances, gaps 
cannot be covered by private insurance, and insurance to cover amounts paid in excess 
of the schedule fee is prohibited. 
For all beneficiaries (individuals and registered families), if the sum of the gaps 
between benefits and schedule fees exceeds a specified amount in any year, the full 
schedule fee is reimbursed for services during the remainder of the year. This 'safety 
net' threshold is linked to the Consumer Price Index, and is adjusted each year. 
Agreements between the Commonwealth and State and Territory governments 
provide for all Medicare beneficiaries to obtain inpatient and non-inpatient care at 
public hospitals without charge. Medical care is provided for such 'public' patients (at 
no cost to them) by doctors appointed by the hospitals. Private health insurance can be 
purchased to cover charges in private hospitals, and for private status in public 
hospitals. Private patient charges in public hospitals are set at levels agreed by the 
Commonwealth. Private health insurance arrangements are describedin greater detail 
in Box 3.3, page 136. 
Pharmaceutical Benefits Scheme 
The Pharmaceutical Benefits Scheme (PBS) subsidises the cost of a wide range of drugs 
and medicinal preparations. Its aim is to ensure that individuals are not financially 
precluded from access to these items. 
There is a set price for every item covered by the scheme. Patients are grouped into two 
classes. Concessional beneficiaries, that is, holders of Pensioner Health Benefits Cards 
and certain other entitlement cards issued by the Departments of Social Security and of 
Veterans' Affairs, pay $2.60 for each item. General beneficiaries, that is, all others, pay 
the first $16.00 for each item. In each case they also pay additional amounts where the 
brand dispensed costs more than the basic level for the drug. The pharmacist then 
claims the remainder of the set price from the HIC. 
The PBS also includes a safety net arrangement, which has been changed many times 
since its introduction in 1986. These changes, which from November 1990 to December 
1993 incorporated a two-tier safety net for general beneficiaries, are shown in Table 3.1. 
.In_J19_9_4, _ after a family of general beneficiaries had spent $400 on pharmaceutical 
benefits, they became entitled to benefits at the concessional rate of $2.60 for the rest of 
the-calendar year; forsubsequent years the $400 threshold was to be increased for CPI 
movements. 
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Table 3.1: History ofthe Pharmaceutical Benefits Safety Net arrangements, 1986 to 1994 
General beneficiaries 
S a f e t y N e t t i e r 1 S a f e t y N e t t i e r 2 
P a t i e n t P a t i e n t 
D a t e o f i n t r o d u c t i o n c o n t r i b u t i o n A n n u a l l i m i t c o n t r i b u t i o n A n n u a l l i m i t 
November 1986 $10.00 25 items - na 
July 1988 $11.00 25 items 
-
na 
November 1990 $15.00 ( a ,$300.00 $2.50 <a)$50.00 
August 1991 $15.70 <a>$309.90 $2.60 <a>$51.60 
August 1992 $15.90 <a)$312.30 $2.60 <a)$52.00 
January 1994 $16.00 $400.00 $2.60 No maximum 
Concessional beneficiaries 
P a t i e n t 
D a t e o f i n t r o d u c t i o n c o n t r i b u t i o n A n n u a l l i m i t 
November 1986 $2.50 25 items 
October 1991 $2.60 25 items 
January 1991 $2.60 $130.00 
January 1992 $2.60 $135.20 
(a) Effective for the following calender year. 
Source: AIHW unpublished data 
For concessional beneficiaries the safety net operates differently. From 1992, after a 
purchase of 52 items at the concessional rate of $2.60, they became entitled to receive 
Pharmaceutical Benefits items free for the rest of the calendar year. 
The items that attract benefits are revised frequently. Unsubsidised prescribed items 
can also be bought at pharmacies, and many remedies can be purchased without 
prescription. 
Other health benefits 
Registered health benefit funds also offer insurance for services not covered by 
Medicare, notably private dentistry, physiotherapy, chiropractic and appliances, and 
for prescribed medicines not covered by pharmaceutical benefits. 
Health promotion and disease prevention 
The promotion of health and the prevention of disease have been receiving increasing 
emphasis in recent years. Specifically designed preventive services include infant 
health centres, school medical and dental services, the fluoridation of water supplies, 
immunisation programs, anti-smoking campaigns, the national AIDS program and the 
National Campaign Against Drug Abuse. State and Territory health authorities have 
branches concerned with health education services and health promotion. 
There is increasing government awareness that the health of the nation depends not on 
its health services alone, but on levels of nutrition, education, employment, income 
and housing, general standards of hygiene, environmental safety and the availability 
of cultural and recreational amenities. These social factors, in turn, are influenced by 
the market, and by financing and regulatory arrangements at different levels of 
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government. Most of the factors influencing health are outside the immediate 
responsibility of health departments, although Australian governments have begun to 
show a commitment to ensuring that all areas of public policy recognise impacts on 
health. 
Health authorities now accept responsibility for monitoring the impact on health of 
harmful elements in the social, economic and physical environments. Their aim is to 
create an environment which nurtures healthy living. Health workers have long been 
involved in motivating people to modify their behaviour in ways that enhance good 
health. During the 1980s it increasingly was recognised that people are not entirely free 
to choose particular lifestyles. They adapt their behaviour to their life situations. 
Consequently, emphasis must be placed on the alteration of adverse influences on 
health that are beyond the control of the individual. 
3.2 Health service funding and expenditure 
This section describes total health expenditure, expenditures by the different 
components of the health care system and the sources of funding for the system. It also 
examines some factors contributing to changes in health expenditure and compares 
health expenditure among States. 
Health expenditure in Australia 
In 1992-93, health expenditure by Australian governments and individuals was 
$34,338 million, an average of $1,944 per person (Table S42, page 279 and Table S45, 
page 281). Health expenditure represented 8.5% of gross domestic product (GDP), an 
increase of 0.8 percentage points from recent years (Table S44, page 281). 
Of the $34,338 million expended on health, governments provided $23.2 billion, the 
Commonwealth Government providing $15.1 billion and State and local governments 
$8.1 billion. The private sector provided $11.1 billion. 
Since 1984-85, the proportion of total expenditure funded by governments has fallen 
from 71% to 68%, with the private sector proportion rising from 29% to 32%. The fall in 
the proportion of health expenditure provided by governments results " from a 
combination' of falls in Commonwealth funding from 46% to 44% of total expenditure, 
and State and local government funding from 25% to 23%. Trends in the contributions 
from Commonwealth government, State and local government, and the private sector 
are displayed in constant price terms in Figure 3.1 (page 125). The contributions from 
all three sources has increased slowly over the-years, with major changes at times of 
change of health insurance agreements. 
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Figure 3.2 (page 126). shows expenditure for 1990-91 (the most recent.year for which 
complete data are available) according to source, Commonwealth government, State 
government, or private. Recurrent health expenditure was $29,162 million, 94% of the 
total $31,132 million. The expenditure on acute hospitals was $11,063 million, made up 
of-$9,242-million on public acute hospitals-and-$1,821 million on-private hospitals,. 
Between 1983-84 and 1990-91, the proportion of recurrent expenditure devoted to 
acute hospitals declinedTrom 40.0% to 37.9%. 
In 1990-91, nursing home care was responsible for $2,550 million (8.7% of the $29,162 
million of recurrent health expenditure), medical services for $5,499 million (18.9%), 
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pharmaceuticals $2,803 million (9.6%) and dental services $1,501 million (5.1%). A total 
of $1,202 million (4.1%) was spent on other health professional services, such as 
physiotherapy, chiropractic and podiatry (see Table S49, page 286). 
Box 3 .1 : Hea l th expend i tu re statistics 
Health expenditure statistics provide the means by which the volume and proportion of 
economic resources allocated to the production and consumption of health services can be 
assessed. In addition to illustrating total health resource use—at a point in time, as well as 
over time—expenditure statistics can be used to show the cost of components of health 
services and the sources from which they are funded. The most interesting questions about 
health expenditure relate to its share of the total economic resources, its growth over time, 
and how a country's performance in these respects compares with that of other countries. 
Absolute dollar expenditures are significant for accounting and budgeting purposes, but 
they are of limited usefulness in analysis of trends in provision and use of health services, 
because they may be heavily influenced by non-health factors, such as general inflation and 
population growth. 
Tor long-term and for international comparisons, the best single indicator is health 
expenditure as a proportion of gross domestic product (GDP). However, over short periods, 
this can fluctuate due to irregularities in the growth of GDP. Even over longer periods, 
international comparisons of health resources may be distorted by widely differing rates of 
GDP growth. Also, use of health services and GDP are influenced by the age structures of 
the countries being compared. 
For short-term comparisons, real (adjusted for inflation) health expenditure per person may 
be the most useful measure, but over longer periods and in international comparisons, there 
are technical and conceptual difficulties with the choice and calculation of appropriate 
inflators and deflators (statistical techniques used to adjusted dollar expenditures to 
estimate 'real' amounts). 
For planning and budgetary purposes, the sources of expenditure and the components of 
expenditure allocated to different services are of particular interest. The classification of 
services is undertaken in accordance with WHO conventions (Abel-Smith 1969) which, 
although clear in theory, are difficult to apply consistently in practice. These difficulties are 
particularly problematical when making international comparisons. 
The main division of funding source is between the public and private sectors. This 
distinction is blurred (in some countries more than in others) by non-government 
organisations that perform quasi-government functions, and by the accounting procedures 
for health expenditures for which tax deductions can be claimed. In Australia, the relative 
contributions of Commonwealth and State governments are of considerable policy interest, 
but public accounting conventions do not always reflect the underlying reality. 
These considerations show why the interpretation of health expenditure statistics needs to 
take account ofthe specific institutional arrangements of each country. 
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Box 3.2: Adjustments to grants to States 
The role of the Commonwealth Grants Commission is to recommend to the Commonwealth 
Government adjustments to General Revenue Grants to ensure 'fiscal equalisation' among 
the States. It enables 'each State to provide, without having to impose taxes and charges at a 
level appreciably higher than the levels imposed by the other States, government services at 
standards not appreciably different from the standards provided by the other States' 
(Commonwealth Grants Commission 1993a, 1993b). 
The Commission's processes allow for State-specific factors such as administration, 
demography and physical and economic environment which might give rise to higher or 
lower levels of use of public services. The factors it takes into account are illustrated by 
those listed below, which are used for hospital services. 
Administrative scale factors allow for the economies of scale that the more populous 
States can realise. 
Input cost factors allow for the differences between States in wage and salary costs, 
accommodation costs and electricity costs. 
For the inpatient services factors, age and sex composition, cross-border provision of 
services, service delivery scale, Aboriginality, dispersion, economic environment and 
socioeconomic composition are taken into account. The economic environment 
component reflects the lack of private hospitals within a given population density and land 
area. The socioeconomic composition component uses weighting for people of non-
English-speaking background and for social security beneficiaries. This component is to 
account for higher demand because of poorer health and the inability to gain access to 
private services. 
The non-inpatient services factor incorporates age, sex, Aboriginality, low socio­
economic status, dispersion and economic environment. 
A revenue raising factor allows for the capacity of a State to raise revenue from private 
patients in public hospitals. 
For each component of each factor, a particular State may be advantaged (scored negatively) 
or 'disabled' (disadvantaged, scored positively). The components for health are totalled. For 
New South Wales and Victoria, which are in aggregate advantaged relative to the standard, 
the totals are negative. The standard expenditure is the national average of actual 
expenditures. A standardised expenditure is also calculated for each State. The standardised 
expenditure is the 'fiscally equalised' expenditure. The difference between it and the 
standard expresses the identified total disability or need. 
Data presented by the Commonwealth Grants Commission include standard, standardised 
and actual expenditure. 
A factor is calculated for each area of expenditure, and the factor for all sectors is derived by 
combining all the different sectoral factors. The combined factor determines the per person 
General Revenue Grant to each State. 
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Year ended 30 June 
] Private 
| State / Local governments 
| Commonwealth government 
Note: Expressed in constant 1989-90 prices. Data for 1991-92 and 1992-93 are preliminary. 
Source: AIHW unpublished data 
Figure 3 .1 : Total health expenditure by source of funds, 1970-71 to 1992-93 
Changes in health expenditure 1975-76 to 1992-93 
From 1975-76 to 1992-93, real health expenditure (in constant 1989-90 prices) 
increased 76% from $17,679 million to $31,068 million, an average annual increase of 
3.5% (see Table S48, page 284). 
Over the period 1975-76 to 1992-93, population growth was 26% (1.4% per year), and 
real per person health expenditure increased from $1,266 to $1,768 in 1990-91 dollars, 
an increase of 40%. This is an average annual increase of 2.0%, or about $680 million 
dollars extra spent per year on health. 
Part of the increase in real health expenditure per person is due to the ageing of the 
population, and part reflects greater use of health services by people of all ages. Of the 
40% increase from 1975-76 to 1992-93, 10% or about $170 million per year can be 
attributed to the increasing proportion of older people in the population. 
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Per cent of recurrent expenditure 
100 Other expenditure 
($1,974)( a) 
Admin & research 
($1,417m) 
Community & public 
health ($1,153m) 
Pharmaceuticals 
($2,803m) 
Dental and other 
professional services 
($2,703m) 
Medical services 
($5,499m) 
Nursing homes 
($2,550m) 
Private hospitals 
($1,821m) 
Public acute hospitals 
($9,242m)( b) 
40 50 80 90 100 0 10 20 30 
] Private ($9,428m) 
| State ($6,743m) 
| Commonwealth ($12,991m) 
(a) Other expenditure includes public psychiatric hospitals, ambulance, aids and appliances, and 
other expenditure not elsewhere classified. 
(b) Public acute hospital expenditure includes recognised public and repatriation hospital expenditure. 
Source: AIHW unpublished data 
F i g u r e 3.2: Recurrent health expenditure at current prices, Australia, 1990—91 
Health expenditure and the recession 
Figure 3.3 shows that health expenditure grows at a relatively steady rate and is much 
less dependent on the business cycle than are other sectors of the economy. 
Manufacturing, construction, and wholesale and retail, for example, show marked 
fluctuations which are not seen in the health industry. 
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Figure 3.3: GDP by industry, seasonally adjusted, constant 1989-90 prices 
In 1990-91 health expenditure grew in real terms by 1.9% and in 1991-92 by 2.3%. The 
growth rates of 1990-91 and 1991-92 were below the average of 4.0% for the previous 
eight years. Thus there were decreases in the growth rates of health expenditure in the 
recession years (AIHW 1993a). 
Health expenditure as a proportion of GDP varied from 7.4% to 7.8% from 1975-76 to 
1989-90. In 1990-91 it increased to 8.2% and then in 1991-92 to 8.4%. These increases 
were due mainly to the fall in or low growth of GDP in these years. Real GDP fell 0.4% 
in 1990-91 and grew only 0.6% in 1991-92. If real GDP had grown in these two years at 
the 3.6% average annual growth rate of GDP of the previous eight years (1981-82 to 
1989-90), then the health expenditure to GDP ratio in 1991-92 would have been 7.9%, 
not the 8.4% it actually was. 
The increases in health expenditure as a proportion of GDP, therefore, can be attributed 
largely to the recession. 
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Health expenditure internationally 
As noted in Box 3.1, health expenditure of nations is best compared as a percentage of 
GDP. This measure gives an indication of resources used in health relative to the 
country's ability to provide them. The change in the share of GDP expended on health 
depends on the growth in GDP as well as on the growth in health expenditure. Since 
the mid-1980s, most OECD countries have shown a levelling off in health expenditure 
as a percentage of GDP. The exception has been the United States (Figure 3.4). 
Per cent 
15 
14 USA 
13-
12-
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Year 
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Source: OECD 1993b 
F i g u r e 3.4: Health expenditure for Australia and selected OECD countries as a 
percentage of GDP, 1970 to 1992 
Most OECD countries have kept health expenditure as a percentage of GDP constant 
without experiencing adverse effects on population health. It is not known what health 
expenditure as a percentage of GDP is necessary to maintain population health. 
From 1989 to 1991 there was an increase from 8.2% to 8.7% in the average percentage of 
GDP spent on health in the OECD countries listed in Table S50 (page 287). Most of this 
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increase was due to a slowdown in economic activity, and did not indicate an 
unusually high increase in health expenditure (OECD 1993a, 1993b). 
Despite the increase in the use of health services in Japan, health expenditure as a 
proportion of that country's GDP is still low relative to most other OECD countries, 
partly due to measurement differences and partly because it started off at such a low 
level. There are some indications that Japanese health expenditure may be 
underestimated by as much as 50%. 
A number of factors contribute to the growth of health expenditure. Broadly, these 
factors relate to inflation, both general inflation and any excess over general inflation of 
cost increases in the health sector. They also relate to greater use of services as a result 
of population growth and greater per person use of services. 
Technically, the effect of the inflation is summarised as a 'health care price deflator' 
(row 3 in Table 3.2, page 130), with the two component parts known as 'GDP deflator' 
(row 4) and 'excess health care inflation' (row 5). The effect of the greater use of 
services is known as 'real expenditure growth' (row 6), with its component parts 
known as 'population growth' (row 7) and 'per person real health expenditure growth' 
(row 8). 
A comparison of health expenditure growth in Australia with that in a number of other 
countries reveals some interesting differences. Since the general inflation rate is not a 
characteristic over which the health system has control, the most useful index of health 
inflationary pressures for international comparisons is the excess health care inflation 
rate. This rate varies greatly from country to country. The United States rate is high at 
an annual average rate of 2.7%, and the Australian rate is low at 0.1%. If Australia had 
experienced the same excess health care inflation rate as the United States in the period 
1979-80 to 1989-90, Australian health expenditure in 1989-90 would have been $7,900 
million dollars (28%) higher than it was. An extra $7,900 million would have lifted 
health expenditure in 1989-90 from 7.8% to 10.0% of GDP. This indicates that a major 
contributor to control of growth in the ratio of health expenditure to GDP is the control 
of price increases in the health sector. 
Compared with the other OECD countries considered, the higher population growth in 
Australia, Canada and the United States means that these countries need a higher 
growth in health expenditure just to keep up with population increase. The other 
component of real expenditure growth, the per person real expenditure growth, is the 
best measure of the increase in provision of health service inputs. The per person real 
expenditure growth in Australia of 2.2% per year over the period 1979-80 to 1989-90 is 
slightly higher than the mean 2.0% per year for eight selected OECD countries listed in 
Table 3.2, and greater than the United Kingdom, West Germany, New Zealand and 
Sweden. 
For Australia, the 2.2% annual average growth in health expenditure per person 
compounds over the ten-year period to a 24% increase. Whether this substantial 
increase in health expenditure translates sufficiently into improvements in outcomes of 
treatment is difficult to answer, and depends on how effectively and wisely health 
professionals and health authorities used these extra resources. 
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T a b l e 3.2: Comparison of health expenditure growth in Australia and selected OECD countries, 
1980 to 1990 (per cent) 
Growth components^ Aust Can Fra <b>Ger NZ Swe UK USA 
Unweighted 
mean 
(1) Share of health 
expenditure in GDP 1980 ( c ) 7.4 7.5 7.5 8.4 7.2 9.2 5.9 9.2 7.8 
(2) Nominal health expenditure 
growth 12.2 10.7 10.4 5.0 12.3 8.9 9.8 10.4 10.0 
(3) Health care price deflator 8.2 6.9 5.2 3.4 11.5 7.1 7.6 6.9 7.1 
(4) Of which GDP deflator 8.1 5.1 6.2 2.6 9.8 7.6 6.1 4.1 6.2 
(5) Of which excess health care 
inflation 0.1 1.8 -0 .9 0.7 1.6 -0 .6 1.3 2.7 0.8 
(6) Real expenditure growth 3.7 3.5 5.0 1.5 0.6 1.7 2.1 3.3 2.7 
(7) Of which population growth 1.5 1.0 0.5 0.3 0.7 0.3 0.2 1.0 0.7 
(8) Of which per person real 
expenditure growth 2.2 2.5 4.5 1.2 -0.1 1.4 1.9 2.3 2.0 
(9) Share of health 
expenditure in GDP 1990 ( c ) 7.8 9.5 8.8 8.3 7.3 8.6 6.0 12.2 8.6 
(a) See text for details. 
(b) West Germany only. 
(c) This table follows the Australian convention of labelling Australian data for a financial year by the second 
year (that is, 1974-75 data are labelled 1975), whereas data for Australia in OECD publications are 
labelled by the first year (that is, 1974-75 data are labelled 1974). Note that data for non-Australian 
countries for health expenditure as a proportion of GDP is slightly inconsistent with some data in Table 
S50, due to inconsistencies in the OECD source document. 
Sources: OECD 1993b; AIHW unpublished data 
Health expenditure by States and Territories 
In this section, 'State' is used to include the two Territories. 
Statistics of health expenditure by State governments are available from a variety of 
central agency sources, including the ABS public finance database, State Health 
Authority annual reports, State Budget papers, and the Commonwealth Grants 
Commission (CGC). 
These bodies have adopted different practices for defining and measuring State health 
expenditure, resulting in differences in statistics reported at the State level. There is 
also a lack of detailed information. For example, the CGC database, one of the better 
databases on State health expenditure for recent years, includes Commonwealth grants 
to States, and reports recurrent expenditure but excludes capital expenditure and 
capital consumption (depreciation). Data presented by the Commission include 
standard, standardised and actual expenditure (see Box 3.2, page 124). 
The National Health Information Agreement has a mandate to coordinate the bodies to 
define a standard set of definitions on agreed expenditure areas and to produce a 
uniform health expenditure data set. 
State government recurrent health expenditure in constant 1989-90 prices increased 
7.2% from $9.2 billion in 1988-89 to $9.9 billion in 1992-93 (CGC 1994). 
Health expenditure as a proportion of total State government expenditure recorded by 
the CGC changed from 24.5% in 1988-89 to 23.3% in 1992-93. 
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Total State government health expenditure per person shows a 1.8% increase in real 
terms from $551 per person in 1988-89 to $561 in 1992-93, but there were considerable 
differences between States. The Queensland government increased real health 
expenditure per person by 15% over the period, from $439 per person to $504 per 
person, at an annual average rate of 3%. The Northern Territory increased its real 
health expenditure by 20%. Expenditure per person by Victoria, South Australia, and 
Tasmania increased by 2.4%, 6.2%, and 1.9% per annum respectively. Per person 
expenditure by New South Wales, Western Australia and the Australian Capital 
Territory fell in real terms by 3.0%, 5.4%, and 6.7% respectively (Figure 3.5). 
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Figure 3.5: State and Territory government total health expenditure, per person, 
1988-89 to 1992-93 (constant 1989-90 prices) 
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The relative order of State government real expenditure per person did not change 
significantly over the period. The Northern Territory Government had the highest 
expenditure per person, whereas the Victoria, New South Wales and Queensland 
Governments continued to have the lowest levels of expenditure. 
Dispersion about the national average decreased significantly. In 1988-89 Queensland 
was 20% below the national average, but in 1992-93 it was only 10% below. Western 
Australia spent 20% above the national average in 1988-89 but only 12% above the 
national average in 1992-93. 
If all States had moved to the Queensland per person level of health expenditure in 
1988-89, State government expenditures would have been reduced by $1,800 million, 
whereas if that had happened in 1992-93 expenditure would have been reduced by 
only $1,100 million (in current prices). 
Only the expenditures of the Queensland and New South Wales Governments lay 
below the national average throughout 1988-89 to 1992-93. The rest of the States spent 
more than the national average. 
Hospital expenditure changes are very different from those of total recurrent health 
expenditure (Figure 3.6). Part of the apparent difference is likely to be due to 
classification differences between States. 
From 1988-89 to 1992-93 there was a decrease in State government hospital 
expenditure per person for Australia. Real expenditure per person, net of patient fees 
and other revenue, fell by 1.3% over the period. The national average was heavily 
influenced by a decline in real hospital expenditure per person of 7% for New South 
Wales, from $401 per person to $350 over the period. 
Cost of hospitals 
Total expenditure by acute care hospitals increased from $5,235 million in 1982-83 to 
$11,637 million in 1991-92, an increase of 122% (AIHW 1994). After taking inflation into 
account, the increase is 32% over 9 years or 3.1% per year. Growth in population was 
1.5% per year over this period, so the real growth in per person expenditure was about 
1.6% per year (Table 3.3, page 134). 
During 1982-83 to 1991-92, total recurrent health expenditure grew faster than acute 
hospital expenditure. Total recurrent health expenditure grew from $19,439 million to 
$28,263 million (adjusted for inflation). Acute hospital expenditure, as a proportion of 
total recurrent health expenditure, fell from 42% to 38% despite a rise in the proportion 
of private hospital expenditure as a part of total health expenditure (Table 3.4, 
page 134). 
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whereas real expenditure for private hospitals increased by 68% over the same period. 
Private acute and psychiatric hospitals had an estimated revenue in 1991-92 of $1,860 
million. Of this, about 60% was expended on salaries, wages and on-costs such as 
superannuation, payroll tax and workers' compensation premiums. 
The average expenditure per occupied bed-day, that is, the total cost for inpatient and 
non-inpatient services divided by the total number of occupied bed-days, was $400. 
This expenditure ranged from $285 for hospitals with 25 beds or fewer to $521 for 
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hospitals with over 200 beds, but it must be recognised that larger hospitals frequently 
treat more resource-intensive conditions (Cooper-Stanbury, Solon & Cook 1994). 
$ per person 
800 
700 -
600 -
500 -
400 -
300 J 
1988-89 1989-90 1990-91 1991-92 1992-93 
800 
700 -
600 -
500 -
400 
300 -
1988-89 1992-93 
Source: Commonwealth Grants Commission 1993b 
Figure 3.6: State and Territory government hospital expenditure,per person, 
1988-89 to 1992-93 (constant1989-90 prices) 
The average cost per admission was $1,689 in private acute and psychiatric hospitals 
and $287 in the freestanding day hospitals. 
Comparison of public and private hospital expenditure is problematic, because public 
and private hospitals have different roles and serve different populations. Public 
hospitals serve greater proportions of the old and the very young. The complexity of 
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services provided to patients (casemix) varies between public and private hospitals: 
highly specialised services such as heart-lung transplants are provided by the public 
teaching hospitals, and less complex services are provided by both public and private 
hospitals. All freestanding day hospitals are private, but both public and private 
hospitals provide same-day surgery. 
T a b l e 3.3: Total recurrent expenditure in acute hospitals,™ current and constant 1989-90 prices, 
1982-83 to 1990-91 ($ million) 
Current prices Constant 1989-90 prices 
Year Public Private Total acute Public Private Total acute As % of GDP 
1982-83 4,519 716 5,235 7,003 1,110 8,112 2.95 
1983-84 4,878 803 5,681 7,120 1,172 8,292 2.84 
1984-85 5,297 869 6,166 7,278 1,194 8,472 2.76 
1985-86 5,784 969 6,753 7,512 1,258 8,770 2.75 
1986-87 6,593 1,127 7,720 7,804 1,334 9,138 2.80 
1987-88 7,249 1,216 8,465 8,138 1,365 9,503 2.77 
1988-89 8,100 1,335 9,435 8,554 1,410 9,963 2.77 
1989-90 8,736 1,540 10,276 8,736 1,540 10,276 2.78 
1990-91 9,242 1,821 11,063 8,734 1,720 10,454 2.84 
1991-92 9,613 2,024 11,637 8,833 1,860 10,693 2.88 
(a) Acute hospitals includes recognised public, private and repatriation hospitals. 
Source: AIHW Health Expenditure Data Base 
T a b l e 3.4: Total recurrent expenditure in acute hospitals™ and as a percentage of total recurrent 
health expenditure, constant 1989-90 prices, 1982-83 to 1990-91 
Public Private All acute Recurrent health 
Year hospitals hospitals hospitals expenditure 
(Per cent) (Per cent) (Per cent) ($m) 
1982-83 36.0 5.7 41.7 19,439 
1983-84 34.6 5.7 40.2 20,603 
1984-85 34.2 5.6 39.8 21,271 
1985-86 33.5 5.6 39.2 22,396 
1986-87 33.2 5.7 38.9 23,490 
1987-88 33.4 5.6 39.1 24,335 
1988-89 33.2 5.5 38.6 25,796 
1989_90 32.5 5.7 38.3 26,849 
1990-91 31.8 6.3 38.1 27,425 
1991-92 31.3 6.6 37.8 28,263 
(a) Acute hospitals includes recognised public, private and repatriation hospitals. 
Source: AIHW Health Expenditure Data Base 
Analysis is further complicated by the way medical services are provided to patients. 
Public patients in public hospitals are provided with medical services by the hospital, 
at no expense to the patient. Private patients in both public and private hospitals pay 
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for medical services by the treating doctor. The cost of these services is not recorded in 
the cost of the hospitals. 
The different accounting rules for the public and private sectors further complicate 
comparison. For example, public hospitals generally do not estimate depreciation, but 
private hospitals generally do. Private hospitals which are run 'for profit' produce a 
profit (or a loss); the not-for-profit private hospitals may produce a surplus and the 
public hospitals produce neither a profit nor a surplus. 
Services for non-admitted patients are another important area of difference. They make 
up 20% to 35% of the expenditure of public hospitals, but are a minor part of the 
services provided by private hospitals. 
Expenditure on public hospitals is estimated from records of expenditure of State, 
Territory and Commonwealth health authorities. Expenditure on private hospitals is 
estimated from the revenue received from patient accommodation, theatre and other 
fees. 
3.3 Private health insurance 
The main source for this analysis is the Private Health Insurance Administration 
Council (PHIAC) database, from which the details of private health fund membership 
for basic and supplementary hospital insurance have been extracted. Other sources are 
the Australian Bureau of Statistics 1992 Health Insurance Survey (ABS 1993), the most 
recent survey of health care and insurance undertaken by TQA Research Pty Ltd (1991) 
and the background paper on private health insurance prepared by the National 
Health Strategy (Willcox 1991). 
An industry in transition 
The introduction of Medicare led to the private health insurance funds' share of health 
expenditure falling from 21.4% to 9.5%, but it has since recovered somewhat to 12.9% 
in 1992-93. 
In 1982-83, prior to the introduction of Medicare, 32% of expenditure by private health 
insurance funds related to medical services. When Medicare was introduced in 1984, it 
took over this responsibility, so the private health insurance funds had to restructure 
and reorient their activities significantly. 
The provision of hospital benefits has continued to be the main task of the private 
health insurance funds, and with the introduction of Medicare this increased from 47% 
to 57% of their expenditure. At the same time, funds put significant effort into 
promoting insurance for ancillary services, and for a short while insurance for these 
services did increase. Ancillary services represented 25% of expenditure in 1984-85 and 
27% in 1985-86, but since then they have declined to be 22% of expenditure in 1992-93. 
Administration costs increased from 10% of expenditure in 1982-83 to 14% in 1984-85, 
but since then the proportion has declined to 12% in 1992-93. 
The activity of private health funds which has shown by far the greatest growth since 
1984-85 has been benefits for patients in private hospitals, which have increased from 
37% to 44% of expenditure and have shown a real growth of 116%. In contrast, benefits 
paid for private patients in public hospitals have declined from 20% of expenditure in 
1984-85 to 14% in 1992-93. 
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Box 3.3: Private health insurance 
Since the introduction of Medicare in 1984, private health insurance funds have not 
provided coverage of medical practitioner services outside hospitals. Private insurance now 
pays benefits principally for hospital services and for medical practitioner services received 
by private patients in both private and public hospitals. For this hospital cover, private 
insurance is available in two forms: basic and supplementary. Ancillary insurance covers 
all other health services, but accounts for only 22% of private health insurance benefits 
payments. 
The basic hospital table provides full coverage for standard facilities for private inpatients of 
recognised public hospitals, and partial coverage for private hospitals and day hospital 
facilities. It also provides coverage of the gap between Medicare benefits and schedule fees 
for services received by private patients in both private and public hospitals. 
The supplementary hospital tables provide additional hospital accommodation benefits to 
cover the higher charges of private hospitals and the extra charge for private rooms in public 
hospitals. Membership of a basic hospital table is a prerequisite for membership of a 
supplementary table. 
The coverage of ancillary insurance varies from fund to fund, but typically includes dental, 
chiropractic, physiotherapy, dietetic and other services rendered by health professionals 
other than medical practitioners, and aids and appliances, especially spectacles, and 
ambulance services. 
Changes to private health insurance arrangements were being canvassed as this edition of 
Australia's health went to press. 
These changes in part reflect an increasing use of private hospitals, and a decreasing 
use of public hospitals, by privately insured patients. In the last three years, the 
number of private hospital bed-days has increased by 7%, and the number of public 
hospital bed-days for private patients has decreased by 15%. 
Benefits paid per private hospital bed-day have increased 36% in real terms in the last 
three years, but much of the increase has been for increases in fees for theatre and other 
services rather than for accommodation charges. Over the same period, benefits paid 
per public hospital bed-day have increased by only 26%. The trend away from use of 
public hospitals, described in the previous paragraph, means that there has been a 
large increase in benefits paid per bed-day. This has been one reason for the large 
increases in premiums for private health insurance in recent years. In turn, the 
increases have affected coverage. 
Trends in private hospital insurance coverage 
The proportion of the population holding private hospital insurance has fallen from 
about 68% in 1982 (prior to the introduction of Medicare), to 50.0% in June 1984 and 
38.4% in December 1993. The fall was rapid around the introduction of Medicare, but 
then slowed to 0.8 percentage points per year from June 1984 to June 1989 (Figure 3.7). 
The decline over this period to June 1989 varied across States, with New South Wales 
experiencing only a small drop of 1.8%, partly offset by a temporary increase in 
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coverage due to concerns arising from the doctors' dispute in 1984. In contrast, Western 
Australia and South Australia experienced declines of 11.3% and 7.9% respectively, 
whereas the lower rate of decline of 4.6% in Victoria was evidently influenced by 
concerns generated by the 1985 nurses' strike. The small decline of 4.1% in Queensland 
may reflect different historical experience; in Queensland, membership of health 
insurance funds has always been low because for decades the State government 
supplied public hospital services free to all. 
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F i g u r e 3.7: Proportion of population ivith basic private hospital insurance, States 
and Territories, 1983 to 1993 
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From June 1989 to December 1993 the rate of decrease for Australia remained fairly 
steady at 1.6% per year, although some States experienced larger decreases. Coverage 
in Victoria fell from 50.8% to 38.9%, an average fall of 2.6 percentage points per year, 
and in South Australia from 48.5% to 35.6%, an average fall of 2.8 percentage points a 
year. Queensland experienced a small increase in coverage, of 0.7 percentage points 
over this period. 
The result of these changes is that State levels of private hospital insurance cover have 
tended to converge, with an average dispersion about the national average of 5.8% in 
June 1984, decreasing to 2.4% in December 1993. 
Marked geographical differences remain nevertheless, although the reasons are 
obscure. Hopkins & Kidd (1993) demonstrated the importance of geographic location 
as a factor independent of age, health status and income. The availability of private 
hospitals may partly explain the differences, especially between the non-metropolitan 
areas, where coverage is lower, and the metropolitan areas, where it is higher. 
Supplementary cover membership has shown three main phases since the introduction 
of Medicare (Figure 3.8). The first phase was from June 1984 to June 1987, when the 
proportion of the Australian population with supplementary cover increased by 8.8 
percentage points (from 29.6% to 38.4%), largely due to a 15.7 percentage points 
increase in New South Wales (from 22.6% to 38.3%). Victoria, Queensland and Western 
Australia also had significant increases, and there were small increases in South 
Australia and Tasmania. 
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Figure 3.8: Proportion of population covered by health insurance funds basic and 
supplementary cover, 1983 to 1997 
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In the second phase, from June 1987 to September 1990, the national proportion with 
supplementary cover increased by 1.3%, an average increase of 0.4% a year. This was 
the net result of increases in New South Wales and Victoria, stability in Queensland 
and South Australia, and declines in Western Australia and Tasmania. 
Lastly, from September 1990 to December 1993 there was a decline of 4.4% in national 
supplementary cover (from 39.7% to 35.3% of the population), with variations from 
State to State. Victoria, South Australia and Tasmania had the biggest declines of, 
respectively, 10.2%, 6.2% and 5.6%. New South Wales had a decline of 3.8%. Western 
Australia had a small decline of 0.4%. There was an increase of 2.4% in Queensland. 
These variations are consistent with the recession experience of each of these States. 
Queensland and Western Australia weathered the recession best and, from September 
1990 to December 1993, had significant employment growth, whereas the other States 
experienced employment declines (ABS 6203.0). Victoria had the most severe decline in 
employment in this period and also the largest decline in supplementary health 
insurance coverage. 
The effects of price and income changes 
The rapid increase in the price of health insurance over recent years may have 
contributed to the reduction in private hospital insurance membership. Of those who 
ceased private health insurance in the two years before a 1992 survey, 67% said they 
had done so because they could not afford it (ABS 1993). 
A 1991 review noted: 'The price of health insurance has reached the "Pain Threshold" 
for many households...It has virtually become a "luxury" item over the past two 
years...The danger of cost increases driving people out of private health insurance is 
far greater now than it was two years ago...The number of respondents stating they are 
likely to opt out of private health cover in the next 12 months has increased by 50%. 
This is a grim forward indicator for the private health insurance market' (TQA 
Research 1991). 
The TQA commentry implies that the high price of health insurance is causing the 
decline in membership, whereas the income falls due to the 1990-91 recession may be 
the major factor, particularly influencing the fall in supplementary membership. Other 
findings of TQA indicated that people with supplementary insurance were not very 
likely to abandon it because of changes in price. However, it has been argued that they 
are significantly influenced by changes in income. Thus, if income declines or is under 
threat of declining, some families will drop their health insurance coverage. The State 
differences in changes in supplementary coverage, discussed above, support this 
hypothesis. 
If income is a major determinant of supplementary coverage, then, as the economy 
grows at a faster rate and employment starts to increase for all States, increases in 
supplementary coverage may be expected in all States. However, a return to pre-
recession levels would not necessarily be expected, because some of those who drop 
private insurance will see no need to return, even though income improvement give 
them the capacity to return. 
Figure 3.8 provides a forward projection of trends since December 1993 in health 
insurance membership for Australia. This projection shows a continued decline in both 
basic and supplementary private hospital insurance coverage to 31.1% in June 1997. 
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The decline in basic coverage is at an annual rate of 2.1%, and in supplementary 
coverage at 1.3% per year. As discussed above, membership of supplementary tables 
might increase as the economic recovery gathers pace. 
Other factors influencing the level of private hospital insurance 
The ABS Health Insurance Survey and other analyses continue to show that the prime 
determinants of demand for private health insurance are age, state of health, and 
material well-being. Declines in coverage among younger people continue, but 
coverage among those aged 60 and over has increased since 1986 (Table S52). 
The 1992 ABS Health Insurance Survey asked why people had private health insurance 
(ABS 1993). With more than one reason allowed to respondents, the reason for having 
private hospital insurance was reported as 'choice of doctor' by 34% of contributor 
units, and 'allows use of private hospitals' by 31%. The proportion giving these reasons 
was lower than in the 1990 survey. In 1992, 31% of contributors gave their reason as 
'shorter wait for treatment/concern over public waiting lists', and 43% sought 
'security/protection/peace of mind'. These proportions had not changed greatly since 
1990. 
3.4 Pharmaceuticals 
A summary of how the Pharmaceutical Benefits Scheme (PBS) operates in 1994 is given 
in Section 3.1. However, there have been many changes affecting the scheme in the 
period covered by this review. 
The most important changes occurred on 1 November 1990. Until then, pensioners 
received PBS prescriptions free. Since then, pensioners, like other concessional 
beneficiaries, have had to pay for prescribed drugs, but have also benefited from the 
safety net arrangements applying to concessional beneficiaries. Again, on 1 November 
1990, there was a substantial increase, from $11 to $15, in the maximum patient 
contribution for general beneficiaries. Since this date there have been changes to the 
safety net affecting general beneficiaries, and increases to $16 in their maximum patient 
contribution. 
The timing of the November 1990 changes makes statistics for the financial year 
1990-91 as a whole difficult to interpret, and this discussion is based on data from 
years during which there were lesser changes. 
The information about pharmaceutical drugs provided on prescription through 
community pharmacies is of good quality. However, over the period examined, many 
drugs previously obtainable only by prescription from a medical practitioner or dentist 
have been made available without prescription. There are no data showing the effects 
of these changes and there is little information about the volume or composition of 
sales of non-prescription drugs (known as over-the-counter drugs or OTCs). Also, 
although amounts of public hospital spending on drugs are available, the breakdown 
between prescription drugs and OTCs is not available. 
The Commonwealth also assists in provision and purchase of drugs through the 
Repatriation Pharmaceutical Benefits Scheme (RPBS), which provides assistance to 
specific groups of Australian war veterans and dependants, but is otherwise similar to 
the PBS for concessional beneficiaries. 
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Composition of the Australian market for prescription drugs 
Prescription drugs can be dispensed under the PBS and RPBS programs, as private 
prescriptions, through hospitals, and through a group of smaller Commonwealth 
Government programs. Each of these segments has its own characteristics. Information 
about RPBS and subsidised PBS prescriptions comes from the Department of Human 
Services and Health, and the wholesaling and dispensing costs are known. The 
numbers of unsubsidised PBS prescriptions and of private prescriptions are provided 
by the Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory 
Committee, their information coming from a survey carried out in conjunction with the 
Pharmacy Guild of Australia; estimates of the prices of these drugs are provided on a 
confidential basis to the Institute by commercial sources. The costs of hospital drugs 
are collected through the Hospital Utilisation and Cost Studies carried out by the 
Institute, and adjusted to exclude estimated dispensing of non-prescription drugs. 
Each market segment has its own mark-ups and dispensing costs and, for hospitals, 
dispensing costs and inventory costs are not known. The relative size of the different 
components of the prescription drug market can thus be obtained only by comparing 
the sales of drugs at manufacturers' prices. Figure 3.9 shows the components of this 
market in 1992-93. 
Private prescriptions 
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Source: AIHW unpublished data 
Figure 3.9: Total cost of manufacturers' prices of pharmaceutical (excluding OTC) drugs, 
1992-93 
Between 1990-91 and 1992-93, the subsidised PBS sector grew from 57.5% to 60.5% of 
all drugs and the unsubsidised PBS sector from 10.7% to 12.5%. The hospital sector 
141 
appears to have decreased a little; this could be due, in part, to the Commonwealth 
Government providing assistance to public hospitals for the provision of highly 
specialised drugs from 1991-92. The likely causes of these changes are discussed 
below. 
Prescr ipt ion d r u g s provided through communi ty pharmac ies 
In 1992-93 community pharmacies supplied 157.5 million prescriptions to patients, an 
increase of 4% over 1991-92 (Table 3.5). Consumption per person was 8.84 
prescriptions, down from the 1989-90 level of 9.54 prescriptions, but 2.7% higher than 
the 8.60 prescriptions in 1991-92. 
Prescription use over this period was influenced by the changes from November 1990, 
but also by increases in the number of people eligible for PBS prescriptions as 
concessional beneficiaries. 
Table 3.5: Estimated number of prescriptions supplied through community pharmacies, by 
category, 1989-90 to 1992-93 (million) 
Drug category 1989-90 1990-91 1991-92 1992-93 
PBS - subsidised 105.0 95.7 93.5 105.3 
Annual growth - 8 . 8 % -2.4% 12.6% 
PBS - unsubsidised ( a ) 33.2 36.4 38.7 34.8 
Annual growth 9.6% 6.5% -10.1% 
RPBS ( b ) 7.6 7.2 6,7 5.9 
Annual growth -4.9% -7.9% -11.7% 
Private 16.7 15.3 12.2 11.6 
Annual growth - 8 . 4 % -20.5% -4.9% 
Total number 162.5 154.7 151.0 157.5 
Annual growth - 4 . 8 % - 2 . 4 % 4.3% 
(a) PBS drugs priced less than the General Patient Contribution level for which no Commonwealth subsidy 
is paid, but which count towards the General Safety Net. 
(b) Repatriation Pharmaceutical Benefits Scheme provides subsidised drugs to certain classes of veterans 
and their dependents. The numbers here include prescriptions supplied as Ordinary and Safety Net 
benefits. 
Sources: Subsidised PBS and RPBS: DCSH 1990; DHHCS 1991, 1992; HHLGCS 1993 and unpublished 
data 
Unsubsidised PBS and private prescriptions: Drug Utilisation Sub-Committee of the Pharmaceuti­
cal Benefits Advisory Committee; Pharmacy Guild of Australia; AIHW unpublished data 
Like any other increase in charges, the increased costs of prescriptions for both 
pensioners and general beneficiaries could have been expected to reduce demand. 
The numbers eligible for cards entitling their families to concessional benefits increased 
from 544,283 in 1990-91 to 730,505 in 1992-93. The increase in the numbers of people 
eligible for drugs at concessional prices was thus considerable. The increase in 
eligibility was due, in part, to increased unemployment. Poor health associated with 
unemployment might have led to an increase in the number of doctor visits and hence 
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of prescriptions, and prescriptions becoming cheaper for new Concessional Card 
holders could have been expected to increase demand. 
The number of prescriptions for which there was some subsidy fell by 11.5 million 
from 1989-90 to 1991-92. Subsidised prescriptions supplied as general benefits 
decreased by 7 million, in part because all prescriptions priced between $11 and $15 
were no longer eligible for subsidy. The number of unsubsidised prescriptions for PBS 
items increased 5.5 million from 33.2 million to 38.7 million. In 1989-90, 7 million 
prescriptions priced between $11 and $15 had been purchased. The increase suggests 
that 5.5 million of them were still purchased in 1991-92. 
The total number of prescriptions of PBS drugs increased from 132.2 million in 1991-92 
to 140.1 million in 1992-93, an increase of 6.0%, or 4.5% per person. The number of 
subsidised PBS prescriptions increased from 93.5 million to 105.3 million, an increase of 
12.6%. The number of unsubsidised prescriptions fell from 38.7 million to 34.8 million. 
The increased number of concessional beneficiaries would have been the main cause of 
this combination. As most new concessional beneficiaries would have been general 
beneficiaries first, all of their PBS drugs costing less than the general beneficiaries 
contribution would not have been subsidised at that time. As concessional 
beneficiaries, all their PBS drugs were subsidised. 
These changes can also be seen in statistics of expenditure. Commonwealth PBS 
expenditure in 1992-93 was $1,418 million (Table 3.6). This was 23.3% higher than in 
1991-92. Concessional Card holders who were formerly general beneficiaries increase 
Commonwealth expenditure even if their use of prescriptions does not change, and 
accounted for much of the 12.6% increase in the number of subsidised prescriptions 
(Table 3.5). That, in turn, implies a 9.5% increase in average costs of subsidised 
prescriptions. New use of higher cost drugs, and the replacement of cheaper drugs by 
higher cost drugs are the components of this increase in average cost per prescription; 
over $90 million was spent on the drug simvastatin, which lowers blood cholesterol 
levels, in 1992-93. 
Table 3.6: Commonwealth and patient expenditure on pharmaceutical drugs, 1989-90 to 1992-93 
($ million) 
1989-90 1990-91 1991-92 1992-93 
PBS 
Commonwealth expenditure 1,135.5 1,094.5 1,132.5 1,417.5 
Patient contributions 184.8 223.8 308.2 359.5 
Total subsidised 1,320.3 1,318.3 1,440.7 1,777.0 
Unsubsidised 331.7 436.2 441.2 428.0 
Total PBS 1,652.0 1,754.5 1,881.9 2,205.1 
RPBS 83.7 86.0 85.9 86.7 
Private scripts 250.7 249.8 251.3 263.3 
Total expenditure 1,986.3 2,090.3 2,219.1 2,555.0 
Sources: Subsidised PBS and RPBS: DCSH 1990; DHHCS 1991, 1992; HHLGCS 1993 and unpublished 
data 
Unsubsidised PBS and private prescriptions: Drug Utilisation Sub-Committee of the Pharmaceu­
tical Benefits Advisory Committee; Pharmacy Guild of Australia; AIHW unpublished data 
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There appears to have been a significant reduction in the number of prescriptions for 
drugs not listed on the PBS over the period 1989-90 to 1992-93 (Table 3.5). These 
prescriptions had made up 10.3% of all prescriptions in 1989-90, but only 7.4% in 
1992-93. It is not known whether drugs listed on the PBS have been prescribed instead. 
Total expenditure on prescription drugs provided through community pharmacies in 
1992-93 was $2,555 million, an increase of 15.1% over 1991-92. A 10.4% increase in 
average prescription costs contributed more to this than the 4.3% increased use of 
prescriptions (2.8% per person). The Commonwealth paid $1,504 million of the $2,555 
million through the PBS and RPBS, and individuals paid $1,051 million (41%), 
including amounts for non-PBS drugs. 
If the increase in the numbers of cardholders over the period 1990-91 to 1992-93 is due 
to unemployment, then it is likely that Commonwealth expenditure through the PBS 
has increased by $100-150 million as a result of the increase in unemployment. 
Other Commonwealth programs for provision of pharmaceutical drugs 
Other major components of Commonwealth expenditure on pharmaceutical drugs are 
shown in Table 3.7. 
Tab le 3.7: Other Commonwealth programs for the provision of pharmaceutical drugs, 
expenditure 1989-90 to 1992-93 ($'000) 
Component 1989-90 1990-91 1991-92 1992-93 
Growth hormone 36,548 42,627 40,272 35,712 
Highly specialised drugs na na 32,602 34,544 
Doctor's bag (a) 12,256 14,729 16,279 
Other 7,304 9,917 13,274 14,987 
Total 43,852 64,800 100,877 101,522 
(a) Doctor's bag drugs included in PBS general benefits up to 1990-91. 
Sources: DCSH 1990; DHHCS 1991, 1992; HHLGCS 1993 
The largest item of expenditure in 1992-93 in this group was for growth hormones, 
which are supplied free through doctors, mainly paediatricians. The amount spent on 
this program has declined somewhat and additional restrictions on use of hormones 
were introduced in the 1993 budget. 
The 'highly specialised drugs' program provides drugs for the treatment of non-
inpatients attending public hospitals. The drugs provided under this program include 
drugs for patients who have had organ or tissue transplants, and for patients with HIV 
infection and AIDS. 
Doctor's bag items are emergency supplies used by doctors and provided through 
community pharmacists. Prior to 1990-91, their cost was included with that of general 
PBS benefits. 
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3.5 Health technologies 
Health care technologies pervade all areas of the prevention and treatment of disease 
and disability. Although their use has significant cost implications for the allocation of 
health care resources, the expenditure on them in Australia is not definitely known, 
although it is certainly substantial. This uncertainty results from difficulties in defining 
'health technologies'. No matter how they are defined, data on expenditure are 
incomplete, particularly for services not funded through Medicare benefits or as 
pharmaceutical benefits. 
For this discussion, technology services are defined as pathology, radiology, 
ultrasound, nuclear medicine, endoscopy and other diagnostic services, radiotherapy, 
laser use, laparoscopic surgery, operations for cataract, lithotripsy, and insertion of 
cardiac pacemakers. Together they accounted for 32% of total Medicare services and 
44% of total Medicare benefits paid in 1991-92 (AIHW 1993b). Figure 3.10 shows how 
these percentages have changed since 1984-85; the drop between 1988-89 and 1989-90 
in percentage of services reflects changes in the schedule of pathology services. As 
significant proportions of expenditure on some service categories such as nuclear 
medicine and radiotherapy services are not funded under Medicare, the proportion of 
expenditure on these technologies is an underestimate. 
Per cent 
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Source: AIHW unpublished data 
Figure 3.10: Technology services as a percentage of total Medicare services and benefits, 
1984-85 to 1991-92 
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Although there have been only comparatively minor changes to the percentage of total 
Medicare benefits paid for health technology services, Figure 3.11 shows that there has 
been considerable growth in the numbers of some services. Further data are given in 
Table S58, page 296. 
Nuclear medicine 
Endoscopy 
Radiology 
Radiotherapy and 
therapeutic nuclear 
medicine 
Pathology 
12 
Source: AIHW unpublished data 
Figure 3.11: Average annual growth rate for some categories of diagnostic technology, 
1984-85 to 1991-92 
Expenditure on health information technologies is also uncertain, but increasing, with 
the prospect of substantial expansion in the near future. Neame (1993) has suggested 
that perhaps 5% of the total health budget, that is, $1,500 million annually, might be 
spent on information technology. 
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statistics on people with a health qualification include those who reported a health 
field as the field of study of their highest qualification. 
Growth in the numbers of people who reported a health qualification as their highest 
qualification greatly outstripped population growth in the period between the 1986 
and 1991 censuses. The largest increases were in psychiatry (103.9%), radiology 
(109.6%), radiography (93.5%), and optometry (161.5%). There was a 15.8% reduction 
in the numbers reporting their highest qualification as being in surgery (Table 4.4). 
Table 4.4: Persons with selected health qualifications, 1986 and 1991 censuses 
1986 1991 1986-1991 
Type of qualification Persons % female Persons % female % change 
Medicine 
General and internal 28,730 26 37,220 32 +29.6 
Surgery 3,850 8 3.240 10 -15.8 
Psychiatry 760 28 1,550 34 +103.9 
Obstetrics and gynaecology 750 23 1,170 32 +56.0 
Anaesthesiology 920 17 1,460 22 +58.7 
Pathology 810 43 950 45 +17.3 
Radiology 520 20 1,090 33 +109.6 
Other<b> 3,250 43 3,520 36 +8.3 
Nursing 283,930 95 332,710 94 +17.2 
Dental science 7,830 17 10,480 28 +33.8 
Pharmacy 15,560 43 17,870 49 + 14.8 
Physiotherapy 8,210 87 10,630 84 +29.5 
Radiography 3,700 67 7,160 70 +93.5 
Occupational therapy 3,850 95 5,450 96 +41.6 
Speech pathology 1,830 95 2,520 97 +37.7 
Optometry 1,920 25 5,020 26 +161.5 
Total 366,420 83 442,040 82 +20.6 
(a) Highest field of qualification reported in census. 
(b) Includes specialist qualifications not elsewhere classified or undefined. 
Sources: AIHW unpublished data; ABS Cat. No. 2731.0 
Employment trends 
For the larger health professions, the census provides data on levels of and trends in 
employment which are useful in assessing concerns about oversupply or shortages, 
and the numbers of students and overseas-trained practitioners. 
Data for the censuses from 1971 to 1991 show that there has been strong growth in the 
total number of people employed in health occupations. However, the level of growth 
between censuses has declined steadily, from 30.9% during 1971 to 1976, to 7.2% 
during 1986 to 1991. This is a more sustainable long-term growth rate as it is similar to 
population growth (Table 4.5). 
The largest health profession is nursing. This has experienced a slower rate of growth 
than other professions, mainly because of restructuring of the hospital sector which has 
seen a decrease in hospital employment and the move of nurse education from 
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T a b l e 4 . 3 : Medical practitioners billing for at least one Medicare service, by major specialty,* 
1986-87 and 1991-92 
M a j o r s p e c i a l t y 1 9 8 6 - 8 7 1991-92 
P e r c e n t i n c r e a s e 
1 9 8 6 - 8 7 t o 1 9 9 1 - 9 2 
General practitioners 19,411 22,962 18.3 
Anaesthetist 
Specialist 1,369 1,656 21 .0 
Non-specialist 63 112 77.8 
Dermatologist 2 2 2 242 9.0 
Obstetricians and gynaecologists 849 930 9.5 
Pathologist^ 
Specialist 490 588 20.0 
Non-specialist 95 104 9.5 
tmagisr*bJ-
Specialist 895 1,063 18.8 
. Non-specialist 97 109 12,4 
Radiation oncologist 80 106 32.5 
Surgeon 
Specialist 3,076 3,365 9.4 
Non-specialist 467 794 70.0 
Physician 
Internal medicine 2,467 3,158 28.0 
psychiatrist 1,173 1,438 2 2 : 6 
Other medical'0' 245 274 11.8 
All specialties, excluding GPs 11,588 13,939 20.3 
A l l s p e c i a l t i e s 3 0 , 9 9 9 36,901 1 9 . 0 
(a) Major specialty in each year was determined with regard to the nature of the service rendered by each 
practitioner and the fields of specialist recognition that the practitioner had under Medicare. Practitioners 
exclude those salaried medical officers in public hospitals who did not have a Medicare provider number. 
(b) tn many cases will relate to the claiming provider. 
(c) Practitioners who could not be more precisely classified. 
Source: DHHCS 1992 
These growth rates differ substantially from those observed between the 1986 and 1991 
censuses—7.0% for general practitioners and 48.0% for specialists—although the 
overall rate of growth in the number of medical practitioners, 18.3% for the census and 
19.0% for Medicare, are similar. The difference is due to the self-reporting process in 
the census and the classification system used. In the Medicare data, specialty is 
determined by the nature of the services rendered and the specialist recognition that 
the practitioner had. 
The highest growth rates for Medicare providers occurred for radiation oncologists 
(32.5%), specialists in internal medicine (28.0%), psychiatrists (22.6%) and specialist 
anaesthetists (21.0%). 
People with health qualifications 
In both 1986 and 1991 the census question on qualifications asked for the. name, 
institution, field of study and year of the highest qualification attained. Therefore, 
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from 94% to 92%, and of female physiotherapists from 84% to 80%. Excluding nurses 
and physiotherapists, the average percentage of females increased from 42% to 47%. 
Table 4.2: Selected health occupations, 1986 and 1991 censuses 
O c c u p a t i o n 
1 9 8 6 1 9 9 1 
1 9 8 6 - 1 9 9 1 
% c h a n g e P e r s o n s % f e m a l e P e r s o n s % f e m a l e 
H e a l t h o c c u p a t i o n s 
Medical practitioners 
General practitioners 23,790 25 25,450 30 +7.0 
Specialists 9,000 16 13,350 25 +48.3 
All medical practitioners 32,790 23 38,800 29 +18.3 
Dentists 6,310 14 6,720 17 +6.5 
Pharmacists 10,640 39 10,880 43 +2.3 
Physiotherapists 
5,930 84 7,120 80 +20.1 
Radiographers 4,270 63 4,760 66 +11.5 
Occupational therapists 2,770 93 3,660 94 +32.1 
Speech pathologists 1,320 96 1,750 97 +32.6 
Optometrists 1,470 22 1,820 29 +23.8 
Chiropractors and osteopaths 1,370 15 1,540 19 +12.4 
Podiatrists 980 69 1,140 66 +16.3 
Other diagnosis and 
treatment practitioners 3,880 69 5,540 76 +42.8 
Nurses 
Enrolled 35,220 94 39,670 92 +12.6 
Registered 138,220 92 139,380 92 +0.8 
Dental 8,800 99 9,590 99 +9.0 
All nurses 182,240 93 188,640 93 +3.5 
Al l h e a l t h o c c u p a t i o n s 2 5 3 , 9 8 0 7 6 2 7 2 , 3 7 0 7 8 + 7 . 2 
H e a l t h - r e l a t e d o c c u p a t i o n s 
Psychologists 3,850 56 4,750 61 +23.4 
Social workers 6,370 75 7,170 78 +12.6 
Counsellors 4,490 63 7,890 67 +75.7 
Medical testing professionals 7,780 52 7,430 55 -4.5 
Medical technical officers and 
technicians 7,570 71 9,760 74 +28.9 
Ambulance officers 5,100 4 5,580 9 +9.4 
Al l h e a l t h - r e l a t e d 
o c c u p a t i o n s 3 5 , 1 6 0 5 5 4 2 , 5 8 0 6 0 + 2 1 . 1 
Al l h e a l t h a n d h e a l t h - r e l a t e d 
o c c u p a t i o n s 2 8 9 , 1 4 0 7 3 3 1 4 , 9 5 0 7 5 + 8 . 9 
Sources: ABS Cat. Nos. 2731.0 and 4346.0 
The Medicare database on active Medicare providers includes all medical practitioners 
who provided at least one service claimed under Medicare during each financial year, 
and covers more than 90% of all medical practitioners. Medicare database statistics 
show an 18.3% increase for 1986-87 to 1991-92 in the number of general practitioners, 
to 22,962, and a 20.3% increase in the number of medical practitioners providing 
predominantly specialist services, to 13,939 (Table 4.3). 
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health services, and the growth of the aged population affects demand for these 
services. 
Table 4.1: Persons employed in the health industry, 1986 and 1991 censuses 
1 9 8 6 1 9 9 1 1 9 8 6 - 1 9 9 1 
H e a l t h i n d u s t r y P e r s o n s P e r c e n t P e r s o n s P e r c e n t % c h a n g e 
Hospitals (excl. psychiatric) 228,270 50.5 205,360 42.6 -10.0 
Psychiatric hospitals 18,730 4.1 14,000 2.9 -25.3 
Nursing homes * 67,570 15.0 76,000 15.7 +12.5 
Hospitals, nursing homes 
undefined 3,300 0.7 18,960 3.9 na 
Medicine 64,960 14.4 73,420 15.2 +13.0 
Dentistry, dental laboratories 22,350 4.9 23.720 4.9 +6.1 
Optometry 5,250 1.2 7,060 15 +34.5 
Ambulance services 6,200 1.4 6,470 1.3 +4.4 
Community health centres 13,650 3.0 17,340 3.6 +27.0 
Other ( a ) 21,590 4.8 40,279 8.3 +86.6 
AM h e a l t h i n d u s t r i e s 4 5 1 , 8 7 0 1 0 0 . 0 4 8 2 , 6 0 9 1 0 0 . 0 + 6 . 8 
(a) Includes health industry not defined or not elsewhere included. 
Sources: ABS Cat. Nos. 2731.0 and 4346.0 and unpublished data 
At the 1986 census, 47.5% of health industry employment was in the private sector. By 
the 1991 census, this had increased to 51.9%, following a 2.1% fall in government sector 
employment and a 16.8% increase in private sector employment. 
Employment in government hospitals and nursing homes fell by 7.1% (14,800 people) 
to 196,300, and that in the private sector grew by 11.0% (11,700 people) to 118,000. 
There was a 5.5% decrease in government sector employment of doctors and a 13.9% 
increase in the private sector. Similarly, dentists experienced a 5.1% decrease in public 
sector employment and a 11.5% growth in employment in the private sector. 
Employment in selected health occupations 
The 1991 census found that there were 272,370 people employed in health occupations, 
representing 3.9% of all employed people. This percentage was unchanged from the 
1986 census. 
There were 188,640 nurses, 38,800 medical practitioners, 10,880 pharmacists and 6,720 
dentists providing health services in 1991 (Table 4.2, page 150). These figures exclude 
practitioners whose employment was mainly in management, education, or research, 
or in other fields not providing clinical services. 
Health occupations with low growth included registered nurses (0.8%), dentists (6.5%), 
and pharmacists (2.3%). High growth occupations included medical practitioners 
(18.3%), enrolled nurses (12.6%), physiotherapists (20.1%), radiographers (11.5%), 
occupational therapists (32.1%), speech pathologists (32.6%), optometrists (23.8%), 
chiropractors and osteopaths (12.4%), and podiatrists (16.3%) (Table 4.2). 
The percentage of females in health-related occupations increased from 1986 to 1991, 
except in nursing and physiotherapy: the percentage of female enrolled nurses fell 
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4 Health care resources and 
their use 
4.1 Health personnel 
Census data help to resolve many of the health labourforce issues that are important in 
Australia, such as: 
• appropriate numbers of health professionals required; 
• labourforce requirements and supply in various health professions, and specialties 
within those professions, both across Australia and within geographic regions; 
• quotas for students undertaking tertiary training to meet future labourforce needs; 
• requirements for maintenance and upgrading of skill levels of health professionals, 
and the retraining needs of qualified professionals re-entering the labourforce after 
an absence; 
• use of overseas-trained health professionals to meet short-term and long-term 
needs; 
• requirements for increasing uniform regulation and mutual recognition processes to 
achieve efficiencies in professional mobility which would assist in addressing 
health labourforce distribution problems; and 
• recognition of changing professional roles within the health care system. 
For many of the smaller health occupations, the census is the only source of national 
data on the numbers working in those occupations. For all health occupations, it 
provides a measure of the numbers of people qualified in the occupation who are 
either not working or are working in another occupation. 
There are, however, limitations on the usefulness of the census data. Full coverage is 
not achieved because of people missed in the census enumeration, and non-response to 
the occupation, qualification and industry questions. The census records only a 
person's highest qualification, so that a health professional with a highest qualification 
in another field might be reported as not being in a health occupation: an example is a 
hospital manager with professional qualifications but who also has a higher 
qualification in management. 
Employment in the health industry 
People employed in the health industry, enumerated in the 1991 national census, 
totalled 482,609, an increase of 6.8% from the 1986 census total of 451,870. Between the 
two censuses, employment for all industries grew by 7.7% and the population grew by 
8.0%. There was a reduction of 10.0% in employment in non-psychiatric hospitals 
which was offset by growth in employment in nursing homes (12.5%), community 
health centres (27.0%) and other areas of the health industry (86.6%) (Table 4.1.). 
These changes may be partly explained by a 15% increase in the population aged 65 
and over and an 18.2% increase in the population aged 75 and over from 1986 to 1991. 
The aged and frail aged are major users of both institutional and community care 
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hospitals to tertiary institutions. Between the 1986 and 1991 censuses, growth in the 
number of nurses was 3.5%; previously it had been much higher. The number of 
employed nurses per 100,000 population fell from a census peak of 1,168 in 1986, to 
1,120 in 1991. 
Table 4.5: Persons employed in health occupations, 1976,1981,1986 and 1991 census 
Health occupation 1976 1981 1986 1991 
Number 
Medical practitioners 21,150 28,010 32,790 38,800 
Dental practitioners 4,550 5,490 6,310 6,720 
Other health practitioners ( a ) 21,080 27,020 32,640 38,210 
Nurses 136,000 159,190 182,240 188,640 
All health occupations 182,600 219,810 253,970 272,370 
All employed persons 5,788,150 6,292,630 6,513,520 7,017,867 
% change from previous census 
Medical practitioners +27.2 +32.5 +17.0 +18.3 
Dental practitioners +33.2 +20.6 +14.9 +6.5 
Other health practitioners*3' +32.1 +28.2 +20.9 +17.1 
Nurses +31.4 + 17.0 +14.5 +3.5 
All health occupations +30.9 +20.4 +15.5 +7.2 
All employed persons + 10.5 +8.7 +3.5 +7.7 
Rate per 100,000 population 
Medical practitioners 156.1 192.2 210.2 230.3 
Dental practitioners 33.6 37.7 40.4 39.9 
Other health practitioners*3' 155.6 185.4 209.2 226.8 
Nurses 1,003.8 1,092.1 1,168.0 1,119.5 
All health occupations 1,347.0 1,508.0 1,627.8 1,616.4 
All employed persons 42,721.9 43,170.2 41,747.6 41,647.7 
(a) Includes pharmacists, occupational therapists, optometrists, physiotherapists, speech pathologists, 
chiropractors and osteopaths, podiatrists, radiographers and other health diagnosis and treatment 
practitioners. 
Sources: ABS Cat. Nos. 2731.0 and 4346.0 and unpublished data 
In contrast, the number of medical practitioners continued to grow strongly, and this 
has led to concerns of oversupply, particularly of general practitioners in the capital 
cities, although there are shortages in some rural and remote areas. The number of 
medical practitioners per 100,000 population increased from 156 in 1976 to 230 in 1991. 
Education and training of health personnel 
The number of students completing tertiary courses in health disciplines annually has 
grown steadily from 7,596 in 1987 to 13,145 in 1992 (Figure 4.1). Most of this increase 
has occurred in nursing, from 2,756 completing nursing in 1987, to 7,027 in 1992. This 
has been due to the phasing-in of tertiary institution-based nurse training in place of 
hospital-based training, a process which began in 1984. A review of nurse education 
during 1993-94 will recommend measures to improve the effectiveness of nurse 
education in providing wider professional preparation and career choices for nurses. 
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Source: Department of Employment, Education and Training unpublished data 
Figure 4.1: Students completing tertiary professional health courses in Australia, 
1987 to 1992 
Total new enrolments in health courses increased from 24,193 in 1991 to 24,900 in 1992, 
a 2.9% increase. There was substantial growth in the number of full-fee-paying 
overseas students in nursing, from 313 to 635 students. This accounted for most of the 
47% increase from 863 to 1,269, in full-fee-paying overseas students undertaking health 
courses (Table 4.6). 
Table 4.6: Commencing tertiary enrolments (excluding non-award) in health fields, 1992 
Health field 
Full-fee-paying 
overseas students All other students 
Podiatry 1 96 
Optometry 5 214 
Dietetics 20 244 
Dentistry 31 241 
Speech pathology/Audiology 3 358 
Radiography 7 232 
Pharmacy 79 555 
Occupational therapy 20 670 
Physiotherapy 40 808 
Medicine* 3 ' 261 2,144 
Other health fields 167 4,272 
Nursing* 3' 635 13,797 
All health fields 1,269 23,631 
(a) Includes undergraduate training and postgraduate specialist training. 
Source: Department of Employment, Education and Training unpublished data 
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4 . 2 I n s t i t u t i o n a l fac i l i t i es 
In 1991-92 there were 713 public acute hospitals, 294 private acute hospitals, 72 (all 
private) freestanding day hospital facilities, 45 public psychiatric hospitals, 25 private 
psychiatric hospitals, 1,444 nursing homes, and 1,198 hostels in Australia (Table 4.7). 
Table 4.7: Institutions and available beds, 1985-86 to 1991-92 
Institution type 1985-86 1987-88 1989-90 1991-92 
Institutions 
Hospitals 
Public acute ( a ) 751 723 690 713 
Private acute ( b ) 332 331 329 319 
Public psychiatric 48 39 59 (c>45 
Aged nursing homes ( d ) 1,410 1,429 1,437 1,444 
Hostels 851 987 1,021 1,198 
Available beds e 
Hospitals 
Public acute ( a ) 64,692 64,465 61,066 57,053 
Private acute' b ) 21,101 21,568 21,733 20,745 
Public psychiatric 12,741 8,620 8,513 7,266 
Aged nursing homes* d' 72,168 72,116 72,615 74,039 
Hostels 39,816 43,004 44,470 49,194 
Nursing home:hostel ratio 64:36 63:37 62:38 60:40 
Available beds (per 1,000 population) ( e ) ( f ) 
Hospitals 
Public acute ( a ) 4.1 3.9 3.7 3.3 
Private acute ( b ) 1.3 1.3 1.3 1.2 
Public psychiatric 0.8 0.5 0.5 0.4 
Aged nursing homes ( d ) 64.9 61.4 58.5 56.3 
Hostels 35.8 36.6 35.8 37.4 
(a) Includes Department of Veterans' Affairs General and Auxiliary hospitals. Queensland outpatient clinics 
aggregated with associated hospitals in 1985-86, 1987-88 and 1989-90. Queensland clinics were not 
aggregated in 1991-92. The 1985-86 data include approximately 19 Western Australian nursing posts 
which have been excluded from later years. 
(b) Private hospitals include private psychiatric hospitals and exclude freestanding day hospital facilities. 
(c) Excludes numbers of institutions in NSW which are not predominately psychiatric hospitals, but have 
psychiatric programs. 
(d) Figures do not include approximately 70 nursing homes for the young disabled. 
(e) Average available beds where possible, otherwise available beds at 30 June. 
(f) Rates per 1,000 population calculated using total population for hospitals and population aged 70 and 
over for nursing homes and hostels. 
Sources: Mathers & Harvey 1988; Gillett et al. 1991; Gillet & Solon 1992; Cooper-Stanbury, Solon & Cook 
1994; DHHCS 1991; ABS Cat. No. 4390.0 
A more important indicator of the supply of health care facilities is the number of beds 
per 1,000 population (bed ratio), provided the beds are available to be filled (see 
Box 4.1, page 156). This section examines recent trends in the availability of beds, as 
indicated by the bed ratio. 
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Box 4.1: Statistics relating to institutional facilities 
Numbers of institutions providing care are not, in themselves, good indicators ofthe supply 
of facilities. This is because institutions differ both in size and in the types of services they 
provide, and their numbers change for a variety of administrative reasons, such as closures 
and mergers. 
Even counting institutions poses problems. For example, a hospital with an attached 
nursing home may be counted as two institutions, whereas multiple but geographically 
separate facilities administered by a single board of management may be counted as a single 
institution. 
The number of beds available to be filled per 1,000 population^ a better measure of the 
provision of health care facilities tlian the number of facilities, but counting hospital beds is 
also not simple. The concept of an 'available bed' is commonly used, but until recently there 
has been no universally accepted definition, so it has been difficult to compare State, 
regional and international provisions. 
To address this problem, AIHW, in consultation with other interested bodies, has developed 
a set of recommended definitions for use in hospitals and related institutions. The National 
health data dictionary—institutional health care (AIHW 1993b) provides a set of data 
items and definitions to enable the collection of uniform data to describe and compare 
institutional health care services throughout Australia. The definition of available beds 
from this dictionary is given in full to illustrate the detailed consideration needed for 
production of comparable statistics: 
Available beds 
For acute and psychiatric hospitals the number of beds which are immediately available to 
be used by admitted patients or residents if required. They are immediately available for use 
if located in a suitable place for care, and there are nursing and other auxiliary staff 
available, or who could be made available within a reasonable period, to service patients or 
residents who might occupy them. The average number of beds should always be shown as a 
whole number. Exclude surgical tables, recovery trolleys, delivery beds, cots for normal 
neonates, emergency stretchers/beds not normally authorised or funded and beds 
designated for same-day non-inpatient care. 
Beds in wards which were temporarily closed due to factors such as renovations or strikes 
but which zvould normally be open and therefore available for the admission of inpatients 
should be included in 30 June financial year-end figures but for average bed numbers, beds 
in wards which were closed for any reason (except weekend closures for beds/wards staffed 
and available for five days per week) should not be included. Numbers to be provided as an 
average for the year and also at a point in time (year-end figures). The average to be 
calculated from monthly figures where available (if not, basis is to be stated). 
The ratio of available beds to population is a usefid statistic for measuring the supply of in­
stitutional health care. Ideally, available beds should be counted in an annual census, but un­
til recently there have been no guidelines relating to counting them. 
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In 1985-86, following a rapid reduction earlier in the 1980s in length of hospital stay, 
the States and Territories were planning to reduce their acute hospital bed ratios from 
between 3.9 and 6.4 beds per 1,000 population, to between 3.25 and 5.0 (Mathers & 
Harvey 1988). By the end of the decade, some authorities had achieved their targeted 
reductions in bed ratios, but others still had some way to go. 
Excluding beds in freestanding day hospital facilities and in public psychiatric 
hospitals, there were 4.5 hospital beds available for acute care per 1,000 population in 
Australia in 1991-92. This followed a steady decline during 1985^86 to 1991-92, mainly 
in the public sector where the ratio of available beds fell by an average of 4% a year, 
from 4.1 to 3.3 beds per 1,000 population (Table 4.7). Over most of this period, the 
supply of private sector hospital beds remained at 1.3 beds per 1,000 population, 
although in 1991-92 this, too, dropped to 1.2 beds per 1,000 population. 
The most recent data available (for 1990) indicate that Australian acute hospital bed 
ratios were high compared with those of many OECD countries, although accurate 
comparison was difficult. Compared with an Australian ratio of 5.0 beds per 1,000 
population in 1989-90, the United States had 3.8, Canada 4.5, the Netherlands 4.3 and 
Norway 4.2. However, some European OECD countries had higher ratios— 
Switzerland 6.5 and Germany 7.3 (OECD 1993). Australian acute hospitals, especially 
country hospitals, provide care for patients who could be accommodated in nursing 
homes, whereas this is not the case in many other health systems. 
The number of beds available in public psychiatric hospitals in Australia decreased 
from 2.3 per 1,000 population in 1970 to 0.4 in 1991-92. During the 1970s and early 
1980s, the supply contracted by 6% per year (Mathers & Harvey 1988). Then, between 
1985-86 and 1987-88, the annual rate of decrease was 21%. This rapid reduction in beds 
resulted from moves to de-institutionalise patients requiring both acute and long-term 
psychiatric care. Since 1987-88, the reduction in bed supply has continued at an 
average of 6% a year. 
In 1991-92 there were 20,745 available beds in private acute and psychiatric hospitals, 
and 556 beds, chairs, recliners, and so on in freestanding day hospitals. Of these beds, 
76% were located in capital city hospitals. 
The average number of full-time equivalent staff was 31,527, with 60% being nurses, 
mainly registered and enrolled nurses. 
Throughout the 1970s and early 1980s, the numbers of nursing home beds per 1,000 
population increased slowly (Mathers & Harvey 1988). The structure of residential care 
was then reshaped by the application in 1985 of a planning ratio of 40 nursing home 
beds and 60 hostel places for each 1,000 people aged 70 years and over, on a regional 
basis. A decline in nursing home bed ratios, of 2.6% per year, from 64.9 beds per 1,000 
population aged 70 years and over in 1985-86, to 58.5 in 1989-90, followed. More 
recently, the rate of decrease has slowed to 1.9% per year, with 56.3 nursing home beds 
available per 1,000 aged people in 1991-92 (Table 4.7). 
Hostels provide long-term accommodation, combined with a basic level of health care, 
for young disabled and the frail aged. The planning ratio for hostel places was 
originally 60 hostel places for each 1,000 people aged 70 years and over, but in 1991 it 
was reduced to 55 beds per 1,000 people aged 70 years or over. 
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Between 1985-86 and 1991-92, the number of hostel beds increased continuously, but 
because of increases in the numbers of people 70 and over, the bed ratio per 1,000 
people increased slightly, resumed its former level, then increased again. By 1991-92, 
hostel bed numbers had reached 49,194, representing an increase of 4% per year since 
1985-86. The hostel bed ratio in 1991-92 was 37.4 beds per 1,000 people aged 70 and 
above. 
The changes in nursing home and hostel bed supply were thus influenced by the 
Commonwealth Government's policy of accommodating older people who are less 
frail in hostels rather than in nursing homes. As well as making these changes, the 
Commonwealth Government has been placing greater emphasis on community care 
for frail aged people. 
Regional variations in bed supply 
Within the public sector the decline in numbers of beds per 1,000 population was 
greatest in those States and Territories where the bed supply had been greatest 
(Table 4.8). For example, in Tasmania wlhere the number of beds was 15% above the 
national average in 1985-86, the decline was 5% per year. By 1991-92 the bed supply in 
Tasmania had declined to 9% above the national average. Of the States which had more 
than the average number of beds per 1,000 population, South Australia alone 
experienced a below-average decline in bed numbers, of 3% per year, leaving it as the 
State with the highest per capita bed supply in the public sector in 1991-92. 
T a b l e 4 .8: Acute public hospital beds™ per 1,000 population, States and Territories, 1985-86 to 
1991-92 
Year NSW Vic Qld WA SA Tas ACT NT Aust 
1985-86 4.1 3.2 4.9 4.5 4.5 4.7 3.6 4.5 4.1 
1987-88 4.0 3.2 4.5 4.2 4.2 4.5 3.3 3.9 3.9 
1989-90 3.6 3.0 3.9 4.0 4.0 4.3 3.1 3.7 3.6 
1991-92 3.2 2.9 3.5 3.2 3.8 3.5 2.8 3.5 3.3 
Average annual growth 
rate 
1985-86 to 1991-92 - 4 % - 2 % —5% - 5 % - 3 % - 5 % - 4 % - 4 % - 4 % 
(a) Includes Department of Veterans' Affairs General and Auxiliary hospitals. 
Sources: Mathers & Harvey 1988; Gillett et al. 1991; Gillet & Solon 1992; Cooper-Stanbury, Solon & Cook 
1994 
On the other hand, in Victoria, which formerly had 20% fewer beds per 1,000 
population than the national average, the bed supply declined by only 2% per year, so 
that by 1991-92 Victoria's bed supply was 10% below the national average. 
The availability of beds in all types of health care institutions varies between States and 
Territories (Table 4.9). For acute hospitals in 1991-92, the Australian Capital Territory 
had a lower bed ratio (3.4 beds per 1,000 population) than the other States or 
Territories. For aged care beds in nursing homes and hostels, the lowest ratio is also in 
the Australian Capital Territory (83.7 beds per 1,000 population aged 70 years or older). 
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In 1991-92 non-metropolitan areas had higher ratios for beds in acute hospitals (5.1 
beds per 1,000 population) than did metropolitan areas (4.2) (Table 4.10). The much 
higher ratio for public hospital beds in non-metropolitan areas (4.1 per 1,000 
population) in comparison with metropolitan areas (2.9) was partly offset by a lower 
ratio for beds in private hospitals (1.0 per 1,000 population in non-metropolitan areas, 
compared with 1.3 in metropolitan areas). 
Table 4.9: Beds per 1,000 population,™ States and Territories, 1991-92 
Institution type NSW Vic Qld WA SA Tas ACT NT Aust 
Hospitals 
Public acute ( b ) 3.3 2.9 3.5 3.2 3.8 3.5 2.8 3.5 3.3 
Private acute' c ) 0.9 1.3 1.3 1.1 1.5 1.2 0.6 0.8 1.1 
Public psychiatric 0.4 0.6 0.5 0.3 0.5 0.3 
- -
0.4 
Aged nursing homes 62.1 49.3 54.6 57.3 56.7 57.2 43.4 64.2 56.3 
Hostels 33.5 34.5 45.9 41.1 44.0 28.9 40.3 43.0 37.4 
(a) Rates per 1,000 population calculated using total population for hospitals and population aged 70 and 
over for nursing homes and hostels. 
(b) Includes Department of Veterans' Affairs General and Auxiliary hospitals. 
(c) Private hospitals include private psychiatric hospitals and exclude freestanding day hospital facilities. 
Sources: Cooper-Stanbury, Solon & Cook 1994; ABS Cat. No. 4390.0 
Despite the higher total bed ratios, people in non-metropolitan areas generally have 
limited access to some specialities and to intensive care beds. For example, all teaching 
hospitals are located in major urban areas. The greater specialisation in major urban 
areas, essential to maintain skill levels and quality of care, means that rural and non­
capital city people are more likely to require inter-hospital transfer than are people 
living in the major urban areas. 
In contrast to acute hospital beds, ratios for beds in nursing homes for the aged were 
lower in non-metropolitan areas (3.3 beds per 1,000 population aged 70 and over) than 
in the metropolitan areas (4.6 beds) (Table 4.10). 
Table 4.10: Beds per 1,000 population, by metropolitan and non-metropolitan areas, 1989-90 
and 1991-92 
Institution type 
1989-90 1991 -92 
Metro Non-metro Metro Non-metro 
Hospitals 
Public acute ( a ) 3.1 4.6 2.9 4.1 
Private acute ( b ) 1.4 0.8 1.3 1.0 
Public psychiatric 0.5 0.5 0.5 0 4 
Aged nursing homes 4.6 3.7 4.6 3.3 
(aj Includes Department of Veterans' Affairs General and Auxiliary hospitals. 
(b) Private hospitals include private psychiatric hospitals and exclude freestanding day hospital facilities. 
Hospitals were classified by ABS as 'capita! city' or 'rest of state'. 
Sources: Gillet & Solon 1992; Cooper-Stanbury, Solon & Cook 1994; ABS Cat. No. 4390.0; DHHLGCS 
unpublished data 
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4.3 Use of hospitals 
This section follows the National Health Data Dictionary (NHDD) definitions and 
presents data only for patients treated within hospitals (see Boxes 4.2 and 4.3). 
Box 4.2: Statistics relating to use of hospitals 
Most of the data on the use of hospitals are based on information collected at the end of 
patients' hospital stay, rather than at the beginning. The reason for this is that the length of 
stay and the procedures carried out are then known, and the diagnostic information is more 
accurate. 
Statistics on use of hospitals, while commonly referred to as admission statistics, are 
therefore more correctly referred to as hospital separation statistics. Separation is defined in 
the National health data dictionary—institutional health care as 'the administrative 
process by which a hospital records the completion of treatment and/or care and 
accommodation of a patient'. This occurs when an admitted patient leaves hospital, 
transfers to another institution, or dies. 
As indicators of community morbidity, hospital separation data have some limitations. Sick 
people who do not use hospitals are not counted. The method of collection also means that 
those who are admitted more than once, or to more than one institution, are usually counted 
on each occasion. 
The States and Territories collect information about hospitalisation, and some produce 
reports containing useful morbidity data. However, the collections have not been managed 
uniformly, resulting in problems of comparability. In recent years, there have been 
encouraging developments towards standardisation, and all States and Territories now 
provide some data to AIHW for inclusion in national reports and databases, but only New 
South Wales, Queensland and South Australia provide comprehensive information about 
hospitalisation in both public and private hospitals. A recent ABS survey of private 
hospitals (ABS 1993) provides data to fill some gaps and to help estimate Australian totals. 
A major step towards standardisation was development of a National Minimum Data Set 
for Institutional Health Care, which was adopted in 1989. AIHW is collaborating with the 
ABS to conduct annual surveys of health institutions over four years from 1991-92. 
Hospital Utilisation and Costs Study 
The Institute undertook its first Hospital Utilisation and Costs Study (HUCS) in 1986. 
The study provided information on the use and costs of hospitals and related institutions 
within Australia in 1985-86. Data from this study were presented in a four-volume report 
and in Australia's health 1988. 
During 1989, the Institute undertook a second HUCS, for 1987-88, and presented the data 
in a special report and in Australia's health 1990. Data from these two HUCS surveys 
and from the third and fourth HUCS, for 1989-90 and 1991-92, are included in this report. 
An annual National Minimum Data Set collection, including data on private hospitals, has 
replaced the original HUCS surveys, although the HUCS title has been retained to ensure 
continuity. Some data from the first of these surveys, in 1991-92, are also included in this 
report. 
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Box 4.3: D e f i n i t i o n s r e l a t i n g to h o s p i t a l ca re 
Hospitals provide a wide range of health services and treat patients in a variety of settings. 
Patients who require admission to hospital have long been referred to as inpatients. Other 
patients are treated in accident and emergency departments, undergo specialised short-term 
treatment such as minor surgery, radiotherapy or chemotherapy, or are treated in their own 
homes through home nursing programs. Such patients are frequently termed outpatients. 
However, the terms 'inpatient' and 'outpatient' are ceasing to be used in statistics, which 
from July 1994 will simply show whether patients have formally been admitted to hospital 
for treatment. Hospital patients will be classified as admitted patients (including same-day 
patients ) and non-admitted patients. A 'patient' is a person for whom the hospital accepts 
responsibility for treatment and/or care. An 'admitted patient' is a patient who undergoes a 
hospital's formal admission process. A 'same-day patient' is a patient who is admitted to 
and separates from the hospital on the same day. 
'Admission' means the process by which an admitted patient commences an episode of care. 
'Bed-day' means the occupancy of a hospital bed (or chair in the case of some same-day 
patients) by an admitted patient for all or part of a day. 
'Occupancy rate' describes the use of hospital beds relative to the capacity in hospitals. 
Occupancy rate is calculated as the ratio of total bed-days in a year to total possible bed-
days in a year times 100, where the total possible bed-days equals available beds (see Box 
4.1, page 156) multiplied by the number of days in the year. 
'Separation' means the process by which an admitted patient completes an episode of care, 
for example leaving the hospital by being discharged, by dying, or by being transferred to 
another hospital for further care. 
Classification of areas into 'metropolitan' and 'non-metropolitan' follows the convention of 
the State and Territory health authorities and HUCS, and has varied little over time. In 
1989-90, the only areas apart from the capital cities classified as 'major urban' were 
Newcastle, Wollongong, Geelong and Launceston. The ABS survey of private hospitals 
classified areas into 'capital cities' and 'other'. 
Use of acute hospitals—admitted patients 
Rates of admission to acute hospitals have fluctuated over the last two decades, an 
increase during the 1970s being followed by a slight decline in the early 1980s. During 
1982-83 to 1988-89, admissions per 1,000 people fluctuated around 215, then increased 
substantially to 240 in 1991-92 (Table 4.11, page 163). 
By international standards, Australia's rate of admission to acute care hospitals seems 
very high. In 1989-90, the Australian rate of 225 per 1,000 population was the highest 
among 17 OECD countries, for which the median rate was 165 per 1,000 population 
(AIHW 1994; OECD 1993). 
Australia's comparatively high admission rate results mainly from the inclusion of 
same-day admissions, which most OECD countries exclude from their calculation. If 
same-day admissions are excluded from the Australian calculations, the admission rate 
161 
drops to 170 per 1,000 population, placing Australia sixth among 16 OECD countries 
(Iceland, which also includes same-day patients in its admission statistics, having been 
excluded from the comparison). 
Australia's comparatively high rates of admission are counterbalanced by its 
comparatively short average length of stay, 5.6 days for 1989-90. This is the lowest 
among the OECD countries. Excluding same-day admissions increases the average 
length of stay to 7.2 days, making Australia fourth lowest in the OECD survey. 
The average time spent in acute hospitals by admitted patients declined by 28% from 
6.9 to 5.0 days between 1982-83 and 1991-92. The rapidity of the decline in length of 
stay has also increased, from 1.9% per year from 1982-83 to 1984-85, to 2.9% per year 
over the next four years to 1988-89, then to 5.5% per year over the years from 
1989-1990 to 1991-92. 
The reductions in length of stay are attributable to many factors including: fewer 
patients who need only nursing home care being cared for in acute hospitals; better 
anaesthetics and antibiotics; and the use of less invasive surgical techniques. The 
continued development and increasing application of these techniques is likely to 
continue the decline in length of stay (Hirsch & Hailey 1992). 
Length of stay decreased more, both absolutely and relatively, in private than in public 
hospitals. Between 1982-83 and 1991-92 the average length of stay in acute private 
hospitals decreased by 34%, from 6.4 to 4.2 days. Average length of stay in public 
hospitals declined by 25%, from 7.1 to 5.3 days (Cooper-Stanbury, Solon & Cook 1994). 
These differences between public and private hospitals at least partly reflect their 
different roles. For example, private hospitals perform more short-stay surgery. In New 
South Wales in 1988-89, 64% of private hospital patients underwent surgery, compared 
with 38% of public hospital patients. Of the patients having surgery, 12% of private 
hospital patients had surgery on the ear, nose, throat or eye, compared with 5% of 
public hospital patients. In contrast, only 6% of surgical patients in private hospitals 
underwent operations involving the circulatory or respiratory systems, compared with 
16% in public hospitals (AIHW unpublished data). 
In recent years, the increasing use of same-day treatments, both those which have long 
been done on a same-day basis and those which until recently have required two or 
three days in hospital, has accelerated the decline in length of stay. 
The sustained reductions in length of hospital stay are reflected in falls in the number 
of bed-days used by patients in acute hospitals. Between 1985-86 and 1991-92, the 
number of bed-days per 1,000 population fell by 2.3% per year, from 1,390 to 1,207 
(Table 4.11). The slight increase from 1989-90 to 1991-92 in the use of private hospitals, 
which reversed the decline since 1982-83, was a significant departure from this trend. 
It contrasted with a fall in the use of public acute hospitals of 2.9% per year over the 
later period. 
Between 1985-86 and 1991-92, occupancy rates for acute hospitals increased, from 69% 
to 74%. This result was the combination of an increase in occupancy rate from 72% to 
79% in the public sector, and a slight increase from 62% to 64% in the private sector, 
where occupancy rates have since recovered from a low of 58% in 1987-88. 
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Table 4.11: Use of acute hospitals,™ 1985-86 to 1991-92 
U s e / A c u t e h o s p i t a l t y p e 1 9 8 5 - 8 6 1 9 8 7 - 8 8 1 9 8 9 - 9 0 1 9 9 1 - 9 2 
A d m i s s i o n s ^ 
Public ('000) 2,466 2,622 2,790 3,025 
Public (per 1,000 population) 157 160 165 174 
Private ('000) 872 878 1,018 1,157 
Private (per 1,000 population) 55 54 60 66 
Total ('000) 3,338 3,500 3,808 4,182 
Total (per 1,000 population) 212 214 225 240 
A v e r a g e l e n g t h o f s t a y (Days) 
Public 6.9 6.5 6.0 5.3 
Private 5.5 5.2 4.6 4.2 
Total 6.5 6.2 5.6 5.0 
B e d - d a y s 
Public ('000) 16,891 17,098 16.669 16,122 
Public (per 1,000 population) 1,089 1,043 983 926 
Private ('000) 4,766 4,532 4,731 4,891 
Private (per 1,000 population) 301 276 279 281 
Total ('000) 21,657 21,630 21,400 21,013 
Total (per 1,000 population) 1,390 1,319 1,262 1,207 
O c c u p a n c y (Percent) 
Public 72 73 75 79 
Private 62 58 60 64 
Total 69 69 71 74 
N o n - i n p a t i e n t s e r v i c e s 
Public ('000) t c ) 37,666 43,711 38,209 30,676 
Public (per 1,000 population) 2,381 2,666 2,253 1,761 
a) Public hospitals include Department of Veterans' Affairs General and Auxiliary hospitals. Private 
hospitals include private psychiatric hospitals and exclude freestanding day hospital facilities. 
(b) The number of separations was taken as the number of admissions. 
(c) Number of services was estimated as the number of treatments plus three times the number of visits for 
1985-86,1987-88 and 1989-90, but as reported for 1991-92. 
Sources. Mathers & Harvey 1988, Gillett et al. 1991; Gillet & Solon 1992; Cooper-Stanbury, Solon & Cook 
1994; ABS Cat. No. 4390.0 
Many factors have influenced occupancy levels. The effects of population growth and 
shorter lengths of stay were similar in public and private hospitals, although the 
increase in admission rates had more effect on occupancy levels in private hospitals. 
Another major difference related to changes in bed supply. In the public sector, the 
reduction in bed supply largely dictated occupancy levels, but the impact of changes in 
bed supply in the private sector was minor. 
Same-day surgery 
The trend over recent years to same-day treatment of hospital patients reflects 
changing medical practice and pressure for increasing productivity. 
As well, more patients in public acute hospitals are being treated on a day-only basis. 
This trend has been encouraged through incentives under the Medicare Agreements 
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for public hospitals to treat suitable surgical patients on a day-only basis. The 
proportion of same-day patients in public acute hospitals has increased from 20% in 
1987-88 to 24% in 1989-90 (AIHW unpublished data). In 1991-92,28% of admissions to 
public acute hospitals and 43% of admissions to private hospitals were same-day 
patients. For many diagnostic procedures, and some surgical procedures, most patients 
receive same-day care. 
The availability of private health insurance benefits for designated procedures 
performed on same-day patients has had a major influence too. In 1985-86 there were 
no freestanding private day surgery centres, in 1989-90 there were 39 (Gillett & Solon 
1992), and in 1991-92 there were 72 (ABS 1993), over one-third of them dedicated to 
endoscopy. These freestanding same-day hospitals had a total of 556 beds, fewer than 
3% of private hospital beds, but they accounted for nearly 10% of private hospital 
separations. 
Use of acute hospitals—non-admitted patients 
In 1991—92 an estimated 30.7 million occasions of service and group sessions per year, 
or 1,761 services per 1,000 population, were provided in public hospitals, compared 
with 850,700, or 48 treatments per 1,000 population, provided in private hospitals, 
which generally do not offer non-admitted patient care. 
The data available on non-admitted patients treated in public hospitals have limited 
reliability because they have not been collected in a consistent manner, either over time 
or between States and Territories (Cooper-Stanbury, Solon & Cook 1994). Since the late 
1980s, New South Wales and South Australia have introduced more rigorous 
guidelines for the counting of non-admitted patients. These changes reflect the NHDD 
principles, and have led to a more consistent count of non-admitted patient services. 
Regional variations in acute hospital use 
In 1991-92 there were 2.0 million admissions to public acute hospitals in metropolitan 
areas, and 1.0 million in non-metropolitan areas. The admission rate to public acute 
hospitals in metropolitan areas was 166 per 1,000 population, somewhat lower than the 
rate of 192 to hospitals in other areas. Patients admitted to metropolitan public acute 
hospitals also had a slightly shorter length of stay, of 5.3 days compared with 5.4 days 
for patients in non- metropolitan hospitals (Table 4.12). 
Metropolitan public acute hospitals provided 10.7 million bed-days or 879 bed-days 
per 1,000 metropolitan population and non-metropolitan public hospitals provided 5.4 
million bed-days or 1,036 per 1,000. The bed-day use per 1,000 population is 18% 
higher for public acute hospitals outside the metropolitan areas than for those in 
metropolitan areas. 
The 1991-92 private hospitals survey revealed that there were 872,000 admissions to 
capital city private hospitals, and 286,000 to private hospitals elsewhere. The capital 
city hospitals had 71 admissions per 1,000 population, other private hospitals having 
55 admissions per 1,000. The average length of stay of 4.2 days in private hospitals was 
the same in capital cities and elsewhere. 
Capital city private hospitals provided 3.7 million bed-days, 302 per 1,000, and other 
private hospitals provided 1.2 million bed-days, or 231 bed-days per 1,000 population. 
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Table 4.12: Regional variations in use of acute hospitals, 1991-92 
Type of hospital 
Region Public ( b ) Private ( c ) Total 
Separations (per 1,000 population) 
Metropolitan 166 71 237 
Non-metropolitan 192 55 247 
All regions 174 66 240 
Average length of stay (days) 
Metropolitan 5.3 4.2 5.0 
Non-metropolitan 5.4 4.2 5.1 
All regions 5.3 4.2 5.0 
Bed-days (per 1,000 population) 
Metropolitan 879 302 1,181 
Non-metropolitan 1,036 231 1,266 
All regions 926 281 1,206 
(a) Public hospitals include Department of Veterans' Affairs General and Auxiliary hospitals. Private 
hospitals include private psychiatric hospitals and exclude freestanding day hospital facilities. 
(b) For public hospitals, 'metropolitan' equates to 'capital city' plus the major regional centres of Newcastle, 
Wollongong, Geelong and Launceston. 'Non-metropolitan' equates to all other areas. 
(c) For private hospitals, 'metropolitan' equates to 'capital city' and 'non-metropolitan' equates to 'rest of 
state'. Private hospitals include private psychiatric hospitals. Rates were calculated using 'non-
metropolitan' population base. 
Sources: Cooper-Stanbury, Solon & Cook 1994; ABS Cat. No. 4390.0 
These differences in acute hospital use may result from factors such as differences in 
the demographic structure and health of the population, differences in the policy and 
structure of the health system, and characteristics of medical practice. In the case of 
private hospitals, use of beds is affected by generally lower levels of private health 
insurance outside metropolitan areas (see Section 3.3). 
Structural and policy differences in the health system which may influence hospital use 
include the distribution of specialty services (and the need to transfer patients), 
numbers of doctors, the de-institutionalisation of psychiatric services and the supply of 
hospital beds. Medical practice may vary in its choice of admitted or non-admitted 
treatment for patients, and in the extent to which surgery is used for particular 
conditions. 
Where people live does not determine where they will attend hospital, and many rural 
and smaller city residents may have to attend hospitals in major urban centres, 
particularly when specialised services are required. Comparison of regional hospital 
use is thus complicated by inter-regional flows, some of which may be significant, of 
patients from one region to a hospital in another. For example, the catchment 
population for hospitals in the Australian Capital Territory includes neighbouring 
areas of south-eastern New South Wales. The lack of data on the catchment 
populations of specific hospitals or groups of hospitals precludes an analysis of the 
inter-regional flow of patients. 
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State and Territory variations in acute hospital use 
There are substantial differences across the States and Territories in the use of acute 
hospitals (Table 4.13, Figure 4.2). Tasmania has the lowest level of public hospital 
admissions, 154 admissions per 1,000 population, but the highest average length of 
stay of 6.3 days. In contrast, South Australia has an admission rate of 193 per 1,000 
population but a shorter average length of stay of 5.4 days. 
Table 4.13: State I Territory use of public acute hospitals,™ 1991-92 
NSW Vic Qld WA SA Tas ACT NT Aust 
Separations (per 1,000 population) 175 161 179 181 193 154 165 183 174 
Average length of stay ( b ) (days) 5.4 5.4 5.2 4.9 5.4 6.3 5.3 5.6 5.3 
Bed-days (per 1,000 population) 944 867 928 893 1,051 960 870 1,028 926 
Occupancy rate (per cent) 80 82 73 76 75 76 85 80 79 
Outpatients*0* (per 1,000 population) 1,748 1,690 1,683 1,767 1,650 1,319 1,238 1,600 1,724 
(a) Public hospitals include Department of Veterans' Affairs General and Auxiliary hospitals. 
(b) Total bed-days / total separations. 
(c) Non-inpatient occasions of services. 
Source: Cooper-Stanbury, Solon & Cook 1994 
Per cent 
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Source: Department of Employment, Education and Training unpublished data 
Figure 4.2: Admission and bed-day rates, difference from Australian average, 1991-92 
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As noted earlier, differences in population age structures can contribute to the 
differences in admission rates between the States and Territories. For example, 12.8% of 
the South Australian population is aged 65 years or more, compared with only 5.9% of 
the population of the Australian Capital Territory, where the admission rate is 
relatively low. 
Other reasons for the differences are not entirely clear. Some of the variation in 
admission rates may result from varying classifications of same-day patients, as 
admitted patients or as non-admitted patients. The lack of data on same-day 
admissions for all States and Territories, and for public and private hospitals, precludes 
a complete evaluation of this factor. 
4.4 Waiting lists 
Uses of waiting list information 
Ideally, patients would be given a firm admission date when their doctor first 
requested hospital care. In practice, this is not possible. Hospitals cannot accurately 
predict the resources required to treat patients requiring immediate admission. 
Consequently, hospitals usually do not allocate admission dates for elective patients 
until they are comparatively close. The maintenance of some form of waiting list 
should therefore be regarded as part of the efficient operation of a hospital. 
Waiting list information can also be used by hospitals to identify the need to allocate 
resources between specialities, such as operating theatre time. District managers can 
use it to identify a need to redistribute resources between hospitals. Health planners 
use data on expected waiting times for different groups of patients as indicators of 
possible inequity within the health system. 
Patients and doctors require data on expected waiting times to choose a hospital. 
Doctors and hospital administrators require data on the numbers of people waiting too 
long for hospital care as a measure of quality of care. 
Unfortunately, waiting lists are often also used as measures of 'unmet community 
need', because they show the number of people who need hospital care but have not 
yet gained admission. As a result, waiting lists have been the subject of political debate. 
Such debate is misguided; waiting lists reflect unmet need only where all people with a 
condition know of it, have sought medical advice, been diagnosed, and accepted a 
recommendation for surgery, the hospital has been notified, and the patient placed on 
the waiting list. 
The interpretation of waiting list information is complicated. Large waiting lists do not 
necessarily indicate poor hospital performance. The numbers waiting may reflect 
factors such as the size of the community served, the amount of surgery performed, the 
proportion of emergency surgery, clinician referral patterns and the overall efficiency 
of the hospital. Provided patients receive appropriate supervision, waiting may not be 
disadvantageous. In some instances, 'watchful waiting' may even be preferred clinical 
management. In others, waiting may result from factors beyond the control of 
hospitals; a good example is the need for transplant recipients to wait for compatible 
donor organs to become available. 
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Australian waiting list data are made harder to interpret because different hospitals 
include different types of patients on their lists: some hospitals include only patients 
requiring surgery, others include both surgical and some medical patients; some 
hospitals include patients who have been given an admission date, others do not; some 
hospitals count patients currently not ready for care, such as women in early 
pregnancy who will later require Caesarean section, others do not. 
There are also data quality issues. Few hospitals routinely review their lists, which can 
include patients who cannot be contacted, have died, have already been treated 
elsewhere or who no longer require hospital care for personal or medical reasons. 
Audits have reported 20% or more of patients on waiting lists as inappropriately listed 
(Fraser 1991; Brewster, Nicholson & Farndon 1991; Standards Sub-Committee of the 
Victorian State Committee of the Royal Australasian College of Surgeons 1991). 
The statistics used have also varied. Average waiting time, median waiting time, 
proportions of patients waiting different lengths of time, and clearance time (the time 
required to treat all patients if no further patients were added to the list) have all been 
presented. 
If these problems can be overcome, good waiting list data will provide valuable 
information to patients, doctors, hospital administrators and health planners. 
Box 4.4: Urgency Categor ies used in Victoria 
Category 1 (urgent): Very early admission desirable for a condition that has the potential 
to deteriorate quickly, to the point where it becomes an emergency. Admission within 30 
days is desirable. 
Category 2 (semi-urgent): Admission within 90 days acceptable for a condition causing 
some pain, dysfunction or disability but which is not likely to deteriorate quickly or become 
an emergency. 
Category 3 (non-urgent): Admission at some time in the future acceptable for a condition 
causing minimal or no pain, dysfunction or disability, which is very unlikely to deteriorate 
quickly and which does not have the potential to become an emergency. 
Source: Victorian Department of Health and Community Services 1993 
Survey of waiting lists 
In order to estimate both the numbers of patients currently waiting for elective surgery 
and the times people wait for surgery in public hospitals, AIHW conducted a survey of 
State and Territory health authorities in October 1993 (Gillett & Mays 1994). Health 
authorities were asked to provide their most recent data on elective surgery waiting 
lists according to a standard format. Only patients who were ready for care were to be 
counted. 
Most States collect waiting list statistics only from large hospitals, advising that in a 
number of smaller hospitals all patients waiting for elective surgery have been 
admitted within a reasonable time. 
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All States and Territories except Queensland provided data, although not always in the 
requested format (Table 4.14). Queensland has not collected waiting list information 
centrally to date, although hospitals maintain data. 
Table 4.14: Available data on public hospital waiting lists, by State I Territory 
D a t e o f H o s p i t a l s P a t i e n t s 
S t a t e / T e r r i t o r y c e n s u s i n c l u d e d i n c l u d e d 
New South Wales 30.11.92 187 public Booked & unbooked 
Victoria 1.7.93 29 major public Unbooked*3* 
Queensland 
- - -
Western Australia 30.9.93 5 public teaching Booked & unbooked 
South Australia 31.7.93 6 major public Booked & unbooked 
Tasmania 1.10.93 3 major public Booked & unbooked 
Australian Capital Territory 30.9.93 2 public Booked & unbooked 
Northern Territory 1.10.93 2 public Booked & unbooked 
(a) Includes booked patients who do not have an admission date up to six weeks from census date (Health 
Department of Victoria Elective Surgery Activity Bulletin No.1 January 1992) 
Source: Gillett & Mays 1994 
Waiting list data were estimated as numbers of patients per 100,000 resident 
population for those States supplying compatible data and extrapolated to the 
Australian population. 
Data were used to describe lists at a given point of time (snapshot data) and to describe 
movement within the lists of patients who had been admitted for surgery or who had 
been removed from the lists for any other reason (throughput data). Clearance time 
was calculated by dividing the number of patients on a list at a given time by the rate at 
which they were removed from the list. 
From the data supplied, there were an estimated 644 people per 100,000 population 
waiting for elective surgery in 1993 (Table 4.15, page 170). As 11% of removals from 
waiting lists are for reasons other than admission for surgery, it is estimated that 
572 people per 100,000 would accept a hospital place if offered. In addition, it is 
estimated that between 22 and 65 patients per 100,000 scheduled for elective surgery in 
small hospitals were not included in the data used in the table. 
After adjusting for people on lists who would not have accepted surgery if offered and 
for small hospitals for which no data were available, it is estimated that there were 
between 103,000 and 112,000 people waiting for elective surgery in Australian public 
hospitals during 1993. However, this estimate needs to be interpreted with care, 
because the underlying data are incomplete and were not collected in a consistent way. 
Using data from hospitals for which comparable data were available, it was estimated 
that 319 people are admitted for elective surgery each month for every 100,000 
Australians. Another 40 people are removed from the waiting list for other reasons, 
making 359 removals per 100,000. The 644 people per 100,000 population waiting for 
elective surgery in these hospitals thus represent a clearance time of 1.8 months. 
These statistics are all easily understood. However, the relationship among them is 
complicated, because waiting lists are, in fact, multiple queues, proceeding at different 
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rates as patients require treatment with differing degrees of urgency. Clearance time 
measures the system's capacity to treat people waiting for care, rather than the time 
any particular patient will wait. Further, the numbers of people waiting are not 
distributed evenly across all hospitals and across all specialties. 
Table 4.15: Estimated statistics for elective surgery watting lists in those public hospitals for 
which comparable data were available,™ Australia, 1993. 
P o i n t - o f - t i m e e s t i m a t e s o f E s t i m a t e d m o n t h l y n u m b e r s o f 
e l e c t i v e s u r g e r y w a i t i n g l i s t s p e r s o n s ( t h r o u g h p u t ) 
T o t a l 
P a t i e n t s W a i t i n g W a i t i n g R o u t i n e R e m o v e d r e m o v a l s 
S p e c i a l t y w a i t i n g <1 m o n t h > 6 m o n t h s (b) (c) (d) 
Per 100,000 
population Per cent Percent Per 100,000 population 
Cardio-thoracic 9.2 41 14 8.3 0.9 9.1 
Ear, nose and throat 101.4 18 43 22.0 5.7 27.8 
General surgery 135.2 35 25 94.9 8.6 103.5 
Gynaecology 73.1 43 17 58.4 4.5 62.9 
Neurology 6.5 50 12 5.9 0.7 6.6 
Ophthalmology 39.6 24 28 17.2 2.7 19.9 
Orthopaedics 129.3 21 38 36.5 7.5 43.9 
Plastic 32.8 19 47 10.6 1.8 12.4 
Urology 60.2 29 31 25.3 3.7 29.0 
Vascular 12.6 32 40 7.4 0.9 8.3 
Other 44.1 40 16 32.2 3.2 35.4 
Al l p a t i e n t s 643.9 2 9 31 318.7 40.1 358.9 
(a) Refer to Table 4.14 for hospitals included. 
(b) Routinely admitted for elective surgery. 
(c) Removed from elective surgery waiting lists for other reasons besides admission including: patient could 
not be contacted, surgery no longer required, patient treated elsewhere, patient previously admitted as 
an emergency. 
(d) Total removals from elective surgery waiting lists. 
Source: Gillett & Mays 1994 
Snapshot data estimates are that at any time 29% of people have been waiting for 
under a month, but 31% have been waiting for over six months. Patients waiting for 
elective surgery are likely to be waiting for general surgery (21% of all patients), 
orthopaedic surgery (20%) or ear, nose and throat surgery (16%). The percentages of 
patients of these specialities who have waited for over six months are 25%, 38% and 
43% respectively (Table 4.15). 
However, snapshot data can distort the time people wait, and the proportions of 
people who have long waits, which are better measured by throughput data. For 
snapshot data, the South Australian results are close to the national average, with 26% 
of people having been waiting for under one month and 29% of people having been 
waiting for over six months. Throughput data show that 51% of patients admitted over 
a six-month period waited less than one month and 12% waited over six months 
(Table 4.16, page 171). 
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Some specialties have large proportions of patients with long waits. The specialties 
with the largest percentages of patients waiting over six months are plastic surgery 
(47%), ear nose and throat surgery (43%) and vascular surgery (40%) (Table 4.15). 
Although more people were waiting for general surgery than for any other specialty, 
general surgery has a relatively high throughput of 30% of all elective surgery 
admissions with a relatively low clearance time of 1.3 months (clearance times can be 
derived from Table 4.15 by dividing the total numbers of patients on the list at 
snapshot by the total removals). In contrast, the clearance times are longest for ear nose 
and throat surgery (3.6 months), orthopaedic surgery (2.9 months) and plastic surgery 
(2.7 months). 
Only Victoria had data by urgency category, which suggest that according to its criteria 
(Box 4.4, page 168), about 23% of patients waiting for care have waited longer than 
clinically appropriate. 
T a b l e 4 .16: Patients waiting less than one month and over six months at a point in time and 
admitted over a six-month period, by specialty, South Australia,™ July 1993 
P e r c e n t o f p a t i e n t s w a i t i n g a t c e n s u s P e r c e n t o f p a t i e n t s a d m i t t e d 
S p e c i a l t y U n d e r 1 m o n t h O v e r 6 m o n t h s U n d e r 1 m o n t h O v e r 6 m o n t h s 
Cardio-thoracic 46 4 74 1 
Ear, nose and throat 17 47 43 23 
General surgery 30 21 55 8 
Gynaecology 33 20 47 6 
Neurology 53 9 75 1 
Ophthalmology 45 6 53 4 
Orthopaedics 20 26 33 24 
Plastic 20 35 54 13 
Urology 26 33 54 13 
Vascular 26 50 75 8 
Other (b ) 61 
-
44 1 
All p a t i e n t s 2 6 2 9 5 1 1 2 
(a) Includes both booked and unbooked patients from the Flinders Medical Centre, Lyell McEwin Health 
Service, Modbury, Royal Adelaide, The Queen Elizabeth and Women and Children's (Adelaide 
Children's Hospital Campus) Hospitals. 
(b) Includes cranio-facial and 'unknown' surgery. 
Source: Gillett & Mays 1994 
Equity of access to public hospitals 
For several years there has been continuing debate whether some patients have 
preferential access to public hospitals. There is anecdotal evidence, for example Davis 
et al. (1991), of private patients having more rapid access to elective surgery than 
public patients. However, shorter waiting times for private patients in public hospitals 
could result where those with least urgent conditions (who potentially would have the 
longest waits) elect to be treated in private hospitals. National implementation of 
urgency categories would go some way to informing the debate, but currently 
available data lack sufficient clinical detail to resolve it. 
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Future directions 
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In recognition of the varying requirements for data, the Australian Institute of Health 
and Welfare has received funding to develop national definitions for counting of 
patients on hospital waiting lists and reporting on these. The Institute expects to 
complete this work during 1993-94, with better data becoming available during 
1994-95. 
These reports will change the emphasis from the numbers of people on the list at a 
point in time to numbers of people who wait an inappropriate time for their clinical 
condition. These numbers should be the main indicators of system performance in 
elective surgery provision. The Department of Human Services and Health has 
initiated a process to involve surgeons in the development of a national set of urgency 
categories and associated maximum waiting times. 
In future, purchaser-provider arrangements could involve assessment of performance 
in the provision of services. The Victorian Department of Health and Community 
Services has begun to apply funding sanctions based on clinically inappropriate waits 
for elective surgery. Where patients are found at census to have been waiting longer 
than the time limit for their urgency category, a hospital is denied access to an 
'additional throughput pool'. As timely access to needed care is an aspect of the quality 
of service provision, tying funding to performance may become more widespread. 
Reports of waiting lists should place a much greater emphasis on throughput data than 
is currently done by State and Territory health authorities, most of which provide 
snapshot data only. Tables 4.15 and 4.16 demonstrate the need for both throughput and 
snapshot data. 
4.5 Medical services 
Services by doctors are a mainstay of Australia's health service system. Under 
Medicare, all Australians are eligible for benefits for private medical services outside 
hospitals and for services as private patients in hospitals; comprehensive data are 
available on these services from the Health Insurance Commission (HIC), which pays 
benefits for them. This section describes use of private medical services covered by 
Medicare. It provides an overview of use of medical services by broad type of service, 
variations in use by age and sex, and variations in use by State. Data have been 
obtained from Medicare claims processed by the HIC and from the claim files held by 
the Commonwealth Department of Human Services and Health. 
Medicare also provides for free treatment, including medical treatment, of public 
patients in public hospitals. These services are not billed to the HIC but are paid by 
hospitals, and they are not reported on here. 
Some types of medical services do not qualify for Medicare benefits, and these types 
also are not included in the analyses below. They include services to eligible military 
service veterans and their dependants, services covered by motor vehicle third party 
insurance and workers' compensation schemes, services provided by public 
authorities and most government-funded community health services, and services not 
necessary for patient care (for example, examinations for employment purposes). 
Use of private medical services 
In 1992-93, Medicare provided benefits for 172.3 million services. This represents an 
increase of 27.5% over the 135.1 million services in 1987-88. The increase over this 
period was due to the combined effect of population growth (6.8%) and a rise in the 
number of services per person (19.4%). 
Over half (54.1%) of the medical services in 1992-93 were general practitioner 
attendances, 23.0% were pathology and 9.5% were specialist attendances (see 
Figure 4.3). 
Other (2.2%) 
Specialist attendances (9.5%) 
Source: DHHLGCS unpublished data 
Figure 4.3: Medicare services by broad type of service, 1992-93 
The most notable increases in total services from 1987-88 to 1992-93 have occurred in 
optometry services (48.3%). The considerable growth in these services is due to a 
number of factors including the increased profile of eye care, especially in schools, 
ageing of the population, and perhaps assessment required with use of computer 
terminals. 
The smallest increase over this five-year period was 14.4% in obstetrics. This value is 
still much higher than the growth in number of births over a comparable period (5.3% 
rise from 1987 to 1992), suggesting that there has been an increase in the number of 
obstetric services not directly related to,the birth, such as diagnostic procedures 
performed during pregnancy. The next smallest increase was 21.8% in anaesthetic 
services; operations increased by 34.9%, suggesting an increase in the average number 
of procedures at each operation. 
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Comparing 1992-93 figures with the previous year reveals a 30.5% increase over 
1991-92 in pathology. The 30.5% increase is due to introduction of a patient episode 
initiation item which accompanied restructure of the pathology schedule in February 
1992. This item was designed to cover the administrative costs associated with the 
collection of specimens, and is therefore counted with almost every pathology episode. 
The number of diagnostic tests fell significantly between 1987 and 1989 following 
changes to the Medicare Benefits Schedule. It has stayed almost constant from 1989-90 
until 1991-92. The number of tests per episode is falling (episode here means services 
provided for one individual on the same day). 
Another way to look at use of medical services is in terms of services per person. On 
average in 1992-93, each person received 9.76 medical services; consulting a general 
practitioner 5.28 times, having 2.25 pathology services and seeing a specialist 0.92 
times. Over the past five years, the number of services per person has increased from 
8.17 to 9.76, an increase of 19.4%, or average annual increase of 3.6% (Table 4.17). 
Table 4.17: Medicare services processed per capita, by broad type of service, 1987-88 and 1992-93 
Services per capita Total Annual 
Type of service 1987-88 1992- -93 change change 
Number Per cent Number Per cent Per cent Per cent 
GP attendances 4.59 56.1 5.28 54.1 15.1 2.9 
Specialist attendances 0.79 9.6 0.92 9.5 17.4 3.3 
Obstetrics 0.03 0.4 0.04 0.4 7.1 14 
Anaesthetics 0.08 1.0 0.09 1.0 14.1 2.7 
Pathology 1.78 21.7 2.25 23.0 26.5 4.8 
Radiology 0.40 4.9 0.52 5.3 28.2 5.1 
Operations 0.22 2.7 0.28 2.9 26.4 4.8 
Optometry 0.12 1.5 0.17 1.7 38.8 6.8 
Other ( a ) 0.16 2.0 0.22 2.2 32.9 5.9 
Total 8.17 100.0 9.76 100.0 19.4 3.6 
(a) Includes assistance at operations, radionuclear therapy and miscellaneous. 
Sources: DHHLGCS unpublished data; ABS Cat. No. 3101.0 
Although the average use per person was 9.76 services, the actual number of services 
per person ranges widely. For example, in 1991-92, 1.3% of Medicare-enrolled people 
received over 50 services, accounting for 15.0% of total benefits paid. At the other end 
of the scale, 36.3% of people received from one to five services, accounting for 10.1% of 
total benefits, and 20.8% of people received no services. 
Use of medical services by age and sex 
There are considerable age and sex variations in the use of Medicare services, 
described in Section 1.2.3 on page 9 and illustrated here in Figure 4.4. 
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Source: Health Insurance Commission 1993 
Figure 4.4: Medicare services processed per capita, by age and sex, 1992-93 
In 1991-92, 24.9% of males and 16.6% of females received no services. Another 40.5% of 
males and 32.2% of females received between one and five services. The age group in 
which the highest proportion of males did not receive a service was 75 years and over 
(46.8%). Similarly, the highest proportion of females not receiving a service was in the 
75 and over age group (40.5%). Somewhat paradoxically, the age group with the largest 
proportion receiving 51 or more services per person was also the 75 and over group 
(4.0% for males and 4.8% for females). 
The explanation of this finding is that while there is a general trend towards more 
services per person with increasing age, older people move out of the private medical 
setting into public hospital inpatient care where medical services are provided without 
charge and hence do not appear in the data presented. Another major portion of 
medical services for the elderly is provided through Veterans' Affairs programs; again, 
these services do not attract benefits under Medicare. The number of Medicare-funded 
services per person in the older age groups is therefore an underestimate of the total 
services provided. 
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Use of medical services by State 
Significant variations in the use of medical services occur across States. In 1992-93 the 
highest use per person was in New South Wales with 10.8 services per person, 10% 
above the national average of 9.8 services per person. Indeed, New South Wales was 
the only State to exceed the national average (Figure 4.5). The next greatest use per 
person occurred in Queensland (9.6 services), followed by South Australia (9.4 
services). The lowest per person use occurred in the Northern Territory (5.1 services). 
Services per capita 
3 J 1 1 1 1 1 1 
1987-88 1988-89 1989-90 1990-91 1991-92 1992-93 
Processing period 
Source: DHHLGCS unpublished data 
Figure 4.5: Medicare services per capita, by state, 1987-88 to 1992-93 
These differences may in part reflect the different mix of public and private patients in 
hospital (since public patients in public hospitals receive non-chargeable services) and 
the differences in age structures among States. An analysis of age structure does 
provide support for this notion: in New South Wales at 30 June 1992 the proportion of 
males aged 65 or over was 10.3%, greater than the national average of 9.9%; the 
proportion of women in these age groups in New South Wales was 13.5%, more than 
the national average of 12.8%. The proportion of these age groups in the Northern 
Territory was 2.8% for males and 3.0% for females. These variations in proportions of 
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elderly residents may go some way to explaining the highest per capita use of medical 
services in New South Wales and the lowest in Northern Territory. 
From 1987-88 to 1992-93 there was a general consistency in the pattern of service usage 
(Figure 4.5). The greatest increase over this period occurred in Victoria (annual increase 
of 4.9% compared with the national average of 3.6%). New South Wales had the lowest 
State increase (2.8%), with all other States approximating the national average. There 
was a relatively sharp increase (national average of 8.9%) between 1991-92 and 
1992-93 (attributable to the increase in pathology services after February 1992, as 
discussed previously). Increases in numbers of service items in Victoria and Western 
Australia exceeded this average (10.6% and 10.3% respectively), while increases in all 
other States and Territories were less than the national average. 
4.6 Dental services 
A decreasing level of tooth loss has a major influence on trends in the use of dental 
services by adults. As explained in Section 2.4, page 94, the increasing numbers with 
natural teeth leads to increasing numbers using dental services. This use, in turn, will 
increase the number retaining at least some natural teeth. 
This section focuses on the use of dental services by adults, and on reasons for using or 
not using these services. The data presented were collected by the Dental Statistics and 
Research Unit in a telephone survey of seven areas in five States in 1992-93. 
Comparisons are made with data from 1979 (Australian Bureau of Statistics 1979a, 
1979b) and 1987^88 (Barnard 1993). 
From 1979 to 1993, the percentage of people up to age 34 who used a dental service in 
the previous 12 months remained relatively stable, whereas at greater ages use of 
dental services within the previous 12 months increased. The proportion aged 65 and 
over who had used a dental service in the previous 12 months nearly doubled 
(Figure 4.6, page 178). 
Approximately half of the people in all household income groups had made a dental 
visit in the last 12 months. However, there was a major difference between lowest and 
highest household income group in the percentage who last visited 5 years ago or 
more. Only 7.6% of people from households earning over $40,000 per year had their 
last dental visit more than 5 years previously, whereas 13.7% from households earning 
less than $12,000 per year had done so. 
Figure 4.7 (page 178) shows that, except in the highest income group, most adults 
visited because of a dental problem. As income increases, the usual reason for visiting 
changes, so that 56% of the highest income group usually visit for a check-up. Reason 
for visiting thus relates to household income. 
The dominance of private dental services in the provision of dental care is more 
substantial than generally recognised. Private dental services are the predominant 
providers of dental care to adults in Australia, with 92% of non-health card holders and 
64% of health card holders having used a private service on their last visit. Only 36% of 
health card holders made their last visit to public dental services. 
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Figure 4.6: Persons visiting a dental provider in the previous 12 months, by age group, 
1979, 1987-88 and 1992-93 
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Source: AIHW DSRU Telephone Survey 1992-93 
Figure 4.7: Dentate persons aged 18 to 64 years visiting a dental provider, by income 
group and usual reason for visit 
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Figure 4.8: Dentate persons aged 18 to 64 years receiving services, by usual reason for 
visit and location 
Although the likelihood of extractions appears to be related to the site of last dental 
visit, this association could be influenced by the usual reason for visiting. The 
percentage of people reporting extractions in their last course of dental treatment is 
almost the same for users of public dental services, regardless of whether they visit for 
a check-up or for a problem, and for users of private dental services who usually visit 
for a problem. Approximately one-quarter of these users of dental services had an 
extraction. Only 9.5% of people who visited a private service for a check-up reported 
an extraction in their last course of treatment (Figure 4.8). 
Figure 4.8 also shows, as might be expected, that the percentage of adults receiving 
restorations was higher among those who usually visit for a problem than among those 
who usually visit for a check-up. Among those who usually visit for a check-up the 
percentage receiving restorations was higher among those whose last visit was to a 
private service. Adults who usually visit for a problem presumably are more likely to 
have active disease and to need restorations. 
Factors affecting use of dental services 
Strategies for improving the dental health of disadvantaged people seek to encourage 
timely treatment to save their natural teeth. In order to identify the groups least likely 
to obtain check-ups, factors influencing people to seek treatment have been identified. 
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The analysis was restricted to people with natural teeth, and focused on the 
characteristics which may be associated with dental service use, rather than on 
attitudes or behaviour. These characteristics were sex, number of natural teeth, 
household income and health card status, and difficulty in paying a $100 dental bill. 
The findings are presented in Table 4.18. 
People eligible for health cards were more likely to visit dental services for problems, 
and despite their lower income and greater difficulty reported in paying a $100 dental 
bill, many of these visits were to private dental services. This may partly be explained 
by problems in gaining access to public care. The cost of private care coupled with 
lower levels of dental insurance among this group increases the probability that these 
visits were problem-motivated. 
Table 4.18: Analysis of characteristics concerning whether persons usually attend for dental 
problems 
Characteristic Independent effect 
Sex Males were 2.1 times as likely as females to attend for problems. 
Number of teeth People with fewer than 24 teeth were 1.8 times as likely as those with 24 teeth 
or more to attend for problems. 
Income People with household incomes below $30,000 were 2.4 times as likely as 
those with incomes above $30,000 to attend for problems. 
Health card status People with health card entitlements were 1.4 times as likely as those without 
to attend for problems. 
Financial hardship People who reported a lot of difficulty paying a $100 dental bill were 2.1 times 
as likely to attend for problems. 
Source: AIHW DSRU Telephone Interview Survey 1992-93 
4.7 Health technologies 
4.7.1 Use of health technologies 
The growth of diagnostic services 
Previous issues of Australia's health have drawn attention to the growth in diagnostic 
services. Important associated issues are increased costs of health care programs and 
uncertainty regarding the degree of benefit from use of these services. 
This discussion considers recent trends in the use of diagnostic services. In 1991-92, 
25.4% of the total Medicare benefits paid for all services were for imaging ($532.9 
million), diagnostic endoscopy ($45.0 million), and pathology services ($585.4 million). 
There is wide variation in the growth of use of different types of tests. Table 4.19 shows 
how use of conventional radiology tests (X-rays) increased by only 0.1% (from 6.432 
million to 6.439 million services) from 1990-91 to 1991-92, and use of ultrasound 
services increased by 11% (from 1.35 million to 1.50 million). 
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Table 4.19: Imaging services, 1984-85 to 1991-92 ('000 services) 
T y p e o f s e r v i c e 
Y e a r X - r a y s CT MRI< a > U l t r a s o u n d T o t a l 
1984-85 4,341.5 172.4 
-
544.0 5,057.8 
1985-86 4,899.9 231.3 
-
680.2 5,811.3 
1986-87 5,195.6 277.1 2.7 802.0 6,277.4 
1987-88 5,358.3 298.7 5.6 895.5 6,558.1 
1988-89 5,5659 328.2 8.4 1,026.1 6,928.6 
1989-90 5,982.8 358.5 10.7 1,176.2 7,528.2 
1990-91 6,432.3 406.6 12.4 1,348.3 8,199.6 
1991-92 6,438.6 448.1 10.6 1,495.9 8,393.2 
A v e r a g e a n n u a l 
g r o w t h r a t e ( % ) 5 . 8 1 4 . 6 n a 1 5 . 5 7 . 5 
(a) As from 1 February 1992, MRI services were covered under Health Program Grants. The tall in the 
number of Medicare services observed in 1991-92 is an artefact of this change. 
Source: AIHW 1993a 
Any change in use of conventional X-ray examinations has large cost implications, as 
$301.6 million or 56.6% of the total expenditure on imaging services was devoted to 
them in 1991-92. However, conventional X-ray examinations as a proportion of 
imaging services have declined from 85.8% in 1984-85 to 76.7% in 1991-92. Over this 
period there was rapid growth in use of newer technologies such as computerised 
tomography (CT) and magnetic resonance imaging (MRI). 
Wall (1993) has queried the radiation exposure involved in the use of X-rays and the 
associated risk of cancer to patients. There is a need to consider whether the risk to the 
patient from a test involving ionising radiation is justified by the potential benefits. The 
NHMRC considers the radiation dose acceptable if CT is the appropriate investigative 
modality. It has stated there is a need to assess the need for each CT examination in the 
light of potential benefits and risks to the individual patient (NHMRC 1991). 
Expressed in terms of number of services per 1,000 population, the average annual 
growth rate in use of imaging services was 5.9% from 1984-85 to 1991-92 (Table 4.20). 
During this period, the growth in expenditure was 4.8% at constant 1984-85 dollars 
(Table 4.21). These trends are believed to reflect growth in use of imaging services 
generally. Transfer of services from the public to the private sector is not seen as a 
significant factor in them (Deeble 1991), and ageing of the population has been 
estimated as contributing only 0.3% per annum to growth in use over the decade to 
1986 (Barer et al. 1990). 
CT and ultrasound accounted for 23.1% of imaging services and for 42.8% of 
expenditure on imaging services in 1991-92 (Tables 4.19 and 4.21). Their increased use 
may simply reflect the usefulness of new technology in diagnosis and management of 
disease, although demonstrations of the effects of tests on patient management and 
patient outcome are still very limited. 
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T a b l e 4 . 2 0 : Imaging services, Medicare rates, 1984-85 to 1991-92 (per 1,000 population) 
T y p e o f s e r v i c e 
Y e a r . X - r a y s C T M R I ( a ) U l t r a s o u n d T o t a l 
1984-85 278.7 11.1 • - 34.9 324.6 
1985-86 310.4 14.7 
-
43.1 • 368.1 
1986-87 324.3 17.3 0.2 50.1 391.9 
1987-88 329.4 18.4 0.5 55.1 403.2 
1988-89 336.4 19.8 0.5 62.0 418.7 
1989-90 355.4 21.3 0.6 69.9 447.2 
1990-91 376.5 23.8 0.7 78.9 479.9 
1991-92 372.3 25.9 0.6 86.5 485.3 
A v e r a g e a n n u a l 
g r o w t h r a t e ( % ) 4 , 2 1 2 . 9 n a 13.8 5 . 9 
(a) As from 1 February 1992,'1MRI services were coveredunder Health Program Grants. The fall in the 
number of Medicare services observed in 1991-92 is an artefact of this change. 
Source: A\HW 1993a 
Other Medicare data show a 118% increase in selected cardiac tests from 1989-90 to 
1991-92. Although this increase may have been .partly due to the availability of new 
technology, such as the Doppler colour ultrasound, the level of benefit associated with 
this increased activity is unclear (Crowe & Hailey 1992). 
Another increase is in the use of diagnostic colonoscopy, from 20,300 procedures in 
1984-85 to 102,700 in 1991-92. Use of an alternative test, barium enema examination, 
decreased from 112,000 to 97,000 over the same period. Thus, diagnostic colonoscopy 
has added to the earlier diagnostic technique, rather than replaced it. 
T a b l e 4 . 2 1 : Imaging services, Medicare benefits paid, 1984-85 to 1991-92 ($ million) 
Y e a r A v . a n n u a l 
P r i c e / 
S e r v i c e 1984-85 1985-86 1986-87 1987-88 1988-89 1989-90 1990-91 1991-92 
g r o w t h 
(%) 
C u r r e n t p r i c e s 
X-rays 166.9 194.5 211.2 218.4 235.8 263.8 296.1 301.6 8.8 
CT 41.3 57.5 67.1 59.9 67.4 78.8 94.8 106.8 14.5 
MRI<a> 
- -
0.6 1.3 2.2 2.9 3.5 3.0 na 
Ultrasound 41.9 55.2 64.2 57.9 69.2 85.1 105.7 121.5 16.4 
Total 250.0 307.1 343.1 337.4 374.6 430.7 500.1 532.9 11.4 
C o n s t a n t 1984-85 p r i c e s 
X-rays 166.9 182.5 181.5 176.0 177.4 187.0 198.5 196.7 2.4 
CT 41.3 53.9 57.7 48.3 50.7 55.9 63.5 69.7 7.8 
MRI<a> 
- -
0.5 1.0 1.6 2.1 2.4 2.0 na 
Ultrasound 41.9 51.8 55.2 46.6 52.1 60.3 70.8 79.3 9.5 
Total ' 250.0 288.1 294.8 271.9 281.9 305.3 335.2 347.6 4.8 
(a) As from 1 February 1992, MRI services were covered under Health Program Grants. The fall in the 
number of Medicare services observed in 1991-92 is an artefact of this change. 
Source: AIHW 1993a 
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Minimal access surgery 
'Minimal access surgery' refers to operations performed through tiny incisions or 
without incisions at all. Compared with traditional open surgery, it generally results in 
less pain, shorter hospital stays and faster recovery times. Patients should benefit by a 
faster return to normal activities; hospitals and the health care system should benefit 
by reducing costs and needing fewer beds; and employers should benefit because their 
employees lose fewer days to illness. But are these benefits being realised? 
The most recent major developments have been in laparoscopic surgery. 
Gynaecologists have been using the laparoscope since the 1970s for diagnosis and 
some surgery. With advances in video technology and development of new 
instruments, surgical use of the laparoscope has increased greatly over the last few 
years. 
The first major change came through its adoption for cholecystectomy (removal of the 
gall bladder) in 1989. Subsequent developments include laparoscopic versions of 
appendicectomy, hernia repair, vagotomy, bladder surgery and ulcer repair. The 
laparoscope has also been used to assist other procedures such as hysterectomy and 
bowel resection. 
The potential impact of these techniques upon surgery in Australia is huge: there were 
47,299 hospital admissions to repair hernias and 27,028 to operate on the appendix in 
1989-90 (Gillett, Liv & Solon 1993). 
Laparoscopic cholecystectomy provides an interesting example of what may happen 
with other laparoscopic surgery. Estimated numbers of cholecystectomies performed 
in Australia are shown in Table 4.22). Laparoscopic cholecystectomy was first 
performed in Australia early in 1990. Some 21,504 cholecystectomies were completed 
using this technique in 1991-92, accounting for 63% of all cholecystectomies 
performed, with a further 3,557 (10.5%) attempted but completed using open surgery 
(Marshall, Clark & Hailey 1994). In 1992-93 this proportion increased further, with 73% 
of all cholecystectomies completed laparoscopically, while the proportion of 
procedures begun laparoscopically but completed using open surgery fell to 6.7% 
(Hailey & Hirsch 1993). 
Table 4.22: Estimated numbers of cholecystectomy procedures in Australia, 1987-88 to 1991-92 
Y e a r 
O p e n 
p r o c e d u r e s 
L a p a r o s c o p i c 
p r o c e d u r e s 
C o n v e r t e d 
l a p a r o s c o p i c 
p r o c e d u r e s ' 3 * 
T o t a l 
c h o l e c y s t e c t o m i e s 
1987-88 27,105 
-
27,105 
1988-89 27,050 
-
27,050 
1989-90 26,564 
-
26,564 
1990-91 24,369 3,221 537 28,397 
1991-92 9,042 21,504 3,588 34,134 
(a) Refers to procedures that were started laparoscopically and completed as open operations. 
Source: Marshall, Clark & Hailey 1994 
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The number of cholecystectomies in 1991-92 was 26% more than the number in 
1987-88, on a constant population basis (Table 4.22). Thus, after a period where 
cholecystectomy rates had shown little or no increase, the introduction and rapid 
diffusion of the laparoscopic technique were associated with an increase in the total 
number of cholecystectomies performed. A similar effect has been noted in Canada 
(Marshall, Clark & Hailey 1994) and in the United States (Steiner et al. 1994). The 
proportion of laparoscopic procedures converted to open operations has fallen as 
further experience with the technique has been gained. 
Where procedures which would not have been attempted as open surgery are 
performed on frailer patients, the laparoscopic approach offers an important gain, 
although there is always the risk of needing to convert the laparoscopic procedure to 
open surgery. However, the technique may also be being used where open surgery is 
considered to offer inadequate benefits. The utility of such additional procedures 
remains unclear. 
The performance of extra procedures erodes the potential cost savings offered by 
laparoscopic cholecystectomy. Preliminary reviews suggest that, although patients 
gain considerably through fewer days lost and reduced costs, savings to the health care 
system are much more limited (Marshall, Clark & Hailey 1994, Hailey & Hirsch 1993). 
These findings suggest a need for appropriate trials and clear guidelines for use of 
laparoscopic surgical techniques. 
Another example of minimal access surgery is endometrial resection or ablation, an 
alternative to hysterectomy in the treatment of menorrhagia (excessive menstrual 
bleeding). This technique makes use of diathermy, lasers or radiofrequency devices. 
Since no incision at all is required, recovery is faster and hospital stays are shorter than 
for laparoscopically assisted hysterectomy. The use of hysteroscopic endometrial 
resection or ablation has spread rapidly; 2,342 Medicare benefits payments were made 
for it in the first six months of 1992. An impact on hysterectomy rates for menorrhagia 
is already discernible (Hirsch 1993). 
Hysteroscopic resection or ablation offers significant financial advantages compared 
with abdorninal hysterectomy (Hirsch 1993). The advantage depends upon the type of 
equipment used. Of the three methods introduced to Australia, diathermy (at about 
$1,500 per patient episode) is cheaper than either laser ($2,200) or the recently 
introduced radiofrequency ablation ($2,500). Since outcomes are reported to be similar, 
it is not surprising to find that 96% of procedures use diathermy. 
Laparoscopically assisted hysterectomy is another minimal access technique that could 
replace some abdominal hysterectomy, although the extent to which it might do so is 
not yet known. It benefits patients through less pain, a faster recovery and a quicker 
return to normal activities. However, its financial impact is less clear. Although the 
laparoscopic technique is cheaper than the abdominal procedure ($2,960 as compared 
with $3,740), the difference is not great and could be less if hospital stays prove to be 
longer than those in early reports. 
Replacement of open surgery by laparoscopic procedures affects hospitals in many 
ways. Hospital budgets must meet the cost of some disposable instruments and of 
additional laparoscopes, video equipment and laparoscopic instruments. Laparoscopic 
equipment is more difficult to clean and sterilise than that used for open surgery. 
184 
Shorter hospital stays have relatively higher administrative costs and increase the need 
for day care and post-discharge services. 
A number of other issues also need close consideration. Although operative mortality 
rates for open and laparoscopic cholecystectomy are similar, technical difficulties in the 
laparoscopic procedure appear to be associated both with a number of deaths and a 
greater risk of bile duct injury (Crist & Gadacz 1993). This points to a need for adequate 
training in laparoscopic techniques and careful evaluation of the safety and efficacy of 
each compared with traditional techniques. Long-term re-operation rates for 
procedures such as laparoscopic hernia repair are unknown and could be a major 
factor in determining the cost-effectiveness and eventual acceptance of the procedure. 
As the example of laparoscopic cholecystectomy illustrates, widening patient selection 
criteria could significantly reduce the savings to the health system offered by rninimal 
access surgery. The probability that these savings will occur needs careful evaluation 
for individual procedures. Although minimal access techniques continue to make a big 
impact on current surgical practice, their net benefits for both patients and the health 
care system will not be known for some time. 
Transplantation services 
Organ transplantation is an area of medical technology in which significant changes 
continue. Kidney and corneal transplantations have been undertaken for many years 
and are standard clinical practice. Other forms of transplantation, such as lung and 
pancreas, are more recent and are still in development. The specialised and evolving 
nature of these technologies is reflected by the number which have received Nationally 
Funded Centre status (awarded to high-cost, low-demand services where there is a 
need to concentrate services in a small number of national centres). Lung and pancreas 
transplantation are supported in this way, and heart and liver transplantation have 
been. 
Corneal transplantation has been used since 1941 and is being performed on an 
increasing number of patients, now over 1,000 per year (Table 4.25, page 186). It cures 
corneal blindness, with one-year graft survival rates of over 90%. Minimal 
immunosuppression is required to prevent rejection and the operation is relatively 
straightforward (Mitchell et al. 1993). 
Table 4.23: Percentage of alt transplant recipients by age group 
Age group Heart Heart-lung Lung Liver 
1-15 2.9 1.7 - 34.3 
16-40 22.5 48.3 14.5 23.7 
41-60 66.7 48.3 83.6 40.0 
More than 60 7.9 1.7 1.9 2.0 
All procedures 418 60 55 460 
Source: AHTAC 1994, in press 
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Table 4.24: Percentage of first kidney transplant recipients by age group, 1991 
P r o p o r t i o n o f p r o c e d u r e s u n d e r t a k e n 
0.5 
3.3 
52.4 
25.2 
14.7 
3.8 
468 
A g e g r o u p 
0-4 
5-14 
15-44 
45-54 
55-64 
65-74 
Number of first transplantations 
Source: Disney 1992 
Bone marrow transplantation is used to treat a number of conditions such as leukaemia 
and aplastic anaemia. Its use increased threefold from 1987 to 1992. Transplanted cells 
are previously harvested either from the patient (autologous) or from a living donor 
(allogenic). Donors can be either related or unrelated to the patient, with major tissue 
types matched closely to those of the recipient. This requirement for tissue matching, 
which is essential in bone marrow transplantation rather than simply desirable as in 
transplantation of other organs, means that large donor registries must be available to 
give a reasonable chance of finding suitable donors. An unrelated donor is usually 
sought only if no suitable related donor is available and an autologous transplant is 
inappropriate. 
The difficulty in finding suitable donors is one reason why bone marrow 
transplantation is performed less frequently than might be expected. In the past, 
survival was poorer for matched unrelated donor transplants than for matched related 
donor transplants. Recent results suggest similar outcomes for the two groups of 
recipients (Atkinson 1992). 
Table 4.25: Number of transplantations, 1987 to 1993 
T y p e of t r a n s p l a n t 1987 1988 1989 1990 1991 1992 1993 
Bone marrow 174 188 225 247 368 506 560 
Unrelated allogenic 3 2 2 6 32 23 27 
Related allogenic 113 106 126 136 147 205 201 
Autologous 58 80 97 105 189 278 331 
Cornea 526 552 608 790 916 1,019 nya 
Heart 28 52 84 98 98 101 105 
Heart-lung 1 2 14 12 19 18 13 
Kidney 391 466 491 443 468 459 442 
Liver 30 63 100 80 116 140 127 
Lung 
- - -
5 18 36 56 
Pancreas 3 7 7 9 8 10 11. 
Source: ACCORD 1994 
Kidney transplantation is the most well-established and widely used solid organ 
transplantation. Young and middle-aged adults are the most frequent recipients 
(Table 4.24). Numbers of procedures are now steady in Australia at between 400 and 
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500 per year (Table 4.25, page 186). For the patient with end-stage renal disease, it 
offers greatest potential for restoration of renal functioning. Patient survival at one year 
was 93% in 1991, with graft survival at one year being 84% (Disney 1993). The number 
of functioning transplants in Australia continues to increase (Table 4.26), though there 
continues to be concern regarding the limited number of donor organs. However, 
kidney transplantation does carry the risk of premature death, kidney rejection and 
complications of immunosuppression, particularly infection and cancer. Advances in 
suppression of the body's immune system should reduce rejection and improve 
outcome. 
Table 4.26: Kidney transplants and renal dialysis, Australia and New Zealand, 1986 to 1992 
1986 1987 1988 1989 1990 1991 1992 
Australia 
Kidney transplant operations 
Number 438 391 466 491 443 469 476 
Per million population 27 24 28 29 26 27 27 
Functioning transplants'3' 
Number 2,388 2,567 2,790 3,042 3,253 3,480 3,699 
Per million population 149 158 169 181 190 201 211 
Patients on dialysis 
Number 2,343 2,537 2,688 2,759 2,963 3,140 3,360 
Per million population 147 156 163 164 173 181 192 
Percentage on CAPD ( b ) 28 30 31 30 29 29 30 
New Zealand 
Kidney transplant operations 
Number 105 79 78 83 102 76 115 
Per million population 32 24 23 25 30 22 33 
Functioning transplants 
Number 426 452 484 531 579 605 675 
Per million population 129 136 145 158 171 176 195 
Patients on dialysis 
Number 401 437 484 530 558 626 666 
Per million population 121 132 145 158 165 183 193 
Percentage on CAPD*b' 42 42 44 46 50 53 56 
(a) Excludes patients lost to follow-up tor at least one year. 
(b) Continuous Ambulatory Peritoneal Dialysis. 
Source: Disney 1993 
Liver transplantation is still increasing in use in Australia, with 138 transplants having 
been performed in 1992, but is nearing a plateau in technical development (AHTAC 
1993). It is now part of the long-term management of chronic liver disease, but due to 
its technical and logistical complexity is unlikely to be available outside a limited 
number of centres. 
Over the past three years, techniques have been developed for reduced-size liver 
transplantation, which allow child patients to receive transplants in the absence of size-
matched donors and allow one donor organ to be used for two recipients. One-year 
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actuarial survival rates in Australia are now reported as 76% to 86% compared with 
72% to 78% in an earlier review of this technology (AHTAC 1991, 1993). As outcomes 
have improved and patient selection criteria widened, use of liver transplantation 
services has increased. 
Heart transplantation has also become increasingly successful, with one-year actuarial 
survival rates of 86% to 90% in Australian units (AHTAC 1994). It, too, is part of the 
long-term management of end-stage cardiac disease but, again due to complexity with 
respect to logistics and patient care, is unlikely to be available outside a limited number 
of centres. The annual number of heart transplants has remained at around 100 in the 
last three years, with shortage of donor organs a major limiting factor. Most recipients 
have been in the 41 to 60 age range (Table 4.23). 
Lung transplantation is evolving rapidly (Table 4.25). Initially, heart and lungs were 
transplanted together. This procedure was introduced to Australia in 1986 and is still 
the most appropriate form for a small group of patients, particularly young adults 
(Table 4.24, page 186). Single-lung transplantation was then developed and has 
replaced heart-lung transplantation for some conditions, including pulmonary 
fibrosis. Double-lung transplantation has progressed from en bloc transplant to 
bilateral sequential single-lung transplants as technical difficulties were overcome. 
This last procedure was introduced to Australia in 1992. 
The developing status of lung transplantation is reflected in poorer outcomes than for 
heart or liver transplantation. In Australia, one-year actuarial survival rates are 70% to 
75% for heart-lung transplantation and 61% to 78% for lung transplantation (AHTAC 
1994). Overseas outcomes as reported by transplantation registries are even poorer: 
59%, 69% and. 62% for heart-lung, single-lung and double-lung transplantation 
respectively, compared with 78% for heart transplantation (Registry of the 
International Society for Heart and Lung Transplantation 1992). 
The early stage of development of lung transplantation is also reflected in the changes 
in numbers performed since its introduction with five operations in 1990; there were 56 
operations in 1993. Numbers of heart-lung transplantations have decreased from 1991 
to 1993 and this trend is likely to continue as use of bilateral sequential single-lung 
transplantation becomes more frequent. Although the national caseload for lung 
transplantation is likely to increase, long-term outcomes are unknown; eventually this 
may affect caseloads. 
Pancreas transplantation is unlike most other forms of transplantation in that it is not 
in itself life-saving. It is used primarily in the treatment of insulin-dependent diabetic 
patients with end-stage renal failure and is accompanied by kidney transplantation. Its 
benefit is that it reduces debilitating complications of diabetes, but it exposes patients 
to the risks of major surgery, organ rejection and side-effects of immunosuppression, so 
that the procedure is performed only about 10 times per year in Australia. 
Transplantation of the islets of Langerhans (insulin-secreting tissue) is being 
investigated as an alternative. 
Donor supply is a limiting factor in most forms of transplantation. Long waiting lists 
for corneal and kidney transplantation and deaths while waiting for heart or liver 
transplantation indicate the impact of donor organ shortages. The cadaveric organ 
donor rate has remained fairly constant since the early 1980s, at 11 to 13 donors per 
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million population per year (Chapman 1992). However, only a minority of those dying 
are suitable to be donors, and how the number of potential organ donors has changed, 
as a result of changes in road accident fatalities, for example, remains largely 
unknown. The Australian Coordinating Committee for Organ Registries and Donation 
(ACCORD) has been formed to address the shortage of cadaveric donors. 
Donor pools vary with the different forms of transplantation due to a variety of factors. 
The potential corneal donor pool is large since age of the donor does not affect graft 
survival, eyes can be harvested up to 12 hours following death and a high proportion 
of the community supports eye donation (Coster & Williams 1992). Living donors add 
to the kidney donor pool, with 13% of the transplant operations performed in 1991 
having used living donors (Disney 1992). Living donor liver transplants have also been 
performed but raise ethical issues such as risks to the donor and the possibility of 
pressure being placed on the potential donor, particularly in urgent situations (AHTAC 
1993). Living donor lung transplants might also be possible in the future. 
Access to highly specialised services such as transplantation is a problem in Australia 
because of the wide geographic distribution of the population. The problem is less 
severe for corneal transplantation, which is performed in smaller provincial hospitals 
as well as large teaching hospitals, and for kidney transplantation, which is performed 
in 24 Australian hospitals. 
One purpose of granting Nationally Funded Centre status to liver, heart and 
heart-lung transplantation has been to provide equitable access for all Australians to 
the two or three units offering each of these services. Despite this national support, 
liver, heart and lung transplantation units have conducted transplants on more 
patients from their home States than from elsewhere. The reasons appear to lie in low 
rates of referral of out-of-State patients to the transplantation units and require further 
study (AHTAC 1994). 
4.7.2 Emerging health technologies 
Technologies in the treatment of benign prostatic hyperplasia 
A minimal access procedure which has replaced open surgery can itself be challenged 
by more recent technological development. 
Benign prostatic hyperplasia (BPH) is an enlargement of the prostate gland; it is 
present in most men over 50 years but without necessarily causing symptoms. When 
symptoms occur, they are of bladder outflow obstruction and urinary retention. 
Transurethral resection of the prostate (TURP), an endoscopic surgical procedure, has 
been the standard treatment when BPH causes sufficiently serious obstruction. More 
than 20,000 TURPs are undertaken in Australia each year. 
Although TURP is perceived as an effective operation, it can fail, re-operation may be 
needed, and there can be clinically important morbidity including sexual dysfunction. 
Also, patient opinion may often differ significantly from that of the urologist, with 
some men being reluctant to accept treatment. 
For these reasons, less-invasive surgical and non-surgical managements of BPH are 
being investigated. Table 4.27 summarises the present management options. Several 
have long been available. Now, other technologies are being proposed as less-invasive 
189 
alternatives which will reduce discomfort and complications, and perhaps provide 
savings to patients and the health care system. 
T a b l e 4 .27: Summary of management options for the treatment of benign prostatic hyperplasia 
O p t i o n D e s c r i p t i o n C a p i t a l c o s t C o m m e n t s 
Microwaves 
Hyperthermia 
Thermo-
treatment 
Pyrotherapy 
High intensity 
focused ultra­
sound 
Balloon dilation 
Laser irradiation 
Medical treatment 
Hormone 
therapy 
Alpha blockers 
Ultrasonic 
aspiration 
Transurethral 
needle ablation 
Cryosurgery 
Surgery 
Open surgery 
Transurethral 
reseclion 
Transurethral 
incision 
Stents 
Watchful waiting 
The tissue is heated either transrec- $10,000 to 
tally or transurethral^ to between $750,000 
42°C and 44°C, 
Tissue is heated transurethral!^ to 
temperatures ranging from 45"C to 
60°C. 
Ultrasound shock waves generated $1,130,000 
outside the body are used to destroy 
tissue. 
Transrectal ultrasound heats the $500,000 
prostate to between 80°C and 90°C. 
A balloon catheter is introduced in the $1,000 
urethra and inflated. 
Energy deposition may be through $150,000 
bare fibre, a sapphire-tipped probe or 
a side-firing probe. 
This therapy blocks testosterone's 
growth-stimulating effect on the 
prostate. 
These drugs affect the muscular tone 
of the prostate capsule. 
The device disrupts the tissue by $40,000 
repetitive striking, and fragments are 
aspirated. 
RF waves are passed through two $40,000 
needles in contact with the tissue. 
Sub-zero temperatures are used to 
destroy tissue. 
Electro-cautery is used to cut the 
prostatic tissue. 
Incisions are made in the bladder 
neck. 
Expandable tubular mesh or $2,000 
removable spiral stents dilate the 
urethra. 
The natural history of BPH is not well 
understood. BPH usually does not 
progress from mild to a more severe 
form. 
The use of this technique is 
decreasing, and thermo-
treatment is being preferred. 
Short-term outcomes only 
are available. 
The technology is in 
development. 
Clinical trials have begun in 
the USA. 
The technology is still in 
development 
The technologies are still in 
development. 
Lifetime commitment and 
compliance is required. 
As above 
The technique is still in 
development. 
Results not yet available. 
Results not yet available. 
Used for large prostates. 
This is the most common 
procedure for BPH. 
Suited to small prostates. 
Considerable morbidity has 
been reported. 
Observation without surgical 
treatment is a more 
reasonable option than 
previously believed. 
Source: Dankiw & Hailey 1993 
Health authorities, hospitals, urologists and their patients will ultimately have to 
choose from several alternatives. Most of them are still at a relatively early stage of 
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development, and the newer methods may not necessarily be superior. Improvements 
in objective symptoms, such as flow rates, following use of most of these technologies 
are generally not as good as those experienced after TURP. However, the incidence of 
sexual dysfunction following the newer procedures appears to be lower although these 
are short-term findings. Technical progress with a number of devices continues. 
It may turn out that some of the newer technologies provide relatively short-term relief 
and that TURP will eventually be needed for some patients. Deferring TURP in the 
short to medium term may be an important consideration. 
As most men with minimal symptoms of BPH seek medical advice, and the less-
invasive alternatives are appealing, there can be a demand for procedures of unproven 
value. The newer methods may extend the indications for intervention for BPH, 
adding to health expenditure for an uncertain benefit to health. 
Telemedicine 
Telemedicine, which involves the use of telecommunications to link general 
practitioners, nurses, patients and specialists, is being used on an experimental basis in 
AustraUa and, following trends in Europe and America, is likely to become available 
for general use within the next few years. The associated technology is improving 
rapidly, although a number of social and professional issues need to be resolved before 
telemedicine becomes widely used. 
Remote consultations 
Telemedicine offers the opportunity for medical consultation and preliminary 
assessment prior to action such as air evacuation of a patient to a base or city hospital. 
The remote consultation may involve a doctor and patient at one end, and a specialist 
at the other, connected by telephone while viewing each other on television monitors 
with the facility to transmit medical notes, pathology reports or X-ray images. 
Recent developments in high-speed telecommunications and computers allow 
consultations to take place between two parties using personal computers rather than 
the more expensive television monitors. A number of evaluation studies are being 
undertaken of the use of remote consultation facilities. An example of a successful 
project was the linking of the Whyalla Base Hospital and Royal Adelaide Hospital for 
the provision of remote psychiatric consultation services. In a changing technical and 
economic environment there is a need for ongoing evaluation to determine the benefits 
to patients of the use of remote consultations, and their costs. 
Privacy and security considerations 
Many people accept that it would be in their interests if their medical information 
could be readily transferred to another location. For example, if they were to fall ill or 
be involved in an accident while travelling and were in need of medical or hospital 
treatment, then the immediate availability of their medical history, including, for 
example, details of drug allergies, could result in better management. Just as customers 
expect their financial details to be available at each branch of their bank, so patients 
might expect their key medical details to be available at every treatment facility. 
Teleconimunications offer the prospect of improved patient care through the transfer of 
patient information between practices and imaging facilities, such as those at hospitals 
and rehabilitation centres. However, the successful introduction of this form of 
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telemedicine requires maintenance of patient records in computer-readable form. Also, 
while the ready transfer of patient information is desirable, present concerns about 
privacy and security of medical data require that details of a medical condition should 
not become known without the consent of the patient. There is a legitimate community 
concern that data stored on individuals, and particularly sensitive personal data such 
as a medical history, should be secure. Discussions are in progress among the several 
parties involved in the issues of appropriate standards,. privacy safeguards, and 
professional responsibilities for patient management. 
Provision of the required level of security is presenting a challenge to the computing 
industry in designing systems which are both fault-tolerant and secure, and at the 
same time are relatively easy to use and low in cost. It is likely that discussions 
between professional bodies, governments and patient and community representatives 
will continue for some time before a satisfactory solution is developed. 
The Health Communications Network (HCN) established recently by the 
Commonwealth Government will, as one of its objectives, provide a forum for 
discussion of these matters. The HCN is currently managing a number of pilot projects, 
collecting information on the problems that are likely to be encountered in the 
provision of services such as telemedicine. 
The future 
A great deal of work is yet to be done in the area of standards for medical records, 
legality, acceptability of computer-based records, security, user education, the accurate 
identification and linkage of patient records, and the need for evaluation and cost-
effectiveness studies. Nevertheless, it needs to be recognised that developments in 
telecommunications and computer technology present interesting possibilities for 
telemedicine. 
A number of related developments, such as the proposed introduction of cable 
television and of the video telephone, provide sufficient bandwidth for home 
consultations. Many patient queries can be as well answered by telephone as by a visit 
to a doctor. Clearly, existing administrative and financial reimbursement arrangements 
would have to be considered if video telephone consultation were to be introduced. 
Other services, such as the monitoring of alarm devices, could also be performed by 
the connection of transmitters to the home telephone. For example, the operation of a 
cardiac pacemaker could be monitored. Also, the analysis of previous history, unique 
to each patient, could detect changes in cardiac performance and monitor the effects of 
cardiac medication. 
Successful use of technology has other requirements. In the scenario described above, 
while it would be possible to transmit a patient's electrocardiographic patterns to a 
computer in a central hospital, there is the need for analysis and reporting to ensure 
appropriate patient management. Thus there is a need for administrative, legal, 
professional and financial arrangements to integrate the home-based telemedicine 
facilities with the patient management systems which have been established over 
many years. Arranging for these will not be simple, but must be done before the 
potential of telemedicine can be fully realised in the Australian health system. 
192 
Use of lasers in medicine 
The most important use of lasers is in eye surgery, particularly for treatment of 
detached retina. They have also been used in tattoo removal, and more recently for 
treatment of some skin blemishes. They are also used to treat some diseases of the 
cervix (Table 4.28). 
T a b l e 4 . 2 8 : Lasers—number of Medicare services, 1984-85 to 1991-92 
P r o c e d u r e s 1 9 8 4 - 8 5 1 9 8 5 - 8 6 1 9 8 6 - 8 7 1 9 8 7 - 8 8 1 9 8 8 - 8 9 1 9 8 9 - 9 0 1 9 9 0 - 9 1 1 9 9 1 - 9 2 
Dermatology - -
- -
6,743 7,821 7,964 7,634 
Ophthalmology 17,017 23,262 27,122 29,785 33,768 39 , 5 6 7 44,533 58,131 
Gynecology 
-
- -
-
8,076 12,633 11,038 11,308 
Gastrointestinal 
tract -
-
- - - -
-
99 
E N T - - 160 239 225 256 348 296 
T o t a l 1 7 , 0 1 7 2 3 , 2 6 2 2 7 , 2 8 2 3 0 , 0 2 4 4 8 , 8 1 2 6 0 , 2 7 7 6 3 , 8 8 3 7 7 , 4 6 8 
Source: MHW 1993a 
Laser systems are devices that emit parallel, coherent beams of radiation which can be 
focused to a small diameter, and can produce a high power-density. The various tissue 
interactions that take place with laser light of different wavelengths offer potential 
treatment of a range of conditions. 
Although lasers have been used in medicine for some time, in many applications their 
place has yet to be established. Few laser applications have been fully evaluated in 
terms of clinical efficacy and comparative advantage over alternative methods 
(Dankiw, Hailey & Angel 1993). They have secured a dominant position in relatively 
few areas. Despite the high hopes and great promise of this technology, the number of 
lasers in medical use in Australia is small. The number of high-powered devices 
increased from 64 in 1983 to 289 in 1991, and there are also about 2,000 low-power 
lasers in use. 
The variety of lasers available for medical use has increased substantially over the last 
decade and, more recently, new lasers have begun to move from research to clinical 
use. Low-power lasers have become more widely used, although their role in medicine 
is less clearly defined. 
Barriers to the adoption of lasers have been uncertainties over cost, and perceptions of 
limited advantage over alternative methods. The uncertainty is compounded by the 
fact that 'it is not simply a case of laser technology rapidly developing in a search for 
superiority over static conventional therapies; in reality, laser technology in many 
clinical areas is competing against equally new and rapidly developing technologies' 
(Sculpher & Buxton 1991). Possible concerns about training and safety have added to 
the uncertainty. 
The use of lasers in medicine can be expected to expand and become more firmly 
established. The newer types of laser promise more selective applications and greater 
convenience, although some devices will also have a higher cost. Intending marketers 
and users of lasers will need to establish not only that they are effective, but that their 
cost-effectiveness and convenience warrant the acquisition of a new device which may 
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require changes to established practice routine. In general, those considering, using 
lasers need to assess the procedure as a whole, comparing the laser with alternatives 
and identifying all costs. 
The effects on established routine may be a significant barrier to laser use. In some 
institutions, arguments against adjusting an established and efficient infrastructure 
and practice may militate against the use of lasers. There may also be practical 
difficulties when different departments within a hospital are sharing a laser facility. 
The economic reality is that it would be very difficult to justify one laser for a single 
application in a large public hospital, except possibly for ophthalmology and for 
obstetrics and gynaecology. 
New technologies for screening for cervical cancer 
Screening for cervical cancer employs the Papanicolaou (Pap) smear test. This is a well-
established technique that has been used for over 30 years. Its principal advantages are 
that a smear can be taken locally by a doctor or nurse, costs are low and the procedure 
is simple, quick and safe. Disadvantages of the Pap smear include problems of 
inadequate sampling and the limited sensitivity and specificity of the test. 
Sometimes a Pap smear may fail to detect abnormality. The reported incidence of such 
false negative results varies from 15% to 55% and depends on the severity of the lesion. 
For CFN3 (Cervical Intra-epithehal Neoplasia grade 3), the most important lesion 
which routine screening aims to recognise, a false-negative rate of 15% to 20% is to be 
expected. There are numerous inherent opportunities for error that can lead to an 
unacceptably high false-negative rate. Poor sampling technique has been suggested as 
being responsible for about half of false-negative results, and errors in laboratory 
diagnosis for the remainder. 
Because of these disadvantages, there is interest in applying new technologies to 
screening for cervical abnormalities. 
Technologies for taking smears 
A variety of implements, ranging from the wooden spatula to specially designed, 
brushes, are currently used to collect samples from the cervix. The cells collected on 
these implements are then streaked upon a glass slide. This process can suffer from a 
number of errors. The transformation zone of the cervix may be inadequately sampled, 
the collected cells may be too heavily layered on the slide, or an inadequate number of 
cells may be applied. The absence of different types of cells may also cause the slide to 
be rejected by the laboratory. Some new brushes appear to improve the reliability of 
sampling. 
As the preparation and reading of Pap smear slides are laborious procedures and 
subject to human error, systems are being developed that reduce the involvement by 
cytotechnologists and produce better quality slides. 
There are two new methods of slide preparation, both of which require the collector of 
the specimen to wash the collected cells into a vial of alcoholic fixative (Braggert et al. 
1993). The vial is then sent to the laboratory where the slides are produced using either 
of the two new instruments. 
Performance data on the two devices are shown in Table 4.29 (page 195). They show an 
improvement over the Pap smear procedure, although the false negative rate is still 
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quite high for a screening procedure. These figures represent the performance under 
laboratory practice conditions as applied in the United States of America, and trials are 
required to establish the place of this technology in Australian cytology laboratories. 
Table 4.29: Data on automated slide preparation 
'Thin Prep' (Cytyc) 'Cyto-Rich' (Roche) 
Agreement with Pap smear test 77.4-91.9% 90.3% 
Agreement within one grade 97.2-99.8% 97.2% 
Sensitivity Thin Prep: 57 -74% 
Pap: 4 6 - 6 7 % 
Specificity Thin Prep: 76% 
Pap: 77% 
(Biopsied patients) 
Additional lesions detected e.g. 9 high grade, 42 low grade 
out of 2,655 smears 
Source: Braggert et al. 1993 
Automated slide screeners 
The desire to remove some of the possibility for human error and to reduce the labour 
component of the screening process has led to the development of automated slide 
readers. These consist of a video camera mounted on a microscope with a computer-
controlled microscope stage. An automatic slide loader is incorporated so that the 
instrument can scan the slides by itself. The computer software translates the 
information on the slide to identify pre-cancerous or cancerous cells. These high-cost 
devices are still at the developmental stage, and are not yet available in Australia. 
All these automated scanners require human review of any abnormal or suspicious 
cells. The images and positions of these cells are stored in the memory of the computer 
for the technologist to review prior to reporting the findings. This means that only the 
negative results would be reported on the basis of the instrumental findings. A 
proportion of the negative results would be reviewed by the cytotechnologists as a 
quality control measure. 
The economies of this new technology are complex. Some of the factors which need to 
be considered in any decision to introduce it are that the slide preparation instruments 
cost approximately $50,000 and the consumables cost approximately $5 per test. The 
time taken to read a machine-prepared slide is approximately half the time to read a 
conventional Pap smear slide, although more time is required within the laboratory to 
prepare it. The automated screening instruments may cost approximately $300,000. 
Direct visualisation techniques 
Cervicography is a photographic technique being used in the United States to identify 
lesions of the cervix. The slides developed from the photographs are reviewed by 
trained colposcopists using a magnification of approximately 16 times, and results are 
reported to the clinician. Although some see cervicography as a replacement for Pap 
smear technology, it seems possible that this technology will be used in addition to the 
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Pap smear. A cerviscope costs US$3,200, with patients being charged $20 to $50 per 
test. 
Another direct visualisation technique currently being developed in Australia 
monitors electrical and optical properties of cells and compares the findings with those 
from normal cells. A diagnosis is then made and follow-up procedures instigated 
immediately, should they be deemed necessary. This instrument also is in the early 
stages of development and little information is available in the refereed literature. 
The place of these technologies in cervical cancer screening still needs to be 
established. The Pap smear is still the technology with which these new methods are 
compared and may itself have scope for improvement. 
To date, no cost-effectiveness studies have been performed to assess the economic 
benefits of the new technologies. Careful consideration will be needed to determine 
whether the additional costs of these approaches can be justified by the benefits they 
offer in terms of improved accuracy, particularly in the context of screening programs 
with limited resources. 
4.7.3 Technologies in aged care 
In 1989, 11% of the Australian population were aged 65 or more. By the year 2031 the 
proportion will have risen to over 20% (ABS 1990). 
Health care technologies add to the potential for improving health and quality of life in 
older people, but they also have their limitations. The following topics provide 
examples of the issues which can arise. 
Number 
1,400 
0 -29 30 -34 35 -39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80+ 
Age group 
Note: Public hospital data only for Vic, public and private hospital data for NSW and SA 
Source: AIHW, derived from State health authority data 
F i g u r e 4.9: Number ofCABG procedures performed in 1991-92 for New South Wales, 
Victoria and South Australia combined, by age group 
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Major surgical procedures 
An example of a major procedure is coronary artery bypass grafting (CABG). It was 
once considered too risky for patients over 70, but is now used increasingly at higher 
ages. Figure 4.9 (page 196) gives the age and sex distribution of patients who 
underwent CABG in New South Wales, Victoria (public hospital patients only), and 
South Australia in 1991-92. While 42% of the patients were from 60 to 69 years, 23% 
were aged 70 or more, and some patients were 80 years or over. 
Decisions on surgery for the very elderly are based more on a patient's condition and 
risk of complications than on age. 
Implants and prostheses 
Implants and prostheses are having a substantial impact on the health care of the 
elderly. Examples of those most commonly used are intra-ocular lenses, prostheses for 
total joint replacement, and cardiac pacemakers. 
Intra-ocular lenses are used in the treatment of cataracts, in which opacification of the 
natural lens of the eye causes impairment of vision and blindness. Lens replacement 
has had a dramatic impact on quality of life for the elderly, having saved many from 
partial or complete blindness. In 1991-92, Medicare benefits were claimed for over 
38,000 lens replacements, 81% in patients aged 65 or more. 
Nearly 39% of Australians who are 65 years or older suffer from arthritis (ABS 1991b), 
and pain and disability may become severe enough to warrant joint replacement. If 
successful, this relieves pain and substantially improves mobility. 
Although the great majority of cases involve hip and knee replacements, prostheses are 
also available for the shoulder, elbow, wrist and ankle. Around 18,000 total joint 
replacements are performed in Australia every year, at a total cost to health care of over 
$200 million. 
Joint replacement is most commonly performed on the elderly. For example, in New 
South Wales in 1991-92, there were 3,433 primary total hip replacements, 75% of which 
were on patients aged 60 years or more, including 44% who were 70 or more. 
For hip and knee replacements, short-term results are reported to be good or excellent 
in 90% of cases (Harris & Sledge 1990a, 1990b). A major long-term complication is 
loosening of the prosthesis. This can result in the need for revision operations, which 
are more difficult and less successful than primary procedures. Considerable effort has 
been devoted to the development of new, more costly implants to overcome these 
problems, but it remains uncertain that they give superior long-term performance. 
Cardiac pacemakers are electronic devices that deliver electrical stimuli to the heart to 
treat heart rhythms which are abnormally slow or abnormally fast. The first 
implantable pacemakers were developed in the 1950s. Since then, there have been 
major advances in the technology (Zipes & Duffin 1988). 
In Australia, the rate of pacemaker implantation is rising steadily. In 1984-85 there 
were 559 Medicare claims for pacemaker implantations. In 1991-92 there were 1,454. 
As the population ages, the demand for pacemakers is likely to increase. 
A characteristic of the evolution of pacemaker technology has been that, as new 
developments were introduced to overcome problems with previous models, new 
problems arose. For example, devices developed in the 1960s caused a condition called 
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pacemaker syndrome. Later devices could cause pacemaker-mediated tachycardia, a 
problem that has been largely but not completely resolved. Further improvements in 
the technology are expected (Shakespeare & Camm 1992). 
Minimally invasive therapy 
Recently, less or non-invasive techniques (discussed above, page 183) have replaced 
many conventional surgical procedures. This trend has particular implications for the 
elderly, who are among those most at risk in conventional surgery. Not only do 
rrunimally invasive techniques reduce risks and improve recovery for the elderly, they 
may also allow patients who might not have been able to undergo treatment by 
conventional surgery to be treated without excessive risk. 
Examples of minimally invasive techniques include laparoscopic surgery, catheter-
based techniques, and non-invasive procedures such as extracorporeal shock wave 
lithotripsy (ESWL). 
There are limitations which need to be kept in mind. For some procedures, for example 
cholecystectomy, the minimally invasive approach needs to be converted to open 
surgery in a proportion of cases. Selection of patients must recognise this. 
One of the most commonly used catheter-based techniques is percutaneous 
transluminal angioplasty. It is used principally in the treatment of coronary artery 
obstructions, and of obstructions in arteries to the legs. Angioplasty can only be 
applied to certain types of obstruction and many patients with cardiovascular disease 
would not benefit from its use. In addition, although initial success rates are high, there 
is a high rate of recurrence of obstruction. It can be difficult to be sure that the patient's 
symptoms are caused by an obstructed artery, and sometimes treatment of the 
obstruction does not relieve symptoms. 
ESWL has become standard procedure for treating kidney stones. Its use for biliary 
stones-is quite ,limited,*'due'iri~parf to the advent of laparoscopic cholecystectomy. 
However, it has a role in treatment of elderly patients with suitable biliary stones who 
are unfit for general anaesthesia. 
Pharmaceutical treatments 
Use of pharmaceuticals increases with age (ABS 1991b). Many elderly people suffer 
from more than one condition, and have a number of different medications on 
prescription. Older people are physiologically at greater risk of adverse reactions to 
pharmaceuticals. The risk increases with the number of drugs taken. 
In a study of elderly people in Sydney, 27% of those living in their own homes, and 
nearly half of those living in nursing homes or hostels, were taking four or more 
regular medications. For the institutionalised elderly, prescription of psychotropic 
drugs (tranquillisers, hypnotics, antidepressants, and so on), was high compared with 
other countries (Snowdon 1993). 
A high proportion of older people have been exposed to the risk of an adverse drug 
reaction, through prescription of drugs unsuitable for older people, combinations of 
drugs with adverse effects, or excessive duration of therapy (National Health Strategy 
1992). 
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5 Health information and 
statistics: sources, developments 
and deficiencies 
5.1 National Health Information Agreement 
In February 1991, the Institute convened a Forum on Priorities for National Health 
Statistics which recommended an agreement between the Commonwealth, States and 
Territories to improve cooperation in the development, collection and exchange of 
national health data. 
In May 1993 the Australian Health Ministers' Advisory Council (AHMAC) endorsed 
the National Health Information Agreement, subsequently signed by the heads of the 
Commonwealth, State and Territory health authorities, the Australian Bureau of 
Statistics and the Australian Institute of Health and Welfare. It came into operation on 1 
June 1993 and is being implemented under AHMAC's authority. 
The Agreement indicates acceptance of a national approach on health information in 
Australia's federal health care system. It will lead to uniformity or at least a high degree 
of compatibility of data collected in different parts of the system. The Agreement also 
signifies a public commitment by Commonwealth, State and Territory health 
authorities to adopt national definitions and to improve Australia's health information. 
Objectives 
The National Health Information Agreement sets out to provide a national framework 
and mechanisms to improve the collection, quality and dissemination of national health 
information. 
Objectives of the Agreement include: 
• promoting the collection, analysis and dissemination of quality health information 
on all health services and on a range of population variables (including health and 
risk factors), in accordance with nationally agreed protocols and standards; 
• developing projects to improve, maintain and share national health information; 
• cooperating in the provision of resources and information required to address 
national health information development priorities efficiently and effectively; 
• promoting the expansion of national health information and encouraging other 
groups and government and non-government sectors to participate and share 
information that they hold. 
The Agreement also aims to improve access to uniform health information by 
community groups, health professionals, and government and non-govemment 
organisations. While improving access to data using information technology is a goal, 
the Agreement will improve the data collections available and, from joint efforts, lead to 
new ones. A critical strategy for improving the current collections is setting national 
data definitions and standards. By recognising the National Health Data Dictionary (see 
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below) as the authoritative source of national data definitions, the Agreement has gone 
a considerable way to achieving this aim. 
A further role for the Agreement is to provide a sense of direction for the development 
of national health information. There are also a number of health information policy 
issues that have broad national implications, including privacy, charging, data access 
and linking of data; it is important that these matters be addressed nationally. 
The Agreement recognises the need for a broader national perspective that 
encompasses the private and non-government sectors, providers, the community and 
researchers. Initially, however, it is between the Commonwealth, State and Territory 
governments, and is mainly concerned with health information issues in the public 
sector. The rationale for this approach is that governments provide or finance most 
health services, largely fund the training of health professionals, and are the major 
producers and users of health information. Obtaining the participation of and 
commitment by governments to improving national health information is clearly the 
first and most crucial step to any broader agreement. 
A National Health Information Management Group consisting of senior representatives 
of all signatories develops and oversees the Work Program to be carried out under the 
Agreement. It meets at least twice a year, and receives progress reports from each 
authority responsible for a project. It reports to AHMAC six-monthly on the Work 
Program progress and annually on national health information developments. The 
Institute provides the Management Group with technical and secretariat support. 
AHMAC's role in respect of national health information is to approve major policy and 
funding aspects, including the Work Program that incorporates the national priorities 
and to receive the annual review of the Work Program with the recommendations of the 
Management Group. 
National' Health Information Work Program 
The major implementation mechanism of the Agreement is a National Health 
Information Work Program of health information activities with a national perspective 
or national implications. The activities range from development work on standard 
charts of accounts, on health outcome measures and on new collections such as mental 
health, to improved definitions and enhancement of existing collections such as vital 
statistics and morbidity data. Many of the issues to be addressed through the 1993-94 to 
1995-96 Work Program are those identified by the 1991 Forum on Priorities for National 
Health Statistics. 
The 1993-94 Work Program lists nearly fifty projects that are accepted by the parties to 
the Agreement and are in accordance with agreed national priority areas. These priority 
areas are: 
• - Health services 
—institutions 
—primary care and community health 
—mental health 
—medical services 
—health service outcomes 
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—pharmaceuticals 
—health insurance 
—national health expenditure 
—health labourforce 
• Health status 
—vital statistics 
—population surveys 
—surveillance 
—population health outcomes 
• Health information 
—national health information policy and infrastructure 
—National Health Data Dictionary 
The National Health Data Dictionary is a key element of the Work Program. The NHDD 
for institutional health care, published by the Institute in 1993, represents a major step 
forward in providing an authoritative set of national definitions. The Work Program 
envisages the expansion of the NHDD to other major health areas including the health 
labourforce, primary care and mental health. 
Development of the NHDD will be coordinated through the National Health Data 
Committee (NHDC) supported by the National Health Information Unit at the 
Institute. The Unit is funded jointly by the Institute and AHMAC. 
Inclusion in the Work Program indicates that the project is either currently under way 
or will be begun within the time frame of the Work Program. Responsibility for each 
project has been assigned to a party to the Agreement. Each party accepting the 
responsibility has agreed roles and responsibilities that include addressing the issues 
from a national rather than a State or Commonwealth perspective, consulting broadly, 
reporting to the Management Group and using agreed national data definitions and 
standards. 
A key measure of the success of the Agreement will be the political and resource 
commitment of the signatories to the Work Program projects. 
Future developments 
Although the current Agreement is between government agencies, the importance of 
the private for-profit and not-for-profit sectors, academic bodies, community 
organisations, and others, is recognised by all signatories. A major challenge will be to 
identify and obtain agreement on priorities for the information needs of these diverse 
interests. 
Major challenges will arise in developing information relating to social, behavioural 
and environmental factors that affect health and illness. These issues pose substantial 
methodological, ethical and information practice_ (storage, transport and data access) 
questions. 
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5 .2 C o m m o n w e a l t h a g e n c i e s a n d n a t i o n a l h e a l t h 
s t a t i s t i c s 
Many Commonwealth Government agencies have interests in national health statistics. 
Those with broad interests are the Australian Institute of Health and Welfare (AIHW), 
the Australian Bureau of Statistics (ABS), and the Department of Human Services and 
Health (DHSH). Other agencies/including Worksafe Australia and the Department of 
Veterans' Affairs, have specialised interests. 
Australian Institute of Health and Welfare (AIHW) 
The AIHW is an independent Commonwealth statutory authority which undertakes 
statistical and research work in the areas of health and welfare. Its functions are to: 
• collect, produce and analyse health- and welfare-related information and statistics; 
• conduct and promote research into the health of Australians and their health 
services; 
• develop statistical standards relevant to health and to health and welfare services; 
• publish methodological and substantive reports on work carried out by or in 
association with the Institute; 
• undertake studies into the provision and effectiveness of health services and 
technologies; and 
• make recommendations on the prevention and treatment of diseases and the 
improvement and promotion of health and health awareness of the people of 
Australia. 
Much of the data used by the Institute in pursuit of its objectives comes from the States 
and Territories, or from the Australian Bureau of Statistics. A detailed discussion of the 
AIHW structure and role was provided in Australia's health 1992. The description 
following mentions, significant developments since 1992, and perceived needs for the 
future. 
Health Monitoring Div is ion 
The Health Monitoring Division monitors and evaluates the health of all Australians 
and population subgroups. 
During the last two years, there have been significant advances in the timeliness of data 
holdings, particularly the National Death Index (see.Section 5.3), national cancer 
statistics, and mortality data. 
The Division published the first two of a series of mortality surveillance reports 
identifying trends in mortality from a wide range of causes of death. It is also 
developing monitoring strategies for national health goals and targets (see Section 1.5, 
page 65) and a comprehensive set of health indicators. 
The Division has played a major role in negotiations and development of proposals for 
a national dietary survey to be conducted in conjunction with the 1994-95 ABS National 
Health Survey (see under Department of Human Services and Health later in this 
section). As part of its work to develop ongoing monitoring and surveillance of the food 
system and its responsibility to report publicly on progress towards meeting food and 
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nutrition goals and targets, the Institute has produced a benchmark report—Australia's 
food & nutrition—released earlier in 1994. 
Health Services Division 
This Division is responsible for developing, collecting and analysing statistics and 
information on the provision and use of health services in Australia. 
Following the 1991 Forum on Priorities for National Health Statistics, the Health 
Services Division had responsibility for development of the National Health 
Information Agreement proposed there (see Section 5.1). 
Work continued on the National Health Data Dictionary including definitions for 
institutional health care, mental health, casemix classifications and health labourforce. 
Significant progress was made on the National Health Labourforce Collection. The 
publication in 1994 of national reports on the characteristics and workforce activities of 
registered nurses, medical practitioners and pharmacists, will be the culmination of 
three years work in obtaining agreement from health authorities and registration 
boards on data definitions and on provision of data to the Institute. AHMAC funded a 
significant part of the development work. 
The Hospital Utilisation and Costs Studies moved from two-yearly to annual reporting 
starting with the 1991-92 collection. Unfortunately, little progress was made in reducing 
the time from the end of the period covered by each report to its publication date. The 
National Health Information Management Group is seeking to ensure more timely 
provision of data in future. 
Health expenditure publications continue to be among the most sought after of the 
Division's publications. Work has started under the National Health Information 
Agreement Work Program to standardise classification of health services financial 
reporting. This should improve the timeliness of reporting of health expenditure data. 
The Australian Health Outcomes Clearing House was established to help in the 
measurement of health outcomes and to act as a focus for methodological work on 
measurement (see section 5.6). 
During the two years under review, the Institute entered into a collaborating 
arrangement with the University of Wollongong. Collaboration has included the 
development of definitions relating to acute inpatient care. Other work for the Casemix 
Development Program of the Department of Human Services and Health has related to 
casemix classifications for rehabilitation services and for the services of allied health 
professionals. Exploratory work has been undertaken for an operations research model 
of hospital waiting lists. 
The 1992 Budget provided for the Institute to develop national reporting of hospital 
waiting lists. Several discussion papers were published in early 1993 and an interim 
report in early 1994. The first national report based on uniform definitions is planned 
for late 1994. 
A survey of quality assurance activities in hospitals was undertaken in 1993. 
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Health Technology Division 
The Health Technology Division assesses the costs, effectiveness and distribution of 
health care technologies in Australia. It is also developing a database on the use and 
distribution of health technologies. 
Amodel for costs of disease has been developed (see Section 1.2.5). Ahealth technology 
statistics bulletin (HealthTechStats) has been established. It provides statistics on the 
distribution, level and trends in the use of health technologies in Australia. The major 
source of data is the Medicare database, but industry and institutional sources are 
increasingly being used. 
Welfare Division 
The work of this Division relates more to welfare services statistics than to health 
statistics. However, a significant achievement in both fields has been development of a 
National Minimum Data Set for services funded under the Commonwealth-State 
Disability Agreement. The data set includes a data collection form, a data dictionary, 
and supporting instructions. A pilot test was conducted early in 1994 and the first 
national data are expected late in 1994. 
Dental Statistics and Research Unit 
The Unit is working to improve the range and quality of statistics on the dental 
labourforce, dental practice, dental illness, and use of dental services. 
Significant progress has been made towards national collections and reports in two of 
the main data collections maintained by the Unit. All States and Territories are now 
contributing to the National Dental Labourforce Data Collection and national reports 
are in preparation for 1993 onwards. National reports from the revised Child Dental 
Health Survey have been published for 1989 and 1990 and further reports have been 
prepared for comment. 
The Child Dental Health Survey has been augmented by a supplementary research 
project, the Child Fluoride Study. This study extends the oral health and social data 
available, permitting the precise estimation of disease incidence for specific social and 
cultural groups within the community and for groups receiving different patterns of 
care. The study will continue until 1995. 
The Unit has also made progress on improving the data available on oral health and use 
of services -among adults. Two surveys, the National Dental Survey and Adult Dental 
Programs Survey, were proposed in 1992 and tested in a consultancy to the Department 
of Health, Housing and Community Services (now the Department of Human Services 
and Health, DHSH) in 1992-93. They generated high-quality data on issues pertinent to 
policy on dental care for adults. The data also served as a basis for the planned National 
Evaluation Project for the Commonwealth Dental Health Program. The Unit is 
conducting the National Evaluation Project over 1994-97, under contract to DHSH. 
National Injury Surveillance Unit 
This Unit (NISU) seeks to make informahon necessary for injury control available to 
those who can use it. 
Since 1992 NISU has initiated improvements in injury surveillance data collection, 
notably a minimum data set for injury surveillance. It has also developed methods for 
208 
routine reporting of injury mortality and morbidity data, continued to compile injury 
data, provided numerous reports based on injury data to inquirers, and produced 
bulletins and a major descriptive survey of injury in Australia. 
Road injury has received special attention through the Road Injury Information 
Program (see section 2.6, page 100). NISU is undertaking a program of research and 
publication which is improving the understanding of road injury (especially non-fatal 
injury) to guide improvements in road safety. Reports to date describe road injuries 
requiring emergency department attendances and admission to hospital, describe and 
analyse deficiencies in blood alcohol data, examine the potential of insurance company 
data to contribute to road safety, and investigate needs for data on exposure to road 
injury risk factors. 
NISU completed a major consultancy for the Department of Human Services and 
Health and produced reports on the occurrence and circumstances of injury in 
Australia, and on programs and activities for the control of injury. The reports provide a 
more complete description of injury in Australia than previously available. Attention 
was given to transport injury, injury in rural settings, domestic injury, sports injury, 
injury involving consumer products, occupational injury, interpersonal violence, 
self-inflicted injury, injury in Aboriginals, health promotional programs, injury 
treatment services, rehabilitation, and injury control activities outside the health sector. 
National Reference Centre for Classification in Health 
The Centre was estabUshed in 1992 as a result of the World Health Organization 
appointing the AIHW as a Collaborating Centre for International Classification of 
Disease. The Reference Centre assists the Institute in its role as a Collaborating Centre. 
The Reference Centre, located at the Queensland University of Technology, has close 
links with the Queensland Department of Health and the Queensland office of the 
AustraUan Bureau of Statistics, which has recently become the location for centraUsed 
coding of mortaUty within the Bureau. 
The Reference Centre has a major role in the introduction of the tenth revision of the 
International Classification of Diseases (ICD-10) into Australia. 
National Perinatal Statistics Unit 
The AIHW National Perinatal Statistics Unit (NPSU) at the University of Sydney was 
reviewed in 1993. The review recommended, and the Institute later accepted, that the 
goal of the National Perinatal Statistics Unit should be to provide national leadership in 
development and study of statistics relating to perinatal health. The objectives of the 
Unit were recast to become, in order of priority: 
1. to monitor and interpret national perinatal mortaUty and morbidity; 
2. to provide a limited perinatal epidemiology service; and 
3. to conduct epidemiological research. 
The coUection, analysis and dissemination of mortality and morbidity data (including 
congenital maUormation data) relating to the perinatal period was to become the 
primary activity of the Unit. 
As a result of these decisions, the direction of the Unit's work changed substantiaUy in 
1993-94. 
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Australian Bureau of Statistics 
The ABS is the central statistical authority for the Commonwealth Government and 
under the Australian Bureau of Statistics Act 1975 has responsibility for the collection, 
compilation, analysis and dissemination of statistics and related information; ensuring 
coordination of the operations of other official bodies in the area (to avoid duplication, 
attain' compatibility and encourage maximum use of statistics); developing and 
mamtaining standards for statistical collections; and providing international liaison in 
relation to statistical matters. . t , 
In health statistics, ABS is responsible for providing and supporting the production of 
statistical information on the health of Australians (including disease prevalence and 
causes of death, and risk factors), their use of and need for health services, the cost of 
health services, and the health labourforce. 
During the last two years, the ABS has continued its regular publications of, for 
example, summary statistics of causes of death. It has also contributed to the major 
developments in health statistics described below. 
Causes of death 
Planning is under way for the implementation of ICD-10 and the introduction of 
automatic coding of causes of death, expected to occur in 1995, subject to the 
availability of documentation and training materials from the World Health 
Organization. 
Work is proceeding on plans to link births, deaths and midwifery data to provide an 
ongoing national linked data source to facilitate research and analysis into events from 
birth to age 2 years. 
National Health Survey 
^The-aim^of thisrseries< of five-yearly;National-Health-Surveys is to provide national 
benchmarks covering a range of key health indicators, and to enable trends in health to 
be-monitored over time. The first survey in the series was conducted in 1989-90. Initial 
results were released in 1991. During 1992 and 1993 three major sets of publications 
were released: Health status indicators (Catalogue nos 4370.0-4374.0), Health related 
actions (4375.0-4379.0) and Health risk factors (4380.0-4384.0). 
The second survey in the series will be conducted during 1994-95. From early 1993, the 
ABS has been engaged in the development of this survey, including extensive 
consultation with data users to ensure that, as far as possible, the survey addresses 
priority data needs. 
Social Health Atlas 
The Social health atlas of Australia, released in two volumes during 1992, brings together 
an extensive range of health information. Using results of the 1989-90 National Health 
Survey, it describes for regions the relations between health and socioeconomic 
characteristics on a regional basis. The atlas was produced'by the South Australian 
Health Commission under the auspices of the National Better Health Program, and 
with the assistance of the ABS. 
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Aboriginal health 
Health is one of the broad subject matter areas being covered in a national survey of 
Aboriginal and Torres Strait Islander people to be conducted from April to June 1994. 
During 1992-93 the ABS conducted widespread consultation with Aboriginal and 
Torres Strait Islander organisations. State and Commonwealth government agencies 
and research organisations to determine priorities for collection of data on Aboriginal 
and Torres Strait Islander populations. 
The ABS, in collaboration with AIHW, is preparing a report on the health of Australia's 
Aboriginal and Torres Strait Islander people. It is based largely on data from the 
1989-90 National Health Survey but also includes information from the 1991 
Population Census and the ABS vital statistics collections. Subjects covered include 
health, risk factors, health-related actions including use of health services, life 
expectancy and mortality, reproduction and associated health issues. 
Women's health 
The publication Women's health (Catalogue No. 4365.0) is a comprehensive social report 
relating to the health of Australian women. It brings together information from a 
variety of sources including ABS collections, information from the Department of 
Human Services and Health and the AIHW, and scientific publications. Subjects 
covered encompass health, health actions, reproductive health, causes of death, life 
expectancy, violence against women, occupational health, risk factors, screening for 
breast and cervical cancer, health of selected groups (migrants, Aboriginals, older 
women and the disabled), medical workforce, and health expenditure and research 
related to women. 
Private hospitals 
Findings from the first survey of private health establishments conducted by the ABS 
are contained in Private hospitals, Australia (Catalogue No. 4390.0).-National data were 
obtained in respect of 1991-92 about the facilities, patients, staffing and finances of 
private acute and psychiatric hospitals and freestanding day hospital facilities. Some 
findings from the collection are discussed in Section 4.2, page 155. 
Infant sleeping positions 
Sleeping position has been associated with the risk of Sudden Infant Death Syndrome. 
In July 1992 the ABS conducted a survey to obtain information on the sleeping positions 
of children aged less than 2 years. Selected results are published in Survey of infant 
sleeping positions, Australia (Catalogue No. 4386.0). 
Survey of Disability, Ageing and Carers 
The 1993 Survey of Disability, Ageing and Carers provides national data on people with 
one or more disabilities and on people aged 60 years or more living in households and 
health establishments. Information was also collected from household carers. Data is 
contained in Disability, ageing and carers: summary of findings (Catalogue No. 4430.0). 
Some findings from the survey are presented in Section 1.2.4, page 10. 
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Department of Human Services and Health 
National Nutrition Survey 
The National Nutrition Survey (NNS) is a joint project between the Australian Bureau 
of Statistics and the Commonwealth Department of Human Services and Health. 
The need for a survey to provide national information about diet and nutrition has been 
recognised in many forums in recent years. The conduct of a national nutrition survey 
was proposed by Commonwealth and State agencies as a national priority under the 
umbrella of the National Health Information Agreement. 
The proposal is to conduct the NNS in association with the National Health Survey in 
1994-95. The main aim is to provide high-quality food and nutrition data on a sample 
sufficient to allow comparison of the results with the 1983 National Dietary Survey of 
Adults. In addition, the NNS will establish national baselines for children, young 
adults, the elderly, and people in rural areas. 
Monitoring of health indicators 
To assist with its reporting on population health indicators, the AIHW has established a 
steering committee to make recommendations about the specification of health 
indicators, and to consider data collection priorities and strategies. Specific activities of 
the Department in this work include preparation of some trial questions about health 
behaviours in the ABS Population Survey Monitor, and analysis of data about the 
incidence and prevalence of asthma in Australia and overseas to help in the 
development of health promotion and other programs. 
Regional database 
The Department has developed a regional and cross-program database, ORPHEUS, as 
part of its Regional Focus and Cross-Program Links initiative. This database provides 
information about target populations for the range of service programs it delivers, and 
information about the availability and use of services it funds or provides. In tandem 
with this development, a revised and expanded version of HEALTHWIZ, a health 
information system for use by primary health care practitioners, has been developed. 
Immunisation monitoring system 
A survey method to help monitor the need for and use of immunisation programs has 
been developed by ABS for the Department. This method can be used to gather more 
information about localised outbreaks of communicable diseases initially identified 
from administrative data sources. 
Health service outcomes 
The recent release of the first set of national cost relativities for acute inpatient episodes 
is a significant early achievement in the development of health service outcome 
measures. The production of these national cost relativities necessitated the 
development of national Diagnostic Related Groups computer software, and this 
software will have extensive use by health service providers. 
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General practice 
The General Practice Evaluation Program is continuing to examine new sources and 
collections of data to shed light on how general practice operates and its place in the 
health system. An aim is to describe general practice over time. 
Preliminary work has begun on developing common definitions and core data items to 
improve comparisons of databases relating to the primary care sector. It is evident that 
data on general practitioner activities and finances are scarce. Data on more sensitive 
subjects such as expectations of practitioners and of consumers are similarly scarce. It is 
anticipated that some of these gaps will be filled by the conduct of a Health Industry 
Survey by ABS in late 1994. 
Disability data 
The development of a needs-based planning system for disability programs will be 
completed in 1994. As a major component of this work, ABS has developed a method 
for estimating the geographic distribution of target populations for the programs, and 
is now assisting the Department of Human Services and Health in the design of a 
planning model that estimates demand for services. In addition, the Department has 
conducted its inaugural census of data about the characteristics of funded services and 
their clients. 
Worksafe Australia 
Worksafe Australia has primary responsibility for national occupational health and 
safety statistics with responsibility for: 
• coordination of major statistical developments; 
• development, maintenance and support of statistical standards and classifications; 
and 
• dissemination and analysis of national statistics. 
It aims to ensure the availability of relevant, timely and comparable national statistics 
on occupational health and safety; and to facilitate standardised collection and 
compilation of information, particularly at the workplace. 
As part of its responsibility for the national monitoring of work-related injuries and 
diseases, Worksafe Australia has developed the National Data Set for 
compensation-based statistics (NDS). The NDS, which was agreed to in 1987, 
recommends a standard set of data items, concepts and definitions for inclusion in 
workers' compensation collections. Its main purpose is to enable the production of 
national and nationally comparable workers' compensation data. The NDS was 
substantially implemented in 1991-92 in State, Territory and Commonwealth workers' 
compensation systems. However, as will be noted from Section 1.3.5, page 41, it was not 
possible to present national statistics in this publication. That must be recorded as a 
deficiency. 
The national injury database, which is maintained by the AIHW National Injury 
Surveillance Unit, contains injury records supplied by hospital Accident and 
Emergency Centres. Its capacity to supplement workers' compensation data, by 
providing occupational injury data for areas such as the rural sector which have poor 
coverage under the NDS, is being evaluated. 
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When the NDS allows the production of national compensation-based statistics, these 
statistics will still not cover all work-related injuries. They exclude: 
• injuries causing absence from work of less than five working days; 
• injuries to the many workers not covered under general workers' compensation 
legislation such as those covered under the NSW Transport Authorities Act; 
• most injuries to the self-employed; and 
• injuries not claimed or unsuccessfully claimed under workers' compensation 
legislation. 
Workers' compensation systems are generally a poor source of data on occupational 
diseases, particularly those involving a long latency period. As a result, Worksafe 
Australia is investigating use of other sources of occupational health and safety data, 
including registrations of births and deaths, cancer registries, coroners' records, and the 
Australian Bureau of Statistics Population Survey Program. 
Worksafe Australia also wishes to assess the feasibility of collecting information on the 
longest held occupation of adult patients admitted to public hospitals. 
Department of Veterans' Affairs 
The Health Program of the Department of Veterans' Affairs (DVA) is responsible for 
meeting the health needs of 340,000 veterans and war widows, a substantial proportion 
of Australia's elderly population. For example, 25% of males aged over 65 years are 
entitled to health treatment from DVA. Treatment is not restricted to war-caused injury, 
and the health services provided are comprehensive; they include medical services, 
allied health services, pharmaceuticals, community nursing,. respite care and hospital 
treatment. 
DVA currently operates a number of hospital facilities: Repatriation General Hospitals, 
which provide inpatient treatment for acute illness and out-patient services; and 
Repatriation Auxiliary Hospitals, which provide rehabilitation, convalescent and 
respite care. The DVA provides morbidity data to State and Commonwealth hospital 
morbidity collections, and also contributes information to collections such as the 
Hospital Utilisation and Costs Shady. It is represented on the National Health Data 
Dictionary Committee. 
It is the Commonwealth Government's policy that DVA withdraw from the direct 
provision of hospital services by 1 July 1995. These services will then be provided 
through the Repatriation Private Patient Scheme. This scheme enables eligible veterans 
and war widows access to local hospitals as repatriation private patients. The 
Repatriation Private Patient Scheme is operating in Tasmania, New South Wales and 
Western Australia. In accordance with Commonwealth and State privacy legislation, 
DVA has arranged for the provision of casemix information on veteran public hospital 
episodes from the New South Wales and Tasmania morbidity databases. Negotiations 
are continuing with other States about the integration of repatriation facilities. 
DVA has extensive information on veterans' and war widows' use of health services, 
derived mainly from administrative systems used for paying accounts and monitoring 
expenditure; the Department processes approximately 18 million accounts per year. As 
far as practicable, the Department uses established classification and coding schemes, 
such as item codes from the Medicare Benefits Schedule. In addition to the 
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administrative systems, there is also a statistical database that contains individual 
profiles of the use of health services, The database covers a random sample of 15,500 
veterans and war widows, and allows patterns of service use to be analysed, as well as 
inter-relationships between the use of different services. 
In 1992 DVA carried out a health survey of a random sample of 2,600 veterans and war 
widows. The survey included questions on chronic conditions, disabilities, risk factor 
behaviour, self-assessed health, and attitudes about lifestyle changes. Carers of disabled 
veterans and war widows were also interviewed about aspects of their role as carers. 
Approximately 90% of respondents consented to DVA lmking their responses with its 
comprehensive data on individuals' use of medical, hospital and allied health services. 
A major identified need is the enhancement of administrative data so that they can be 
used to assess the outcomes and effectiveness of current services and programs. Areas 
needing development include: the establishment of appropriate conceptual frameworks 
and outcome measures; the identification of additional information that is needed, 
ways of collecting it and ways of integrating it with administrative data; and the 
development of methodologies for analysing and presenting the information. 
5.3 National Death Index 
The National Death Index (NDI) is a database housed at the AIHW which will 
eventually contain records of all deaths occurring in Australia since 1980. 
The NDI was developed for use by medical researchers, who frequently need to find 
out whether the subjects of their studies have died and, if so, when and from what 
cause, hi many research studies, particularly those which are long term or involve large 
numbers of individuals, researchers experience difficulty in tracing their subjects. 
Examples of such projects include follow-up of people known to have been exposed to 
specific health hazards, people suffering from a particular disease, or patients taking 
part in clinical trials. 
Australian death records are kept separately for each State and Territory by the local 
Registrar of Births, Deaths and Marriages. To search for a group of subjects in eight 
different registries entails obtaining permission from each registrar and then using a 
number of different systems which vary greatly in their accessibility and capacity to 
provide information on specific people. 
Searches are made more difficult by changes and errors in personal details, both of 
which occur frequently. The change in surname when women marry is well recognised, 
but it is not well known that incorrect details are often supplied when deaths are 
registered. Given names are often transposed, incorrectly spelt, or partly replaced by 
nicknames. The date of birth is often wrong; many people know the birthday of an 
elderly relative, but not the year of birth. 
The National Death Index has been equipped to overcome these difficulties. Through a 
suite of computer programs it is able to link death data to records supplied by 
reseaichers. To use the NDI, medical researchers need apply only to the AIHW in order 
to match their subjects to the death records held in the database. Strict controls are 
applied, for much of the information is of a personal and confidential nature. All 
applications for access to it must have been approved by the ethics committee of the 
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host institution and by the AIHW Ethics Committee. No personally identifying 
information may be published. 
The successful development and implementation, in 1994, of the NDI is attributable to 
the effective cooperation between the Institute, the State and Territory Registrars, and 
the Australian Bureau of Statistics which codes the causes of death. By late 1992, all 
States and Territories had agreed to participate in the NDI. During 1993, the Institute 
put much effort into obtaining data from previous years, establishing procedures for 
updating information from registries, and choosing a linkage system. 
5.4 Health statistics for Aboriginals and Torres 
Strait Islanders 
In this section, 'Aboriginals' and related terms are used to refer to both Australian 
Aboriginals and Torres Strait Islanders. 
Achievements 
The need for more comprehensive national Aboriginal health statistics has been 
recognised for many years. In 1984 a Commonwealth Government Task Force reached 
agreements with all States and Territories except Queensland (which it did not visit) to 
identify Aboriginals in the birth and death registration systems, and the hospital 
morbidity and perinatal data collections (Task Force on Aboriginal Health Statistics 
1985). 
Since then, provision has been made for some identification of Aboriginals in all these 
collections except the birth and death registration systems in Queensland. Following a 
review of information systems for registration, it is likely that Queensland will 
introduce Aboriginal identification on birth and death certificates. 
All cancer registries provide for Aboriginal identification in cancer registrations, 
although data quality and completeness are variable. Less progress has been made in 
providing for Aboriginal identification in communicable disease notifications, where 
Victoria and Tasmania do not yet collect this information. 
The Institute has undertaken a small survey of disability and handicaps among 
Aboriginal people (see Section 1.3.3, page 26). 
Recent developments 
The 1989-90 National Health Survey was the first major health survey undertaken by 
ABS to provide for the identification of Aboriginals, but no special sampling procedures 
were employed to ensure that the number of Aboriginals included in the survey was 
large enough to provide detailed information on Aboriginal health. Some information 
on Aboriginals from the Survey has been published (ABS 1993). 
To overcome this problem in the National Health Survey to be conducted in 1994 and 
1995, ABS will increase the Aboriginal sample in that survey. The increased sample, 
funded by AIHW, the Aboriginal and Torres Strait Islander Commission, and 
Commonwealth and State health agencies, will yield national estimates of key 
Aboriginal health indicators for urban and rural areas, and permit comparison with 
those for non-Aboriginals. 
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As part of its response to the Royal Commission into Aboriginal Deaths in Custody, the 
Commonwealth Government funded ABS to conduct a national Aboriginal survey in 
the first half of 1994. Information has been collected on the demographic, social, 
economic and health characteristics through a representative sample of the Aboriginal 
and Torres Strait Islander population. Findings from this survey will include 
information on self-reported illness, risk factors, health-related actions taken by 
individuals, and disability and handicap. 
Although draft health goals and targets for Aboriginal health have been developed 
(Wronski & Smallwood, undated), these targets were not widely accepted by 
Aboriginal representative groups, and will be revised in conjunction with the national 
health targets for the four identified priority areas (cardiovascular disease, cancers, 
injury and mental health—see Section 1.5). 
The Institute is developing databases for vital statistics and hospital morbidity 
collections identified by the Task Force on Aboriginal Health Statistics. As part of this 
initiative, the Institute convened a workshop on Aboriginal health statistics and 
research in Brisbane in June 1993. 
Gaps and deficiencies 
Provision for the identification of Aboriginals in major health statistical collections and 
surveys and the conduct of a national Aboriginal survey represent important advances. 
However, providing for identification does not guarantee that Aboriginals are so 
identified. This incomplete recognition is most significant in the larger urban centres. 
To ensure that adequate levels of Aboriginal identification are achieved in the 
health-related collections, intensive validation studies and concerted action to improve 
the identification of Aboriginals are needed. There is also a need for Aboriginal 
identifiers collected by some States only, such as in communicable disease notifications, 
to be included in all States' major health collections. 
The National Perinatal Statistics Unit is developing a national perinatal data collection 
and, as part of this task, will address the lack of national data on Aboriginal perinatal 
outcomes. 
5.5 Developments in injury surveillance 
The main objectives of injury surveillance are to: 
• describe injury levels and patterns, to inform communities and provide a basis for 
policy development; 
• set targets for categories of injury and injury risk factors which are to be the subject 
of control efforts, and monitor progress towards these; 
• identify new, unusual, and previously unrecognised forms of injury, refine and 
update understanding of injury and monitor occurrence of 'sentinel events'; and 
• describe and characterise groups of injury cases to generate hypotheses and to 
provide the basis for research into causes or risk factors and the effectiveness of 
preventive measures. 
Monitoring of trauma management and rehabilitation services may also be regarded as 
an aspect of injury surveillance. 
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Table 5.1 summarises the main data sources for each of these aspects of injury 
surveillance and indicates the levels of detail required. 
Currently, information for injury surveillance is derived from ongoing mortality data, 
hospital inpatient collections, and surveillance systems from some hospital emergency 
departments. It also comes from special sources, such as a register of spinal cord 
injuries, police reports of people injured in road crashes, and the National Health 
Survey. 
Enhancements are necessary if the objectives of injury surveillance are to be met. A 
proposed injury surveillance data standard will help direct attention to the most 
important information needs, improve data consistency, and facilitate comparisons and 
linkage. New data sources may be needed for certain aspects of injury surveillance. 
National Minimum Data Set—Injury Surveillance 
A minimum data set for injury surveillance, the National minimum data set—injury 
surveillance (NMDS[IS]), has recently been developed by NISU, in collaboration with 
injury surveillance and prevention workers (NISU 1993). The data set is based on 
extensive experience in surveillance in emergency departments, is compatible with the 
International Classification of Diseases and the National health data dictionary— 
institutional health care (AIHW 1993), and is designed to enable effective injury 
surveillance. Endorsement of the NMDS[IS] as a national standard will be sought from 
the National Health Data Committee. 
Data collected according to the NMDS[IS] is of sufficient detail to satisfy the first injury 
surveillance objective listed above, and will go a long way towards meeting the others. 
It has been designed to enable national injury targets to be monitored. 
Although work to date has focused on the use of the NMDS[IS] in emergency 
departments of hospitals, the standard is intended to provide a core of data items for 
use in other settings. Many of the enhancements of existing data sources described 
below are designed to increase compatibility with the NMDS[IS]. 
Mortality data 
As recommended elsewhere (AIH 1991; AIHW 1992), the classification of causes of 
death from injury should be expanded to include the nature of injury, place of 
occurrence, and activity at time of occurrence. 
The mortality data collection should also enable access to the narrative descriptions that 
exist in coroners' records for most fatal injuries. Such access would be achieved 
efficiently through a national coroners' information system, which coroners support. 
The practical obstacle is the lack of an adequate electronic data system. Endorsement by 
the health sector of the need for such a system, which should be consistent with the 
NMDS[IS], and contribution to its development costs, may lead rapidly to substantial 
benefits. 
Enhancement of mortality information along these lines will bring it into accord with 
the proposed NMDS[IS]. 
Inpatient data 
Injury surveillance requires improved national compatibility and accessibility of 
hospital separations data. The potential for greater use of computerised patient 
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management information systems (PMIs) requires exploration, as these offer the 
prospect of much more timely informahon than separations data can provide. 
Ambulatory patient data 
The primary need is for formal endorsement of, and support for, a national data 
standard, and for incorporation of this standard into PMIs now being introduced into 
hospital emergency departments. The NMDS[IS] has been developed for this purpose, 
and has now been taken up in several PMIs. 
In the longer term, representative national coverage of injury attendances is desirable. 
The practicability of this depends on the development and implementation of a 
national minimum data set for ambulatory health care to include injury surveillance 
data items. 
PMIs offer potential improvements in data collection for injury surveillance. For 
example, sampling of cases on which to collect data will be possible in many settings. 
Rare injury registers 
A rare injury register is similar in concept to a disease register. Certain injuries, 
although relatively rare, are important subjects for injury surveillance. Their 
importance may derive from severity of outcome {such as spinal cord injury), current 
research needs {near drowning in early childhood), type of trauma (severe brain 
injuries, severe burns) or an exposure factor (injuries related to tractor roll-over). 
Operation of the register must be tailored to the problem. A review, which is nearing 
completion, of a previously used method for registration of spinal cord injuries will 
recommend a modified method. 
Integration of information 
Several types of analysis of injury surveillance data depend on an ability to link data. 
For example, estimates of the incidence of injury leading to admission to hospital are 
distorted by inability to identify readmissions to the same or to another hospital. 
Information obtained in emergency departments on the circumstances of injury usually 
cannot be linked easily to information on length or outcome of inpatient stay— 
information essential for estimating the severity and costs of injuries. 
Potential gains from linking data from othej sectors with health sector data are also 
great. For example, police and transport departments collect information on the 
circumstances of road crashes, but have poor data on resulting injuries. Heal.-h sector 
data have complementary strengths and weaknesses. The Road Injury Informahon 
Program at NISU is investigating the potential of linking data (O'Connor 1992). 
Progress in this area depends on technical and policy factors. The key technical 
consideration is data comparability, which can be improved by use of data standards 
such as the NMDS[IS], and by inclusion of common case identifiers. The policy issue is 
the balance that Australian society chooses to adopt between considerations such as 
protection of privacy, which limit the use of information, and the costs that result from 
more expensive and less powerful injury prevention research. 
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ro ro o Table 5.1: Overview of purposes of injury surveillance and corresponding data requirements 
F u n c t i o n s 
a n d p u r p o s e s 
R e l e v a n t 
d a t a s o u r c e s 
D a t a r e q u i r e d — 
i n j u r y c a t e g o r i e s 
D a t a r e q u i r e d — 
p l a c e s a n d p e r s o n s 
D a t a c o l l e c t i o n 
a n d a n a l y s i s 
Describe injury levels and 
patterns to inform policy 
Identify and monitor specific injury 
or risk-factor groups which are to 
be the subject of control efforts 
(targets) 
Identity classes of injuries or risk 
factors which are not common, yet 
are severe, or are easily 
preventable 
Identify specific risk factors for 
injury 
Develop injury prevention 
measures 
Monitor injury management and 
rehabilitation 
• Mortality 
• Hospital separations 
• Emergency departments 
• Periodic surveys (e.g. NHS) 
• Routine mortality 
• Hospital separations 
• Emergency departments 
• Special-purpose surveys 
• In-depth studies 
• Emergency departments 
• Coroner case registers 
• 'Near-miss' reports 
• Routine mortality 
• Hospital separations 
• Emergency departments 
• Trauma registers 
• Risk-factor surveys 
• Special studies 
• Detailed and specific 
research projects 
• Retrieval service 
• Emergency departments 
• Trauma service 
• Rehabilitation service 
• Hospital separations 
NISU minimum data set 
aggregation of ICD 'exter­
nal cause' categories 
ICD 'external cause' and 
injury classifications at 
detailed level (may need 
more) 
Well-defined categories of 
injuries and events, revised 
periodically 
Varies. Purpose-specific 
Varies. Increasing interest 
in standards (e.g. National 
Health Data Dictionary) 
Australia; States and 
Territories 
Varies. Targets may be 
national, State/Territory, 
regional, local or for a risk 
group 
National 
Varies. May best be studied at 
national, State, regional or 
local level, or in a population 
group 
Varies. Project-specific Varies 
Often specific to a treatment 
service. Some interest in 
standardisation (e.g. 'regional 
trauma services') 
Administrative by-product 
data 
Administrative by-product 
data. Also special, targeted 
research 
Usually based on administra­
tive by-product data. Needs 
formal assessment and 
follow-up of cases 
Often use by-product data. 
Analysis is topic-specific, 
may be complex, and will 
involve a number of research 
centres 
Usually collected for the 
project 
Primary product or 
by-product of administrative 
systems 
Trauma service monitoring 
Some inter-related needs for information systems have emerged as a result of trauma 
care services being increasingly organised on a regional or State basis, to encompass 
several clinical facilities and ambulance services. 
• Many hospitals which provide high-level trauma treatment services now have 
specialised trauma teams to deal with severe injuries. Clinicians involved in the 
trauma teams need detailed case information for patient management, clinical audit 
and research purposes, necessitating the establishment of information systems, 
usually referred to as trauma registers. 
• Some hospitals collect information on all injury patients, whether or not managed 
by a specialist team. Such data systems tend to be distinct from the hospital 
separations system, and provide more detailed and clinically relevant information. 
These systems are usually simpler than the trauma registers. 
• Regional and State trauma services require information systems to monitor their 
work loads and evaluate performance. For this purpose, patient information 
collected is limited to indicators of severity and type of injury, and information on 
transfers and times of treatment. 
In the absence of agreed Australian information standards (National Road Trauma 
Advisory Council Working Party on Trauma Systems 1993), it is timely to encourage the 
development of mutually compatible, national data standards preferably within the 
framework of the National Health Information Agreement, and the National Health 
Data Dictionary. The standards should also be compatible with the NMDS[IS]. 
Risk factor and exposure monitoring 
Information on risk factors enhances interpretation of information about the occurrence 
of injury. The frequency or severity of an injury may warrant research, but risk factor 
information helps determine priorities for research. Research into causes of injury and 
evaluation of interventions usually requires exposure data. Moreover, where a risk 
factor has a well-established relationship to an injury, and where the injury is rare or 
otherwise difficult to measure, monitoring of risk factor exposure may provide more 
useful information than monitoring of the injury. 
This aspect of injury surveillance is increasingly becoming the focus of attention. ABS 
Surveys of Safety in the Home, recently conducted in New South Wales and Victoria, 
have provided useful information on domestic accidents (Lazzaro 1993; Parrell 1993). 
Consideration should be given to extending them nationally, and to repeat surveys to 
monitor changes in exposure. The NISU Road Injury Information Program has studied 
needs and opportunities for improved exposure data relevant to road safety (ARC 
1993). 
Research into causes of injury and prevention strategies 
Resolution of questions of cause and effect requires information beyond that which a 
surveillance system can provide. Two types of injury research question can be 
distinguished: questions about causation (e.g. What are the relative contributions of 
several causal factors to a particular type of injury?); and questions about activities to 
prevent injury (Does a certain intervention work?). 
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Surveillance data often provide a starting point for causal research, highlighting areas 
warranting investigation, suggesting hypotheses, and sometimes providing cases on 
which a study can be based. However, a special collection of information is generally 
needed. 
Topics most urgently in need of research emerge from the processes for setting priorities 
among injury control targets, and planning work programs to achieve them. 
Formal evaluation of measures to prevent injury is widely advocated, but poses an 
important question: which measures should be evaluated, and in which way? Injury 
prevention efforts are sometimes expensive, may have important unintended 
consequences, and may be acceptable'only if a certain level of effectiveness can be 
demonstrated. Formal evaluation of effectiveness tends to be expensive, difficult and 
time-consuming. 
The question, then, is how to decide when an Australian evaluation of effectiveness is 
warranted. It might be warranted for measures such as vehicle air bags, random breath 
testing, and swimming pool fences. However, much of the injury burden is made up of 
large numbers of individually dissimilar types of event. 
Sometimes suspected risk factors change in a way that complicates the study. This 
particularly causes problems in studies of consumer products that have a market life 
shorter than the time required to demonstrate levels and mechanisms of risk. 
The cost of formal evaluation is unlikely to be much less for a rare problem than for a 
common one (indeed, rarity poses special difficulties), so the cost^benefit of 
undertaking formal evaluation is likely to be poor for uncommon problems. 
Development of criteria to assist funding agencies and researchers decide on these 
matters would be useful. 
5.6 Developments in health outcomes 
measurement 
Are resources being used efficiently to improve the health of the Australian population 
in an equitable manner? Do Australians receive value for money from their expenditure 
on health? Do consumers know the likely outcome of various treatments for their 
condition in order to make informed choices about health interventions? The 
measurement of health outcomes is one approach to answering these questions. 
Why measure health outcomes? 
The health outcomes, and hence effectiveness, of many widely used health services are 
not well documented, or may not even be known. Systematic measurement of health 
outcomes has gained prominence because of this. 
Measurement of health outcomes is well developed in the United States, where the 
Agency for Health Care Policy and Research has established Patient Outcome Research 
Teams (PORTs). These undertake long-term follow-up on major treatments, document 
outcomes, and develop guidelines recommending for whom treatments are suitable 
and how they should be performed. 
The PORTs make extensive use of condition-specific measurements, and many use the 
SF-36 (see Box 5.1) to place the condition-specific changes into a wider framework of 
222 
health. This also allows the outcomes (favourable or not) of different treatments for one 
condition to be compared, and for outcomes of treatments for different conditions to be 
compared. 
Box 5.1: De f i n i t i ons re la t ing to hea l th outcomes 
'Health outcomes' lacks an internationally accepted definition, hut is being used in North 
America, the United Kingdom, and Australia to mean changes in health attributable to 
intended or unintended interventions, whether in health or in other sectors. An AHMAC 
Health Outcomes Seminar in 1993 accepted a health outcome as a change in the health of an 
individual, a group of people or a population, which was attributable to an intervention or 
series of interventions. A favourable health outcome is an improvement in, maintenance of, 
or slowing of deterioration of health. 
'Health outcomes' is also sometimes used to include process outcomes which are measures 
of how health services are delivered and are thus mainly indicators of quality of health care. 
Health interventions are actions intended to improve health, maintain it, or reduce the rate 
at which it deteriorates. The actions may be of any kind, for example, diagnostic tests, 
medical or nursing treatments, counselling or social service support, educational measures, 
a change in administrative or budgetary responsibilities, or regidations relating to safety. 
They may also include intersectoral actions such as relief of poverty and improvement of 
housing, as these may affect the total well-being and the health-related quality of life of 
individuals. These latter actions can also be viewed as welfare interventions. 
Health services outcomes are the effects of health services. Most are effects on health as 
measured by clianges in health or perceived health but they also include consumers' 
satisfaction with and attitudes to health services. 
Many instruments and measures are used in health outcomes research. They include 
disease-specific measures (e.g. the Arthritis Impact Measurement Scale), general health 
profiles and general health indices. Other measures tliat have been used include mortality, 
morbidity and co-morbidity, functional status, single aspects of health (e.g. of pain, mental 
health, social adjustment and support) and patient satisfaction. 
General health profiles cover several dimensions of health such as physical functioning, role 
limitations, mental health perceptions and pain. The SF-36 (Medical Outcome Survey 
36-Item Short Form Questionnaire), the Nottingham Health Profile, and the Functional 
Limitations Profile are commonly used measures. General health indexes include the Rosser 
Disability/Distress Scale and the Quality of Weil-Being Scale. These rate individual health 
on a scale of 1 (full health) to 0 (death) with negative values for some extreme states of 
disability. They are used to calculate QALYs (Quality Adjusted Life Years) saved, enabling 
cost-benefit analyses and comparisons of treatments to be undertaken. 
The UK Clearing House for Information on the Assessment of Health Outcomes 
became operational in 1992. Its initial aims were to establish a resource centre and focal 
point for the exchange of health outcomes assessment materials; to review and appraise 
outcome measures and methods; to stimulate improvements in design and field 
application where necessary; and to provide an information and advisory service. The 
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Australian Health Outcomes Clearing House has been established recently at the 
AIHW to perform a similar role. 
This systematic gathering of data informs patients of the outcomes of choices 
confronting them, informs clinicians of when different procedures may be appropriate, 
and informs hinders of health services of the benefits and costs of different treatments. 
Comparisons are not always of the outcomes of alternative treatments. Competition for 
funding means health promotion programs need to be compared with treatment 
programs. For example, which would give the greater benefit for the same cost: more 
seat belt and drink-driving education or more helicopters for emergency transport of 
people injured in motor vehicle crashes? 
Measuring health outcomes 
Developing measures of health, and of changes in health, is not easy, but some 
quantification is necessary. Outcomes of health services are measured in terms of 
people's capacity to live their lives as they want. They are generally described in terms 
of dimensions such as limitation of function, and social and psychological well-being, 
as well as morbidity. 
Many studies measure health or perceived health before and after treatment so as to 
gain some assessment of the outcome of treatment, although a range of other research 
designs can be used. Evaluating the effectiveness of different treatments for the same 
condition also calls for measuring and comparing outcomes. Resources used for one 
purpose cannot be used for another purpose, and services to one person may deny or at 
least delay services to another, so there are advantages if resources are used where they 
will have the best effect. Thus, there is a great demand for instruments to measure 
changes in health. 
At the most basic level, health outcomes measurement consists of documenting changes 
in function in people who have undergone particular treatments. Currently, efforts are 
generally made to measure post-operative infection rates, immediate mortality rates, 
and the frequency with which procedures have to be repeated. These process outcomes 
are widely used in place of definitive health outcomes, which take long periods to 
measure. 
In the past, number of lives saved was sometimes used to justify funding one service 
instead of another. Then the number of life-years saved became a commonly used 
measure, but the capacity to keep comatose people alive almost indefinitely has meant 
that quantity of life is not always a useful measure of outcome. Efforts are now being 
directed to measuring the quality of life-years saved. 
There is a wide range of instruments designed for measurements of health (see Box 5.1). 
Some measure directly, or are indicative of, the presence of disease. Others focus on 
function. The ability to walk and to carry on an independent life will be determined by 
the extent that a joint is mobile and the degree of pain associated with movement. 
Instruments are available to measure these dimensions. 
Formerly there was a tendency to focus on a single disease-specific outcome of 
treatment. Now there is a desire to place outcomes into a broader context. Many 
'multidimensional' measures of health try to measure both objective elements of 
functioning and individuals' perceptions about their health. (Some of these are 
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described in Table 5.2.) This acknowledges that individuals may function similarly but 
experience different levels of distress, disability or handicap. Likewise, people 
reporting similar levels of disability may report different levels of mental and social 
functioning. 
T a b l e 5 .2: Multidimensional measures of health 
N a m e o f i n s t r u m e n t N u m b e r o f i t e m s N u m b e r o f d i m e n s i o n s 
Medical Outcomes Short Form 3 6 (SF-36) 3 6 9 
Nottingham Health Profile (Part 1) 3 8 6 
Sickness Impact Profile and Functional 
Limitation Profile (UK version) 136 12 
McMaster Health Index Questionnaire 68 3 
Source: Adapted from UK Clearing House 1993 
By combining clinical information and information such as that gathered in 
multidimensional questionnaires such as the SF-36, it is possible to develop a broad 
understanding of the impact of illness. This is the basis of assessing the health of an 
individual or population. 
A number of attempts have been made to produce single measures of perceived health. 
The simplest asks global questions such as 'In general, would you say your health is — 
excellent, very good, good, fair, poor?' as contained within the SF-36. Such questions 
may provide basic indicators of health service outcomes and predictors of subsequent 
mortality. 
More complex instruments seek to measure 'health-related quality of life' by weighting 
the results obtained from multidimensional questionnaires to obtain a single numerical 
value. They define a set of illness states that are used to classify patients, then others 
(e.g. health professionals, patients) assign values to these states (Table 5.3, page 226). 
Although such approaches make explicit their methods and the implications of these 
for decision making, and even for possible rationing of health services, they are the 
subject of much current debate. 
The Australian Health Outcomes Clearing House 
AIHW has a long-standing interest in measures of health and in outcomes measures 
that can demonstrate the effectiveness of interventions (for individuals, for an 
identified group, or for the population as a whole). As a result, the Australian Health 
Outcomes Clearing House (AHOCH) was established in January 1994. 
The objectives of the AHOCH are to provide a focus for activity at the AIHW and to 
work with others to: 
• develop and refine measures and descriptors of health which may be useful in the 
measurement or monitoring of health outcomes; 
• measure and monitor the health outcomes associated with health interventions; 
• examine methodological issues related to the acquisition of valid and reliable 
information on the outcomes of interventions; 
• establish a database of projects being undertaken which seek to measure and 
monitor health outcomes; 
225 
Table 5.3: Some utilities for health states 
. H e a l t h s t a t e U t i l i t y 
Healthy (reference state) 1.00 
Life with menopausal symptoms 0.99 
Side effects of hypertension treatment 0.95-0.99 
Mild angina 0.90 
Kidney transplant 0.84 
Moderate angina 0.70 
Some physical and role limitation with occasional pain 0.67 
Hospital dialysis (dialysis patients) 0.57-0.59 
Hospital dialysis (general public) 0.56 
Severe angina 0.50 
Anxious / .depressed and lonely much of the time 0.45 
Being blind or deaf or dumb 0.39 
Hospital confinement 0.33 
Mechanical aids to walk and learning disabled 0.31 
Dead (reference state) 0.00 
Quadriplegic, blind and depressed <0.00 
Confined to bed with severe pain <0.OO 
Unconscious <0.00 
Source: Torrance 1987 
• promote the exchange of information and views about the measurement and 
monitoring of health outcomes and related research; 
• make data available to collaborative investigators to facilitate research in health 
outcomes where practical. 
Developments in health outcomes and related work are occurring through national and 
State and Territory initiatives, and within many academic instituhons. Health outcomes 
are included in the new Medicare Agreements. A.major consultancy on Mental Health 
Consumer Outcomes is about to begin and the AIHW will be contributing to this work. 
The quarterly Health outcomes bulletin features such developments and activities. The 
first issue (February 1994) described the New South Wales health outcomes programs, 
research at the National Centre for Epidemiology and Population Health, and work oh 
clinical care guidelines by the NHMRC Standing Committee on Quality of Health Care. 
5.7 Deficiencies in statistics on health of 
Australians 
Statistics have many purposes. But they cannot serve these purposes if they are not 
available at all, and can do so less convincingly if they are incomplete or if there are 
problems with their quality or validity. If the purpose requires comparison, their 
usefulness is reduced if they are not directly comparable with other statistics with 
which they need to be compared. 
In the course of preparation of this edition of Australia's health, deficiencies of all these 
kinds were noted. For the subjects discussed there was only one area where it could be 
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said there was no current information: data on the dietary intake of iron and its supply 
in food are now very old, and not up to date. 
There were, however, a number of subjects which could not be included in Australia's 
health at all, for lack of data. Foremost among these is mental health. There are only 
National Health Survey data on self-reported prevalence of mental ill-health, and a 
general survey cannot be expected to yield information on specific illnesses. There are 
no data on incidence of mental disorders, or on the welfare of mentally ill people in the 
community. Data on use of mental health services are sparse. 
Generally, we lack incidence data for most diseases, except for cancer and for notifiable 
communicable diseases {although these are often incomplete). Survival data are 
available only for cancer. The impact of disease in terms of impairment, disability and 
handicap is very poorly documented. Two other subjects where data are lacking are 
disorders managed in ambulatory patients and environmental exposures relevant to 
health. 
Statistics on some subject areas are incomplete because the collections are made in some 
States only. For example, only South Australia and the Northern Territory collect 
population-based data on induced abortions. In South Australia in 1989, there were 
4,342 abortions and 19,610 live births; thus 18% of pregnancies resulted in abortions. 
Almost 50% of teenage pregnancies were terminated (Chan & Taylor 1991). The deficit 
in abortion statistics is significant. Data on induced abortions are required for all States 
and Territories to enable mapping of national information on fertility and an evaluation 
of family planning services. 
Another reason for statistics being of limited usefulness because they are incomplete is 
that the collection is voluntary. Home births have not always been notified to the State 
and Territory perinatal collections, so Homebirth Australia, a consumer organisation, 
and the National Perinatal Statistics Unit collected data from homebirth practitioners 
and published two reports on home births in Australia for the periods 1985-1987 and 
1988-1990. Since then, notification of home births to the perinatal collections has 
improved. 
Deficiencies of coverage can be severe. The major problem of identifying Aboriginals 
and Torres Strait Islanders was mentioned in Section 5.4. Where there is provision for 
recording race, the data can be of poor quality. Another problem of coverage, 
mentioned in Section 2.1, page 78, is that notification of notifiable communicable 
disease is, strictly, compulsory, but the requirement is not enforceable in practice. The 
highest notification rates for sexually transmitted diseases are 100 times the lowest; 
much of this apparent variation relates to completeness of notification. There is great 
scope for improvement in these statistics. 
An example of problems of non-comparability of statistics is described in detail in 
Section 1.5, page 65. Data on one indicator of obesity are available, but a possibly better 
indicator has been devised. Whenever a better indicator is devised, or a classification is 
updated, measures should be taken to ensure that the opportunity for comparison of 
old and current data is not lost. As noted in Section 1.5, page 65, standard instruments, 
definitions, and classifications should be used whenever possible. 
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Extensions needed in existing collections 
Some existing collections need to be extended to include additional items. Birthing 
centres are a comparatively new development, and births in them have not been readily 
identified in perinatal collections. On the recommendation of the National Perinatal 
Data Advisory Committee, such births are now being increasingly indicated in these 
collections. 
Section 1.3.4, page 36, considered the health of rural Australians, but the only 
comparisons that could be presented were of metropolitan and non-metropolitan areas. 
The areas designated as metropolitan range from Sydney to Hobart. Australia has many 
medium-sized and small country towns. It also has rural areas that are close to major 
centres, at intermediate distances, and remote. Statistics are needed on the health of 
residents of each of them; some information could be obtained by more informative 
classification of addresses in many existing collections. 
One strategy which is being used to remedy the lack of information on health of 
comparatively small populations is taking larger samples of these populations in 
national surveys. Section 5.4 described how this was planned to be done for Aboriginals 
in the 1994-95 National Health Survey. 
The size of many of Australia's populations of particular interest means that this 
strategy should be considered on many occasions. In Section 1.3.2, page 25, it was noted 
that migrants born in Europe had the highest prevalences of disability and handicap 
and those born in Asia and the Middle East had the lowest. Migrants from Italy and 
Greece had particularly high prevalences of self-reported severe handicap. Explanation 
of this finding would be helped by either a special survey or by taking a larger sample 
of migrants in a national survey. 
Monitoring health 
The Institute has a responsibility to monitor and report on all important aspects of the 
health of Australians, including areas of public health significance outside the initial 
four priority areas for National Health Goals and Targets (cardiovascular disease, 
cancers, injury and mental health) and areas for which goals will not be set because 
there are no identified effective intervention strategies. For this reason, AIHW is 
developing a concise but comprehensive set of indicators, to be published regularly, 
which will monitor national health trends over time. It is intended to enhance this set 
by the collection of additional data in population surveys and later to extend the 
monitoring to State and regional level and perhaps to population subgroups such as 
Aboriginals and Torres Strait Islanders. 
The monitoring role should not be limited to accepted national goals and targets. As 
noted in Section 1.2.1, the high death rates for the Northern Territory mainly reflect the 
much higher mortality of Aboriginal people, who constitute 31% of the population 
there. Reasons death rates for Tasmania should exceed those in the Australian Capital 
Territory by 25% (males) and 26% (females), and other variations in death rates among 
States and Territories, have not been studied in detail, but clearly they should be. 
It is also desirable to evaluate public health action. An example is monitoring the 
incidence of anencephalus and spina bifida, serious malformations of the brain and 
spine that result in death or major disability and handicap. A study in the United 
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Kingdom has shown that supplements of a vitamin, folic acid, are effective in 
preventing these neural tube defects in subsequent children of women who have 
already had an affected child (Medical Research Council Vitamin Study Research 
Group 1991). Other studies indicate that supplements of folic acid are also likely to 
prevent many first occurrences of neural tube defects. 
The National Health and Medical Research Council has made a series of 
recommendations on periconceptional folic acid supplementation for women likely to 
become pregnant and for those with a close family history of neural tube defects 
(National Health and Medical Research Council 1993). Monitoring the effectiveness of 
these recommendations in reducing the occurrence of neural tube defects requires 
notification of any malformations in births and in pregnancies terminated after prenatal 
diagnosis of neural tube defects. 
Another example, described in Section 2.6, page 100, is the demonstration of the 
effectiveness of legislation requiring helmet wearing by cyclists in the prevention of 
head injury. 
Much of the information in Section 2.6, which presents only a sample of the data 
available from the NISU Road Injury Information Program, has not been available 
before and will enable better targeting of safety problems. The Program is developing 
national data on the incidence and severity of road injury to improve monitoring and 
prevention of road injury (O'Connor 1992). For example, information on head injury in 
road crashes in Australia will enable development of goals for a targeted level of 
reduction in head injury. Information on the apparent severity of pedestrian injury and 
lower limb injuries may lead to a shift in priorities in treatment of crash victims. 
There is also the need for an improved level of analysis of road safety problems and 
countermeasures in Australia to enable better priority setting. This analysis must 
include comparative assessment of countermeasure options, based on information on 
community interests and concerns, as well as data on the manageability of the problem 
and on cost-benefit ratios. 
5.8 Deficiencies in statistics on health care 
funding, resources and use 
Health expenditure 
Statistics of health expenditure by State governments are available from a variety of 
central agency sources, including the ABS public finance database, State health 
authority annual reports, State Budget papers and the Commonwealth Grants 
Commission (CGC). 
These bodies have adopted different practices for defining and measuring State health 
expenditure, resulting in discrepancies between sources and a lack of detailed 
information at the State level. For example, the CGC database, one of the better 
databases on State health expenditure, includes Commonwealth grants to States, 
reports recurrent expenditure only and excludes capital expenditure and capital 
consumption (depreciation). Data presented by the Commission includes standard, 
standardised and actual expenditure (see Box 3.2). 
229 
The Work Program for the National Health Information Agreement has a project to 
develop a standard set of definitions on agreed expenditure areas and to produce a 
uniform health expenditure data set. 
Costs of health services 
With the exception of medical services billed to the Health Insurance Commission, 
information about care provided outside institutions is poor: little is known about the 
types of people who use the services, who they attended and why, what services are 
provided, and what the services cost. 
There is also very limited information about the costs of providing all complex health 
services (such as the cost of a hip replacement) or about the efficiency with which 
services are delivered. There is even less information about the costs of 'episodes of 
care', where care is provided by a number of clinicians in different locations (such as 
treatment that requires care in the community, then hospitalisation, then rehabilitation 
in the community). 
Health labourforce 
There, are limitations on each of the present national health labourforce data collections. 
ABS national census statistics are based on the highest qualification obtained and thus 
generally do not count as health professionals those whose activity is mainly in a 
non-clinical area such as research, education or administration, because their highest 
qualifications are in other fields. ABS quarterly estimates of numbers of people 
employed in health professions overcome this problem but suffer from significant 
sampling error. 
For doctors, Medicare provider statistics from the Health Insurance Commission 
provide very important and useful profiles of active practitioners. However, they do not 
achieve full coverage of the medical labourforce because salaried practitioners and 
those 'working in fields where , services are not covered by Medicare, such as 
occupational medicine, are not included. 
Another source of data on health professions is by surveys at the time of annual 
registration. Response rates in such surveys for medicine, nursing, dentistry, pharmacy, 
podiatry and physiotherapy vary from 70% to 96%. The extent to which this 
non-response is related to registration of the one individual in several States, or to other 
factors, is unknown. 
To overcome this problem, the Australian Medical Council and the Australian Nursing 
Council are introducing mutual recognition by 1996. This will greatly improve the 
quality of national statistics in medicine and nursing. The improvements include 
elimination of duplication in registration statistics, synchronisation of State and 
Territory collection periods, and improved recording of information to meet national 
standards. Statistics relating to other health professions would be improved by 
introduction of similar arrangements. 
Public hospital workforce planning suffers from a lack of statistics in sufficient detail to 
address distribution, training, and other workforce issues. Periodic surveys to collect 
sufficiently detailed statistics from public hospitals achieve at best a 70% response. 
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Hospital morbidity 
Information on sickness and disease is available through the hospital morbidity 
collections maintained by all State and Territory health authorities and the Department 
of Veterans' Affairs. These collections, based on inpatient episodes, include 
sociodemographic, diagnostic, and duration of stay data, and information on 
procedures performed. 
The Institute is encouraging greater uniformity of existing collections through the 
definitional work of the National Health Data Committee. The Institute is currently 
developing the National Hospital Morbidity data base, which will be based on the 
National Minimum Data Set for institutional health care. Standardised coding is not yet 
fully implemented. 
Morbidity data are coded from the hospital records of individual patients. These data 
are primarily patient management instruments incorporating data from the patient's 
admission form, and data recorded during the stay and on separation (see Table 5.4). 
Such records have deficiencies for statistical purposes. Among these are the focus on the 
hospital stay and the lack of a unique national patient identifier. As a patient may enter 
hospital several times for the same condition, this means that statistics relate only to 
admissions and not to patients. 
Table 5.4: Australian Institute of Health and Welfare Hospital Morbidity data collection, latest 
holdings 
State Year Coverage Completeness 
New South Wales 1991-92 Public and private Full NMDS data 
Victoria 1991-92 Public Full NMDS data 
Queensland 1990 Public and private Partial NMDS data 
Western Australia 1991-92 Public Partial NMDS data 
South Australia 1991-92 Public and private Full NMDS data 
Tasmania 1991-92 Public and private Partial NMDS data 
Australian Capital Territory 1991-92 Public Full NMDS data 
Northern Territory 1990-91 Public Full NMDS data 
Department of Veterans' Affairs 1991-92 Public Full NMDS data 
The hospital record is a complex document which requires trained coders to abstract 
and code relevant information. Such people are in relatively short supply. The recently 
established National Coding Centre will be instrumental in developing standards for 
coding and for training coders. 
Waiting lists 
A number of States and Territories have collected and published significant amounts of 
waiting list information, but there has been no consistency in the definitions used or the 
manner in which the information has been presented. Consequently, AIHW has been 
asked to develop a national set of definitions for waiting lists and to routinely publish 
national data based upon these definitions. Improvement of waiting list data has also 
been identified as a key activity under the National Health Information Agreement. 
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AIHW began to develop national definitions in early 1993 in consultation with State 
and Territory health authorities and in conjunction with the waiting list management 
reforms being undertaken through the Hospital Access Program of the Department of 
Human Services and Health. Recommended definitions were proposed to the National 
Health Data Committee in March 1994. 
In March 1994 AIHW published a report summarising the data available in late 1993. 
This report highlighted differences in scope and quality of the data available at that 
time. It emphasised a need to change the focus of waiting list statistics from the 
numbers of people waiting for elective surgery at any time to the numbers of patients 
failing to receive care in a clinically or socially acceptable time. 
Quality of health care 
Information about the quality of care provided, whether in institutions or out, is totally 
lacking. Though the majority of hospitals are accredited with the Australian Council on 
Healthcare Standards, accreditation is only now starting to move away from being 
based on the physical structure of hospitals and the processes of care. It is starting to 
look at the quality of care provided, and at process 'outcomes' rather than the processes 
themselves. Accreditation for other health services is less developed. 
There is almost no information about the health outcomes that result from the $3,500 
million spent on health services. 
Health technology 
There is a lack of data on the level of use of various technologies on outpatients of 
public hospitals. Data remain sparse on the use of magnetic resonance imaging and 
other technologies which do not attract reimbursement through Medicare benefits. 
Good data on renal transplantation are provided by the annual ANZDATA report (see 
Table 4.26, page 187). The more limited data in Table 4.25 (pagel86) are obtained from 
ACCORD. Numbers for the different forms of transplant are as supplied by the 
transplant registries and coordinators to ACCORD. There may be small discrepancies 
with data collected and published elsewhere, for example in reports from AHTAC. 
Consistent national level data on one-year graft survival are available for kidney 
transplantation but not for most other forms of transplantation. 
5.9 Towards an optimised health information and 
statistics system 
The National Health Information Agreement is a major contribution to the 
development of national health information. Support for the Agreement has increased 
as health authorities have become aware of the possibilities that it offers for effective 
concerted action. Non-government bodies who are not signatories to the Agreement are 
also showing great interest in it, and many of them are seeking to have their work 
recognised in the National Health Data Dictionary. The vital role of these bodies is 
recognised, and the National Health Information Management Group will be reviewing 
ways of maximising involvement of non-signatories in the processes of the Agreement. 
As part of its continuing responsibility for identifying national health statistics 
priorities, the Institute will, during 1994, develop a National Health Information 
232 
Framework to provide a logical structure for the description and classification of health 
information. The framework will assist in identifying priority areas for work. Then, 
towards the end of 1994, the Institute will conduct a National Health Information 
Forum. Following the Forum the Institute will consult with other stakeholders, then 
publish a National Health Information Plan. In turn, this will influence the 
developmental work of the Institute and of other signatories to the National Health 
Information Agreement. 
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Statistical tables 
Fertility and pregnancy 
Table Si: Estimated resident population by sex and age group, selected years, 1901 to 1991 
(number) 
A g e g r o u p 1 9 0 1 1 9 2 1 1941 1 9 6 1 1 9 8 1 1 9 8 6 1 9 9 1 
M a l e s 
Less than 1 47,247 68,140 64,746 116,736 117,842 122,376 132,946 
1-4 172,957 237,382 235,996 451,006 465,376 496,644 519,356 
5-14 450,067 569,576 572,940 1,058,453 1,321,340 1,277,080 1,290,729 
15-24 366,146 455,681 631,286 776,319 1,320,618 1,368,973 1,405,897 
25-34 320,455 453,279 594,709 728,618 1,244,663 1,317,452 1,416,512 
35-^4 279,558 367,484 493,543 739,220 931,360 1,161,863 1,319,366 
45-54 156,674 280.969 434,359 628,894 772,879 810,180 960,260 
55-64 99,170 207,023 305,575 428,856 661,984 736,433 734,081 
65-74 64,716 89,483 172,064 266,069 426,174 475,396 548,636 
75-84 18,731 29,188 68,762 102,292 158,247 199,083 243,406 
85 and over 2,207 4,665 7,739 15,789 27,784 34,707 44,220 
Al l a g e s 1 , 9 7 7 , 9 2 8 2 , 7 6 2 , 8 7 0 3 , 5 8 1 , 7 1 9 5 , 3 1 2 , 2 5 2 7 , 4 4 8 , 2 6 7 8 , 0 0 0 , 1 8 7 8 , 6 1 5 , 4 0 9 
F e m a l e s 
Less than 1 46,077 65,312 62,008 111,755 112,880 116,208 126,139 
1-4 168,836 229,372 226,841 429,996 443,520 473,257 493,262 
5-14 441,003 555,222 551,617 1,009,052 1,264,582 1,213,953 1,223,098 
15-24 365,792 462,563 613,096 730,052 1,278,293 1,314,958 1,354,941 
25-34 293,424 458,492 573,606 665,421 1,212,261 1,300,222 1,408,886 
35-44 216,135 351,166 473,819 707,223 891,517 1,119,161 1,303,292 
45-54 118,574 255.574 439,892 596,964 737,394 768,943 915,819 
55-64 80,302 178,233 305,835 435,378 691,752 738,536 728,737 
65-74 48,935 80,705 184,734 332,702 511,502 567,952 633,509 
75-84 14,757 30,777 78,425 148,351 256,487 310,384 370,917 
85 and over 2,038 5,448 10,714 29,040 74,805 94,589 110,027 
All a g e s 1 , 7 9 5 , 8 7 3 2 , 6 7 2 , 8 6 4 3 , 5 2 0 , 5 8 7 5 , 1 9 5 , 9 3 4 7 , 4 7 4 , 9 9 3 8 , 0 1 8 , 1 6 3 8 , 6 6 8 , 6 2 7 
Sources: Commonwealth Statistician 1925; Commonwealth Bureau of Census and Statistics 1943,1970a; 
ABS Cat. No. 3201.0 
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T a b l e S 2 : Age-specific birth rates™ and total fertility rates,ih) 1921 to 1992 (live births per 1,000 
females) 
A g e g r o u p o f m o t h e r ( y e a r s ) 
T o t a l 
f e r t i l i t y 
r a t e 
L e s s 
t h a n 2 0 2 0 - 2 4 2 5 - 2 9 3 0 - 3 4 3 5 - 3 9 4 0 - 4 4 
4 5 a n d 
o v e r 
A n n u a l a v e r a g e s 
1921-1925 27.3 133.7 167.0 137.0 96.9 40.4 4.2 3,032 
1941-1945 23.9 126.9 152.8 114.3 66.3 21.1 1.7 2,535 
1961-1965 46.5 204.0 207.2 122.4 59.2 17.5 1.2 3,289 
1981-1985 25.7 100.8 144.5 82.0 25.4 4.4 0.3 1,915 
A n n u a l r a t e s 
1988 20.3 81.5 '. 136.9 93.3 30.5 4.6 0.2 1,837 
1989 . 20.6 78.4 135.4 96.1 32.6 5.0 0.2 1,842 
1990 22.1 79.4 ' 137.9 101.7 34.7 5.5 0.2 1,907 
1991 22.1 75.0 132.0 100.2 36.0 5.5 0.2 1,855 
1992 21.9 74.9 132.6 104.6 38.4 6.1 0.3 1,895 
(a) Age-specific birth rates are the live births registered during the calendar year, according to age of mother, 
per 1,000 of the female resident population of the same age as estimated for 30 June. 
(b) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It 
represents the number of children 1,000 women would bear during their lifetimes if they experienced the 
rates of the year shown. 
Source: ABS 1977, Cat. No. 3301.0 
T a b l e S 3 : Age-specific birth rates™ and total fertility rates. States and Territories, 1992 (live 
births per 1,000 females) 
A g e g r o u p o f m o t h e r ( y e a r s ) 
L e s s 4 5 a n d f e r t i l i t y 
S t a t e / T e r r i t o r y t h a n 2 0 2 0 - 2 4 2 5 - 2 9 3 0 - 3 4 3 5 - 3 9 4 0 - 4 4 o v e r r a t e 
New South Wales 22.8 79.6 136.4 107.8 41.5 6.7 0.3 1,975 
Victoria 14.7 61.8 130.3 109.6 41.2 6.5 0.4 1,822 
Queensland 26.5 84.9 134.2 100.1 34.6 5.3 0.3 1,930 
Western Australia 25.0 77.3 132.7 100.8 33.7 5.8 0.3 1,878 
South Australia 18.7 66.7 120.3 94.9 34.2 5.4 0.4 1,703 
Tasmania 29.0 92.3 141.4 92.8 30.1 4 . 4 0.3 1,951 
ACT 14.0 . 54.3 127.3 107.2 36.3 5.8 0.3 1,725 
Northern Territory 90.5 122.7 121.5 95.2 41.5 7.5 
-
2,394 
A u s t r a l i a 2 1 . 9 7 4 . 9 1 3 2 . 6 1 0 4 . 6 3 8 . 4 6 . 1 0 . 3 1 , 8 9 5 
(a) Age-specific birth rates are the live births registered during the calendar year, according to age of mother, 
per 1,000 of the female resident population of the same age as estimated for 30 June. 
(b) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It 
represents the number of children 1,000 women would bear during their lifetimes if they experienced the 
rates of the year shown. 
Source: ABS 1993a, 1993c 
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T a b l e S4: Crude birth rates™ and total fertility rates,' selected countries, latest available year 
C r u d e b i r t h r a t e T o t a l f e r t i l i t y r a t e 
C o u n t r y Y e a r R a t e Y e a r R a t e 
A u s t r a l i a 1 9 9 0 - 9 5 1 5 . 1 1 9 9 2 1 , 8 9 5 
Canada 1990-95 14.2 1989 1,768 
Chile 1990-95 22.5 1990 2,660 
France 1990-95 73.7 1990 1,780 
Germany 1990-95 11.4 na na 
Greece 1990-95 10.4 1984 1,821 
Hong Kong 1990-95 12.7 1989 1,229 
Iceland 1990-95 17.4 1990 2,310 
India 1990-95 29.2 1988 4,000 
Indonesia 1990-95 26.6 1989 3,380 
Ireland 1990-95 14.4 1990 2,194 
Israel 1990-95 21.1 1990 3,016 
Italy 1990-95 10.0 1990 1,310 
Japan 1990-95 11.2 1989 1,572 
Lebanon 1990-95 27.1 1985-90 3,790 
Malaysia 1990-95 28.6 1985-90 4,000 
Malta 1990-95 15.2 1989 2,109 
Netherlands 1990-95 13.7 1990 1,617 
New Zealand 1990-95 17.4 1990 2,155 
Norway 1990-95 14.8 1990 1,932 
Philippines 1990-95 30.3 1985-90 4,330 
Poland 1990-95 14.3 1990 2,039 
Russian Federation 1990-95 16.0 1989 2,016 
Singapore 1990-95 15.9 1988 1,975 
South Africa 1990-95 31.3 1985-90 4,480 
Spain 1990-95 10.8 1988 1,427 
Sweden 1990-95 14.0 1990 2,137 
Switzerland 1990-95 12.7 1990 1,590 
United Kingdom 1990-95 13.9 1990 1,840 
USA 1990-95 15.9 1989 2,019 
Vietnam 1990-95 29.2 1985-90 4,100 
Yugoslavia 1990-95 14.1 1989 1,881 
na Not available. 
(a) Live births per 1,000 mid-year population. 
(b) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It 
represents the number ol children 1,000 women would bear during their lifetimes if they experienced the 
rates of the year shown. 
Sources: United Nations 1992; World Health Organization 1993 
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T a b l e S 5 : Birthweight distribution of total births,™ States and Territories, 1991 
B i r t h s / B i r t h w e i g h t N S W V i c W A S A T a s A C T N T A u s t r a l i a 
( N u m b e r ) 
B i r t h s 
Less t h a n 2,500 g 5,191 3,844 2,948 1,551 1,253 438 220 349 15,794 
Al l b i r t h s 8 6 , 7 3 8 6 5 , 0 0 7 4 4 , 7 0 1 2 4 , 9 3 5 1 9 , 7 1 5 f > ,951 4 , 5 2 0 3 , 4 8 3 2 5 6 , 0 5 0 
( P e r c e n t ) 
B i r t h w e i g h t ( g ) 
500 to 999 * 0.5 0 .5 0.6 ' 0.4 0 .5 0 .5 0.4 1.1 0 .5 
1,000 to 1,499 0.6 0.6 0.7 0.7 0.7 0.6 0.6 0.8 0.'6 
1,500 to 1,999 1.2 1.2 1.3 1.2 1.4 1.4 0.8 2.0 1.2 
2,000 to 2,499 3.7 3.7 
.
 4 0 3.9 3.7 3.8 3.0 6.2 3.8 
5 0 0 t o 2 , 4 9 9 6 . 0 5 . 9 6 . 6 6 . 2 6 . 4 6 . 3 4 . 9 1 0 . 0 6 . 2 
2,500 to 2,999 15.8 • 15.4 15.4 15.9 15.7 16.1 15.6 21.6 15.7 
3,000 to 3,499 36.9 37.0 36.4 36.8 36.8 35.3 39.5 37.6 36.9 
3,500 to 3,999 30.1 30.4 30.4 30.6 30.1 30.5 29.3 23.2 30.2 
4,000 to 4,499 9 .5 9.6 9.4 9.0 9.3 10.3 9.3 6.6 9.4 
4,500 and over 1.6 1.6 1.7 1.5 1.7 1.5 1.4 1.0 1.6 
(a) Includes live births and foetal deaths (stillbirths) with known birthweight of at least 500 g. 
(b) Provisional data. Totals include births with unstated birthweights. 
Source: AIHW National Perinatal Statistics Unit, derived from data provided by State and Territory health 
authorities 
T a b l e S 6 : Infant mortality rates, States and Territories, selected years, 1901 to 1992 (per 1,000 
live births) 
Y e a r N S W V i c Q l d W A S A T a s A C T N T A u s t r a l i a 
1901 '103.7 102.9 101.9 128.9 100.0 89.0 (a) 62.5 103.6 
1921 * r 62.6 72.6 54.2 78.3 65.5 78.0 74.0 63.3 65.7 
1941 43,8 36.2 39.1 35.3 32.5 49.0 16.4 83.3 39.7 
1961 20.8 17.8 20.0 19.7 20.0 16.8 15.6 23.9 19.5 
1981 10.3 9.3 10.4 8.9 8.0 12.3 8.9 23.5 10.0 
1988 9.2 7.8 8.4 8.5 7.9 9.6 8.1 <b>19.2 8.7 
1989 8.7 6.5 8.5 7.8 7.4 10.6 6.5 14.5 8.0 
1990 8.1 7.8 7.7 8.6 8.5 8.9 9.4 15.2 8.2 
1991 7.2 6.5 7.6 7.2 5.5 9.0 7.6 14.2 7.1 
1992 7.4 5.6 7.9 7.0 6.1 6.6 6.3 15.5 7.0 
(a) Partof New South Walespriorto 191J. 
(b) Northern Territory rate for 1988 was affected by changed registration requirements. 
Sources: Commonwealth Bureau of Census and Statistics 1963; ABS Cat. No. 3302.0. 
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Table S7: Perinatal mortality rates,™ States and Territories, 1981 to 1992ib) (per 1,000 live births 
plus foetal deaths) 
Year NSW Vic Qld WA SA Tas ACT NT Australia 
1981 13.8 13.3 13.0 12.4 10.6 13.2 10.1 27.9 13.2 
1982 13.5 14.5 12.5 11.6 12.8 11.0 11.1 27.1 13.4 
1983 12.1 12.5 12.1 10.8 11.3 12.9 11.5 21.1 12.2 
1984 12.4 11.7 11.4 12.0 10.3 12.5 9.2 19.5 11.9 
1985 11.2 12.2 12 0 10.8 12.4 13.8 10.9 17.4 11.8 
1986 11.5 11.7 10.9 11.0 10.1 15.7 10.7 19.7 11.5 
1987 10.8 10.2 11.0 10.6 8.8 9.4 10.9 19.0 10.6 
1988 11.1 10.1 10.6 9.0 10.0 13.0 11.0 19.9 10.7 
1989 10.3 9.3 9.7 8.8 10.1 11.0 9.6 21.1 9.9 
1990 10.5 10.5 9.3 9.3 10.2 10.0 12.0 17.0 10.3 
1991 10.0 8.8 10.3 8.8 8.0 11.9 10.5 16.8 9.6 
1992 10.6 8.2 9.3 8.7 8.1 9.1 9.0 17.0 9.4 
(a) Perinatal deaths consist of foetal deaths (stillbirths) and neonatal deaths (within 28 days of birth). The 
perinatal mortality rate is defined as the number of deaths per 1,000 live births and foetal deaths 
combined. 
(b) Comparable perinatal mortality data not available before 1973. 
Source: ABS Cat. No. 3304.0 
Table S8: Perinatal mortality rates,™ by age group of mother, 1981 to 1992(b) (per 1,000 live 
births plus foetal deaths) 
Age group of mother (years) 
Year Under 20 20-24 25-29 30-34 35-39 40 and over Total 
1981 18.1 12.5 11.7 12.7 17.9 27.8 13.2 
1982 18.4 12.8 11.4 12.8 17.8 22.6 13.4 
1983 15.4 11.8 10.9 11.6 13.7 25.5 12.2 
1984 15.1 11.7 10.1 11.4 15.8 28.1 11.9 
1985 14.6 11.8 10.2 11.5 14.4 11.8 11.8 
1986 14.3 11.3 9.9 10.5 14.8 23.9 11,5 
1987 14.0 10.4 9.1 10.4 12.1 17.6 10.6 
1988 14.5 11.0 9.2 9.6 12.9 17.8 10.7 
1989 13.2 10.2 8.5 9.6 11.0 16.6 9.9 
1990 14.0 10.4 9.2 9.7 11.6 17.0 10.3 
1991 14.0 10.0 8.1 9.3 9.8 18.9 9.6 
1992 12.9 9.7 8.2 8.7 10.0 15.4 9.4 
(a) Perinatal deaths consist of foetal deaths (stillbirths) and neonatal deaths (within 28 days of birth). The 
perinatal mortality rate is defined as the number of deaths per 1,000 live births and foetal deaths 
combined. 
(b) Comparable perinatal mortality data not available before 1973. 
Source: ABS Cat. No. 3304.0 
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Table S9: Neonatal, postneonatal and infant mortality rates,™ by sex, selected countries, latest 
year (per 1,000 live births) 
C o u n t r y 
M a l e s F e m a l e s 
N e o n a t a l 
P o s t ­
n e o n a t a l I n f a n t N e o n a t a l 
P o s t ­
n e o n a t a l I n f a n t 
A u s t r a l i a ( 1 9 9 2 ) 5.1 2 . 8 7 . 9 3 . 9 2 .1 6 . 0 
Canada (1990) 5.1 2.5 7.5 4.1 2.0 6.1 
Chile (1989) . 10.0 8.7 18.7 8.2 7.2 15.4 
France (1990) 4.0 4.4 8.4 3.1 3.1 6.2 
Germany (1990) 4.3 3.7 8.0 3.2 2.9 6.1 
Greece (1990) 7.0 2.9 9.9 6.0 3.5 9.6 
Hong Kong (1987) 5.0 3.0 7.9 4.7 2.4 7.0 
Iceland (1991) 5.5 3.0 5.5 3.2 2.3 5.5 
Ireland (1990) 5.3 3.8 9.0 4.3 2.9 7.3 
Israel (1989) 6.8 3.7 10.5 6.3 3.3 9.6 
Italy (1989) 7.2 2.0 9.3 6.1 1.8 7.9 
Japan (1991) 2.5 2.1 4.6 2.3 1.9 4.2 
Malta (1991) 10.4 2.2 12.6 3.5 3.1 6.5 
Netherlands (1990) 5.4 2.6 8.0 4.2 1.9 6.1 
New Zealand (1989) 4.8 7.2 11.9 4.3 4.3 8.7 
Norway (1990) 5.1 3.2 8.2 2.7 3.0 5.7 
Poland (1991) 12.2 4.6 16.8 9.2 3.8 13.0 
Russian Federation (1990) na na 24.8 na na 19.0 
Singapore (1990) 5.1 2.0 7.1 4.1 2.0 6.2 
Spain (1989) 5.6 3.0 8.6 4.6 2.3 7.0 
Sweden (1989) 4.3 2.3 6.6 3.0 2.0 4.9 
Switzerland (1991) 4.2 2.9 7.1 3.0 2.3 5.3 
United Kingdom (1991) 4.9 3.4 8.3 3.8 2.5 6.3 
USA (1989) 6.8 4.0 10.8 5.6 3.1 8.8 
Yugoslavia (1990) 12.6 8.0 20.5 10.1 7.9 17.9 
na Not available. 
(a) Neonatal: Less than 28 days. 
Postneonatal: 28 to 364 days. 
Infant: Less than 1 year. 
Sources: World Health Organization 1993; United Nations 1992; ABS 1993b 
240 
Table SlO: Maternal deaths and death rates,™ by triennium, 1964-66 to 1988-90 
M a t e r n a l d e a t h r a t e s 
T r i e n n i u m 
T o t a l 
c o n f i n e m e n t s 
D i r e c t 
d e a t h s ' " * 2 4 1 2 4 1 
T o t a l 
d e a t h s * 0 ' D i r e c t T o t a l 
(Per100,000 
(Number) (Number) (Number) (Number) (Number) confinements) 
1964-1966 667,649 202 -
-
275 30.3 41.2 
1967-1969 713,064 166 
- -
237 23.3 33.2 
1970-1972 790,818 150 - - 244 19.0 30.8 
1973-1975 726,690 ^60 32 45 137 8.3 18.9 
1976-1978 678,098 52 35 19 106 7.7 15.6 
1979-1981 682,880 54 34 9 <9>98 7.9 14.4 
1982-1984 713,985 42 25 27 94 5.9 13.2 
1985-1987 726,642 32 30 24 86 4.4 11.8 
1988-1990 754,468 37 33 26 96 4.9 12.7 
(a) Maternal mortality as defined by the World Health Organization is the death of a woman during 
pregnancy, childbirth or in the 42 days of the puerperium, irrespective of the duration and the site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its management. This 
definition includes deaths from abortion and ectopic pregnancy, but excludes deaths from incidental 
causes. In this table, incidental deaths are included as are deaths occurring more than 42 days after 
termination of the pregnancy, when they have their origin and illness related to the pregnancy. 
(b) Direct maternal deaths are those resulting from obstetric complications of the pregnant state 
(pregnancy, labour and the puerperium), from interventions omissions, incorrect treatment, or from a 
chain of events resulting from any of the above—they are complications of the pregnancy itself, e.g. 
eclampsia, rupture of the uterus, postpartum hemorrhage. 
(c) Indirect obstetric deaths are those resulting from pre-existing disease or disease that developed during 
pregnancy and was not due to direct obstetric causes, but which may have been aggravated by the 
physiological effects of pregnancy, e.g. heart disease, diabetes, renal disease. 
(d) Incidental deaths are due to causes such as road accidents, malignancies and suicide where the 
pregnancy is unlikely to have contributed significantly to the death. 
(e) Prior to 1973-1975, no distinction was made between indirect and incidental deaths. 
(1) Only 60 of the 69 certified causes of death were judged by the State maternal mortality committees as 
being direct maternal deaths. 
Source: NHMRC 1970, 1972, 1976, 1979, 1981, 1987, 1988, 1991,1993 
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Table Sll: Maternal death rates,™ selected countries, 1981 to 1990 (per 1,000 live births) 
C o u n t r y 1 9 8 1 1 9 8 2 1 9 8 3 1 9 8 4 1 9 8 5 1 9 8 6 1 9 8 7 1 9 8 8 1 9 8 9 1 9 9 0 
A u s t r a l ia< b > * 1 0 . 6 * 1 0 . 4 * 6 . 2 * 7 . 7 * 4 . 4 " 5 . 8 * 5 . 3 * 4 . 9 n a n a 
Canada * '6.2 '1.9 '5 . 4 "3.2 "4.0 * *3.0 • *4.1 •4.8 *4.'1 1 na 
Chile 43.8 51.8 40.3 34.7 50.0- 47.3 48.3 na na na 
France J r 15.5' 13.8; 15.1 14,2 12.0 . 10.9 9.6 9.3 8.5 na 
Germany 20.0 17.7 ; 11.4 10.8 • 10.7 8.0 8.7 8.9 5.3 7:3 
Greece -11.4 *11.7 *14.3 *8.7 •6:9 ""'8.0 •4.7 '5.6 *4.0 ; na 
Hong Kong *8.1 '1.2 '7.2 "6,5 "5.3 '2.8 "4.3 *4.0 •5.7 na 
Iceland • na na na , na na na '23.8 na na '21.0 
lreland ( b ) *4.2 *5.6 *11.9 •6.2 •6.4 *4.9 •3.4 '1.8 "3.8 na 
Israel na *3.1 *2.0 •5.1 '8.0 *6.0 *3.0 '5.0 . "6.9 na 
Italy 13.2 9.6 9.2 9.2 8.1 5.6 •4.5 7.7 na na 
Japan 19.2 18.4 15.5 15.3 15.8 • 13.5 12.0 9.6 10.8 8.6 
Malta *18.3 *32.9 . na na '35.8 na na na na na 
Netherlands •7.8 *6.4 *5.3 *9.7 '4.5 ;8.1 "7.5 '9.6 '5.3 na 
New Zealand ( b J '5.9 '12.0 *19.8 *5.8 '13.5 •18.9 •12.7 '17.4 na na 
Norway *2.0 na *4.0 *2.0 *2.0 •13.8 •5.6 •3.5 *8.4 na 
Philippines'^ 105.5 na na na na na na na na na 
Poland 14.6 14.2 16.2 14.2 11.1 13.1 15.5 11.6 10.7 12.8 
Singapore'1*' M.7 "11.7 *14.8 •"12.0 '4.7 "13.0 *6.9 "7.6 '2.1 na 
Spain na 10.5 7.6 '5.2 *4.4 *5.5 '5.0 na na na 
Sweden •4.3 '4.3 na *2.1 *5.1 *2.9 '4.8 '8.9 '5.2 na 
Switzerland *6.8 *12.0 *5.4 *1.3 *5.4 •3.9 *6.5 '10.0 '3.7 "6.0 
United Kingdom: 
England & Wales 9.0 6.7 8.6 8.2 7.0 6.8 6.7 5.9 8.1 8.1 
Northern lreland'b) *3.7 *7.4 M4.7 '10.8 na na '3.6 '3.6 na na 
Scotland"" •18.8 "9.1 '12.3 "12.3 '13.5 *10.6 *3.0 *12.1 '6.3 "6.1 
US A 8.5 7.9 8.0 7.8 7.8 7.2 6.6 8.4 na na 
Yugoslavia 26.6 22.4 16.8 17.2 16.4 14.7 10.6 16.3 15.5 na 
na Not available 
Rate based on 30 or fewer maternal deaths, 
(a) Data in this table are not directly comparable with those in Table Si 0. The number of maternal deaths 
•>. reported in Table S10 have been adjusted after examination by State and Territory maternal mortality 
committees. 
(b) Data tabulated by date of registration rather than occurrence. 
Source: United Nations 1992 
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Mortality 
Table S12: Life expectancy at selected ages by sex, States and Territories, 1992 (years) 
A t b i r t h A t a g e 1 5 A t a g e 6 5 
S t a t e / T e r r i t o r y M a l e s F e m a l e s M a l e s F e m a l e s M a l e s F e m a l e s 
New South Wales 74.1 80.2 59.9 65.9 15.2 19.1 
Victoria 74.8 80.7 60.6 66.3 15.4 19.2 
Queensland 74.4 80.2 60.4 66.0 15.5 19.3 
Western Australia 75.2 80.9 61.1 66.6 15.8 19.7 
South Australia 75.1 80.9 60.8 66.6 15.7 19.7 
Tasmania 74.0 79.2 59.8 64.9 15.1 18.3 
Australian Capital Territory 76.6 81.3 62.4 67.0 16.3 19.5 
Northern Territory 68.3 72.5 54.6 59.1 13.4 14.8 
A u s t r a l i a 74.5 80.4 60.3 66.1 15 . 4 1 9 . 2 
Sources: ABS 1993b, and unpublished data 
Table S13: Life expectancy at selected ages by sex, 1901 to 1992 (years) 
A t b i r t h A t a g e 1 5 A t a g e 6 5 
Y e a r M a l e s F e m a l e s M a l e s F e m a l e s M a l e s F e m a l e s 
A n n u a l a v e r a g e s 
1901-1910 55.2 58.8 49.0 51.9 11.3 12.9 
1920-1922 59.2 63.3 51.4 54.6 12.0 13-6 
1946-1948 66.1 70.6 54.3 58.3 12.3 14.4 
1960-1962 67.9 74.2 55.1 61.0 12.5 15.7 
1980-1982 71.2 78.3 57.4 64.3 13.8 18.0 
A n n u a l r a t e s 
1988 73.1 79.5 59.1 65.3 14.8 18.7 
1989 73.3 79.6 59.3 65.4 14.7 187 
1990 73.9 80.0 59.8 65.8 15.2 19.0 
1991 74.4 80.3 60.2 66.0 15.4 19.1 
1992 74.5 80.4 60.3 66.1 15.4 19.2 
Sources: Commonwealth Bureau of Census and Statistics 1970b; Office of the Australian Government 
Actuary 1985; ABS Cat. No. 3302.0 
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Table S14: Life expectancy at selected ages, selected countries, latest year (years) 
C o u n t r y / Y e a r 
A t b i r t h A t a g e 1 5 A t a g e 6 5 
M a l e s F e m a l e s M a l e s F e m a l e s M a l e s F e m a l e s 
A u s t r a l i a ( 1 9 9 2 ) 7 4 . 5 8 0 . 4 6 0 . 3 66 .1 1 5 . 4 1 9 . 2 
Canada (1990) 74.0 80.8 59.9 66.5 15.5 .19.9 
Chile (1989) 69.4 76.5 56.2 63.1 14.0 17.6 
France (1990) 73.4 81.8 59.3 67.5 16.1 20.7 
Germany (1990) 72.0 78.6 57.9 64.3 14.1 17.8 
Greece (1990) 74.6 79.8 60.7 65.7 15.8 18.3 
Iceland (1991) 74.9 80.4 60.5 67.0 15.6 20.0 
Ireland (1990) 72.0 77.7 57.9 63.4 13.2 17.0 
Israel (1989) 74.6 78.1 60.7 64.1 15.6 17.3 
Italy (1989) 73.6 80.4 59.6 66.2 15.0 19.0 
Japan (1991) 76.4 82.8 62.0 68.4 16.6 21.0 
Malta (1991) 73.6 77.1 59.6 63.8 14.1 16.5 
Netherlands (1990) 73.9 80.3 59.7 66.0 14.4 19.2 
New Zealand (1989) 71.9 78.1 5 8 . 2 64.0 14.3 18.1 
Norway (1990) 73.4 79.9 59.3 65.6 14.6 18.7 
Poland (1991) 66.1 75.4 52.6 61.6 12.3 16.0 
Russian Federation (1990) 64.2 73.9 51.7 61.1 12.4 16.0 
Singapore (1990) 72.3 77.5 58.2 63.2 14.4 17.2 
Spain (1989) 73.4 80.5 59.4 66.3 15.5 19.2 
Sweden (1989) 74.8 80.8 60.5 66.4 15.5 19.4 
Switzerland (1991) 74.2 81.4 60.0 67.1 15.6 20.1 
United Kingdom (1991) 73.3 78.8 59.1 64.5 14.3 18.0 
USA (1989) = 71.9 78.9 58.1 64.9 15.3 19.2 
Yugoslavia (1990) 69.5 75.7 56.4 62.4 13.6 16.3 
Sources: World Health Organization 1992, 1993; ABS 1993b 
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Table S15: Age-specific death rates, all causes by sex, selected years, 1921 to 1992 (per 1,000 
population) 
S e x / A g e g r o u p ( y e a r s ) 1 9 2 1 1 9 4 1 1 9 6 1 1 9 8 1 1 9 8 6 1 9 9 2 
M a l e s 
0-4 2,213 1,289 564 281 244 197 
5-9 200 139 49 34 25 20 
10-14 172 108 52 29 29 20 
15-19 219 159 123 124 106 81 
20-24 321 205 161 153 153 119 
25-29 373 199 146 133 131 128 
30-34 442 232 169 123 132 135 
35-39 584 339 229 165 143 147 
40-44 730 461 380 261 227 200 
45-49 994 737 588 455 351 298 
50-54 1,299 1,161 992 790 626 507 
55-59 1,895 1,775 1,614 1,294 1,070 866 
60-64 2,878 2,774 2,619 1,983 1,794 1,523 
65-69 4,199 4,251 4,117 3,231 2,832 2,503 
70-74 6,199 6,479 6,252 5,195 4,537 3,976 
75-79 10,076 10,054 9,312 8,018 7,206 6,640 
80-84 15,368 15,264 14,084 12.112 11,055 10,441 
B5 and over 26,213 29,453 23,772 20,814 18,722 18,046 
C r u d e r a t e 1 , 1 0 6 1 , 0 9 9 9 4 6 8 1 5 7 7 8 7 5 9 
A S R < a > 1 , 6 8 9 1 , 5 3 2 1 , 3 1 7 1 , 0 7 5 9 5 3 8 5 5 
F e m a l e s 
0-4 1,771 1,022 443 216 189 152 
5-9 192 103 38 18 18 16 
10-14 128 73 30 20 16 13 
15-19 205 104 47 45 41 33 
20-24 290 155 61 48 54 43 
25-29 377 202 74 51 49 43 
30-34 426 234 92 57 57 56 
35-39 535 311 146 87 76 73 
40-44 563 374 209 143 135 113 
45-49 690 565 347 265 217 182 
50-54 943 780 542 378 353 311 
55-59 1,289 1,103 785 617 573 494 
60-64 1,915 1,805 1,298 971 883 778 
65-69 3,112 2,884 2,178 1,568 1.508 1,267 
70-74 5,041 4,789 3,652 2,552 2,479 2,169 
75-79 8,295 8,275 6,271 4,426 4,107 3,797 
80-84 13,136 12,704 10,241 7,597 7,113 6,728 
85 and over 22,345 25.457 20,670 16,035 14,825 14,893 
C r u d e r a t e 8 7 3 9 0 1 7 4 5 6 4 6 6 5 8 6 5 6 
A S R < a > 1 , 3 5 6 1 , 1 8 7 8 4 5 6 1 1 5 7 0 5 2 0 
(a) Age-standardised rates. Reference population is the 30 June 1988 Australian population. 
Sources: d'Espaignet et al. 1991; AIHW unpublished data 
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Table S16: Age-specific death rates, all causes by State or Territory of usual residence, 1992 (per 
1,000 population) 
S e x / A g e g r o u p 
( y e a r s ) N S W Vic Q l d W A S A T a s A C T N T A u s t 
M a l e s 
0-4 217 166 220 193 157 156 163 388 197 
5-9 16 22 22 21 15 11 43 12 20 
10-14 18 23 24 16 14 22 9 14 20 
15-19 83 67 89 94 76 94 30 160 81 
20-24 118 102 128 128 118 193 101 196 119 
25-29 129 124 111 .131 133 154 120 345 128 
30-34 159 117 136 122 100 153 86 241 135 
35-39 156 140 142 130 148 124 150 302 147 
40-44 220 203 197 138 180 167 121 502 200 
45-^9 306 299 287 260 304 309 295 493 298 
50-54 512 495 515 480 487 511 430 1,123 507 
55-59 922 837 908 739 833 793 411 1,452 B66 
60-64 1.615 1,469 1,556 1,303 1,447 1,628 928 2,659 1,523 
65-69 2,569 2,448 2,545 2,324 2,417 2,534 2,283 4,930 2,503 
70-74 4,147 3,944 3,957 3,816 3,784 3,698 2,668 4,000 3,976 
75-79 6,792 6,634 6.540 6,140 6,454 7,545 5,952 7,764 6,640 
80-84 10,744 10,448 9,740 10,094 10,219 11,995 11,628 15,152 10.441 
85 and over 18.624 18,476 17,406 16.917 16,954 19,179 14,749 16,327 18,046 
C r u d e r a t e 8 0 8 7 6 3 7 3 6 6 4 3 8 0 4 8 3 2 3 9 2 5 4 5 759 
A S R < a > 8 8 7 8 4 5 8 4 5 7 9 6 8 1 7 9 0 1 7 2 0 1 , 2 1 7 8 5 5 
F e m a l e s 
0-4 159 119 177 159 123 144 118 458 152 
5-9 15 10 19 14 20 11 46 39 16 
10-14 9 15 17 12 19 29 
-
15 13 
15^19 28 32 43 41 39 17 15 48 33 
20-24 40 38 44 53 40 79 56 60 43 
25-29 37 30 65 56 50 29 24 47 43 
30-34 59 46 52 66 66 56 16 146 56 
35-39 78 66 81 74 62 72 40 141 73 
40-44 105 119 117 117 108 124 72 196 113 
45-49 184 183 188 162 181 156 133 358 182 
50-54 350 267 291 269 322 417 134 899 311 
55-59 499 472 509 478 469 539 515 1,299 494 
60-64 814 715 812 716 734 898 851 1,600 778 
65-69 1.294 1,250 1,241 1,211 1,172 1.499 1.329 3,437 1,267 
70-74 2,199 2,119 2,248 2,084 2,016 2,274 2,281 5,197 2,169 
75-79 3.942 3,880 3,646 3,418 3,460 4,389 2,987 5,744 3,797 
80-84 6,703 6,954 6,672 6,006 6.395 8.637 6.005 8,673 6,728 
85 and over 15,214 15,068 14,472 14,384 14,114 16,068 13,642 16,667 14,893 
C r u d e r a t e 6 9 6 6 7 5 6 1 7 5 5 2 6 9 7 7 5 9 3 3 8 3 7 7 6 5 6 
A S R ( a ) 2 4 5 5 1 3 5 2 1 4 9 2 4 9 1 5 9 0 4 7 0 9 2 4 520 
(a) Age-standardised rates. Reference population is the 30 June 1988 Australian population. 
Source: AIHW unpublished data 
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Table S17: Age-specific death rates, all causes, by sex, selected countries, latest year (per 100,000 
population) 
A g e g r o u p ( y e a r s ) 
C o u n t r y / Y e a r o»o 1-4 5 - 1 4 1 5 - 2 4 25-34 35 -44 
M a l e s 
A u s t r a l i a (1992) 791 4 2 2 0 1 0 0 132 173 
Canada (1990) 752 43 26 109 134 200 
Chile (1989) 1,865 97 40 131 201 352 
France (1990) 839 45 21 115 174 284 
Germany (1990) 799 47 24 98 129 240 
Greece (1990) 986 35 26 105 105 184 
Hong Kong (1989) 746 33 17 46 80 163 
Iceland (1991) 553 44 5 155 96 128 
Ireland (1990) 904 48 20 82 107 173 
Israel (1989) 1,050 53 21 73 93 144 
Italy (1989) 928 32 21 93 124 170 
Japan (1991) 464 46 19 67 77 157 
Malta (1991) 1,257 9 7 84 75 111 
Netherlands (1990) 800 43 23 61 85 157 
New Zealand (1989) 1,194 66 34 179 151 199 
Norway (1990) 825 46 26 87 117 199 
Poland (1991) 1,684 59 33 135 234 515 
Russian Federation (1990) 2,476 195 64 178 334 591 
Singapore (1990) 713 46 26 87 120 203 
Spain (1989) 855 52 27 127 174 235 
Sweden (1989) 655 30 16 77 112 190 
Switzerland (1991) 711 37 26 134 173 205 
United Kingdom (1991) 831 40 22 83 95 179 
USA (1989) 1,081 54 30 147 201 307 
Yugoslavia (1990) 2,052 70 34 90 143 293 
Continued next page 
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Table S17: Age-specific death rates, all causes, by sex, selected countries, latest year (per 100,000 
population) (continued) 
A g e g r o u p ( y e a r s ) 
C o u n t r y / Y e a r 4 5 - 5 4 5 5 - 6 4 6 5 - 7 4 7 5 a n d o v e r C r u d e r a t e A S R ^ l 
M a l e s 
A u s t r a l i a ( 1 9 9 2 ) 3 9 1 1 , 1 9 0 3 , 1 2 8 9 , 5 9 2 7 5 9 8 9 7 
Canada (1990) 463 1,314 3,229 9,594 794 930 
Chile (1989) 776 1,860 4,059 11,204 656 1,204 
France (1990) 614 1,429 2,822 9,619 987 945 
Germany (1990) 625 1,577 3,681 11,903 1,111 1,119 
Greece (1990) 430 1,164 2,994 9,746 995 896 
Hong Kong (1989) 517 1,321 3,242 7,612 547 na 
Iceland (1991) 402 1,147 3,120 10,625 . 777 893 
Ireland (1990) 464 1,634 4,294 12,834 962 1,189 
Israel (1989) 430 1,253 3,083 9,647 669 907 
Italy (1989) 475 1,397 3,308 10,032 993 977 
Japan (1991) 406 1,067 2,464 9,016 745 801 
Malta (1991) 359 1,378 3,636 12,071 825 1,041 
Netherlands (1990) 423 1,295 3,653 11,282 902 1,001 
New Zealand (1989) 509 1,430 3,810 10,812 867 1.068 
Norway (1990) 441 1,359 3,578 11,146 1,139 1,010 
Poland (1991) 1,248 2,635 5.084 13,478 1,169 1,566 
Russian Federation (1990) 1,348 2,706 5,104 12,477 1,074 1,604 
Singapore (1990) 596 1,700 3,880 9,063 564 1,097 
Spain (1989) 530 1,284 3,079 9,901 903 954 
Sweden (1989) 406 1,166 3,100 10,115 1,141 906 
Switzerland (1991) 426 1,141 3,038 10,088 966 914 
United Kingdom (1991) 471 1,419 3,871 10,971 1,118 1,025 
USA (1989) 618 1,565 3,439 9,743 921 1,027 
Yugoslavia (1990) 800 1.969 4,073 11,659 958 1,236 
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Table S17: Age-specific death rates, all causes, by sex, selected countries, latest year (per 100,000 
population) (continued) 
A g e g r o u p ( y e a r s ) 
C o u n t r y / Y e a r <a)0 1 -4 5 - 1 4 1 5 - 2 4 2 5 - 3 4 3 5 - 4 4 
F e m a l e s 
A u s t r a l i a ( 1 9 9 2 ) 5 9 9 3 6 1 4 3 8 5 0 9 3 
Canada (1990) 609 33 18 37 53 103 
Chile (1989) 1,540 74 27 43 75 159 
France (1990) 624 31 16 38 60 116 
Germany (1990) 606 38 18 37 53 126 
Greece (1990) 956 26 16 35 51 84 
Hong Kong (1989) 628 27 14 31 44 86 
Iceland (1991) 550 24 10 29 14 97 
Ireland (1990) 726 29 15 36 54 104 
Israel (1989) 961 46 18 32 51 97 
Italy (1989) 787 26 14 27 43 93 
Japan (1991) 421 36 13 25 40 89 
Malta (1991) 654 48 7 12 34 108 
Netherlands (1990) 611 40 18 28 45 104 
New Zealand (1989) 865 39 20 59 56 128 
Norway (1990) 573 32 18 29 49 106 
Poland (1991) 1,301 47 23 39 67 177 
Russian Federation (1990) 1,901 163 35 66 94 190 
Singapore (1990) 617 27 19 37 66 131 
Spain (1989) 696 38 20 40 56 99 
Sweden (1989) 493 28 12 32 45 111 
Switzerland (1991) 530 42 15 44 62 99 
United Kingdom (1991) 634 34 16 32 45 108 
USA (1989) 877 44 20 52 75 139 
Yugoslavia (1990) 1,792 62 24 35 57 137 
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Table S17: Age-specific death rates, all causes, by sex, selected countries, latest year (per 100,000 
population) (continued) 
A g e g r o u p ( y e a r s ) 
C o u n t r y / Y e a r 45-54 55-64 65-74 75 a n d o v e r C r u d e r a t e A S R W 
F e m a l e s 
A u s t r a l i a (1992) 239 636 1,677 7,284 656 551 
Canada (1990) 268 687 1,698 6,885 653 546 
Chile (1989) 406 920 2,276 8,607 510 738 
France (1990) 255 538 1,193 7,295 871 493 
Germany (1990) 300 745 1,919 8,909 1,208 670 
Greece (1990) 204 522 1.744 8,295 873 600 
Hong Kong (1989) 246 642 1,761 5,644 439 na 
Iceland (1991) 227 660 1.488 7,514 614 524 
Ireland (1990) 311 879 2.333 9,230 829 729 
Israel (1989) 249 811 2,253 8,243 597 693 
Italy (1989) 243 590 1,616 7,536 859 568 
Japan (1991) 208 459 1,217 6,229 605 457 
Malta (1991) 209 702 2,336 10,212 781 728 
Netherlands (1990) 257 656 1.646 7,879 822 571 
New Zealand (1989) 359 860 2,133 8,098 752 677 
Norway (1990) 239 671 1,774 8,313 1,033 593 
Poland (1991) 426 1,023 2,602 10,449 949 854 
Russian Federation (1990) 481 1,122 2,740 9,709 1,001 893 
Singapore (1990) 353 947 2.516 7,612 462 729 
Spain (1989) 223 526 1,504 7,747 770 558 
Sweden (1989) 248 594 1.581 7,650 1,029 550 
Switzerland (1991) 224 523 1.401 7,465 880 514 
United Kingdom (1991) 294 839 2,220 8,502 1,124 655 
USA (1989) 340 882 2,011 7,434 814 626 
Yugoslavia (1990) 365 919 2,459 9,615 825 811 
(a) Infant mortality per 100,000 births. 
(b) Age-standardised rate. Reference population is the European standard population (WHO 1993). 
Standard death rates in this table are different from the standard rates in other tables because of the 
use of a different reference population. 
Sources: World Health Organization 1992, 1993; AIHW unpublished data 
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T a b l e S 1 8 : Age-standardised death rates, by sex and ICD-9 chapter, selected years, 1921 to 
1992 (per 100,000 population) 
S e x / I C D - 9 c h a p t e r 1 9 2 1 1 9 4 1 1 9 6 1 1 9 8 1 1 9 8 6 1 9 8 9 1 9 9 0 1 9 9 1 1 9 9 2 
M a l e s 
Infectious and parasitic 208 92 17 5 5 6 6 6 6 
Neoplasms 154 175 192 236 234 237 232 230 233 
Endocrine, nutritional 16 23 16 18 19 21 23 24 24 
Blood diseases 10 5 4 3 4 3 3 3 3 
Mental disorders 7 4 5 9 12 15 14 12 13 
Nervous system diseases 46 25 14 13 14 16 15 15 17 
Circulatory diseases 376 614 733 545 446 414 383 365 360 
Respiratory diseases 201 145 105 94 82 95 79 75 81 
Digestive diseases 58 56 38 35 31 32 29 28 26 
Genitourinary diseases 122 133 42 15 13 13 13 13 12 
Skin diseases 5 3 2 1 1 1 1 1 1 
Musculoskeletal diseases 7 5 4 3 3 3 3 3 3 
Congenital diseases 9 10 10 7 5 5 5 5 5 
Perinatal diseases 55 43 21 7 6 6 6 5 5 
Ill-defined conditions 300 98 14 6 6 6 6 5 5 
Injury and poisoning 116 103 103 80 71 70 68 64 61 
Al l c a u s e s 1 , 6 8 9 1 , 5 3 2 1 , 3 1 7 1 , 0 7 5 9 5 3 9 4 4 8 8 5 8 5 3 8 5 5 
F e m a l e s 
Infectious and parasitic 157 58 9 3 3 4 4 4 4 
Neoplasms 155 159 135 133 141 139 138 140 137 
Endocrine, nutritional 26 40 20 15 14 14 14 15 15 
Blood diseases 13 6 4 3 2 2 2 2 2 
Mental disorders 3 3 2 6 9 11 10 9 10 
Nervous system diseases 36 21 9 8 10 12 11 11 12 
Circulatory diseases 334 503 493 333 284 267 248 234 237 
Respiratory diseases 155 111 43 31 31 42 34 33 37 
Digestive diseases 56 39 23 19 20 19 19 18 17 
Genitourinary diseases 65 74 19 11 10 10 10 10 9 
Complications of pregnancy 24 14 3 -
-
- -
-
-
Skin diseases 5 3 2 
-
1 1 1 1 1 
Musculoskeletal diseases 9 6 4 4 4 5 4 4 5 
Congenital diseases 7 9 8 6 5 5 5 4 4 
Perinatal diseases 41 34 15 5 5 5 5 4 4 
Ill-defined conditions 237 70 14 4 4 4 4 3 3 
Injury and poisoning 34 39 42 30 28 27 25 25 24 
Al l c a u s e s 1 , 3 5 7 1 , 1 8 7 8 4 5 6 1 1 5 7 0 5 6 3 5 3 2 5 1 6 5 2 0 
(a) Reference population is the 30 June 1988 Australian population, classified by five-year age groups. 
Sources; d'Espaignet et al. 1991; AIHW unpublished data 
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Table S19: Age-standardised death rates,1" by sex and ICD-9 chapter, States and Territories, 
1992 (per 100,000 population) 
S e x / I C D - 9 c h a p t e r N S W V i c Qld W A S A T a s A C T N T A u s t 
M a l e s 
Infectious and parasitic 8 5"'" 6 6 5 3 2 32 6 
Neoplasms 240 235 231 220 216 231 201 290 233 
Endocrine, nutritional 25 32 19 22 16 17 20 71 24 
Blood diseases 4 2 3 3 1 1 4 3 3 
Mental disorders 14 14 11 11 10 12 6 13 13 
Nervous system diseases 15 19 16 20 15 17 20 19 17 
Circulatory diseases 380 346 358 326 354 382 300 388 360 
Respiratory diseases 82 79 76 72 85 105 74 200 81 
Digestive diseases 28 28 24 25 27 16 20 23 26 
Genitourinary diseases 12 13 13 12 10 8 6 19 12 
Skin diseases 1 
-
1 1 1 
-
2 - 1 
Musculoskeletal diseases 3 3 3 2 2 4 
-
6 3 
Congenital diseases 5 5 6 5 3 7 7 9 5 
Perinatal diseases 7 4 6 4 5 5 3 6 5 
Ill-defined conditions 5 3 3 7 4 14 4 31 5 
Injury and poisoning 60 57 67 59 63 78 51 106 61 
A l l c a u s e s 887 845 845 796 817 901 720 1,217 855 
F e m a l e s 
Infectious and parasitic 4 4 3 2 3 2 8 36 4 
Neoplasms 136 142 134 138 129 152 121 240 137 
Endocrine, nutritional 13 18 14 15 14 14 13 73 15 
Blood diseases 2 2 2 1 2 2 2 
-
2 
Mental disorders 9 11 9 12 8 8 2 10 10 
Nervous system diseases 12 13 10 15 11 15 11 15 12 
Circulatory diseases 249 228 239 209 229 256 222 225 237 
Respiratory diseases 38 35 35 31 37 53 38 166 37 
Digestive diseases 17 16 16 19 15 19 13 22 17 
Genitourinary diseases 10 8 11 7 7 8 8 28 9 
Complications of pregnancy 
-
- - -
- -
-
-
-
Skin diseases 1 
-
1 1 1 1 1 5 1 
Musculoskeletal diseases 5 5 5 3 2 4 2 1 5 
Congenital diseases 4 4 5 4 3 7 1 7 4 
Perinatal diseases 5 3 4 5 3 2 6 13 4 
Ill-defined conditions 3 3 3 3 4 14 6 29 3 
Injury and poisoning 21 22 28 25 24 32 16 53 24 
Al l c a u s e s 530 5 1 3 521 492 4 9 1 590 470 924 520 
(a) Reference population is the 30 June 1988 Australian population, classified by five-year age groups. 
Source; AIHW unpublished data 
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Table S20: Age-standardised death rates,™ by selected ICD-9 chapters and sex, selected 
countries, latest year (per 100,000 population) 
I C D - 9 c h a p t e r 
I n f e c t i o u s I n j u r y & Al l 
C o u n t r y / Y e a r & p a r a s i t i c N e o p l a s m s C i r c u l a t o r y D i g e s t i v e p o i s o n i n g c a u s e s 
M a l e s 
A u s t r a l i a ( 1 9 9 2 ) 7 2 4 8 3 7 8 2 9 61 8 9 7 
Canada (1990) 6 258 356 34 70 930 
Chile (1989) 42 215 344 107 150 1,204 
France (1990) 12 298 267 52 102 945 
Germany (1990) 8 269 510 56 69 1,119 
Greece (1990) 6 217 420 25 59 896 
Iceland (1991) 3 234 407 18 75 893 
Ireland (1990) 7 268 547 28 63 1,189 
Israel (1989) 15 174 388 27 66 907 
Italy (1989) 4 286 384 60 62 977 
Japan (1991) 13 228 268 38 62 801 
Malta (1991) 7 231 492 43 41 1,041 
Netherlands (1990) 6 296 391 31 43 1,001 
New Zealand (1989) 6 261 471 28 87 1,068 
Norway (1990) 7 223 464 27 77 1,010 
Poland (1991) 14 297 797 48 140 1,566 
Russian Federation (1990) 26 284 800 47 198 1,604 
Singapore (1990) 31 259 411 32 59 1,097 
Spain (1989) 12 251 340 62 75 954 
Sweden (1989) 6 197 444 31 74 906 
Switzerland (1991) 17 263 360 28 95 914 
United Kingdom (1991) 5 274 462 30 45 1,025 
USA (1989) 14 246 428 37 89 1,027 
Yugoslavia (1990) 14 228 613 51 92 1,237 
Continued next page 
253 
Table S20: Age-standardised death rates,™ by selected ICD-9 chapters and sex, selected 
countries, latest year (per 100,000 population) (continued) • . . . 
I C D - 9 c h a p t e r 
C o u n t r y / Y e a r 
I n f e c t i o u s 
& p a r a s i t i c N e o p l a s m s C i r c u l a t o r y D i g e s t i v e 
I n j u r y & 
p o i s o n i n g 
A l l 
c a u s e s 
F e m a l e s 
A u s t r a l i a ( 1 9 9 2 ) 4 1 4 9 2 4 8 1 8 2 4 5 5 1 
Canada (1990) 4 163 209 20 27 546 
Chile (1989) 25 162 244 52 35 738 
France (1990) 7 129 159 27 44 493 
Germany (1990) 5 160 327 30 31 670 
Greece (1990) 4 111 322 12 23 600 
Iceland (1991) 6 157 214 16 21 .524 
Ireland (1990) 5 182 319 22 26 729 
Israel (1989) 14 146 291 19 37 693 
Italy (1989) 2 146 253 29 25 568 
Japan (1991) 6 113 181 19 26 457 
Malta (1991) 4 141 388 22 16 728 
Netherlands (1990) 4 162 217 23 23 571 
New Zealand (1989) 5 188 283 21 33 677 
Norway (1990) 4 150 252 19 33 593 
Poland (1991) 5 155 476 25 38 854 
Russian Federation (1990) 10 134 534 24 50 893 
Singapore (1990) 17 153 295 15 26 729 
Spain (1989) 6 118 251 29 22 558 
Sweden (1989) 4 144 252 19 31 550 
Switzerland (1991) 7 146 215 16 40 514 
United Kingdom (1991) 3 184 279 24 19 655 
USA (1989) 10 162 266 23 31 626 
Yugoslavia (1990) 8 129 467 23 33 811 
(a) Reference population is the Europen standard population (WHO 1993). Standard death rates in this 
table are different from the standard rates in other tables because of the use of a different reference 
population. 
Sources: World Health Organization 1992, 1993; AIHW unpublished data 
254 
Other health conditions 
Table S21: Notifiable diseases, 1987 to 1992 (number) 
Disease 1987 1986 1989 1990 1991 1992 
Arbovirus infection, nec 1,085 897 2,809 2,008 201 303 
Dengueta> nn nn nn nn 46 366 
Ross River virus'9' nn nn nn nn 3,532 5,630 
Brucellosis 12 16 20 46 28 29 
Campylobacteriosis 2,923 4,082 4,279 5,683 8,672 9,135 
Chancroid 4 4 3 13 
-
5 
Cholera 
-
2 
-
1 
-
3 
Chlamydial infection'b> 274 268 504 5 4,044 6,293 
Diphtheria 32 61 1 7 8 14 
Donovanosis 148 133 99 91 72 78 
Gonococcal infection 4,984 4,082 3,154 1,919 2,530 2,908 
Haemophilus influenzae, type b 
infection nn nn nn nn 549 501 
Hepatitis A 715 600 460 530 2,195 2,109 
Hepatitis B 1,605 1,683 3,017 2,970 3,652 5,219 
Hepatitis C nn nn nn nn 4,116 8,812 
Hepatitis, nec 131 69 43 707 338 70 
Hydatid infection 17 15 15 16 44 38 
Legionellosis 96 67 104 90 110 185 
Leprosy 31 20 34 31 13 16 
Leptospirosis 133 104 99 121 169 159 
Listeriosis nn nn nn nn 44 38 
Lymphogranuloma venereum 
-
-
-
-
-
3 
Malaria 574 601 770 882 790 712 
Measles nn 248 169 880 1,380 1,425 
Meningococcal infection 96 126 204 295 285 292 
Mumps nn nn nn nn nn 23 
Ornithosis 13 21 25 23 136 94 
Pertussis 291 153 614 862 337 739 
Plague -
-
-
-
-
-Poliomyelitis 
-
- -
-
-
-Q fever 355 424 353 431 595 543 
Rabies _ 
-
_ 
-
- -
Rubella^ 3 2 
-
2 620 3,810 
Salmonellosis 2,739 3,484 4,492 4,564 5,440 4,614 
Shigellosis 586 581 779 610 902 694 
Syphilis 3,190 3,056 2,099 1,754 2,053 2,695 
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Table S21: Notifiable diseases, 1987 to 1992 (number) (continued) 
Disease 1987 19B8 1989 1990 1991 1992 
Tetanus 5 5 11 6 7 14 
Tuberculosis^ 868 925 902 979 903 nya 
Typhoid 47 40 57 70 89 50 
Viral haemorrhagic fever 
-
- - -
- -Yellow fever 
- - - -
-
-Yersiniosis 122 172 241 433 515 567 
nec not elsewhere classified, 
nn not notifiable, 
nya not yet available. 
(a) Dengue fever and Ross River fever included in the Arbovirus infection from 1987 to 1990. 
(b) Trachoma only from 1987 to 1990. 
(c) Congenital rubella syndrome only from 1987 to 1990. 
(d) Data from National Tuberculosis Notification System. 
Source: Communicable Diseases Network-Australia New Zealand-National Notifiable Diseases 
Surveillance System, personal communication 
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T a b l e S 2 2 : Virus and selected non-virus reports,™ 1987 to 1992 (number) 
1 9 8 7 1 9 8 8 1 9 8 9 1 9 9 0 1 9 9 1 1 9 9 2 
Virus 
Measles, mumps, rubella 
Measles 136 45 69 221 256 204 
Mumps 72 49 60 54 32 48 
Rubella 394 196 582 300 246 753 
Hepatitis viruses 
Hepatitis A 483 380 221 262 444 371 
Hepatitis B 3,021 2,466 3,061 2,981 2,182 2,303 
Hepatitis C 
-
-
115 1,212 2,603 
Hepatitis D 
- -
-
1 37 45 
Hepatitis E 
- -
- - -
1 
Hepatitis, other non-A or B 
- -
2 5 18 7 
Arboviruses 
Alphaviruses 
Ross River 926 679 2,076 669 833 1,319 
Other alphaviruses 3 5 67 10 36 251 
Flaviviruses 
Dengue 14 11 39 68 29 385 
MVE virus 2 1 1 2 10 1 
Other flaviviruses / not typed 28 16 32 21 47 57 
Other DNA viruses 
Adenovirus 1,298 1,476 1,641 1,432 1,518 1,722 
Cytomegalovirus 1,484 1,424 1,614 1,810 1.820 1,728 
Epstein-Barr virus 802 781 1,051 1,211 1,360 1,625 
Herpes simplex 
HSV type 1 3.949 3,636 2,948 3,343 3,073 3,502 
HSV type 2 7,197 6,414 4,776 4,431 3,810 4,330 
HSV not typed 689 1,403 2,637 1,180 820 825 
Herpes Type 6 
-
-
1 1 3 2 
Varicella zoster 319 346 436 450 522 684 
Herpes virus group / not typed 119 120 366 210 114 36 
Other ( b ) 12 13 16 20 67 206 
Other RNA viruses 
Coxsackievirus A 75 165 33 57 59 43 
Coxsackievirus B 239 179 117 132 154 128 
Echovirus 318 524 515 204 154 496 
HIV-1 10 60 55 75 54 45 
HTLV-1 
-
-
-
3 8 2 
Influenza 
Influenza A 305 1,543 572 255 60 1,322 
Influenza B 398 50 435 41 408 126 
Other 6 11 11 4 6 2 
Poliovirus 231 176 239 248 194 185 
Parainfluenza 735 1,056 970 835 805 974 
Continued next page 
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Table S22: Virus and selected non-virus reports,^ 1987 to 1992 (number) (continued) 
1987 1988 1989 1990 1991 1992 
Respiratory syncytial virus 2,104 1,931 3,066 3,132 2,555 3,554 
Rhinovirus 553 773 759 470 653 683 
Rotavirus 1,545 1,638 1,693 1,876 2,642 2,134 
Other<c> 811 692 621 914 870 945 
Non-viral 
Chlamydia 
Trachomatis 3,917 2,822 3,394 3,250 2,626 2,563 
Pneumoniae 
-
_ 
- -
2 14 
Psittaci 62 90 92 86 139 97 
Other 
- - - -
1 16 
Mycoplasma 
Mycoplasma pneumoniae 993 1,240 703 402 381 1,579 
Mycoplasma hominis 
- - -
-
2 4 
Rickettsiae 
Coxiella burneti (Q fever) 351 272 227 250 240 269 
Other rickettsiae 3 2 4 2 1 31 
Total 33,604 32,138 35,283 30,977 30,570 38,220 
(a) As reported by virus laboratories through the Commonwealth Diseases Intelligence network. Data 
collected under the Notifiable Diseases Returns (Table S21) may bear little or no correlation to that 
collected under the CDI laboratory scheme. Although the latter is a sampling program, the Notifiable 
Diseases data depend on voluntary reporting by medical practitioners, etc. 
(b) Other DNA viruses include papovavirus (untyped), molluscum contagiosum, Orf virus, parvovirus, 
milkers nodule virus, poxvirus (untyped) and cowpox virus. 
(c) Other RNA viruses include enterovirus type 70 and 71, picomavirus (not typed), enterovirus (not typed), 
. paramyxovirus (unspecified), reovirus, coronavirus, astrovirus, calcivirus, Norwalk agent and small 
virus-like particles. 
Sources: DHHCS 1992; DHHLGCS 1993a 
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T a b l e S 2 3 : Characteristics of AIDS cases, by age, sex, State/Territory, exposure category and 
defining condition, 1985 to 1993 
D e s c r i p t i o n 1 9 8 5 1 9 8 6 1 9 8 7 1 9 8 8 1 9 8 9 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 ( a ) 
T o t a l c a s e s 1 2 7 2 2 7 3 8 1 5 3 1 6 0 0 6 5 3 7 6 3 6 9 2 2 3 1 
M e a n a g e ( y e a r s ) 
Males 37 38 37 38 38 38 38 40 40 
Females 46 53 41 31 34 38 36 40 43 
M a l e s ( p e r c e n t ) 9 0 . 6 9 6 . 9 9 6 . 1 9 7 . 2 9 7 . 7 9 7 . 5 9 6 . 8 9 5 . 2 9 6 . 0 
S t a t e / T e r r i t o r y ( p e r c e n t ) 
NSW 70.9 70.5 65.6 60.0 58.1 62.2 54.1 53.2 51.5 
Vic 9.4 15.9 20.7 22.3 21.4 18.6 23.7 23.6 30.3 
Old 9.4 5.7 6.6 7.4 8.2 9.1 10.8 10.9 6.9 
WA 6.3 4.8 3.4 4.7 5.0 4.0 4.9 5.1 1.7 
SA 1.6 2.2 2.4 4.2 4.8 3.8 5.0 4.5 5.6 
Tas 0.8 
-
0.5 0.2 1.0 0.8 0.3 1.3 
-
NT 1.6 
- - -
0.2 0.3 0.7 0.7 0.9 
ACT 
-
0.9 0.8 1.5 1.5 1.5 1.1 1.0 3.0 
E x p o s u r e c a t e g o r y ( p e r c e n t ) 
Male homosexual / bisexual 
contact 81.9 87.2 86.9 88.9 86.5 85.7 82.1 79.1 82.3 
Male homosexual / bisexual 
contact and ID use 0.8 4.8 2.4 3.0 2.7 2.0 3.3 4.2 5.6 
ID use (female and hetero­
sexual male) 
-
0.9 0.5 2.1 2.2 1.8 3.6 1.7 0.9 
Heterosexual contact 0.8 
-
1.6 1.7 1.3 3.2 4.5 6.8 6.1 
Haemophilia / coagulation 
disorder 0.8 0.9 1.8 1.3 2.2 1.8 1.3 1.9 0.9 
Receipt of blood transfusion, 
blood components or tis­
sue 13 .4 5.3 5.2 1.3 1.7 1.7 2.0 2.0 1.7 
Mother with / at risk for HIV 
infection 0.8 
- -
0.2 0.2 0.5 0.4 0.4 
-
Other / undetermined 1.6 0.9 1.6 1.7 3.5 3.5 3.3 4.1 2.6 
A I D S - d e f i n i n g c o n d i t i o n ( p e r c e n t ) 
Pneumocystis carinii pneu­
monia (PCP) 40.9 3 7 . 4 41.5 40.2 34.7 28.3 31.2 27.0 26.8 
Kaposi's sarcoma (KS)-skin 20.5 15.4 17.1 15.1 14.0 11.1 11.8 11.6 10.8 
PCP and other (not KS) 3.1 4.4 7.1 5.5 3.5 6.3 3.9 5.4 1.7 
HIV encephalopathy 
-
-
1.1 2.3 4.2 4.3 2.6 2.0 3.5 
Other 35.4 42.7 33.3 37.2 43.7 50.4 50.8 54.3 57.1 
(a) Diagnosed by 30 June and reported by 30 September. 
Source: National Centre in HIV Epidemiology and Clinical Research 
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Table S24: Leading cancers, new cases and deaths by type and sex, 1988 
N e w c a s e s D e a t h s 
P e r L i f e t i m e P e r 
C a n c e r N u m b e r c e n t R a t e < b > r i s k ' 0 * N u m b e r c e n t R a t e < b > 
M a l e s 
Lung 4,792 15.8 65.2 1 in 17 4.595 27.4 63.0 
Prostate 4,566 15.0 67.5 1 in 23 1,883 11.2 29.0 
Melanoma 3,087 10.2 39.6 1 in 30 478 2.9 6.3 
Colon 2,691 8.9 37.1 1 in 33 1,550 9.3 22.7 
Rectum 1,732 5.7 23.3 1 in 47 652 3.9 9.1 
Bladder 1,652 5.4 23.2 1 in 55 502 3.0 7.5 
Unknown primary 1,376 4.5 19.1 1 in 67 969 5.8 13.6 
NHL ( a ) 1,146 3.8 15.2 1 in 80 592 3.5 8.1 
Stomach 1,135 3.7 15.8 1 in 81 861 5.1 12.3 
Kidney 799 2.6 10.7 1 in 108 378 2.3 5.2 
AH c a n c e r s 30,511 100.0 414.6 1 i n 3 16,747 100.0 234.7 
F e m a l e 
Breast 6,540 24.8 75.3 1 in 15 2,361 18.7 26.3 
Melanoma 2,751 10.4 33.5 1 in 37 326 2.6 3.6 
Colon 2,643 10.0 28.7 1 in 42 1,535 12.1 16.4 
Lung 1,681 6.4 18.8 1 in 55 1,520 12.0 16.9 
Unknown primary 1,190 4.5 12.7 1 in 105 832 6.6 8.8 
Rectum 1,170 4.4 12.9 1 in 89 406 3.2 4.3 
Cervix 1,061 4.0 12.6 1 in 95 345 2.7 3.9 
Uterus 1,057 4.0 12.1 1 in 84 194 1.5 2.1 
NHL t d ) 933 3.5 10.5 1 in 105 478 3.8 5.2 
Ovary 890 3.4 10.2 1 in 104 610 4.8 6.9 
AM c a n c e r s 26,490 100.0 297.5 1 i n 4 12,652 100.0 137.7 
(a) Rankings are based on the number of new cases; excludes non-melanocytic skin cancers. 
(b) Age-standardised rates are expressed per 100,000 population using the 1988 Australian population. 
(c) Lifetime risk—a measure which approximates the risk of contracting a particular cancer in a lifetime if 
the risks at the year of estimation remained throughout a person's life. For the purposes of this table, 
'lifetime' is defined as ages 0 to 74. 
(d) Non-Hodgkin's lymphoma. 
Source: Jelfs et al. 1994 
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Table S25: Major cancers, age-standardised incidence rates,™ by sex, 1982 to 1988 (per 100,000 
population) 
Cancer 1982 1983 1984 1985 1986 1987 1988 
Males 
Lung 74.0 73.9 73.7 75.5 71.3 70.7 65.2 
Prostate 63.3 64.6 65.4 69.2 68.0 68.9 67.5 
Melanoma 24.4 24.9 27.1 30.3 32.2 36.8 39.6 
Colon 35.1 35.7 36.9 41.2 39.6 37.9 37.1 
Rectum 22.6 22.6 22.0 23.1 21.8 22.4 23.3 
Bladder 27.4 25.5 25.8 27.7 25.1 23.1 23.2 
Non-Hodgkin's lymphoma 13.6 12.6 12.8 14.5 14.9 15.8 15.2 
All cancers 408.0 402.3 408.7 431.2 419.7 418.5 414.6 
Females 
Breast 70.5 71.1 72.3 72.3 72.3 77.3 75.3 
Melanoma 23.3 25.5 25.8 28.5 28.0 31.8 32.3 
Colon 30.8 30.1 31.0 32.5 31.7 30.3 28.7 
Lung 16.2 17.1 17.6 18.1 18.3 18.2 18.8 
Rectum 14.0 13.7 13.7 14.2 13.1 13.1 12.9 
Cervix 13.4 13.7 13.4 13.3 13.1 13.3 12.6 
Body of uterus 11.7 11.8 12.8 12.4 13.0 12.4 12.1 
Bladder 7.9 6.6 7.3 6.8 7.5 6.7 6.8 
Non-Hodgkin's lymphoma 10.0 9.5 9.9 10.1 10.0 10.6 10.5 
Ail cancers 285.0 290.4 294.6 298.8 295.8 300.8 297.5 
(a) Age-standardised to the 1988 Australian population. 
Source; AIHW unpublished data 
Table S26: Major cancers, average annual age-standardised incidence rates,™ by sex, States and 
Territories 1984-88 and Australia 1988 (per 100,000 population) 
Cancer NSW Vic Qld WA SA Tas ACT NT Aust 
Males 
Lung 68.9 69.1 79.5 67.9 62.4 71.1 62.6 64.9 65.2 
Prostate 59.1 63.0 77.4 65.4 66.7 56.2 50.3 36.4 67.5 
Melanoma 35.7 21.6 53.6 33.5 32.0 23.1 36.8 12.8 39.6 
Colon 35.3 38.9 42.7 35.1 30.6 34.8 34.6 
-
37.1 
Rectum 20.3 24.1 20.8 21.9 22.7' 19.2 24.3 12.2 23.3 
Females 
Breast 64.9 76.1 79.2 74.3 65.8 64.2 70.5 45.7 75.3 
Melanoma 29.0 22.3 45.4 29.3 32.3 29.2 29.3 10.2 32.3 
Colon 27.8 32.3 36.0 28.0 26.2 29.8 31.2 17.4 28.7 
Lung 15.5 19.2 18.9 19.6 14.2 18.6 18.9 15.2 18.8 
Rectum 12.7 14.3 12,6 13.1 13.1 14.5 14,8 3.1 12.9 
(a) Age-standardised to the 1988 Australian population. 
Source: Jelfs et al. 1994 
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Table S27: Major cancers, age-standardised incidence rates/3' by sex, selected countries 1984-88 
and Australia 1988 (per 100,000 population) 
M a l e s C o l o n R e c t u m L u n g M e l a n o m a P r o s t a t e 
All 
c a n c e r s 
Australia 26.5 17.5 46.9 33.1 41.8 302.9 
Brazil 17.0 11.3 85.7 5.8 49.6 191.7 
Canada 27.8 16.6 68.5 6.7 51.4 318.1 
England and Wales 17.1 13.7 65.4 3.0 23.1 240.0 
Italy 24.0 14.8 82.3 3.9 25.5 344.1 
Japan 14.8 11.6 41.5 0.2 6.6 265.4 
Netherlands 19.7 16.2 83.4 3.9 29.6 272.5 
New Zealand 
(non-Maori) 30.9 20.4 51.7 18.6 35.4 283.4 
USA 27.4 13.4 56.4 14.6 51.9 293.7 
Al l 
F e m a l e s C o l o n R e c t u m L u n g M e l a n o m a B r e a s t c a n c e r s 
Australia 20.8 9.6 14.2 28.3 62.3 235.9 
Brazil 11.0 6.2 16.8 3.7 78.5 215.9 
Canada 23.6 10.2 23.9 7.0 71.1 253.4 
England and Wales 14.6 7.8 20.5 5.0 56.1 198.8 
Italy ' 17.3 7.9 8.2 4.4 66.0 215.3 
Japan 10.1 6.3 11.7 0.2 21.9 155.2 
Netherlands 17.1 10.3 9.1 5.6 68.1 194.8 
New Zealand 
(non-Maori) 30.5 12.3 15.7 23.0 64.3 248.0 
USA 20.7 8.4 32.1 11.6 88.5 273.6 
-(a) Age-standardised lo the World Standard Population. 
Source: Parkin et al. (ads) 1992 
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T a b l e S 2 8 : Dental caries experience™ of 6-year-old and 12-year-old school children, States and 
Territories, 1988 to 1992 (mean number of teeth) 
N S W V i c Q l d W A S A T a s A C T N T A u s t r a l i a 
6 - y e a r - o l d s ( d m f t ) 
1988 1.83 1.89 2.40 1.52 2.02 1.66 1.29 1.81 1.93 
1989 2.21 2.16 2.34 1.62 2.21 1.70 1.17 2.04 2.16 
1990 2.20 2.10 2.43 1.54 1.88 1.59 1.15 2.08 2.06 
1991 2.05 2.04 2.48 1.29 1.98 1.57 1.14 1.96 1.94 
1992 2.00 2.05 2.37 1.32 1.53 1.48 1.09 1.99 1.95 
1 2 - y e a r - o l d s ( D M F T ) 
1988 1.24 1.93 1.85 1.96 1.69 1.29 1.20 1.34 1.62 
1989 1.33 1.72 1.66 2.11 1.46 1.06 1.12 1.10 1.56 
1990 1.32 (b) 1.69 1.75 1.26 1.11 1.03 1.18 1.44 
1991 1.18 (b) 1.54 1.43 1.06 1.18 0.91 1.26 1.29 
1992 1.19 (b) 1.50 1.22 1.04 0.98 0.76 0.91 1.22 
(a) As measured by dmft / DMFT index. Beginning in 1989, the dmft index (number of decayed, missing 
and filled primary teeth) was recorded in all States and Territories other than Queensland. In 
Queensland during 1989 the dft (number of decayed and filled primary teeth) was recorded. Prior to 
1989 the dft index was recorded in all States and Territories. The increase in caries experience in 1989 
may therefore be associated with the adoption of the more comprehensive dmft index. 
(b) Insufficient numbers examined to provide an estimate. 
Source: AIHW Dental Statistics and Research Unit unpublished data 
T a b l e S 2 9 : Primary teeth with caries experience (dmft),™ 4- to 10-year-old children, 1977 and 
1988 to 1992 (mean number of teeth) 
A g e ( y e a r s ) 
F o u r F i v e S i x S e v e n E i g h t N i n e T e n 
1977 2.86 2.96 3.13 3.35 3.37 3.01 2.23 
1988 1.68 1.73 1.93 2.12 2.20 2.23 1.86 
1989 (b) 2.01 2.15 2.38 2.31 2.26 1.88 
1990 (b) 1.85 2.06 2.20 2.31 2.28 1.78 
1991 (b) 1.78 1.94 2.13 2.24 2.22 1.81 
1992 (b) 1.80 1.95 1.93 2.21 2.11 1.74 
(a) Beginning in 1989, the dmft index (number of decayed, missing and filled primary teeth) was recorded in 
all States and Territories other than Queensland. In Queensland during 1989 the dft (number of decayed 
and filled primary teeth) was recorded. Prior to 1989 the dft index was recorded in all States and 
Territories. The increase in caries experience in 1989 may therefore be associated with the adoption of 
the more comprehensive dmft index. 
(b) Insufficient numbers examined to provide an estimate. 
Source: AIHW Dental Statistics and Research Unit unpublished data 
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Table S30: Permanent teeth with caries experience (DMFT), 6- to 12-year-old children, 1977 and 
1988 to 1992 (mean number of teeth) 
Age (years) 
Six Seven Eight Nine Ten Eleven Twelve 
1977 0.51 1.21 1.94 2.50 3.10 3.92 4.80 
1988 0.08 0.28 0.49 0.70 0.99 1.26 1.62 
1989 0.09 0.26 0.46 0.65 0.83 1.37 1.56 
1990 0.10 0.24 0.42 0.63 0.76 1.00 1.44 
1991 0.09 0.24 0.40 0.56 0.83 0.91 1.29 
1992 0.09 0.21 0.38 0.53 0.69 0.90 1.22 
Source: AIHW Dental Statistics and Research Unit unpublished data 
Table S31: Current smokers, by age group and sex, 1974 to 1989 (per cent) 
Year of survey 
Age group 1974 1976 1980 1983 1986 1989 
Males 
16-19 37.7 37.2 35.7 31.9 31.2 20.0 
20-24 52.0 47.6 56.5 44.9 41.1 41.0 
25-29" 49.2 46.8 48.6 49.2 38.8 38.9 
30-34 52.4 45.7 40.0 43.5 34.5 36.7 
35-39 ; 48.1 46.9 41.8 42.2 34.7 35.4 
40-44 45.9 43.4 43.1 42.6 36.6 32.3 
45-49 47.2 40.7 47.4 43.1 29.0 26.3 
50-54 46.8 53.9 47.1 38.0 35.5 22.1 
55-59 40.6 39.7 40.1 38.1 34.8 25.5 
60-69 36.2 36.0 26.8 33.7 29.2 21.4 
70 and over 31.4 35.3 18.5 26.6 16.3 20.8 
Total 45.3 43.9 41.1 40.3 33.4 30.2 
Females 
16-19 29.8 32.2 37.3 44.9 27.9 31.1 
20-24 38.0 44.1 40.0 44.9 41.2 37.7 
25-29 37.4 43.5 40.5 34.5 39.0 36.7 
30-34 30.4 37.9 35.8 32.1 31.3 30.4 
35-39 29.4 28.0 33.3 28.8 29.0 26.4 
40-44 27.5 34.4 29.5 28.1 30.0 24.2 
45-49 32.6 35.8 20.0 38.5 25.1 28.8 
50-54 37.0 38.3 31.3 25.5 27.6 27.9 
55-59 25.4 17.9 26.1 29.1 23.6 17.6 
60-69 16.2 18.8 23.0 22.2 20.9 19.6 
70 and over 9.9 11.3 10.1 8.4 11.6 10.5 
Total 29.6 32.5 31.1 30.9 28.9 27.0 
Source; Hill, White & Gray 1988,1991 
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Hospital morbidity and utilisation 
T a b l e S32: Separation rates from public acute and DVA hospitals, by sex and age group, States 
and Territories, 1991-92 or latest year™ (per 1,000 population) 
S e x / 
A g e g r o u p N S W V i c Q l d W A S A T a s A C T N T T o t a l 
M a l e s 
Less than 1 545.7 408.3 428.6 477.6 584.4 371.5 777.4 933.5 491.5 
1-14 102.3 86.2 99.5 108.0 124.6 68.0 78.2 128.1 99.1 
15-34 85.1 70.6 101.4 92.6 93.3 76.5 67.9 104.5 85.2 
35 -49 108.2 94.0 121.4 107.2 117.1 87.4 104.3 112.3 106.8 
50 -64 212.2 193.6 222.7 217.3 236.0 200.5 278.6 223.6 212.3 
65 -74 435.9 390.2 395.2 527.0 487.7 375.4 573.4 369.4 429.5 
75 and over 620.1 537.2 587.4 810.0 685.9 598.8 660.9 560.0 615.1 
All ages 160.9 137.8 159.9 166.9 183.8 137.8 141.9 147.5 156.2 
F e m a l e s 
Less than 1 403.7 295.1 319.6 373.1 395.8 323.9 537.8 783.8 363.2 
1-14 72.9 59.9 73.0 80.2 90.1 48.4 56.8 100.3 71.1 
15-34 208.5 187.2 206.2 223.2 221.6 208.9 205.5 260.1 205.6 
35 -^9 134.6 126.6 131.8 146.2 133.7 109.6 146.0 156.3 132.9 
50 -64 185.2 152.5 197.0 190.6 188.7 150.8 216.9 188.2 178.8 
65 -74 296.5 249.2 291.8 315.7 322.0 273.6 352.2 295.3 287.3 
75 and over 382.6 318.0 366.6 432.1 384.8 329.0 403.9 400.0 365.9 
All ages 185.4 160.5 177.9 192.5 197.0 162.5 180.8 203.2 178.8 
P e r s o n s 173.4 149.4 168.9 179.8 190.5 150.5 161.7 173.9 167.7 
(a) Queensland 1990, Northern Territory 1990-91 . Department of Veterans'Affairs (DVA) hospital data for 
1991-92 is included for NSW, Vic, Qld, WA, SA and Tas only. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
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Table S33: Occupied bed-days in public acute and DVA hospitals, by sex and age group, States 
and Territories, 1991-92 or latest year™ (per 1,000 population) 
Sex/ 
Age group NSW Vic Qld WA SA Tas ACT NT Total 
Males 
Less than 1 2,921.3 2,329 1 2,683 0 2,610 1 2,963.4 1,920.5 4,876 5 8.075.9 2,770,2 
1-14 244.3 200 7 248 8 271 7 294.6 169.0 199 2 745.1 244.2 
15-34 323.0 240 2 421 3 317 4 306.7 310.9 329 3 638.8 319.9 
35-49 443.5 353 3 522 3 397 0 436.7 386.1 423 4 715.7 429.5 
50-64 1,128.9 939 6 1,265 4 1,023 9 1,112.7 1,002.7 1,314 6 1,611.2 1,093.6 
65-74 2,813.6 2,423 3 2,865 4 3,006 3 2,901.7 2,611.5 3,945 5 3,056.9 2,752.9 
75 and over 5,545.8 4,976 1 6,164 2 6,871 2 6,062.0 6,368.9 7,386 5 6,293.3 5,699.0 
All ages 835.3 690 3 885 6 796 6 897.8 792.1 752 5 1,002.1 807.4 
Females 
Less than 1 2,341.2 1,880 6 2,159 8 2,221 0 2,497.2 1,568.9 3,642 2 7,655.6 2,258.6 
1-14 185.9 152 3 189 4 217 5 235.1 131.0 162 8 687.2 189.2 
15-34 765.5 695 3 776 2 773 4 766.2 807.1 839 9 1,196.7 757.5 
35-49 527.4 455 8 566 4 515 6 476.4 461.4 612 1 826.6 511.9 
50-64 890.4 706 3 992 7 859 4 860.3 816.8 1,051 1 1.568.2 855.7 
65-74 2,009.0 1,694 2 2,174 0 2,099 2 2,021.0 2,119.7 2,573 2 2,292.0 1,969.3 
75 and over 4,082.5 3,495 5 4,709 1 4,582 8 4,039.1 4,909.5 4,667 6 4,654.3 4,074.7 
All ages 966.3 819 9 956 0 931 4 989.9 986.7 921 5 1,194.2 927.2 
Persons 902.0 756 5 920 7 864 7 944.8 891.7 838 5 1,093.5 868.2 
(a) Queensland 1990, Northern Territory 1990-91. Department of Veterans'Affairs (DVA) hospital data for 
1991-92 is included for NSW, Vic, Qld, WA, SA and Tas only. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
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Table S34: Occupied bed-days in private acute and private psychiatric hospitals, by sex and age 
group, States and Territories, 1991-92 or latest year^ (per 1,000 population) 
S e x / 
A g e g r o u p 
N S W 
a n d A C T < b > V i c Q l d W A 
S A 
a n d N T T a s T o t a l 
M a l e s 
Less than 1 133.7 216.6 263.1 225.1 121.5 61.3 181.9 
1-14 30.7 46.8 41.2 28.8 45.8 43.9 38.1 
15-34 77.0 99.1 70.8 73.3 102.5 83.5 83.8 
35-49 138.9 190.3 139.7 136.7 197.6 158.4 157.8 
50-64 292.6 405.7 358.9 322.5 392.7 278.2 344.4 
65-74 540.4 832.5 1,031.7 462.6 650.1 514.6 698.9 
75 and over 890.4 1,464.0 2,068.9 735.6 1,406.8 842.1 1,268.3 
All ages 169.4 246.2 243.0 153.2 233.4 173.3 205.9 
F e m a l e s 
Less than 1 96.9 182.2 230.3 239.3 98.2 31.4 153.3 
1-14 28.8 40.6 34.2 25.4 37.6 32.3 33.3 
15-34 199.7 311.7 276.3 306.0 344.4 160.3 264.4 
35-49 249.1 374.8 317.1 330.2 416.8 341.7 318.7 
50-64 313.6 459.4 446.4 369.4 494.6 376.7 395.9 
65-74 485.0 762.0 899.7 499.4 840.4 563.4 658,6 
75 and over 913.9 1,536.7 2,378.2 792.5 1,914.8 916.0 1,368.6 
All ages 260.7 406.8 405.3 300.3 462.8 281.7 345.3 
P e r s o n s 215.9 328.3 323.9 227.5 349.7 228.8 276.6 
(a) Queensland 1990. 
(b) Data presented for Vic, ACT and NT are estimated from the ABS Private Health Establishments 
collection published as ABS Cat. No. 4390.0 Private Hospitals Australia 1991-92. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
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Table S35: Percentage of bed-days occupied by private and other patients in public acute and 
repatriation hospitals, by sex and age group, States and Territories, 1991-92 or latest year™ (per 
cent) 
S e x / 
A g e g r o u p N S W V i c Qld W A S A T a s A C T T o t a l 
M a l e s 
Less than 1 30.1 29.6 10.1 20.0 30.4 23.0 66.2 25.8 
1-14 35.8 29.4 11.0 24.0 25.3 23.4 34.2 26.1 
15-34 27.9 28.5 5.2 22.6 21.2 23.7 35.8 21.3 
35-49 33.3 27.1 11.2 23.3 25.5 21.7 42.3 25.3 
50-64 35.8 28.2 12.8 24.4 22.6 21.6 46.6 27.1 
65-74 46.6 45.2 30.4 32.2 33.4 53.7 50.9 41.0 
75 and over 35.4 37.1 25.1 31.1 25.7 45.7 41.0 32.9 
Unknown 100.0 7.1 100.0 
-
0.6 
- -
8.9 
All ages 36.6 34.3 17.4 27.1 26.7 36.2 45.6 30.4 
F e m a l e s 
Less than 1 30.7 28.3 10.3 20.5 31.6 34.2 67.5 25.9 
1-14 34.2 28.8 10.3 22.8 23.0 18.1 42.2 24.9 
15-34 34.9 26.9 15.7 16.7 21.1 21.8 54.2 26.6 
35-49 38.5 32.9 15.3 22.4 27.2 18.3 52.9 29.9 
50-64 36.0 28.4 13.6 21.4 20.4 19.5 42.9 27.1 
65-74 30.7 30.9 18.0 19.8 18.6 27.3 45.0 26.5 
75 and over 28.0 30.6 20.6 18.5 19.0 42.5 37.7 26.2 
Unknown 100.0 29.0 
-
100.0 7.6 
-
- 20.8 
All ages 32.6 30.1 16.5 19.4 21.0 29.2 48.9 26.8 
P e r s o n s 34.4 32 .0 17.0 22.9 23.6 32.2 47.4 28.5 
(a) Queensland 1990. Data for NT unavailable. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
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Table S36: Separations from public acute and DVA hospitals, by 40 most frequently occurring procedures, States and Territories, 1991-92 or 
latest year (per 100,000 population) 
NSW Vic Qld WA SA Tas ACT NT 
ICD-9-CM procedure 1991-92 1991-92 1990 1991-92 1991-92 1991-92 1991-92 1990-91 Total 
135 Other extracapsular extraction of lens 92 96 80 92 93 35 76 58 89 
200 Myringotomy 67 81 55 84 137 39 88 67 76 
231 Surgical removal of tooth 76 70 40 85 116 42 220 143 75 
283 Tonsillectomy with adenoidectomy 50 47 50 56 73 23 42 37 51 
332 Diagnostic procedures on lung and bronchus 81 70 69 59 94 113 77 33 75 
372 Diagnostic procedures on heart and pericardium 140 63 10 181 130 85 310 
-
102 
399 Other operations on vessels 5 764 1,159 1,059 1,159 729 1,238 24 630 
441 Diagnostic procedures on stomach 230 163 242 64 59 192 23 330 181 
451 Diagnostic procedures on small intestine 277 295 129 419 567 367 774 43 304 
452 Diagnostic procedures on other intestine 253 176 242 205 269 264 455 100 230 
470 Appendectomy 126 107 96 120 101 83 91 110 112 
512 Cholecystectomy 117 113 110 92 134 85 67 74 112 
530 Unilateral repair of inguinal hernia 105 94 108 99 101 76 63 69 100 
542 Diagnostic procedures of abdominal region 89 76 58 53 114 92 111 193 81 
573 Diagnostic procedures on bladder 147 118 151 183 184 165 58 65 145 
602 Transurethral prostatectomy 74 88 58 71 93 68 73 30 76 
640 Circumcision 61 58 23 52 73 30 67 112 54 
662 Bilateral endoscopic destruction or occlusion of 
fallopian tubes 62 59 17 92 80 59 78 84 58 
673 Other excision or destruction of lesion or tissue 
of cervix 70 68 94 47 84 39 64 72 72 
684 Total abdominal hysterectomy 71 64 71 72 66 55 70 55 69 
690 Dilation and curettage of uterus 325 335 316 337 259 281 296 465 321 
695 Aspiration curettage of uterus 98 140 4 80 317 112 122 394 114 
730 Artificial rupture of membranes 158 159 74 55 51 125 410 228 129 
736 Epesiotomy 123 86 138 86 68 113 195 192 109 
741 Low cervical caesarean section 204 184 192 156 188 172 308 247 192 
756 Repair of other current obstetric laceration 308 254 137 141 168 220 253 223 234 
(Continued next page) 
v i . " Table S36: Separations from public acute and DVA hospitals,™ by 40 most frequently occurring procedures, States and Territories, 1991-92 or 
latest year (per 100,000 population) (continued) 
N S W V i c Q l d W A S A T a s A C T N T ' 
I C D - 9 - C M p r o c e d u r e 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 - 9 1 T o t a l 
786 Removal of internal fixation device 57 49 64 57 57 56 67 71 57 
790 Closed reduction of fracture without internal 
fixation 149 107 104 116 133 102 85 169 124 
793 Open reduction of fracture with internal fixation 109 116 93 122 114 101 127 191 111 
802 Arthroscopy 47 55 63 37 121 38 - 48 77 57 
815 Joint replacement of lower extremity 98 74 25 91 108 72 102 10 78 
852 Excision or destruction of breast tissue . 59 62 49 62 30 61 73 37 56 
860 Incision of skin and subcutaneous tissue 60 34 76 73 72 44 18 . 269 59 
862 Excision or destruction of lesion or tissue of skin 
and subcutaneous tissue 85 74 64 75 98 70 55 117 78 
863 Other local excision or destruction of lesion or 
tissue of skin and subcutaneous tissue 197 168 305 162 208 140 210 106 203 
865 Suture of skin and subcutaneous tissue 33 40 117 49 79 35 6 75 54 :' 
870 Soft tissue X-ray of face, head and neck 17 108 105 159 234 133 26' 151 91 
884 Arteriography using contrast material 38 50 38 63 81 83 108 20 49 
990 Transfusion of blood and blood components 41 1 3 1 66 149 240 179 20 16 98 
992 Injection or infusion of other therapeutic or 
prophylactic substance 50 507 227 742 549 346 817 5 326 
T o t a l 4 , 4 5 1 5 , 4 0 0 5 , 1 1 8 5 , 9 9 5 6 , 9 0 4 5 , 1 2 7 7 , 3 9 0 4 , 7 6 1 5 , 2 3 1 
(a) Department of Veterans' Affairs (DVA) hospital data for 1991-92 is included for NSW, Vic, Qld, WA, SA and Tas only. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
Table S37: Occupied bed-days in public acute and DVA hospitals,™ by 40 most frequently occurring procedures, States and Territories, 1991-92 
or latest year (per 1,000 population) 
NSW Vic Qld WA SA Tas ACT NT 
1CD-9-CM procedure 1991-92 1991-92 1990 1991-92 1991-92 1991-92 1991-92 1990-91 Total 
135 Other extracapsular extraction of lens 2.3 1.9 2.1 2.3 2.0 1.1 1.9 3.3 2.1 
200 Myringotomy 0.8 0.9 0.7 0.9 1.6 0.5 1.0 0.8 0.9 
231 Surgical removal of tooth 0.9 0.8 0.9 1.0 1.7 0.5 2.3 1.6 1.0 
283 Tonsillectomy with adenoidectomy 1.2 0.9 0.8 1.0 1.4 0.6 0,5 0.5 1.0 
332 Diagnostic procedures on lung and bronchus 4.3 5.0 5.6 4.3 6.5 5.4 5.0 2.7 4.9 
372 Diagnostic procedures on heart and pericardium 4.6 2.6 0.5 6.5 5.0 2.3 11.9 
-
3.6 
399 Other operations on vessels 0.4 8.6 12.6 11.1 13.1 7.8 14.7 1.7 7.1 
441 Diagnostic procedures on stomach 7.7 5.9 8.0 1.4 1.3 5.2 0.6 8.4 6.0 
451 Diagnostic procedures on small intestine 10.1 10.2 5.4 12.4 17.3 9.1 22.6 0.8 10.2 
452 Diagnostic procedures on other intestine 6.4 4.4 5.7 5.0 6.1 5.0 10.0 4.7 5.6 
470 Appendectomy 5.6 4.6 4.1 4.9 4.4 3.8 4.4 5.8 4.9 
512 Cholecystectomy 9.2 7.8 9.0 7.1 9.1 6.4 5.8 6.9 8.5 
530 Unilateral repair of inguinal hernia 4.3 3.4 3.9 3.6 4.4 3.0 2.1 4.8 3.9 
542 Diagnostic procedures of abdominal region 1.8 1.4 1.4 1.1 2.6 1.6 1.7 3.4 1.7 
573 Diagnostic procedures on bladder 4.5 2.9 5.3 4.4 4.8 4.5 2.9 2.6 4.2 
602 Transurethral prostatectomy 6.5 7.4 5.0 5.4 7.2 6.3 10.0 3.4 6.5 
640 Circumcision 0.9 0.7 0.4 0.9 0.9 0.5 2.9 5.5 0.8 
662 Bilateral endoscopic destruction or occlusion of 
fallopian tubes 0.7 0.8 0.3 1.1 1.0 0.7 0.8 1.6 0.7 
673 Other excision or destruction of lesion or tissue 
of cervix 0.8 0.8 1.2 0.5 1.1 0.4 0.7 0.8 0.8 
684 Total abdominal hysterectomy 5.8 5.5 5.5 5.7 5.1 5.4 6.6 4.7 5.6 
690 Dilation and curettage of uterus 4.2 4.5 5.3 4.4 3.7 4.0 3.7 9.1 4.5 
695 Aspiration curettage of uterus 1.1 1.5 0.1 0.9 3.6 1.4 1.6 4.3 1.3 
730 Artificial rupture of membranes 6.9 8.7 3.5 2.4 2.7 6.4 19.5 11.8 6.3 
736 Epesiotomy 5.8 4.6 6.9 4.2 3.2 5.6 8.9 11.1 5.4 
741 Low cervical caesarean section 17,1 16.5 15.2 12.8 15.7 15.0 24.8 26.3 16.2 
756 Repair of other current obstetric laceration 13.5 12.8 6.6 6.5 7.5 10.6 11.0 11.0 10.9 
io (Continued next page) 
Table S37: Occupied bed-days in public acute and DVA hospitals, by 40 most frequently occurring procedures, States and Territories, 1991-92 
or latest year (per 1,000 population) (continued) 
N S W V i c Q l d W A S A T a s A C T N T 
I C D - 9 - C M p r o c e d u r e 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 - 9 1 T o t a l 
786 Removal of internal fixation device 1.9 1.4 2.2 2.4 1.7 1.4 1.7 2.0 1.9 
790 Closed reduction of fracture without internal 
fixation 4.2 3.4 3.3 3.4 3.5 5.0 2.6 9.6 3.7 
793 Open reduction of fracture with internal fixation 12.3 14.5 11.8 11.1 9.8 13.8 13.6 26.5 12.6 
802 Arthroscopy 1.1 1.0 1.3 0.8 2.3 0.9 1.2 2.6 1.2 
815 Joint replacement of lower extremity 17.7 13.1 4.3 16.3 14.2 14.7 16.6 2.9 13.7 
852 Excision or destruction of breast tissue 1.4 1.3 1.5 1.5 0.9 1.6 1.3 0.7 1.3 
860 Incision of skin and subcutaneous tissue 2.9 1.7 3.6 3.2 3.3 2.4 0.9 19.4 2.9 
862 Excision or destruction of lesion or tissue of skin 
and subcutaneous tissue 5.3 5.1 4.2 4.5 6.8 4.4 5.6 13.4 5.2 
863 Other local excision or destruction of lesion or 
tissue of skin and subcutaneous tissue 5.3 3.8 8.0 3.6 7.3 3.7 3.3 2.7 5.3 
865 Suture of skin and subcutaneous tissue 1.1 1.2 2.9 1.5 2.1 1.6 0.2 3.1 1.6' 
870 Soft tissue X-ray of face, head and neck 0.8 13.7 15.6 25.0 25.4 19.5 1.0 15.7 11.6 
884 Arteriography using contrast material 1.7 2.4 1.8 2.7 3.3 2.4 6.7 0.5 2.2 
990 Transfusion of blood and blood components 1.9 5.9 4.3 9.2 7.3 7.0 0.7 2.0 4.6 
992 Injection or infusion of other therapeutic or 
prophylactic substance 1.2 9.7 5.2 17.0 12.7 8.0 13.0 0.1 6.9 
T o t a l 1 8 6 . 1 2 0 3 . 8 1 8 5 . 8 2 1 4 . 1 2 3 3 . 8 1 9 9 . 4 2 4 6 . 5 2 3 8 . 8 1 9 9 . 2 
(a) Department of Veterans' Affairs (DVA) hospital data for 1991-92 is included for NSW, Vic, Qld, WA, SA and Tas only. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
T a b l e S 3 8 : Separations from public acute and DVA hospitals,™ by 40 most frequently occurring diagnoses, States and Territories, 1991-92 or 
latest year (per 1,000 population) 
N S W Vic Qld W A S A T a s A C T N T 
I C D - 9 - C M d i a g n o s i s 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 - 9 1 T o t a l 
173 Other malignant neoplasm of skin 92 85 147 108 100 76 115 43 101 
250 Diabetes mellitus 89 86 88 78 122 88 73 128 90 
345 Epilepsy 96 69 90 101 86 60 52 111 66 
366 Cataract 133 147 139 150 135 41 108 67 136 
410 Acute myocardial infarction 182 150 160 155 188 171 116 79 166 
411 Other acute and subacute forms of ischaemic 
heart disease 146 112 38 111 91 172 131 22 111 
413 Angina pectoris 79 62 150 88 125 59 46 64 90 
414 Other forms of chronic ischaemic heart disease 246 159 133 193 266 200 199 18 197 
427 Cardiac dysrhythmias 137 104 106 109 128 113 87 71 118 
428 Heart failure 192 165 185 177 240 157 111 96 183 
474 Chronic disease of tonsils and adenoids 96 100 103 120 137 65 98 72 103 
493 Asthma 356 250 359 420 480 192 233 324 339 
496 Chronic airway obstruction, not elsewhere 
classified 130 95 116 83 126 105 49 99 111 
530 Diseases of oesophagus 187 146 140 150 279 219 282 94 174 
535 Gastritis and duodenitis 101 74 72 107 83 101 145 111 89 
550 Inguinal hernia 125 116 126 117 129 88 91 76 120 
558 Other non-infectious gastroenteritis and colitis 172 94 131 156 162 124 112 54 139 
574 Cholelithiasis 159 139 119 125 170 113 140 86 142 
599 Other disorders of urethra and urinary tract 104 84 118 122 122 107 49 149 104 
626 Disorders of menstruation and other abnormal 
bleeding from female genital tract 119 127 119 144 156 134 114 148 127 
634 Spontaneous abortion 121 86 100 103 72 75 129 171 102 
635 Legally induced abortion 53 106 3 72 278 83 73 386 83 
642 Hypertension complicating pregnancy, childbirth 
and the puerperium 109 88 90 94 101 101 106 141 98 
644 Early or threatened labour 117 126 127 101 109 144 151 185 121 
(Continued next page) 
Table S38: Separations from public acute and DVA hospitals,™ by 40 most frequently occurring diagnoses, States and Territories, 1991-92 or 
latest year (per 100,000 population) (continued) 
NSW V i c Q l d W A S A T a s A C T N T 
I C D - 9 - C M p r o c e d u r e 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 - 9 1 T o t a l 
650 Delivery in a completely normal case 263 142 518 246 181 200 266 500 266 
656 Other foetal and placental problems affecting 
management of molher 170 157 92 123 158 115 125 142 145 
664 Trauma to perineum and vulva during delivery 268 251 139 140 192 274 271 260 224 
662 Other cellulitis and abscess 93 66 109 105 86 53 45 366 90 
715 Osteoarthrosis and allied disorders 103 75 78 116 123 77 111 22 93 
724 Other and unspecified disorders of back '103 82 167 173 201 84 78 75 122 
780 General symptoms 186 123 210 193 261 131 115 196 178 
786 Symptoms involving respiratory system and 
other chest symptoms 204 134 243 181 277 152 162 144 194 
789 Other symptoms involving abdomen and pelvis 257 209 443 289 320 209 205 266 282 
813 Fracture of radius and ulna 133 91 105 130 131 80 78 192 115 
854 Intracranial injury of other and unspecified nature 81 49 192 74 69 59 40 133 89 
• 996 Complications peculiar to certain specified 
procedures 96 78 60 116 128 63 87 32 88 
V25 Contraceptive management 128 131 65 170 169 108 94 120 125 
V56 Aftercare involving intermittent dialysis 1,026 1,035 1,150 1,050 1,155 723 1,232 1,048 
V58 Other and unspecified aftercare 415 402 272 661 469 393 783 36 418 
V67 Follow-up examination 78 21 70 325 127 64 61 31 89 
T o t a l 6 , 9 4 3 5 , 6 1 4 6 , 8 6 9 7 , 2 7 6 7 , 9 3 2 5 , 5 7 7 6 , 5 6 6 5 , 3 1 0 6 , 6 9 7 
(a) Department of Veterans'Affairs (DVA) hospital data for 1991-92 is included for NSW, Vic, Qld, WA, SAand Tas only. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
Table S39: Occupied bed-days in public acute and DVA hospitals, by 40 most frequently occurring diagnoses, States and Territories, 1991-92 
or latest year (per 1,000 population) 
N S W V i c Q l d W A S A T a s A C T N T 
I C 0 - 9 - C M d i a g n o s i s 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 1 - 9 2 1 9 9 0 - 9 1 T o t a l 
173 Other malignant neoplasm of skin 3.6 3.0 5.1 3.7 3.9 3.5 1.8 0.9 3.7 
250 Diabetes mellitus 8.0 8.3 7.6 6.9 10.9 10.6 11.1 11.9 8.3 
345 Epilepsy 3.5 3.4 4.1 4.1 4.6 4.6 2.4 6.2 3.7 
366 Cataract 3.0 3.0 3.7 3.8 3.1 1.2 1.8 3.4 3.1 
410 Acute myocardial infarction 15.4 12.4 14.5 12.6 15.3 14.0 10.1 5.9 14.0 
411 Other acute and subacute forms of ischaemic 
heart disease 8.5 5.9 2.4 5.8 5.2 9.2 7.4 0,8 6.2 
413 Angina pectoris 3.2 2.4 6.9 3.6 5.2 2.4 2.6 2.7 3.8 
414 Other forms of chronic ischaemic heart disease 15.5 9.8 9.6 9.8 15.1 10.1 6.8 0.9 12.1 
427 Cardiac dysrhythmias 6.7 4.9 5.4 4.6 5.9 5.4 3.9 3.6 5.6 
428 Heart failure 19.7 17.1 19.7 18.5 23.6 16.3 12.3 9.3 18.9 
474 Chronic disease of tonsils and adenoids 2.2 2.0 1.7 2.4 2.7 1.6 1.3 1.0 2.1 
493 Asthma 12.3 7.9 11.5 12.8 17.2 8.2 8.5 11.7 11.3 
496 Chronic airway obstruction, not elsewhere 
classified 12.7 9.7 12.3 9.1 11.9 10.8 5.3 8.8 11.2 
530 Diseases of oesophagus 4.7 4.0 3.7 3.4 6.5 4.7 5.9 1.6 4.4 
535 Gastritis and duodenitis 2.2 1.6 1.7 2.3 1.7 1.9 2.1 2.1 1.9 
550 Inguinal hernia 4.9 4.1 4.1 4.2 5.0 3.4 2.6 2.6 4.4 
558 Other non-infectious gastroenteritis and colitis 4.6 2.8 4.1 5.5 4.8 3.5 2.9 2.6 4.1 
574 Cholelithiasis 9.5 7.9 7.5 8.1 9.4 6.9 9.0 5.9 8.5 
599 Other disorders of urethra and urinary tract 5.1 4.7 6.3 5,6 5.6 5.3 2.8 12.7 5.3 
626 Disorders of menstruation and other abnormal 
bleeding from female genital tract 2.3 2.2 3.3 3.6 4.0 2.9 2.6 3.3 2.7 
634 Spontaneous abortion 1.6 1.1 1.5 1.4 0.9 1.1 1.6 3.7 1.4 
635 Legally induced abortion 0.6 1.1 0.1 0.9 3.2 1.0 0.8 4.2 0.9 
642 Hypertension complicating pregnancy, childbirth 
and the puerperium 6.5 5.2 4.5 5.1 5.7 5.7 7.5 10.8 5.7 
644 Early or threatened labour 4.0 3.6 2.9 2.7 3.3 3.5 5.4 9.0 3.6 
M (Continued next page) 
^ Table S39: Occupied bed-days in public acute and DVA hospitals,™ by 40 most frequently occurring diagnoses. States and Territories, 1991-92 
0 1
 or latest year (per 1,000 population) (continued) 
NSW Vic . Qld WA SA Tas ACT NT 
ICD-9-CM procedure 1991-92 1991-92 1990 1991-92 1991-92 1991-92 1991-92 1990-91 Total 
650 Delivery in a completely normal case 10^ 2 6.4 22.7 10.6 8.3 8.4 10.0 27.1 11.3 
656 Other foetal and placental problems affecting 
management of mother 8.9 8.8 4.6 7.0 8.4 6.1 7.3 9.0 7.8 
664 Trauma to perineum and vulva during delivery 11 i2 12.4 6.4 6.4 8.6 12.8 12.3 12.9 10.1 
682 Other cellulitis and abscess '' 6.4 4.8 6.5 6.5 4:9 3.5 2.7 24.8 5.9 
715 Osteoarthrosis and allied disorders 12.3 8.8 9.4 14.1 12.8 11.6 12.3 3.9 11.0 
724 Other and unspecified disorders of back 6:3 4.6 10.7 8.0 9.6 5.4 3.9 3.7 7.0 
780 General symptoms 5.6 3.9 6.8 5.7 8.7 5.3 4.0 7.9 5.6 
786 Symptoms involving respiratory system and 
other chest symptoms 5.8 3.6 7.6 5.2 8.7 4.2 4.4 6.3 5.6 
789 Other symptoms involving abdomen and pelvis 6.3 4.6 10.7 7.4 8.4 4,9 5.1 8.1 6.8 
813 Fracture of radius and ulna 3.0 2.3 3.2 3.3 3.2 2.9 1.9 9.3 2.9 
854 Intracranial injury of other and unspecitied nature 1,8 1.2 4.2 1.3 1.8 1.3 2.6 6.3 2.0 
996 Complications peculiar to certain specified 
procedures 10.8 8.1 7.4 13.8 11.7 6.4 • 10.2 2.3 9.7 
V25 Contraceptive management 15 1.5 1.1 2.0 2.2 1.3 1.0 2.1 1.5 
V56 Aftercare involving intermittent dialysis 10.4 10.9' 11.8 10.6 11.6 7.4 12.4 
-
10.7 
V58 Other and unspecified aftercare 7.3 6-5 4.9 11.6 8.9 8.0 12.1 1.3 7.3 
V67 Follow-up examination 1.4 0.6 1.3 3.5 2.0 2.6 • 1.4 2.3 1.5 
Total 269.3 217.2 263.7 257.3 294.5 230.1 220.0 252.8 253.9 
(a) Department of Veterans'Affairs (DVA) hospital data for 1991-92 is included for NSW, Vic, Qld, WA, SA and Tas only. 
Sources: Cook & Sardana 1994; AIHW unpublished data 
Nursing homes 
Table S40: Nursing home residents™ and proportion of population resident, by age and sex, 
States and Territories, 30 June 1993 (number) 
A g e g r o u p N S W V i c Q l d W A S A T a s A C T N T A u s t 
% o f 
p o p ' n 
F e m a l e s 
Less than 50 203 86 71 42 73 12 4 6 497 0.01 
50-54 103 48 40 23 23 12 5 1 255 0.06 
55-59 201 79 64 34 42 12 4 7 443 0.12 
60-64 355 174 125 77 74 30 9 1 845 0.24 
65-69 737 367 297 146 180 45 12 5 1,789 0.50 
70-74 1,536 724 577 243 322 88 30 15 3,535 1.16 
75-79 2,932 1,655 1,187 564 690 237 54 11 7,330 3.17 
80-84 4,717 2,565 1,902 958 1,096 370 91 22 11,721 7.42 
85-89 4,958 2,969 2,070 1,067 1,176 356 88 17 12,701 15.33 
90-94 3,408 2,122 1,503 758 848 257 60 12 6,968 28.56 
95-99 1,198 799 540 218 349 72 19 2 3,197 42.16 
100 and over 274 202 109 42 88 17 4 2 738 55.95 
Total 20,622 11,790 8,485 4,172 4,961 1,508 380 101 52,019 6.59 
M a l e s 
Less than 50 207 69 74 77 78 17 4 . 11 537 0.01 
50-54 84 66 29 24 22 7 2 2 236 0.05 
55-59 233 73 61 35 40 9 4 3 458 0.12 
60-64 397 181 159 80 63 18 2 6 906 0.25 
65-69 759 377 279 140 156 39 19 6 1,775 0.54 
70-74 1,034 515 425 206 262 78 21 11 2,552 1.02 
75-79 1,536 909 626 305 347 125 22 7 3,877 2.37 
80-84 1,651 1,006 714 374 409 108 33 16 4,311 4.61 
85-89 1,262 792 566 322 300 92 25 6 3,365 8.66 
90-94 550 351 270 133 150 52 9 5 1,520 13.84 
95-99 145 114 71 24 44 12 2 
-
412 25.15 
100 and over 36 36 16 6 12 4 -
-
110 37.04 
Total 7,894 4,489 3,290 1,726 1,883 561 143 73 20,059 0.23 
Al l p e r s o n s 28 ,516 16,279 11,775 5 , 8 9 8 6 , 8 4 4 2,069 523 174 72,078 0.41 
(a) Excludes homes not specifically catering for aged persons. 
Sources: DHHLGCS 1993a; AIHW unpublished data 
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Table S41: Nursing home separations by length of stay, States and Territories, 1991-92 (per cent) 
Duration NSW Vic Qld WA SA Tas ACT NT Aust 
Less than 4 weeks - 28.0
 : 
32.8 17.1 23.7 30.3 26.2 15.3 22.7 27.7 
4 to 7 weeks 11.9 10.4 8.2 8.1 10.3 10.0 7,6 12.5 10.5 
8 to 12 weeks 5.8 5.4 4.9 4.7 6.1 4.9 3.8 4.5 5.5 
13 to 25 weeks 8.0 7.2 7.9 . 7.8 7.7 7.2 86 13.6 7.7 
26 to 38 weeks 4.1 3.7 4.8 5.0 4.0 5.6 4.3 1.1 4.2 
39 to 51 weeks 4.1 3.7 4.8 5.0 4.0 5.6 4.3 3.4 4.2 
1 to < 2 years 11.1 10.2 14.7 11.5 10.3 10.7 15.8 10.2 11.3 
2 to < 3 years 7.3 7.9 9.8 9.4 7.1 9.5 17.3 3.4 8.0 
3 to < 4 years 5.0 5.0 7.0 6.2 5.5 5.9 6.2 11.3 5.4 
4 to < 5 years 3.7 3.6 5.3 4.2 3.4 4.1 7.6 2.2 3.9 
5 to < 10 years 7.7 6.6 11.0 10.0 7.8 7.8 6.2 13.6 8.0 
10 or more years 2.0 1.6 2.6 2.9 2.3 1.6 
-
1.1 2.0 
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Separations 15,469 10,127 4,793 2,773 4,102 1,196 208 88 38,756 
Source: DHHLGCS 1993b 
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Health expenditure 
Table S42: Total health expenditure (current and constant 1989-90 prices) and rate of growth, 
1982-83 to 1992-93 
T o t a l h e a l t h e x p e n d i t u r e ( $ m ) A n n u a l r a t e o f g r o w t h ( % ) 
C u r r e n t C o n s t a n t C u r r e n t C o n s t a n t 
Y e a r p r i c e s 1 9 8 9 - 9 0 p r i c e s * 8 * p r i c e s 1 9 8 9 - 9 0 p r i c e s * 8 * 
1982-83 13,239 20,673 
1983-84 14,958 21,989 13.0 6.4 
1984-85 16,546 22,862 10.6 4.0 
1985-86 18,586 24,180 12.3 5.8 
1986-87 21,115 25,341 13.6 4.8 
1987-88 23,328 26,294 10.5 3.8 
1988-89 26,154 27,748 12.1 5.5 
1989-90 28,814 28,814 10.2 3.8 
1990-91 31,132 29,358 8.0 1.9 
1991-92*b> 32,758 30.020 5.2 2.3 
1992-93 t b ) 34,338 31,068 4.8 3.5 
(a) Health expenditure 1982-83 to 1992-93 deflated to constant prices using specific health deflators. 
(b) Based on preliminary AIHW and ABS estimates. 
Source: AIHW unpublished data 
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Table S43: Total, recurrent and capital health expenditure (current and constant 1989-90 prices), 
1975-76 to 1992-93 ($ million) 
Y e a r 
R e c u r r e n t G o v e r n m e n t c a p i t a l C a p i t a l T o t a l 
e x p e n d i t u r e c o n s u m p t i o n e x p e n d i t u r e e x p e n d i t u r e 
C u r r e n t p r i c e s 
1975-76 5,092 
1976-77 5,901 
1977-78 6,762 
1978-79 7,462 
1979-80 8,297 
.1980-81 9,457 
1981-82 11,049 
1982-83 12,434 
1983-84 13,996 
1984-85 15,397 
1985-86 17,172 
1986-87 ' 19,528 
1987-88 21,569 
1988-89 24,302 
1989-90 26,849 
1990-91 29,162 
1991-92 t a ) 30,879 
1992-93 t a ) 32,379 
C o n s t a n t 1 9 8 9 - 9 0 p r i c e s ( b ) 
1975-76 15,706 
1976-77 16,017 
1977-78 16,979 
1978-79 17,589 
1979-80 17,769 
1980-81 18,182 
1981-82 19,087 
1982-83 19,439 
1983-84 20,603 
1984-85 21,271 
1985-86 22,396 
1986-87 23,490 
1987-88 24,335 
1988-89 25,796 
1989-90 26,849 
1990-91 27,425 
1991-92 ( a ) " 28,298 
1992-93<a) 27 
114 
150 
176 
200 
241 
268 
303 
341 
358 
380 
416 
454 
476 
487 
510 
521 
536 
543 
350 
417 
450 
479 
515 
510 
511 
506 
499 
507 
509 
522 
525 
513 
510 
510 
491 
491 
513 
552 
531 
579 
540 
499 
446 
464 
604 
769 
998 
1,133 
1,282 
1,365 
1,456 
1,449 
1,343 
1,416 
1,623 
1,587 
1,412 
1,449 
1,219 
1,007 
795 
728 
887 
1,084 
1,274 
1,329 
1,434 
1,440 
1,456 
1,423 
1,231 
1,281 
5,719 
6,603 
7,469 
8,240 
9,078 
10,224 
11,798 
13,239 
14,958 
16,546 
18,586 
21,115 
23,328 
26,154 
28,814 
31,132 
32,758 
34,338 
17,679 
18,021 
18,841 
19,517 
19,502 
19,699 
20,393 
20,673 
21,989 
22,862 
24,180 
25,341 
26,294 
27,748 
28,814 
29,358 
30,020 
31,068 
(a) Based on preliminary AIHW and ABS estimates. 
(b) Health expenditure 1975-76 to 1992-93 deflated to constant prices using specific health deflators. 
Source: AIHW unpublished data 
2 8 0 
Table S44: Total health expenditure, GDP and rate of growth (current prices), 1982-83 to 1992-93 
T o t a l h e a l t h e x p e n d i t u r e G D P 
A m o u n t G r o w t h A m o u n t G r o w t h H e a l t h e x p e n d i t u r e 
Y e a r ( $ m ) r a t e ( % ) ( $ m ) r a t e ( % ) a s % o f G D P 
1982-83 13,239 171,774 7.7 
1983-84 14,958 13.0 194,831 13.4 7.7 
1984-85 16,546 10.6 216,257 11.0 7.7 
1985-86 18,586 12.3 240,224 11.1 7.7 
1986-67 21,115 13.6 264,521 10.1 8.0 
1987-88 23,328 10.5 298,426 12.8 7.8 
1988-89 26,154 12.1 339,723 13.8 7.7 
1989-90 28,814 10.2 370,007 8.9 7.8 
1990-91 31,132 8.0 379,902 2.7 8.2 
1991-92 t a ) 32,758 5.2 388,071 2.2 8.4 
1992-93<a) 34,338 4.8 401,698 3.5 8.5 
(a) Total health expenditure figures are based on preliminary AIHW and ABS estimates. 
Sources; AIHW unpublished data; ABS Cat. No. 5206.0 
T a b l e S45: Health expenditure per person (current and constant 1989-90 prices) and rate of 
growth, 1982-83 to 1992-93 
E x p e n d i t u r e p e r p e r s o n ( $ ) R a t e o f g r o w t h ( % ) 
C o n s t a n t C o n s t a n t 
Y e a r C u r r e n t p r i c e s 1989-90 p r i c e s < a } C u r r e n t p r i c e s 1989-90 p r i c e s 
1982-83 866 1,352 
1983-84 966 1,420 11.6 5.0 
1984-85 1.055 1,458 9.2 2.7 
1985-86 1,169 1,521 10.8 4.3 
1986-87 1,309 1,571 12.0 3.3 
1987-88 1,424 1,605 8.8 2.2 
1988-89 1,569 1,664 10.2 3.7 
1989-90 1,703 1,703 8.5 2.3 
199CK91 1,813 1,710 6.5 0.4 
1991-92<b) 1,881 1,724 3.7 0.8 
1992-93 ( b ) 1,944 1,768 3.9 2.6 
(a) Health expenditure 1982-83 to 1992-93 deflated to constant prices using specific health deflators. 
(b) Based on preliminary AIHW and ABS estimates. 
Sources; AIHW unpublished data; ABS Cat. No. 3101.0 
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Table S46: Total health expenditure (current prices), 1980-81,1985-86 and 1990-91 ($ million) 
H e a l t h e x p e n d i t u r e 1 9 8 0 - 8 1 1 9 8 5 - 8 6 1 9 9 0 - 9 1 
R e c u r r e n t h e a l t h e x p e n d i t u r e 
Institutional 
Hospitals 
Recognised public 3,365 5,518 8,726 
Repatriation 164 266 516 
Private 454 969 1,821 
Public psychiatric 465 619 780 
Total hospitals 4,448 7,372 11,843 
Total nursing homes 788 1,546 2,550 
Other institutional services 175 304 465 
Total institutional 5,412 9,221 14,857 
Non-institutional 
Medical services 1,607 3,091 5,499 
Dental services 430 879 1,501 
Other professional services 241 572 1,202 
Community and public health 282 689 1,153 
Pharmaceuticals 810 1,491 2,803 
, Other non-instrtutional(a) 675 1,229 2,147 
Total non-institutional 4,045 7,951 14,305 
T o t a l r e c u r r e n t h e a l t h e x p e n d i t u r e * 6 ) 9 , 4 5 7 1 7 , 1 7 2 2 9 , 1 6 2 
C a p i t a l h e a l t h e x p e n d i t u r e 4 9 9 9 9 8 1 , 4 4 9 
C a p i t a l c o n s u m p t i o n 2 6 8 4 1 6 5 2 1 
T o t a l h e a l t h e x p e n d i t u r e 1 0 , 2 2 4 1 8 , 5 8 6 3 1 , 1 3 2 
(a) Includes aids and appliances, research, administration and other non-institutional services. 
(b) Does not include capital consumption. 
Source: AIHW unpublished data 
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Table S47: Total health expenditure (constant 1989-90 prices), 1980-81,1985-86 and 1990-91 
($ million) 
H e a l t h e x p e n d i t u r e 1980-81 1985-86 1990-91 
R e c u r r e n t h e a l t h e x p e n d i t u r e 
Institutional 
Hospitals 
Recognised public 6,478 7,166 8,246 
Repatriation 316 346 487 
Private 874 1,258 1,720 
Public psychiatric 896 804 737 
Total hospitals 8,564 9.575 11,191 
Total nursing homes 1,518 2.008 2,410 
Other institutional services 338 394 439 
Total institutional 10,420 11,977 14,040 
Non-institutional 
Medical services 3,143 4,099 5,107 
Dental services 995 1,284 1,390 
Other professional services 460 741 1,136 
Community and public health 507 840 1,099 
Pharmaceuticals 1,442 1,930 2,620 
Other non-institutional*3* 1,215 1,526 2,035 
Total non-institutional 7,762 10.420 13.385 
T o t a l r e c u r r e n t h e a l t h e x p e n d i t u r e * " * 18,182 22,396 27,425 
C a p i t a l h e a l t h e x p e n d i t u r e 1,007 1,274 1,423 
C a p i t a l c o n s u m p t i o n 510 509 510 
T o t a l h e a l t h e x p e n d i t u r e 19,699 24,180 29,358 
(a) Includes aids and appliances, research, administration and other non-institutional services. 
(b) Does not include capital consumption. 
Source: AIHW unpublished data 
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Table S48: Total health expenditure (constant 1989-90 prices)™ by source of funds, 1970-71 to 
1992-93 ($ million) 
P u b l i c s e c t o r 
C o m m o n w e a l t h S t a t e a n d l o c a l T o t a l P r i v a t e A l l 
Y e a r g o v e r n m e n t g o v e r n m e n t g o v e r n m e n t s e c t o r s e c t o r s 
1970-71 3,262 3,340 6,602 5,043 11,644 
1971-72 3,656 3,521 7,179 5,157 12,336 
1972-73 3,866 3,717 7,583 5,393 12,977 
1973-74 4,039 4,152 8,191 5,299 13.489 
1974-75 4,436 5,120 9,556 5,680 15.237 
1975-76 8,301 4,457 12,758 4,921 17,679 
1976-77 7,403 4,522 11,926 6,095 18,021 
1977-78 6,798 4,801 11,599 7,243 18,841 
1978-79 6,872 5,233 12,105 7,412 19,517 
1979-80 6,747 5,180 11,927 7,575 19.502 
1980-81 6,957 5,318 12,276 7,424 19.699 
1981-82 7,068 5.530 12,597 7,795 20,393 
1982-83 6,972 5,467 12,439 8.234 20,673 
1983-84 8,353 5,705 14,058 7,931 21,989 
1984-85 10,454 5,797 16,250 6,611 22,862 
1985-86 11,030 6,147 17,177 7,003 24,180 
1986-87 11,253 6.557 17,810 7,531 25,341 
1987-88 11,544 6,799 18,343 7,951 26,294 
1988-89 11.804 7,305 19,109 8,639 27.748 
1989-90 12,104 7,635 19,739 9,076 28.814 
1990-91 12,422 7,603 20,024 9,333 29,358 
1991-92 ( t ) ' 12,957 7,313 20,270 9,749 30,020 
1992-93<b) 13,704 7.288 20,992 10,077 31,068 
(a) Health expenditure 1970-71 to 1992-93 deflated to constant prices using specific health deflators. 
(b) Based on preliminary AIHW and ABS estimates. 
Source: AIHW unpublished data 
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Table S49: Total health expenditure by area of expenditure and source of funds, 1990-91 
($ million) 
P u b l i c s e c t o r P r i v a t e s e c t o r 
H e a l t h 
C o m m o n ­ S t a t e / i n s u r a n c e I n d i v ­ (b) P e r 
A r e a o f e x p e n d i t u r e w e a l t h l o c a l T o t a l f u n d s i d u a l s O t h e r T o t a l T o t a l c e n t 
T o t a l h e a l t h 
e x p e n d i t u r e 13,219 7,992 21,211 n a n a n a 9,921 31,132 
C a p i t a l 
(e) e x p e n d i t u r e 181 775 956 n a n a 493 1,449 
C a p i t a l 
c o n s u m p t i o n 47 474 521 «0 <<*) (0) td) 521 
T o t a l r e c u r r e n t 
e x p e n d i t u r e 12,991 6,743 19,734 3,491 5,096 841 9,428 29,162 100.0 
T o t a l i n s t i t u t i o n a l 6,070 5,526 11,596 2,075 856 328 3,262 14,857 50.9 
Total hospitals 4,307 5,012 9,319 2,012 207 305 2,524 11,843 40.6 
Recognised 
public 3,711 4,301 8,012 550 
-
164 714 8,726 29.9 
Private 86 
-
86 1,451 152 132 1,734 1,821 6.2 
Repatriation 494 3 497 11 
-
8 19 516 1.8 
Public 
psychiatric 17 707 724 
-
55 1 56 780 2.7 
Total nursing homes*6' 1,658 325 1,983 
-
562 5 567 2,550 8.7 
Other institutional serv­
ices 105 189 294 63 89 19 171 465 1.6 
Ambulance 38 189 227 63 69 19 171 398 1.4 
Other institutional 
(nec) 67 
-
67 
-
- - -
67 0.2 
T o t a l n o n -
i n s t i t u t i o n a l 6,921 1,218 8,138 1,416 4,238 513 6,166 14,305 49.1 
Medical services 4,384 8 4,392 173 636 297 1,107 5,499 18.9 
Dental services 33 62 95 503 887 16 1,406 1,501 5.1 
Other professional 
services 138 
-
138 156 749 159 1,064 1,202 4.1 
Community and public 
health'** 293 844 1,138 1 
-
14 15 1,153 4.0 
Continued next page 
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Table S49: Total health expenditure by area of expenditure and source of funds, 1990-91 
($ million) (continued) 
P u b l i c s e c t o r P r i v a t e s e c t o r 
A r e a o f e x p e n d i t u r e 
C o m m o n ­
w e a l t h 
S t a t e / 
l o c a l T o t a l 
H e a l t h 
i n s u r a n c e 
f u n d s 
I n d i v ­
i d u a l s O t h e r T o t a l T o t a l 
P e r 
c e n t 
T o t a l n o n - i n s t i t u t i o n a l (continued) 
Total 
pharmaceuticals 1,245 
-
1,245 39 1,506 13 1,558 2,803 9.6 
Benefit paid items 1,245 
-
1,245 
-
224 
-
224 1,468 5.0 
All other items 
- -
39 1,282 13 1,335 1,335 4.6 
Aids and 
appliances 60 2 62 153 407 13 573 635 2.2 
Administration 470 126 596 391 
-
-
391 986 3.4 
Research 279 98 378 
-
53 - 53 431 1.5 
Other non-
institutional 17 77 94 
-
-
- -
94 0.3 
(a) This table records the amounts provided by the Commonwealth, State and local governments and the 
private sector to fund expenditure on health. It does not give the actual amount spent directly on health 
goods and services by each sector. 
(b) The 'Other' column includes the health costs paid by workers' compensation and motor vehicle third 
party insurance funds. 
(c) Capital expenditure for the private sector cannot be broken down by source of funds. 
(d) Capital consumption (depreciation) for the private sector is included in recurrent expenditure. 
(e) Nursing home expenditure for 1987-88 to 1990-91 is not comparable with earlier years because from 
1987-88 non-aged nursing homes expenditure was not included and the methodology for calculating 
individual contributions changed. 
(f) This includes the old categories of community health services and health promotion and illness 
prevention. 
Source: AIHW unpublished data 
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Table S50: Total health expenditure as a percentage of GDP, Australia and selected OECD 
countries, 1970 to 1992 (per cent) 
Year Aust<8> Can Fra GerW Jpn NZ Swe UK USA 
Nine 
country 
mean ( c* 
Eight 
country 
mean*"* 
1970 5.2 7.1 5.8 5.9 4.6 5.2 7.2 4.5 7.4 5.9 5.7 
1971 5.7 7.4 6.0 6.3 4.7 5.2 7.5 4.6 7.5 6.1 5.9 
1972 5.9 7.2 6.1 6.5 4.8 5.3 7.5 4.7 7.6 6.2 6.0 
1973 5.8 7.0 6.2 6.8 4.7 5.5 7.4 4.6 7.6 6.2 6.0 
1974 5.9 6.8 6.3 7.4 5.1 6.1 7.6 5.3 7.9 6.5 6.3 
1975 6.5 7.2 7.0 8.1 5.6 6.7 7.9 5.5 8.4 7.0 6.8 
1976 7.5 7.2 7.0 8.1 5.6 6.3 8.2 5.5 8.6 7.1 6.9 
1977 7.5 7.2 7.0 8.1 5.8 6.6 9.1 5.3 8.7 7.3 7.1 
1978 7.8 7.2 7.3 8.1 6.0 7.1 9.2 5.3 8.7 7.4 7.2 
1979 7.6 7.1 7.4 8.1 6.1 7.0 9.0 5.3 8.7 7.4 7.2 
1980 7.4 7.4 7.6 8.4 6.6 7.2 9.4 5.8 9.2 7.7 7.5 
1981 7.3 7.5 7.9 8.7 6.6 6.9 9.5 6.1 9.6 7.8 7.6 
1982 7.5 8.4 8.0 8.6 6.8 6.6 9.7 5.9 10.3 8.0 7.7 
1983 7.7 8.6 8.2 8.5 6.9 6.5 9.6 6.1 10.6 8.1 7.8 
1984 7.7 8.5 8.5 8.7 6.7 6.1 9.4 6.1 10.4 8.0 7.7 
1985 7.7 8.5 8.5 8.7 6.5 6.5 8.8 6.0 10.5 8.0 7.6 
1986 7.7 8.8 8.5 8.7 6.6 6.7 8.5 6.1 10.8 8.0 7.7 
1987 8.0 8.9 8.5 8.7 6.7 7.0 8.6 6.1 11.0 8.2 7.8 
1988 7.8 8.8 8.6 8.8 6.6 7.1 8.6 6.1 11.3 8.2 7.8 
1989 7.7 9.0 8.7 8.3 6.6 7.1 8.6 6.1 11.6 8.2 7.8 
1990 7.8 9.5 8.8 8.3 6.5 7.2 8.6 6.2 12.4 8.4 7.9 
1991 8.2 10.0 9.1 8.5 6.6 7.6 8.6 6.6 13.4 8.7 8.2 
1992 8.5 14.0 
Average 7.2 8.0 7.6 8.0 6.0 6.5 8.6 5.6 9.8 7.5 7.2 
(a) This table follows the Australian convention of labelling Australian data for a financial year by the second 
year (that is, 1974-75 data are labelled 1975), whereas data for Australia in OECD publications are 
labelled by the first year (that is, 1974-75 data are labelled 1974). 
(b) West Germany only. 
(c) Unweighted means. 
(d) Unweighted means. Excludes USA. 
Source: OECD 1993; AIHW unpublished data 
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Table S51: Proportion of population with basic and supplementary hospital insurance,™ States, 
1983 to 1993 (per cent) 
D a t e N S W < b > Vic Qld W A SA< C > T a s A u s t 
B a s i c 
31 December 1983 63.9 70.2 38.9 60.5 66.3 64.7 61.5 
31 December 1984 47.0 52.8 35.5 52.0 54.2 51.4 47.9 
31 December 1985 50.1 53.8 35.6 50.9 53.4 50.6 49.1 
31 December 1986 51.5 55.0 34.7 47.2 51.3 50.7 49.2 
31 December 1987 50.5 52.2 33.3 45.5 49.3 49.6 47.5 
31 December 1988 49.3 50.3 32.7 43.6 48.3 48.8 46.2 
31 December 1989 47.0 50.0 32.1 41.8 44.3 48.2 44.5 
31 December 1990 47.0 51.2 31.8 40.8 43.1 46.9 44.5 
31 December 1991 45.2 44.5 32.8 41.0 40.0 43.8 41.9 
31 December 1992 43.4 42.0 32.7 40.8 37.8 42.7 40.4 
31 December 1993 41.0 38.9 32.9 39.6 35.6 40.2 38.4 
S u p p l e m e n t a r y 
31 December 1983 21.6 36.7 19.9 32.3 41.0 46.8 28.8 
31 December 1984 24.2 35.6 24.2 33.1 40.0 43.3 30.0 
31 December 1985 30.1 41.1 24.9 35.1 40.3 43.5 33.9 
31 December 1986 32.8 43.0 24.5 39.9 39.4 44.4 35.7 
31 December 1987 38.7 42.8 26.6 40.9 40.8 44.5 38.3 
31 December 1988 39.6 42.1 26.7 39.9 41.4 44.6 38.4 
31 December 1989 39.5 43.3 26.9 38.9 38.7 44.8 38.4 
31 December 1990 40.1 46.6 27.1 38.4 39.3 44.2 39.4 
31 December 1991 39.1 40.7 28.5 39.0 37.4 41.5 37.6 
31 December 1992 38.1 39.1 28.8 39.3 36.0 40.9 36.7 
31 December 1993 36.5 36.7 29.5 34.1 38.4 38.8 35.3 
(a) Holding basic insurance is a prerequisite for taking out supplementary insurance cover. Therefore, the 
population holding supplementary insurance is included in the data for those holding basic insurance 
coverage. 
(b) Includes ACT. 
(c) Includes NT. 
Source: Private Health Insurance Administration Council unpublished data 
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1 
T a b l e S 5 2 : Private health insurance, proportions of contributor units with hospital coverage, by 
age group, 1983 to 1992 
P e r c e n t o f c o n t r i b u t o r u n i t s 
A g e g r o u p o f h e a d o f 
c o n t r i b u t o r u n i t ( y e a r s ) 1 9 8 3 1 9 8 6 1 9 8 8 1 9 9 0 1 9 9 2 
15-24 54.6 29.3 30.0 29.5 29.3 
25-34 70.4 46.5 43.0 40.1 35.8 
35-49 75.6 55.5 53.8 52.7 46.7 
50-59 71.4 56.4 56.5 55.6 52.2 
60-69 45.3 42.0 43.4 45.1 45.5 
70 and over 36.0 31.5 34.9 36.8 36.4 
Al l a g e s 6 2 . 1 4 4 . 2 4 3 . 6 4 3 . 1 4 0 . 5 
Sources: Willcox 1991; ABS 1992 Health Insurance Survey unpublished data 
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Health labourforce 
Table S53: Employment in the health industry, August 1981 to August 1993 
Y e a r 
E m p l o y e d i n 
h e a l t h i n d u s t r y 
A l l e m p l o y e d 
p e r s o n s 
P r o p o r t i o n o f a l l 
e m p l o y e d p e r s o n s 
C i v i l i a n 
l a b o u r f o r c e ' 8 * 
P r o p o r t i o n o f 
c i v i l i a n l a b o u r f o r c e ' 8 * 
('000) (VOO)' (Per cent) (WO) (Percent) 
1981 406.1 6,393.7 6.4 6.774.3 6.0 
1982 424.5 6,379.3 6.7 6,840.7 6.2 
1983 440.6 6,241.1 7.1 6,927.9 6.4 
1984 453.6 6,466.1 7.0 7,070.1 6.4 
1985 461:6 6,675.6 6.9 7,248.3 6.4 
1986 489.2 6,918.6 7.1 7,516.2 6.5 
1987 510.5 7,092.3 7.2 7,694.4 6.6 
1988 530.7 7,353,4 7.2 7,892.1 6.7 
1989 520.3 7,727.6 6.7 8,197.0 6.3 
1990 557.9 7,825.0 7.1 8,412.5 6.6 
1991 580.0 7,669.2 7.6 8,475.2 6.8 
1992 575.3 7,679.3 7.5 8,585.7 6.7 
1993 561.4 7,684.9 7.3 8,609.1 6.5 
(a) Includes unemployed persons looking for work. 
Sources; ABS unpublished data; ABS Cat. No. 6203.0 
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Use of professional services 
Table S54: Medical and optometrical services, fees and benefits under Medicare, 1986-87 to 
1992-93 
N u m b e r F e e s S c h e d u l e B e n e f i t s 
Y e a r o f s e r v i c e s c h a r g e d f e e s p a i d 
(million) ($ million) ($ million) ($ million) 
G P a t t e n d a n c e s 
1986-87 71.5 1,146.0 1,215.8 1,034.6 
1987-88 75.8 1,324.0 1,407.4 1,197.3 
1988-89 80.1 1,483.9 1,573.3 1,338.3 
1989-90 85.2 1,677.4 1,775.0 1,509.3 
1990-91 85.0 1,800.7 1,919.5 1,631.4 
1991-92 89.0 1,974.4 2,135.2 1,781.8 
1992-93 93.2 2,166.2 2,353.4 1,997.8 
S p e c i a l i s t a t t e n d a n c e s 
1986-87 12.7 520.5 522.8 447.7 
1987-88 13.0 584.4 582.1 491.5 
1988-89 13.7 651.9 646.8 544.2 
1989-90 14.3 719.9 707.0 595.0 
1990-91 14.9 792.5 770.8 648.4 
1991-92 15.6 863.7 840.6 705.0 
1992-93 16.3 930.9 908.0 763.3 
O b s t e t r i c s 
1986-87 0.6 58.1 52.9 49.2 
1987-88 0.6 67.1 57.2 45.7 
1988-89 0.6 74.1 59.8 45.9 
1989-90 0.6 82.8 63.3 48.7 
1990-91 0.6 95.4 76.0 58.3 
1991-92 0.6 95.5 73.9 56.7 
1992-93 0.7 93.7 71.8 55.3 
A n a e s t h e t i c s 
1986-87 1.3 83.0 76.4 66.3 
1987-88 1.3 97.7 86.7 67.4 
1988-89 1.4 107.5 94.1 71.3 
1989-90 1.4 119.7 102.7 77.7 
1990-91 1.5 135.5 113.5 85.9 
1991-92 1.6 151.3 125.4 94.9 
1992-93 1.6 165.4 137.9 104.4 
P a t h o l o g y ' 8 ' 
1986-87 27.2 485.3 501.0 427.1 
1987-88 29.3 544.6 559.9 470.6 
1988-89 31.5 600.5 605.7 507.6 
1989-90 26.0 648.7 661.8 554.5 
1990-91 26.1 729.0 754.2 631.9 
1991-92 30.4 725.4 751.7 629.2 
1992-93 39.7 734.5 757.0 634.0 
Continued next page 
291 
Table S54: Medical and optontetrical services, fees and benefits under Medicare, 1986-87 to 
1992-93 (continued) 
N u m b e r F e e s S c h e d u l e B e n e f i t s 
Y e a r o f s e r v i c e s c h a r g e d f e e s p a i d 
(million) ($ million) ($ million) ($ million) 
D i a g n o s t i c i m a g i n g 
1986-87 6.4 396.9 409.5 357.6 
1987-88 6.7 429.4 414.2 353.1 
1988-89 7.2 483.8 464.2 394.7 
1989-90 7.7 554.8 537.4 458.7 
1990-91 8.3 638.6 626.3 534.9 
1991-92 8.5 683.9 678.8 578.8 
1992-93 9.1 761.8 764.8 654.4 
O p e r a t i o n s 
1986-87 4.1 398.4 380.7 349.0 
1987-88 3.7 423.7 392.7 319.6 
1988-89 3.8 464.7 424.2 334.6 
1989-90 4.1 526.0 474.6 375.3 
1990-91 4.5 595.5 532.4 420.9 
1991-92 4.7 666.4 594.0 468.8 
1992-93 4.9 721.1 645.2 510.7 
O p t o m e t r y 
1986-87 1.9 65.3 72.4 62.2 
1987-88 2.0 69.0 77.6 66.0 
1988-89 2.2 76.2 85.8 73.0 
1989-90 2.4 87.1 98.8 84.1 
1990-91 2.6 99.4 113.6 96.6 
1991-92 2.8 108.6 124.8 -- 106.1 
1992-93 3.0 119.1 137.6 117.0 
A l l o t h e r s e r v i c e s < b ) 
1986-87 3.1 108.6 107.8 92.9 
1987-88 2.7 103.9 101.7 84.3 
1988-89 2.9 114.9 111.7 91.9 
1989-90 3.1 134.7 130.0 107.0 
1990-91 3.4 169.4 162.6 135.2 
1991-92 3.6 206.6 199.9 166.9 
1992-93 3.8 229.5 222.7 186.8 
T o t a l s e r v i c e s 
1986-87 128.8 3,262.0 3,339.3 2,886.5 
1987-88 135.1 3,643.8 3,679.4 3,095.6 
1988-89 143.4 4,057.7 4,065.5 3,401.4 
1989-90 144.9 4,551.1 4,550.6 3,810.1 
1990-91 146.9 5,056.0 5,069.1 4,243.3 
1991-92 156.8 5,475.8 5,524.3 4,588.2 
1992-93 172.3 5,922.1 5,998.5 5,023.7 
(a) Pathology schedule structure changed in August 1989 with a 35% reduction in number of items. In Feb­
ruary 1992, a patient episode initiation item was introduced, artificially inflating the number of pathology 
services (See Section 4.5 for more details). 
(b) Includes radiotherapy and nuclear medicine therapy, assistance at operations and other 
miscellaneous items. 
Source: DHHLGCS unpublished data 
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Table S55: Medicare services, age-specific rates, by sex, 1987-88 to 1992-93 (per person) 
S e x / A g e g r o u p 1987-88 1988-89 1989-90 1990-91 1991-92 1992-93 
M a l e s 
0-4 8.09 8.48 8.67 8.49 8.90 9.69 
5-9 4.68 4.94 5.09 4.76 5.00 5.39 
10-14 3.91 4.09 4.23 3.98 4.22 4.50 
15-19 3.94 4.12 4.32 4.22 4.37 4.68 
20-24 4.30 4.42 4.45 4.37 4.57 4.90 
25-34 4.73 4.90 4.89 4.88 5.14 5.49 
35-44 5.51 5.76 5.71 5.72 6.00 6.39 
45-54 7.31 7.47 7.37 7.39 7.66 8.22 
55-64 10.05 10.53 10.76 10.98 11.70 12.74 
65-74 10.99 11.18 11.32 11.47 12.55 14.19 
75 and over 15.68 16.08 16.32 16.43 17.35 18.74 
C r u d e r a t e 6.40 6.65 6.73 6.72 7.11 7.73 
A g e - s t a n d a r d i s e d r a t e ' 8 ' 6.54 6.77 6.85 6.82 7.20 7.79 
F e m a l e s 
0-4 7.31 7.73 7.91 7.71 8.10 8.84 
5-9 4.66 4.91 5.04 4.73 4.99 5.39 
10-14 4.08 4.30 4.39 4.17 4.39 4.68 
15-19 6.82 7.25 7.34 7.31 7.62 8.18 
20-24 9.93 10.23 9.96 9.70 10.20 11.13 
25-34 11.04 11.47 11.09 10.89 11.38 12.40 
35-44 9.49 10.00 9.84 9.81 10.36 11.27 
45-54 10.76 11.19 11.09 11.18 11.71 12.77 
55-64 12.38 12.87 12.89 13.03 13.85 15.05 
65-74 15.01 15.44 15.48 15.50 16.46 17.74 
75 and over 18.44 18.83 19.15 19.33 20.41 21.84 
C r u d e r a t e 9.90 10.33 10.29 10.24 10.81 11.75 
A g e - s t a n d a r d i s e d r a t e ' 8 ' 9.75 10.16 10.10 10.01 10.54 11.43 
(a) Reference population is the 30 June 1988 Australian population. 
Sources: Health Insurance Commission 1988,1989,1990,1991,1992,1993; AIHW unpublished data 
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Table S56: Medicare services, age-specific rates, by sex, States and Territories, 1992-93 (per 
person) 
S e x / A g e g r o u p 
( y e a r s ) N S W Vic Old W A S A T a s A C T N T A u s t 
M a l e s 
0-4 10.42 9 37 9 69 8.42 10.04 8.63 9.66 6.12 9.69 
5-9 5.86 5 39 5 27 4.62 5.28 4.79 5.22 2.99 5.39 
10-14 4.93 4 32 4 56 3.91 4.30 4.10 4.50 2.60 4.50 
15-19 5.17 4 45 4 75 4.06 4.51 4.01 4.20 2.83 4.68 
20-24 5.53 4 94 4 58 4.04 4.70 4.20 3.82 2.77 4.90 
25-34 6.32 5 39 5 05 4.52 5.26 4.65 4.52 3.43 ' 5.49 
35-44 7.35 6 06 6 20 5.38 5.96 5.31 5.36 4.45 6.39 
45-54 9.45 7 68 7 96 7.10 7.51 7.06 6.95 5.94 8.22 
.55-64 14.67 12 03 11 86 11.24 11.51 10.89 10.84 8.58 12.74 
65-74 15.70 13 60 13 22 13.89 13.50 10.33 13.07 9.33 14.19 
75 and over 20.26 18 70 17 90 17.51 17.31 15.19 17.28 9.84 . 18.74 
C r u d e r a t e 8.76 7 47 7 35 6.62 7.46 6.54 6.27 4.37 7.73 
A S R * 8 ' 8.74 7 51 7 46 6.84 7.37 6.54 6.90 4.95 7.79 
F e m a l e s 
0-4 9.53 8 46 8 97 7.70 9.06 8.02 8.86 5.38 8.84 
5-9 5.79 5 39 5 29 4.62 5.41 4.83 5.44 3.05 5.39 
10-14 5.00 4 55 4 71 4.23 4.57 4.58 4.58 2.88 4.68 
15-19 8.75 7 44 8 68 7.78 7.69 8.42 7.25 6.86 8.18 
.20-24 12.14 10 60 11 05 10.64 10.15 11.33 9.58 8.73 11.13 
25-34 13.37 12 07 12 05 11.85 11.67 11.73 11.58 9.12 12.40 
35-44 12.43 10 77 11 06 10.35 10.54 10.20 10.21 8.56 11.27 
45-54 14.14 12 04 12 57 11.77 11.94 .11.64 10.97 9 . 1 5 12.77 
55-64 16.81 14 15 14 77 13.53 13.68 13.46 12.99 9.71 15.04 
65-74 19.48 16 81 17 83 16.20 16.00 15.41 15.09 11.33 17.74 
75 and over 22.70 21 97 22 10 20.06 20.40 19.43 19.24 13.18 21.84 
C r u d e r a t e 12.88 11 35 11 54 10.62 11.22 10.81 10.02 7.43 11.75 
A S R ( a ) 12.44 10 95 11 35 10.54 10.71 10.58 10.28 7 . 9 9 11.43 
(a) Age-standardised rates. Reference population is the 30 June 1988 Australian population. 
Sources: Health Insurance Commission 1993; AIHW unpublished data 
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T a b l e S 5 7 : Medicare services, percentage of enrolled persons by number of services, by age group 
and sex, 1991-92 (per cent) 
S e x / A g e g r o u p 
N u m b e r o f s e r v i c e s 
0 1 2 3 4 5 o r m o r e 
M a l e s 
0-4 7.83 7.52 8.20 B.38 7.99 60.08 
5-9 16.90 13.13 12.04 10.37 8.67 38.89 
10-14 21.73 15.73 13.07 10.40 8.17 30.90 
15-19 23.46 15.58 12.46 9.75 7.67 31.08 
20-24 28.05 14.35 11.17 8.85 7.06 30.52 
25-34 31.06 13.70 10.40 8.08 6.46 30.30 
35-44 26.49 13.24 9.96 7.90 6.46 35.95 
45-54 21.45 11.80 8.94 7.21 6.22 44.38 
55-64 17.77 7.96 6.53 5.75 5.31 56.68 
65-74 30.15 5.53 4.40 3.97 3.75 52.20 
75 and over 46.79 2.76 2.29 2.16 2.14 43.86 
Al l a g e s 2 4 . 9 3 1 1 . 6 4 9 . 3 5 7 . 6 8 6 . 4 3 39 .97 
F e m a l e s 
0-4 8.69 8.47 9.05 8.94 8.38 56.47 
5-9 16.94 13.40 12.17 10.50 8.58 38.41 
10-14 21.29 15.77 12.97 10.41 8.09 31.47 
15-19 14.70 11.46 10.34 8.91 7.55 47.04 
20-24 13.42 6.48 6.84 6.83 6.50 59.93 
25-34 15.29 5.79 6.01 6.06 5.83 61.02 
35-44 13.78 7.52 7.05 6.88 6.36 58.41 
45-54 11.30 6.54 5.91 5.85 5.75 64.65 
55-64 12.00 5.28 4.87 4.88 4.83 68.14 
65-74 17.32 3.64 3.48 3.52 3.61 68.43 
75 and over 40.50 1.77 1.73 1.79 1.94 52.27 
Al l a g e s 1 6 . 6 3 7 . 3 5 6 . 9 2 6 . 5 3 5 . 9 8 56.59 
Source: Health Insurance Commission 1993 
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Health technology 
T a b l e S 5 8 : Usage of selected health technologies, 1987-88 to 1991-92' 
1987 -88 1 9 8 8 - 8 9 1 9 8 9 - 9 0 1 9 9 0 - 9 1 1 9 9 1 - 9 2 
S e r v i c e s 
Ultrasound {'000) 895.5 1,026.1 1,176.2 1,348.3 1,495.9 
CT scanning ('000) 298.7 328.2 358.5 406.6 448.1 
X-rays ('000) 5,358.3 5,565.9 5,982.8 6,432.3 6,438.6 
MRI (Number) 5,637 8,438 10,705 12,373 <t>) 
Pathology ('000) 29,543.7 31,825.9 24,342.9 25,779.2 26,022.6 
Nuclear medicine ('000) 124.3 238.5 151.3 137.8 155.9 
Radiotherapy ('000) 324.4 258.6 274.8 287.0 316.7 
Endoscopy ('000) 526.9 584.8 645.4 702.4 751.7 
S e r v i c e s a s a p e r c e n t a g e o f t o t a l M e d i c a r e s e r v i c e s (c) (Per cent) 
Ultrasound 0.7 0.7 0.8 0.9 1.0 
CT scanning 0.2 0.2 0.3 0.3 0.3 
Radiology 3.9 3.9 4.2 4.4 4.1 
Pathology 21.7 22.3 17.1 17.7 16.6 
Nuclear medicine 0.1 0.2 0.1 0.1 0.1 
Radiotherapy 0.2 0.2 0.2 0.2 0.2 
Endoscopy 0.4 0.4 0.5 0.5 0.5 
(Number) 
Lasers in: Ophthalmology 29,785 33,768 39,567 44,533 58,131 
Gynaecology - 8,076 12,633 11,038 11,308 
Dermatology 
-
6,743 7,821 7,964 7,634 
Gastrointestinal tract 
-
- -
-
99 
Ear, nose and throat 239 225 256 348 296 
Laparoscopic procedures 
Laparoscopic cholecystectomy 
-
- - 1,984 13,863 
Laparoscopy for.gynaecological 
conditions 24,075 25,024 25,345 25,318 21.266 
Female sterilisation including lapar­
oscopy 20,978 19,519 17,732 14,215 13,311 
Diagnostic laparoscopy 17,427 16,970 16,379 16,730 17,145 
Ocular lens extraction 29,614 31,300 33,018 35,574 38,304 
Artificial lens insertion, removal, repo­
sitioning 30,612 32,211 33,928 36,322 38,985 
Shockwave lithotripsy 1,180 1,409 1,481 2,036 2,196 
Cardiac pacemakers 948 954 1,133 1,214 1,424 
(a) Only covers serices for which fees were charged under Medicare. Does not include services to public 
inpatients. 
(b) As from 1 February 1992. MRI services were covered under Health Program Grants, rendering the 
Medicare benefit item superfluous. 
(c) Recorded on a date-rendered basis. 
Source: Health Insurance Commission unpublished data 
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Table S59: Health technology facilities in Australia, 1993 
T y p e o f h e a l t h t e c h n o l o g y o r f a c i l i t y N u m b e r 
Magnetic resonance imaging (MRI) scanner 32 
CT scanners 292 
Extracorporeal Shockwave lithotriptors (ESWL) 12 
Mammographic units 258 
Ultrasound equipment 1,300-1,400 
Nuclear medicine centres 69 
Cardiac surgery units 26 
Sources; AIHW 1992,1993; National Heart Foundation 1991 
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Appendix 
Methods and conventions 
Methods 
Details of methods used in particular sections of the report are included in the text and 
Boxes, and in footnotes to Figures and Tables. Readers are also referred to the Glossary. 
Age-standardisation has been used to facilitate the comparison of populations with 
differing age compositions, either different populations at a point in time or the same 
population at different points in time. The 1988 Australian population (ABS 1989) has 
been used as the standard population for all intra-Australia comparisons, but the 
European and World Standard Populations have been used for some international 
comparisons. Details of these standard populations were published in Australia's health 
1992. 
In rates derived from population surveys, uncertainty results from the fact that only a 
sample of the population was included. In some places, this is shown by confidence 
intervals. In other places, differences which are statistically significant are indicated by 
an asterisk, in the text, they are described as 'significant'. Neither approach allows for 
non-sampling errors, such as those which may arise from reporting biases or 
misclassification. 
Average annual rates of change or growth rates have been calculated as geometric rates: 
Average rate of change = ( ( P n / P Q ) 1 / N - 1 ) x 100 
where P n = value in later time period 
P Q = value in earlier time period 
N = number of years between the two time periods 
The classification of diseases follows the Ninth Revision of the International 
Classification of Diseases (WHO 1977), and as adapted for hospital indexing by the 
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 
(1991). 
References 
References use a simplified version of the author-date (or Harvard) system. General 
references to ABS series (for example, the Deaths, Australia series) provide full 
identifying information, including Catalogue number, but do not include a year of 
publication. References to specific issues within a series include a year of publication. 
Symbols 
$ Australian dollars, unless otherwise specified 
- zero 
% per cent 
g gram 
kg kilogram 
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kj kilojoule 
m million 
MJ megajoule 
mL millilitre 
mm Hg millimetres of mercury 
mmol/L millimoles per litre 
na not applicable, not available 
nec not elsewhere classified 
nn not notifiable 
nya not yet available 
microgram 
Geographic classifications 
Within Australia, most regional comparisons are between States and Territories. Largely 
reflecting variations in the classifications used in the data sources, the definitions for 
other regional comparisons are not always precise. For example, comparisons are made 
between major urban and other areas. Some sources do not include all capital cities as 
urban, while others include other major centres such as Newcastle and Wollongong. 
References 
Australian Bureau of Statistics (1989) Estimated resident population by sex and age. 
States and Territories of Australia. June 1988 and preliminary June 1989. Catalogue 
No. 3201.0, ABS, Canberra 
International classification of diseases, 9th revision, clinical modification (ICD-9-CM) 
(1991) Commission on Professional and Hospital Activities, Ann Arbor, Michigan 
World Health Organization (1977) Manual of the international statistical classification 
of diseases, injuries and causes of death. Ninth revision, volumes 1 and 2. WHO, 
Geneva 
World Health Organization (1992) World Health Statistics Annual 1991. World Health 
Organization, Geneva 
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Abbreviations 
ABS Australian Bureau of Statistics 
ACCORD Australian Coordinating Committee for Organ Registries and Donation 
AHMAC Australian Health Ministers' Advisory Council 
AHMC Australian Health Ministers' Conference 
AHOCH Australian Health Outcomes Clearing House 
AHTAC Australian Health Technology Advisory Committee 
AIDS Acquired Immune Deficiency Syndrome 
AIH Australian Institute of Health 
AIHW Australian Institute of Health and Welfare 
ANZDATA Australian and New Zealand Dialysis and Transplant Registry 
ARC Accident Research Centre 
ASR Age standardardised rate 
BAC Blood alcohol concentration 
BMI Body mass index 
BPH Benign prostatic hypertrophy 
CABG Coronary artery bypass graft 
CAPD Continuous ambulatory peritoneal dialysis 
CGC Commonwealth Grants Commission 
CHD Coronary heart disease 
CI Confidence interval 
CIN3 Cervical intra-epithelial neoplasia grade 3 
COI Cost of illness 
CPI Consumer price index 
CSIRO Commonwealth Scientific and Industrial Research Organisation 
CT Computerised tomography 
CVD Cardiovascular disease 
DCIS Disease costs and impact study 
DCSH Department of Community Services and Health 
DHHCS Department of Health Housing and Community Services 
DHSH Department of Human Services and Health 
dift Decayed, indicated for extraction, or filled primary teeth 
dmft Decayed, missing or filled primary teeth 
DMFT Decayed, missing or filled permanent teeth 
DSRU AIHW Dental Statistics and Research Unit 
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\ 
DVA Department of Veterans' Affairs 
ENT Ear nose and throat 
ESWL Extracorporeal shock wave lithotripsy 
GDP Gross domestic product 
GP General practitioner 
HCN Health communication network 
HHLGCS Department of Health Housing Local Government and Community 
Services 
HIC Health Insurance Commission 
HIV Human immunodeficiency virus 
HUCS Hospital Utilisation and Costs Study 
ICD International Classification of Diseases 
ICD-9-CM International Classification of Diseases Ninth Revision, Clinical 
Modification 
ID Intravenous drug 
IRSD Index of relative socio-economic development 
IVF In vitro fertilisation 
Metro Metropolitan 
MRI Magnetic resonance imaging 
NDI National Death Index 
NDS National Data Set 
NHDC National Health Data Committee 
NHDD National Health Data Dictionary 
NHIA National Health Information Agreement 
NHL non-Hodgkin's lymphoma 
NHMRC National Health and Medical Research Council 
NHS National Health Survey or National Health Service 
NHGT National Health Goals and Targets 
NIDDM non-insulin-dependent diabetes mellitus 
NISU AIHW National Injury Surveillance Unit 
NMSC non-melanocytic skin cancer 
NMDS [IS] National Minimum Data Set (Injury Surveillance) 
NNS National Nutrition Survey 
non-Metro non-Metropolitan 
NPSU AIHW National Perinatal Statistics Unit 
OECD Organisation for Economic Co-operation and Development 
OTC Over-the-counter drug 
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Pap Papanicolau 
PBS Pharmaceutical Benefits Scheme 
PHIAC Private Health Insurance Administration Council. 
PMIs Patient Management Information systems 
PORT Patient Outcome Research Team 
PYLL Years of Life Lost 
QALY Quality Adjusted Life Year 
RDI Recommended Dietary Intake 
RFPS Risk Factor Prevalence Study 
RPBS Repatriation Pharmaceutical Benefits Scheme 
RR Relative risk 
SF-36 Medical Outcome Survey 36-Item Short Form Questionnaire 4466 
SLA Statistical local area 
SMR Standardised Mortality Ratio 
SSPE Subacute Sclerosing Panencephalitis 
TURP Transurethral resection of prostate 
WHO World Health Organization 
WHR Waist to hip ratio 
Abbreviations of places 
ACT Australian Capital Territory 
Aust Australia 
Can Canada 
Fra France 
Ger Germany 
Jpn Japan 
NSW New South Wales 
NT Northern Territory 
NZ New Zealand 
Qld Queensland 
SA South Australia 
Swe Sweden 
Tas Tasmania 
UK United Kingdom 
USA United States of America 
Vic Victoria 
WA Western Australia 
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Glossary 
Aboriginal: A person of Aboriginal or Torres Strait Islander descent who identifies as an 
Aboriginal or Torres Strait Islander and is accepted as such by the community in which 
he or she lives (Department of Aboriginal Affairs 1981). 
acute: Having a short course. 
acute hospitals: Establishments which provide at least minimal medical, surgical or 
obstetrical services for inpatient treatment and/or care, and which provide 
round-the-clock comprehensive qualified nursing service as well as other necessary 
professional services. Most patients require a relatively short stay. 
admission: Admission to hospital. In this report, the number of separations (q.v.) has 
been taken as the number of admissions. Hence an admission rate is the same as a 
separation rate. 
admitted patient: See inpatient. 
age-specific death rate: See Box 1.1, page 5. 
age-specific rate: A rate for a specific age group. The numerator and denominator relate 
to the same age group. 
age-standardised death rate: See Box 1.1, page 5. 
age-standardised rate: Weighted average of age-specific rates according to a standard 
distribution of age to eliminate the effect of different age distributions and thus 
facilitate valid comparison of groups with differing age compositions. 
bed-day: The occupancy of a hospital bed for up to 24 hours. 
capital expenditure: Expenditure of a non-recurrent nature (for example, new 
buildings, equipment used for a number of years). 
casemix: A means of .classifying hospital patients to provide a common basis for 
comparing cost effectiveness and quality of care across hospitals. 
cause of death: From information reported on the medical certificate of cause of death, 
each death is classified by the underlying cause of death according to rules and 
conventions of the ninth revision of the International Classification of Diseases (q.v.). 
The underlying cause is defined as the disease which initiated the train of events 
leading directly to death. Deaths from injury or poisoning are classified according to the 
circumstances of the violence which produced the fatal injury, rather than to the nature 
of the injury. 
chronic: Persisting over a long period. 
confidence interval (CI): A range determined by variability in data, within which there 
is a specified (usually 95%) chance that a calculated parameter (e.g. relative risk) is 
thought to lie. 
congenital: A condition that is recognised at birth, or that is believed to have been 
present since birth, including conditions which are inherited or caused by an 
environmental factor. 
crude death rate: See Box 1.1, page 5. 
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direct bill: The process by which a medical practitioner or optometrist sends the bill for 
services direct to Medicare. 
disability: See Box 1.3, page 11. 
employed: Employed people are those aged 15 years and over who, during the 
reference week: worked for one hour or more for pay; worked for one hour or more 
without pay in a family business; or had a job but were not at work because of leave or 
other reasons. Unemployed are those aged 15 years and over who were not employed 
in the reference week and: had actively looked for work; were available for work; or 
were waiting to start a new job or be called back to a job from which they had been 
stood down for less than 4 weeks. The labourforce comprises employed and 
unemployed; others are described as not in the labourforce (ABS 6203.0). 
epidemiology: The study of the distribution and determinants of health-related states 
and events in populations, and the application of this study to control of health 
problems. 
expectation of life: See life expectancy. 
foetal death: Birth of a foetus weighing at least 500 grams (or where birthweight is 
unavailable, of at least 22 weeks gestation), which shows no signs of life. Commonly 
referred to as stillbirth. 
foetal death rate: Number of foetal deaths per 1,000 total births (foetal deaths plus live 
births). 
freestanding day hospital: A private hospital where only minor operations and other 
procedures not requiring overnight stay are performed, not forming part of any private 
hospital providing overnight care. 
handicap: A social disadvantage resulting from disability or impairment. 
health promotion: Activities to improve health and prevent disease. 
hostels: Establishments providing board, lodging or accommodation for the aged, 
distressed, or disabled who cannot live independently but do not need nursing care in a 
hospital or nursing home. Residents are generally responsible for their own provisions, 
but may be provided with domestic assistance (meals, laundry, personal care). Only 
hostels subsidised by the Commonwealth are included in statistics. 
incidence rate: The number of instances of illness commencing, or of persons falling ill, 
during a given period in a specified population divided by the population at risk. 
inpatient: A person formally admitted by a hospital. Healthy newborn infants are not 
regarded as inpatients unless they have a stay of more than 10 days, or are the second or 
subsequent birth in multiple births. Also known as admitted patient. 
intersectoral action: Involvement of government sectors other than the health sector in 
actions affecting health. 
Intern ati on al Classification of Diseases: WHO's internationally accepted classification 
of death and disease. The ninth revision (ICD-9) is currently in use. In this report, 
causes of death classified before 1979 under previous revisions have been reclassified to 
ICD-9 by AIHW. 
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length of stay: Duration of hospital stay, counted by regarding the days of admission 
and of separation as one day plus all intervening days. Where a patient is admitted and 
discharged on the same day, the length of stay is taken as one day. 
life expectancy: Average number of years of life remaining to a person at a particular 
age if death rates do not change. 
low birthweight: Birth of a baby weighing less than 2,500 grams. 
morbidity: Any departure, subjective or objective, from a state of physiological or 
psychological wellbeing. 
neonatal death: Death of an infant within 28 days of birth. 
neonatal mortality rate: Number of neonatal deaths per 1,000 live births. 
non-inpatient: A patient not requiring admission to hospital, but who receives 
treatment in accident and emergency (casualty) departments, undergoes short-term 
specialist treatment (such as minor surgery, radiotherapy or chemotherapy), or is 
treated at home. Previously referred to as outpatient, also known as non-admitted 
patient. 
nursing homes: Establishments which provide long-term care involving regular basic 
nursing care to chronically ill, frail, disabled or convalescent people or senile inpatients. 
Organisation for Economic Co-operation and Development: An organisation of 24 
developed countries, including Australia. 
outpatient: See non-inpatient. 
Pap smear: Papanicolaou smear, a procedure for the detection of cancer and 
pre-cancerous conditions of the female genital tract. 
perinatal: Pertaining to or occurring in the period shortly before of after birth. 
perinatal death: Foetal or neonatal death. 
perinatal mortality rate: Number of perinatal deaths per 1,000 total births (foetal 
deaths plus live births). 
potential years of life lost: Number of potential years of life lost in a population as a 
result of premature death. 
prescription drugs: Pharmaceutical drugs available only on the prescription of a 
registered medical practitioner and available only from pharmacies. 
prevalence: The number of instances.of a given disease or other condition in a given 
population at a designated tune divided by the population at risk of having the disease 
or condition. 
private health insurance: See Box 3.3, page 136. 
private hospitals: Privately owned and operated institutions approved by DHSH. 
Private hospitals cater only for private patients who are treated by a doctor of their own 
choice and are charged fees for accommodation and for medical services. Private 
hospitals can be further classified as acute or psychiatric. 
psychiatric hospitals: Establishments devoted primarily to the treatment and care of 
inpatients with psychiatric, mental, or behavioural disorders. 
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public health: One of the efforts organised by society to protect, promote, and restore 
the people's health. It is the combination of sciences, skills, and beliefs that are directed 
to the maintenance and improvement of the health of all the people through collective 
or social actions. The programs, services, and institutions involved emphasise the 
prevention of disease and the health needs of the population as a whole. Public health 
activities change with changing technology and social values, but the goals remain the 
same: to reduce the amount of disease, premature death, and disease-produced 
discomfort and disability in the population. Public health is thus a social institution, a 
discipline, and a practice. 
public hospitals: Hospitals providing free shared-ward accommodation for all who 
require it and free treatment there by a hospital-appointed doctor. In addition, they 
provide, to those who are prepared to pay for it (for example, through private 
insurance), private ward accommodation and the doctor of choice. Thus, public 
hospitals service much private medical practice as well as public. 
quality adjusted life year (QALY): A measure of the outcome of actions (either 
individual or treatment interventions) in terms of their health impact. If an action gives 
a person an extra year of healthy life expectancy, that counts as one QALY. If an action 
gives a person an extra year of unhealthy life expectancy (partly disabled or in some 
distress), it has a value of less than one. Death is rated at zero. 
quintile: Strictly the five values at or below which 20%, 40%, 60%, 80% and 100% of the 
data in a sample fall. The term is also used to denote the successive one-fifths of the 
values in a sample which are bounded by the lowest value and each of the other values. 
real cost: Cost expressed in terms which have been adjusted for inflation (for example, 
in 1984-85 dollars). This enables comparisons to be made between expenditures in 
different years. 
recurrent expenditure: Expenditure which recurs continually or very frequently (for 
example, salaries). It may be contrasted with capital expenditure, such as the cost of 
hospital buildings and diagnostic equipment, for which expenditure is made 
infrequently. 
repatriation general hospitals: Acute care hospitals run by the Commonwealth 
Department of Veterans' Affairs. 
risk: The probability that an event will occur. 
risk factor: An attribute or exposure that is associated with an increased probability of a 
specified outcome, such as the occurrence of a disease. Risk factors are not necessarily 
causes of disease. 
Risk Factor Prevalence Study: A series of three surveys conducted by the National 
Heart Foundation of Australia in 1980,1983 and 1989. 
separation: When an inpatient leaves hospital to return home, transfers to another 
institution, or dies. 
separation rate: The number of separations per 1,000 total population per year. 
stillbirth: See foetal death. 
symptom: Any evidence of disease apparent to the patient. 
Torres Strait Islander: See Aboriginal. 
309 
References 
AustraUan Bureau of Statistics. The labour force, AustraUa. Catalogue No. 6203.0: 
Canberra: ABS. 
Department of Aboriginal Affairs. Report on a review of the administration of the 
working definition of Aboriginal and Torres Strait Islanders. Canberra: Constitutional 
Section, Department of Aboriginal Affairs, 1981. 
World Health Organization. Manual of the international statistical classification of 
diseases, injuries and causes of death. Ninth revision, volumes 1 and 2. Geneva: WHO, 
1977. 
Dictionary references 
Dorland's iUustrated medical dictionary, 26th edition. Philadelphia: WB Saunders, 1985. 
Last JM, ed.A dictionary of epidemiology. New York: Oxford University Press, 1983. 
Concise medical dictionary. Oxford: Oxford University Press, 1980. 
310 
Index 
abbreviations, 303-05 
Aboriginal & Torres Strait Islander 
peoples 
alcohol consumption, 35-36 
birthweights, 98 
communicable diseases, 216 
death rates, 7 
disability & handicaps, 216 
government agencies' role in health, 
117 
health, 26-36,211 
goals & targets, 217 
statistics, 216-17,227 
risk factors, 34-36 
suicide, 109 
women's health, 211 
Aboriginal & Torres Strait Islanders 
Commission, Aboriginal health, 216 
Adult Dental Programs Survey, 208 
age 
road fatalities, 103 
standardisation of data, 67-68, 84, 301 
use of Medicare, 174-77 
aged 
cancer, 84 
diet, 48,51-53 
employment in health care, 148—49 
health care technologies, 196-98 
hypertension, 60 
minimally invasive therapy, 198 
nursing homes & hostels, 157-58 
pharmaceutical treatments, 198 
prevalence of disability, 13-16 
role of DVA, 214 
standardised death rates, 5 
strategies, 40-41 
Survey of Disability, Ageing & Carers, 
211 
surveys, 37 
use of medical services, 175 
women's health, 211 
AIDS, 81-83 
coordination of information, 119 
statistics, 259 
alcohol consumption, 62-64 
Aborigines, 35-36 
cost of related disease, 55 
information coordination, 119 
intake of men & women, 58 
involvement in road crashes, 106 
targets, 49 
Apparent Consumption of Foodstuffs & 
Nutrients, 49 
Australia's food & nutrition, 207 
Australian Bureau of Statistics, 210 see also 
individual surveys 
Aboriginal health, 211,217 
agreement with AIHW, xi 
breastfeeding, 50 
coding of mortality, 209 
compensation-based statistics, 41 
dental health, 96 
disability surveys, 10-14, 26, 34, 213 
Health Industry Survey, 213 
Health Insurance Survey, 135,140 
health information agreement, 203 
health labourforce, 230 
health statistics, 203, 210 
infant sleeping positions, 211 
monitoring of immunisation, 212 
national health atlas, 210 
NDI, 216 
private hospitals, 160,161, 211 
safety in the home, 221 
socioeconomic indexes, 111 
Australian Consensus Panel for tlie 
Management of Hyperlipidaemia, 59 
Australian Coordinating Committee for 
Organ Registries & Donation 
(ACCORD), 189, 232 
Australian Council on Healthcare 
Standards, 232 
311 
Australian Health & Nutrition Survey, 37, 
51-52 
Australian Health Ministers' Advisory 
Council (AHMAC), 66,119 
funding for collection of labourforce 
data, 207 
information agreement, 203 
rural health, 41 
Australian Health Ministers' Conference 
(AHMC), 119 
Australian Health Outcomes Clearing 
House, 207, 223-26 
Australian health care system 1992,116 
Australian Hearing Service, 117 
Australian Medical Council, 230 
Australian Nursing Council, 230 
Better Health Commission, 66 
birthing centres, 228 
blood pressure see hypertension 
body mass index (BMI), 60,62 
breastfeeding see mothers & infants 
Brotherhood of St Laurence, survey on 
breastfeeding, 50 
Bureau of Transport & Communications 
Economics, 100 
calcium intake, 53 
cancer, 83-89 
Aboriginal registrations, 216 
causes of death, 5, 7 
data collection, xi 
screening, 194-96 
statistics, 260-62 
survival rates, 88 
cardiovascular disease (CVD), 89-93 
definition, 93 
migrants vs Australian-born, 26 
mortality rates, 5, 7, 89-93 
risk factors, 64 
carers 
data, 215 
Survey of Disability, Ageing & Carers, 
211 
Casemix Development Program, 207 
causes of ill-health, 78-112 
census 
employment in health industry, 
149-50,152-53 
labourforce data, 148, 230 
Child Dental Health Survey, 94, 208 
Child Fluoride Study, 208 
children see also mothers & infants 
effect of immunisation, 78-79 
nutrient intake, 53, 54 
trends in dental health, 94-95 
cholesterol 
desirable levels, 59 
risk factor for cardiovascular disease, 
64-65 
classification of disease, 209, 301 
Commonwealth Dental Health Program, 
National Evaluation Project, 208 
Commonwealth Grants Commission 
(CGC) 
expenditure on health, 229 
provision of data, 130 
role, 124 
Commonwealth Rehabilitation Service, 
117 
Commonwealth, State & Territory health 
authorities, 116-17 
involvement in health statistics, 206-15 
Commonwealth-State Disability 
Agreement, 208 
communicable diseases, 78-83 
Aborigines, 216, 217 
community health services, 118-19 
community pharmacies, 142 
compensation in the workplace, 41-45 
statistics, 213-14 
computerised tomography (CT), 181 
coronary heart disease (CHD) 
effect of cholesterol level, 59 
312 
effect of excess alcohol consumption, 
62 
effect of excess weight, 61 
effect of smoking, 60 
indicators, 69 
mortaUty rate, 89-90 
targets, 70 
trends, 70-71 
cost of illness, 55-56 
AIDS, 82-83 
costing of illness (COI), 18-21 
health services, 230 
role of AIHW, 208 
technology, 145-46 
transport-related deaths, 100 
workers' compensation, 43-45 
criteria for national health goals, 67 
CSIRO, Survey of the Elderly, 48,51-53 
data 
see also ACCORD 
see also New Zealand ANZDATA 
see also information & statistics 
Aboriginal health, 217 
CGC database, 229 
collection, xi-23, 203 
data links, 219 
deficiencies in statistics, 226-29 
dental health, 208 
disabUity, 213 
DVA database, 215 
general practice, 213 
health expenditure, 130 
health labourforce, 148,230 
hospital use, 160 
hospital waiting lists, 167-71, 231 
injury data, 208-09,218-22 
medical services, 172 
Medicare database, 150-51, 208-
morbidity data, 231 
perinatal data for Aborigines, 217 
regional database, 212 
role of AIHW, 119,141, 207-09 
uniformity of coUections, 231 
use in setting goals & targets, 68-69 
use of health technologies, 208,232 
welfare statistics, 208 
workers' compensation, 213-14 
death see also NDI 
Aborigines, 7, 26, 27-33 
AIDS, 83 
cancer, 83-88 
coding, 209-10 
CVD, 89-91 
effect of alcohol consumption, 62-64 
effect of diet, 55-56 
effect of physical inactivity, 64 
injury, 218-20 
major causes, 2,5-7, 9,18 
coding, 210 
maternal mortaUty, 24-25, 241-42 
migrants, 25 
morbidity data, 18 
mortaUty data, 68,69 
occupational fataUties, 42—43 
perinatal mortaUty, 24, 239 
preventable causes, 32-33,37 
rates in Australia, 4-5, 228, 238-42, 
245-54 
State differences, 7, 246 
stroke, 89 
suicide, 107 
transport injuries, 100-06 
trends, 5-7,9, 25 
young men, 7 
definitions 
acute inpatient care, 207 
expenditure on health, 230 
general practice, 213 
health outcomes, 223 
hospital care, 161 
hospital waiting lists, 172, 207, 231-32 
institutional facilities, 156 
National Data Set, 41 
National Health Surveys, 38 
nutrition terms, 47 
313 
Dental Statistics & Research Unit, 96,177, 
208 
dental health, 94-97 
dental services, 177-80 
factors affecting use, 179-80 
relationship to diet, 55 
statistics, 263 
Dept of Community Services & Health, 
nutrient intake of children, 53 
Dept of Health, Housing & Community 
Services 
dental surveys, 208 
expansion, 117 
health policy, 46 
Dept of Health, Housing, Local 
Government & Community . 
Services, 117 
Dept of Human Services & Health 
(DHSH), 117,212-13 
see also Casemix Development 
Program , 
care of the disabled, 119 
dental health evaluation, 208 
health statistics, 206 
Hospital Access Program, 232 
hospital waiting lists, 172, 
Medicare claims, 172 
position of AIHW, 117 . 
prescription drugs, 141 
road injuries, 209 
Dept of Social Security, pensioner 
benefits,' 120 
Dept of.Veterans' Affairs (DVA) 
health role, 117, 119,175, 214-15 
health statistics, 206, 215 
morbidity data, 23i 
pensioner benefits, 120 
diabetes, 55 
see fl/so.NIDDM 
effect of physical activity, 64 
prevalence in Aborigines, 32 
Diagnostic Related Groups (DRG), 212 
diet see also nutrition 
diet-related diseases, 53-56 ' 
dietary guidelines, 46 
disability & handicap, 10-18 
Aborigines, 33-34,216 
data, 213 
deficiency of data, 227 . 
migrants, 26 
women's health, 211 
disabled 
Commonwealth-State Disability 
Agreement, 208 
health services, 118-19 
Survey of Disability, Ageing & Carers, 
211 
Disease Costs & Impact Study (DCIS), 18, 
20 
diseases see also communicable diseases 
classification, 301 
cost to the community, 55, 208 
diet-related disease, 55 
lack of data, 227 
notifiable diseases, 255-56 
risk factors, 59-65 
doctors, recruitment in rural areas, 41 
drug abuse, coordination of information, 
119 
economic prosperity, relationship with 
health, 4 
education & training of health personnel, 
153-54 
employment in the health industry, 
148-53 
environmental health & hygiene, 118 
equity 
access to public hospitals, 171 
nutrition, 55-57 
establishment of AIHW, i . 
Ethics Commiftee of AIHW, 216 
ethnicity 
effect on nutritional status, 57-59 
women's health, 211 , 
expenditure on health services see funding 
& expenditure on health 
314 1 
fast food, 48-49 
fertility & pregnancy 
fertility drugs, 22 
statistical tables, 235-37 
financial reporting, standardisation, 207 
food consumption, 46—49 
funding & expenditure on health, 122-35, 
229-30 
deficiencies in statistics, 229-32 
expenditure on pharmaceutical drugs, 
143-44 
publications, 207 
reporting on hospital waiting lists, 207 
standardisation of reporting, 207 
statistics, 279 
technology, 145-46 
women, 211 
general practice, evaluation, 213 
geographic classifications, 302 
glossary, 306-09 
goals & targets 
Aboriginal health, 217 
national health, 65-71, 228 
grants to States, 124 
gross domestic product (GDP), 123, 
127-29 
health 
determinants, 1—4 
overview, 1 
priorities, xi 
states, 226 
WHO definition, 1 
Health Communications Network (HCN), 
192 
Health for All Committee, 66 
Health Insurance Commission (HIC), 
119-20,172, 230 
Health Monitoring Division, 206-07 
Health Services Division, 207 
Health Targets & Implementation 
Committee see Health for All 
Committee 
Health Technology Division, 208 
health insurance, 119-21,139^0 
private health insurance, 135—40 
statistics, 288-89 
health services, 116-46 
costs, 230 
funding & expenditure, 122-35 
measurement of outcomes, 212 
quality of health care, 232 
rural areas, 40 
structure & administration, 116-22 
health strategy, rural health, 40 
health technologies see technology in 
health services 
HealthTechStats, 208 
HEALTHWIZ, 212 
Home & Community Care program, 118 
Homebirth Australia, 227 
homebirths, deficiency in statistics, 227 
Hospital Access Program, 232 
Hospital Utilisation & Cost Studies 
(HUCS), xi, 141,160,161, 207, 214 
hospitalisation, 9, 160 
migrants, 25-26 
Aborigines, 33 
remote areas, 40—41 
road injured, 103-06 
hospitals 
administration & finance, 118 
admission to acute hospitals, 161-64 
regional variations, 164-65 
State & Territory variations, 166-67 
available beds, 155,157 
regional variations, 158-59 
cost, 132-35 
differences between private & public, 
162 
effects of minimal access surgery, 
183-85 
equity of access, 171 
morbidity & utilisation data, 231, 
265-76 
numbers, 155 
occupancy levels, 163 
315 
PMIs, 219 
private hospitals, 211 
sarne-day treatment, 162,163-64 
transplantation services, 185-89 
urgency categories, 168 
utilisation, 160-67 
waiting lists, 167-72 
role of AIHW, 207 
statistics, 231-32 
withdrawal of DVA from hospital 
services, 214 
hostels see nursing homes & hostels 
Household Expenditure Survey, single 
parents, 56 
hypertension 60,92 
effect of excess alcohol consumption, 
62 
' effect of physical activity, 64 
risk of cardiovascular disease, 64-65 
immunisation 
monitoring, 212 
prevention of communicable diseases, 
78-83 
Index of Relative Socio-Economic 
Disadvantage (IRSD), 111 
indicators, 66, 67-6S 
monitoring role of AIHW, 212, 228 
infants see mothers & infants 
information & statistics, 203-34 
see also data 
coordination & research, 119 
injury surveillance, 217-20 
national Agreement, 203-05 
role of AIHW, 206-09 
injury see also road injury deaths . 
causes & prevention, 221-22 .,. 
developments in surveillance, 217-22 
rare injury register, 219 
risk factors, 221 
institutional facilities, 155-59 
International Classification of Diseases 
(ICD), 98-99, 209, 210, 301 
international health expenditure, 128-30 
iron intake, 53 
labourforce in health, 148-54, 207 
statistics, xi, 208, 230,290 
women, 211 
lasers, use in medicine, 193-94 
letter of transmittal, iv 
life expectancy, 7-9,243-44 
local governments, role in environmental 
health, 118 
Longitudinal Study of Adolescents, 48 
Lower Hunter Stroke Study, 60 
magnetic resonance imaging (MRI), 181 
medical practitioners 
increase in numbers, 153 
provision of Medicare services, 150-51 
medical services, 172-77 
growth in diagnostic services, 180-82 
issues for the future, 192 
major surgical procedures, 197-98 
minimal access surgery, 183-85,198 
Pap smears, 194-95 
telemedicine, 191-92 
transplantation services, 185-89 
use of lasers, 193-94 
use of private services, 173-74 
use of general services, 9-10,291 
Medicare, 119-20,172-75 
Agreements, 66,163-64, 226 
Benefits Schedule, 174 
database, 150-51, 208 
private health insurance, 135-36 
statistics, 10,230 
technological services 145-46 
use by the aged, 175 
use of diagnostic services, 180,182 
use of professional services, 291-95 
Mental Health Consumer Outcomes, 226 
mental health, deficiency in statistics, 227 
methods used in the report, 301 
316 
migrant health, 26-27 
see also ethnicity 
see also NESB 
mission, i, xi 
monitoring & surveillance of health, 122 
AIHW role, 58, 66,228-29 
health indicators, 212 
immunisation, 212 
injury, 217-22 
risk factors, 221-22 
trauma service, 221 
use of data, 69 
morbidity see also death 
data base, 231 
statistics, 160, 265 
survey,18 
mortality see death 
mothers & infants see also perinatal health 
Aborigines, 29-31 
birthing centres, 228 
birthweight, 2, 238 
breastfeeding, 50-51 
infant mortality rates, 238, 240 
maternal deaths, 241-42 
sleeping positions of infants, 211 
multiple births, 22-23 
National Better Health Program, 210 
National Campaign Against Drug Abuse, 
121 
National Cancer Statistics Clearing 
House, 84 
National Centre for Epidemiology & 
Population Health, 226 
National Data Set (NDS), 41, 213-14 
National Death Index (NDI), xi, 206, 
215-16 
National Dental Labourforce Data 
Collection, 208 
National Dental Survey, 208 
National Dietary Survey of Adults, 51,212 
National Dietary Survey of 
Schoolchildren, 53, 54,56-57 
National Health & Medical Research 
CouncU (NHMRC), 119 
decline in dental caries in children, 94 
dietary guidelines, 46 
guidelines for preventing alcohol 
abuse, 64 
nutritional intake, 52-53 
Standing Committee on Quality of 
Health Care, 226 
use of imaging services, 181 
vitamin supplements for pregnant 
women, 229 
National Health Data Committee, 218, 
231.232 
National Health Data Dictionary 
(NHDD), xi, 68,156,164, 205,207, 
214, 221, 232 
National Health Goals & Targets (NHGT), 
49,65-71, 228 
National Health Information Agreement, 
xi, 130,203-05, 232 
definitions for expenditure, 230 
nutrition survey, 212 
objectives, 203-04 
trauma, 221 
waiting list data, 231 
Work Program, 204-05 
National Health Information Framework, 
232-33 
National Health Information Plan, 233 
National Health Information, Forum, xi, 
203.233 
Management Group, 207, 232 
National Health Labourforce CoUection, 
207 
National Health Strategy, 40-41 
adverse drug reactions in the aged, 198 
private health insurance, 135 
suicide, 109 
National Health Surveys, 58,210, 212 
Aborigines, 216 
avaUability of data, 69 
breastfeeding, 50 
cooperation with AIHW, 206-07 
317 
r -CVD, 91, 93: , 
definitions, 38
 ( 
immunisation against measles, 78 
mental health, 227 , 
rural Australia, 36-41 
National Heart Foundation see Risk Factor 
Prevalence Survey 
National Hospital Morbidity data base, 
231 
National Injury Surveillance Unit (NISU), 
208-09 
national injury database, 213 
Road Injury Information Program, 101, 
- --106,219,221,229 
National Minimum Data Sets, xi, 160,208, 
231 
injury surveillance, 218-20 
Institutional Health Care, 160 
National Nutrition Survey (NNS), 212 
National Occupational Health & Safety 
Commission see Worksafe Australia 
National Oral Health Survey, 97 
National Perinatal Statistics Unit (NPSU), 
-98-100, 209,217, 227,228 ^ 
National Reference Centre for 
Classification in Health, 209 
National Road Injury Database, 101-02 
National Road Trauma Advisory Council, 
Working Party on Trauma Systems, 
221 
National-Rural Health Conference 
Organising Committee, 40 
National Rural Health Unit, 41 
National Survey of Morbidity & ' 
Treatment in General Practice, 18 
national health 
goals & targets, 65-71 
monitoring role of AIHW, 66 
Nationally Funded Centres, 185,189, 209 
New Zealand • 
ANZDATA/232 - * 
kidney transplants & renal dialysis, 
187 
non-English speaking background 
(NESB) 
see also ethnicity 
see also migrant health 
immunisation of children, 78 
nutrition, 57-59 
women's health, 211 
non-insulin-dependent diabetes mellitus 
(NIDDM), 54-55 
non-melanocytic skin cancers (NMSC), 84 
North Australia Social Justice Strategy, 41 
nursing homes & hostels, 118, 155 
beds available, 157-58 
statistics, 277-78 
nutrition, 46-59 
equity & nutrition, 55-57 
monitoring role of AIHW, 58 
National Nutrition Survey, 212 
NESB families, 57-59 
nutritional deficiencies, 53 
nutrient intakes, 51-53 
RDIs, 51,52 
obesity & over consumption, 53-55,61-62 
effect of physical inactivity,:64 
measurement, 60, 68-69 
statistics, 227 
objectives, vii 
nutritional deficiencies, 53 
occupational health & safety, 41-45 
see also Worksafe 
occupational health, 117 
OECD countries 
admission to acute hospitals, 161-62 
expenditure on health, 128-30. 
hospital bed ratios, 157 
life expectancy, 9 . 
ORPHEUS, 212 
Ottawa Charter, 2 
effects on public policy, 2 
health promotion strategies, 2 
outcomes, measurement in health 
services, 212, 222-26 
318 
Papanicolaou (Pap) smear test, 194-94 
patient management information systems 
(PMIs), 219 
pensioners 
changes to PBS, 140 
Health Benefits Cards, 120 
perinatal health, 98-100 
Aborigines, 217 
mortality, 239 
statistics, 209,217, 227, 228 
personnel see labourforce in health 
Pharmaceutical Benefits Advisory 
Committee, Drug Utilisation 
Sub-Committee, 141 
Pharmaceutical Benefits Scheme (PSB), 
119-21,141-44 
changes, 140 
safety net arrangements, 121 
pharmaceuticals, 140-44 
use by the aged, 198 
Pharmacy Guild of Australia, 141 
physical activity 
importance, 64 
migrants vs Australian-born, 26 
policy, food & nutrition, 46 
Population Survey Monitor, 69,212 
population census, 111, 301 
potential years of life lost (PYLL), 90 
pregnancy see fertility & pregnancy 
prescription drugs see pharmaceuticals 
preventable causes of death, 37,229 
Aborigines, 32-33 
drink driving, 101 
roles of State & local governments, 118 
prevention & promotion of health, 121-22 
injuries, 221-22 
priorities for health, xi 
privacy & security in medical information, 
xi, 191-92, 214, 219 
Private Health Insurance Administration 
Council (PHIAC), 135,138 
private health insurance, 135-40 
statistics, 288-89 
productivity, relationship with health, 3-4 
prosperity and health, 3-4 
publications 
health expenditure, 207 
road injury, 209 
women's health, 211 
qualifications in health, 151-52 
quality assurance survey, 207 
quality of health care, 232 
Queensland Dept of Health, 209 
Queensland University of Technology, 
Reference Centre for Classification 
in Health, 209 
rare injury registers, 219 
recession, effect on health expenditure, 
126-27 
Recommended Dietary Intakes (RDIs), 47, 
51, 52,53 
references in the report, 301 
regional database, 212 
Registrars of Births, Deaths & Marriages, 
collection of cancer information, xi, 
83, 215 
rehabilitation services, casemix 
classifications, 207 
remote areas 
deficiencies in statistics, 228 
geographic classifications, 302 
health, 36-41,57 
hospital bed supply, 159 
regional database, 212 
telemedicine, 191-92 
variations in acute hospital use, 164-65 
Repatriation Pharmaceutical Benefits 
Scheme (RPBS), 140,141 
Repatriation Private Patient Scheme, 214 
research needs, injuries, 222 
resources in health care, 148-98 
deficiencies in statistics, 229-32 
measurement of outcomes, 222-26 
319 
respiratory disease -> ' .• 
Aborigines, 32 
mortality rates, 7 
reviews of health, migrants vs 
Australian-bom, 25 
Risk Factor Prevalence Survey (RFPS), 26, 
59,68 
Aborigines, 34-36 
alcohol consumption, 63 
hypertension, 60 ' -
iron deficiencies, 53 
obesity, 60 
physical inactivity, 64 
risk factors for disease, 59-65 
alcohol consumption, 62-64 
monitoring, 221 
physical inactivity, 64 r 
Road Injury Information Program, 101, 
106, 209 
road injury deaths, 100-06 ~4 
data, 208-09 
Royal Commission into Aboriginal 
Deaths in Custody, 109,217 
Rural Health Support Education & 
Training Programs, 41 
Rural Incentives Program, 41 
rural areas see remote areas 
School Dental Service, 94 
sex differences 
coronary heart disease, 69 
CVD, 89-93 
hypertension, 92 
recommended levels of alcohol 
consumption, 64 
use of Medicare, 174-75 
youth diet, 57-58 
sexually transmitted diseases, 80-83 
single parents, nutrition of families, 56-57 
skin cancer see NMSC 
smoking 
increase in cancer, 84-85 
migrants vs Australian-born, 26 
relationship to cardiovascular disease, 
60-61,64-65 
Social Health Atlas, 210 
social factors 
effect on health, 2,55-56,121-22 
effect on suicide rates, 109 
social justice 
equity & nutrition, 55-57 
rural areas, 41 
social security benefits 
effect on birthweight of babies, 2 
effect on nutrition, 56 
socioeconomic disadvantages, 111 
South Australian Cancer Registry, 88-89 
South Australian Health Commission, 210 
standards, AustraUan Council on 
Healthcare Standards, 232 
States & Territories 
expenditure on health, 130-35,229 
health authorities, 116-17 
role in health promotion, 121 
statistics, 227 
survey of hospital waiting lists, 168-71 
use of medical services, 176-77 
variations in acute hospital use, 166-67 
variations in hospital bed supply, 
158-59 
statistics, 203-34 
Aboriginal health, 33,216-17 
AIDS, 259 
cancer, 83-88,260-62 
collections, xi 
compensation, 213 
death rates, 4-5 
deficiencies, 226-29 
dental statistics, 95-97, 208, 263-64 
DVA statistics, 215 
fertility & pregnancy, 235-42, 
health expenditure, 123, 279-87 
States & Territories, 130-32 
health Insurance, 288-89 
hospital morbidity & utilisation, 160, 
265-76 
320 
hospital waiting lists, 167-71 
importance in setting goals & targets, 
68-69 
institutional facilities, 155-56 
labourforce, 230, 290 
medical services use, 291-95 
Medicare database, 150-51 
Medicare use, 10, 291-95 
mortality, 243-54 
notifiable diseases, 80-81, 235 
nursing homes, 277-78 
perinatal statistics, 98-100 
references, 298-300 
role of AIHW, 206-09 
statistical tables, 235-97 
suicide, 107-12 
technology use, 296-97 
welfare, 208 
strategy in health , 40-41 
stroke 
importance of hypertension, 60, 62 
mortality rate, 89, 90 
subacute sclerosing panencephalitis 
(SSPE), 78 
Sudden Infant Death Syndrome (SIDS), 
211 
suicide & self injury, 107-12 
surgery 
major surgical procedures, 197-98 
minimal access, 183-85 
surveillance see monitoring & surveillance 
of health 
surveys see also individual surveys 
Aboriginal health, 211, 217 
breastfeeding, 50 
compensation-based statistics, 41 
dental health in children, 94 
dental health, 177-80, 208 
diet of schoolchildren, 54 
diet of the elderly, 48, 51-52 
disability, 10-14, 26,34, 37, 211 
disabled & handicapped Aborigines, 
216 
health industry, 213 
health institutions, 160 
hospital waiting lists, 168-71 
labourforce, 230 
morbidity, 18 
nutrient intake, 51 
children, 53 
private health establishments, 211 
quality assurance, 207 
risk factors, 26 
rural health, 36-41 
Survey of Disability, Ageing & Carers, 
211 
symbols in the report, 301-02 
Task Force on Aboriginal Health Statistics, 
216, 217 
technology in health services, 145-46, 
180-98, 232 
aged care, 196-98 
role of AIHW, 208 
use, 296-97 
telemedicine, 191-92 
Toowoomba National Rural Health 
Conference, 40 
transplants see medical services 
trauma service monitoring, 221 
trend analyses 
AIHW results, 69, 70-71 
cancers, 84 
dental health in children, 94-95 
employment in health industry, 152-53 
United Kingdom (UK) 
Clearing House for Information on the 
Assessment of Health Out­
comes, 223 
Working Group on Inequalities in 
Health, 2 
United States of America (USA) 
Patient Outcome Research Teams 
(PORTs), 222-23 
preventable deaths, 37 
Task Force on Disease Costing, 19 
321 
University of Wollongong, collaboration, 
207 
Victorian Dept of Health & Community 
Services, hospital waiting lists, 172 
virus & selected non-virus reports, 257-58 
waist-to-hip ratio (WHR), 60-62, 68 
waiting lists see hospitals 
Welfare Division, 208 
welfare, statistics, 208 
well-being, 1,3 
women 
Aboriginal life expectancy, 27-33 
health, 211 
hospitalisation of migrants, 26 
life expectancy, 9 
workers' compensation, 41—45, 213-14 
Worksafe Australia, 41,117, 206, 213-14 
World Health Organization (WHO) see 
also Ottawa Charter 
appointment of AIHW in classification 
of disease, 209, 301 
coding of causes of death, 210 
definition of health, 1 
European standard population, 5 
International Classification of 
Impairments, Disabilities and 
Handicaps (ICDH), 10,11 
Study Group on Diet, 62, 64 
youth see also Longitudinal Study of 
Adolescents 
road accidents, 101-02 
sex differences in diet, 57-58 
322 
